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1.1 Transition metal-catalyzed coupling reactions 
Metal-catalyzed coupling reactions have become one of the most important synthetic tools in 
modern organic synthesis.
1
 Nowadays, more and more new synthetic transformations via 
metal-catalyzed coupling reactions have been invented.
2
 As shown in scheme 1, a typical 
cross-coupling reaction involves a formal nucleophilic substitution at aryl and alkenyl halides 
or pseudohalides by an organometallic reagent. Transition metals such as Pd, Ni, Cu, Fe, Pt, 
Rh, Ru, etc. are the most effective catalysts for these reactions providing synthetic 
methodologies for the regioselective construction of new C-C and C-heteroatom bonds. In 
addition to metal-catalyzed cross-coupling reactions to form asymmetric C-C bonds, 
homocouplings to form symmetric biaryls or bisalkynes have also been developed.
3
 
 
Scheme 1. Metal-catalyzed cross-coupling reactions. 
More recently, the dehydrogenative couplings of hydrocarbons especially arenes bearing 
certain directing groups with carbon eletrophiles, organometallic reagents or other 
hydrocarbons have also been reported (Scheme 2).
4
 
 
Scheme 2. Metal-catalyzed cross-coupling reactions. 
1.1.1 Coupling reactions forming C–C bonds 
1.1.1.1  Cross-coupling of aryl / alkenyl (pseudo)halides with main group 
organometallic nucleophiles 
In 1941, Kharasch reported the synthesis of asymmetric biarlys from arylmagnesium halides 
and aryl halides in the presence of catalytic amounts of cobalt (II) chloride (Scheme 3).
5
 In 
another report, Kharasch cross-coupled aryl Grignard reagents with vinyl halides catalyzed by 
cobalt or chromium compounds (Scheme 3).
6
  
 
Scheme 3. Early examples of Grignard reagents in metal-catalyzed cross-coupling reactions. 
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Although such pioneering work has shown the concept of metal-catalyzed cross-coupling 
reactions, the synthetic utility of these findings has been underestimated and even forgotten 
until 30 years later. In 1972, Kumada
7
 and Corriu
8
 independently reported the Ni-catalyzed 
cross-coupling reaction of aryl halides with Grignard reagents—the so-called Kumada-Corriu 
reaction (Scheme 5). A similar transformation using iron complexes was also developed by 
Kochi
9
 at almost the same time. Starting in 1975, the value of palladium complexes had been 
soon discovered, and their applications in Kumada-Corriu reactions allow the coupling of a 
much broader array of Grignard reagents.
10
  
 
Scheme 5. Kumada-Corriu reaction under different catalysts. 
Since the invention of Kumada-Corriu reaction, a great deal of research efforts has been 
focused on transition metal-catalyzed C–C bond forming reactions of aryl and alkenyl halides 
and various organometallic reagents (Scheme 6). The use of Grignard reagents limits the 
synthetic utility of Kumada-Corrriu reaction, due to the low tolerance towards functional 
groups resulting from the strong basicity. 
 
Scheme 6. Metal-catalyzed cross-coupling reactions of various organometallic reagents. 
In order to improve the functional group tolerance of the Kumada-Corrriu coupling processes, 
other organometallic coupling partners containing less electropositive metals than lithium and 
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magnesium were later employed in the transition metal-catalyzed coupling reactions. In late 
1970s, Negishi et al. sequently repoted the applications of organoaluminiums
11
 and 
organozincs
12
 in the coupling reactions of aryl and alkenyl halides. Their further extensive 
investigations showed that the best reaction results were obtained by using organozinc 
compounds in the presence of palladium(0) catalysts (Scheme 6, I). 
In 1976, Eaborn fistly used organostannanes in the palladium-catalyzed coupling reactions.
13
 
In the following several years, Stille investigated the use of organotin compounds in the C–C 
bond forming reactions and significantly improved the yields under much milder reaction 
conditions.
 14
 The organotin reagents are stable to chromatography, water and oxygen, which 
make their purification much easier than other main group organometallic reagents. However, 
the formation of stoichiometric tin halides after the reaction limits their practical application 
in chemical industry (II). The organosilanes are less toxic, but are also less reactive. 
Therefore, their use in coupling reactions normally requires an activating agent such as the 
fluoride ion or a base (III).
15
 In 1979, Suzuki and Miyaura reported the first Pd-catalyzed 
cross-coupling of 1-alkenylboranes with aryl halides (IV).
16
 Nowadays, Suzuki-Miyaura 
reaction has become the most commonly used cross-coupling process because of its mild 
reaction conditions and high functional group tolerance. Moreover, boronic acids are 
environmentally safer and much less toxic than organostannanes, and the inorganic by-
products are easily removed from the reaction mixture, making the reaction suitable for 
industrial processes. 
 
Scheme 7. General mechanism of Pd-catalyzed cross-coupling of main group organometallic 
nucleophiles. 
As depicted in scheme 7, a typical palladium-catalyzed cross-coupling reaction of various 
organometallic reagents contains three stages: oxidative addition, transmetallation, and 
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reductive elimination. Initially, a low-valent palladium complex reacts with the aryl halide by 
oxidative addition to generate an arylpalladium (II) halide complex. The carbon fragment is 
then transferred from the organometallic reagents to the arylpalladium species forming a new 
organopalladium (II) complex. Finally, this complex undergoes reductive elimination to form 
the coupling product that contains a new carbon-carbon bond while regenerating the Pd(0) 
catalyst. 
1.1.1.2 Cross-coupling of aryl / alkenyl (pseudo)halides with alkynes 
Terminal alkynes containing reactive C–H bonds (the pKa of phenylacetylene is 28.8, 17 
similar to alkyl esters) can be reacted with aryl or vinyl halides in the presence of transition 
metal catalysts. In 1975, Cassar
18
 and Heck
19
 independently disclosed the alkyne coupling 
reactions in the presence of catalytic Ni(0) or Pd(0) complexes. At the same time, 
Sonogashira
20
 discovered that the coupling of terminal alkynes and aryl halides could readily 
occur at room temperature in the presence of a bimetallic palladium / copper catalyst system 
(Scheme 8). The in situ generated copper acetylide, which takes the role of an organometallic 
reagent, reacts with the aryl palladium halide species forming the aryl-Pd-alkynyl 
intermediate, which undergoes reductive elimination, releasing the product and the 
palladium(0) catalyst.  
 
Scheme 8. Sonogashira coupling of aryl/alkenyl halides with terminal alkynes. 
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1.1.1.3 Cross-coupling of aryl / alkenyl (pseudo)halides with alkenes 
The coordination of olefin to palladium species allows the coupling between olefins and aryl 
or alkenyl halides. Indeed, Mizoroki
21
 and Heck
22
 independently reported the Pd-catalyzed 
cross-coupling of olefins with organohalides. Electron-deficient olefins such as styrene or 
acrylate derivatives show particularly high reactivity in the coupling reaction of aryl halides, 
leading to the aryl-vinyl compounds. Due to its high functional group tolerance and mild 
conditions, the Mizoroki-Heck reaction has become one of the most widely used methods that 
forms carbon-carbon bonds in organic synthesis. However, the coupling reactions of aryl 
halides with sterically congested olefins is difficult, especially the reactions of cycloalkenes 
are particularly slow or may even be inhibited because the C-C bond rotation of the vinylic 
palladium intermediate is not possible (Scheme 9).  
 
Scheme 9. Mizoroki-Heck coupling of aryl/alkenyl halides with alkenes. 
In principle, two regioisomeric products could be generated during the Heck reaction. The 
coupling reactions of aryl halides with electron-deficient olefins, such as acrylates and 
acrylonitriles, normally give rise to the linear -arylated products. However, when replacing 
halides by triflates and employing a bidentate ligand, electron-rich olefins bearing a 
heteroatom adjacent to the C=C double bond could be regioselectively arylated on the -
carbon. The introduction of stoichiometric amounts of halide scavengers such as silver or 
thallium salts could also lead to the -arylated product.  
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Scheme 10. Regioselectivity in Mizoroki-Heck reaction. 
These observations could be explained by two competing reactions pathways, each leading to 
a different regioselectivity in Mizoroki-Heck coupling reactions.
23
 As illustrated by the 
simplified mechanism in Scheme 10, the β product is generated via the neutral pathway A, 
which is triggered by the dissociation of a neutral ligand from Pd
II
. In the ionic pathway B, a 
cationic palladium intermediate is formed through the replacement of the halide ligand by the 
olefin, yielding the -arylated product. Therefore the use of aryl triflates in Mizoroki-Heck 
couplings favors the ionic pathway because of the liability of the Pd-OTf bond.
24
 Ionic liquids 
such as imidazolium salts have also proved to be effective for the -regioselective Mizoroki-
Heck coupling reactions due to the electrostatic interactions.
25
 
1.1.1.4  Cross-coupling of aryl / alkenyl (pseudo)halides with enolates 
Carbonyl compounds could function as nucleophiles which are coupled with aryl or vinyl 
halides in the presence of appropriate bases and transition metal catalysts (Scheme 11). In the 
first stage of these coupling processes, enolates of ketones, esters, amides, aldehydes, nitriles, 
malonates, cyanoacetates, cyclic 1,3-diketones, and nitroalkanes are in situ generated by 
treating them with an appropriate strong base, normally MHMDS or MOtBu (M = Li, Na or 
K).
26
 This metal enolate then reacts with the aryl palladium halide complex generated from 
the oxidative addition, forming the aryl-palladium-enolate complex, which undergoes 
reductive elimination, forming -arylated carbonyl products and liberating the initial catalyst.  
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Scheme 11. Transition metal-catalyzed coupling of enolates. 
Nowadays, the coupling chemistry of enolates with organohalides has been intensively 
investigated. It turned out to be a versatile methodology for the -functionalization of 
carbonyl compounds. However, the requirement of extremely strong bases in most cases 
greatly limits their synthetic utilities. These drawbacks are somewhat addressed by the 
introduction of zinc
27
 and silicon
28
 enolates into the reaction system, whereas these variant 
procedures require one more step for the syntheses of the organometallic reagents and the 
coupling of silicon enolates usually needs an activator such as fluorides (Scheme 12). 
 
Scheme 12. Pd-catalyzed couling of zinc and silyl enolates with aryl bromides. 
More recently, Baudion and his coworkers developed a novel method for the -arylation of 
esters (Scheme 13).
29
 The key to this -regioselectivity is the rearrangement of the palladium 
enolate A to the palladium homoenolate C, from which reductive elimination occurs more 
readily. The use of -branched esters and sterically congested aryl halides further increases 
the regioselectivity. When amino esters were used as the coupling partners, this reaction could 
be even extended to longer-range ( to ) arylations.30  
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Scheme 13. Pd-catalyzed -arylation of esters. 
1.1.1.5  Carbonylative cross-coupling reactions 
In 1974, Heck disclosed a series of reports on carbonylative cross-coupling reactions.
31
 Aryl 
and vinyl halides react with carbon monoxide in the presence of a palladium catalyst to form 
acylpalladium intermediates, which are then treated with nucleophiles such as alcohols and 
amines to generate the corresponding carbonyl products (Scheme 14). Replacing of the 
nucleophiles with hydrogen, a reductive carbonylation process occurs, affording the 
corresponding aldehydes. 
 
Scheme 14. Heck carbonylations. 
The efficient and convenient construction of carbonyl compounds is of great interest for 
organic chemists. Since its discovery, substantial contributions have been made to the 
development of the carbonylative coupling reactions. Nowadays carbon monoxide has 
become the most important C1 building block to introduce a carbonyl group into the parent 
molecules. As shown in Scheme 15, by treating carbon electrophiles with various 
nucleophiles including organometallic reagents and hydrocarbons, a vast range of carbonyl 
products can be readily realized.
32
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Scheme 15. Pd-catalyzed carbonylative cross-coupling reactions. 
1.1.1.6  Cross-coupling of aryl / alkenyl (pseudo)halides with cyanide 
Nitriles are important synthons, e.g. for the synthesis of carboxylic acid derivatives and 
heterocycles. Moreover, the nitrile group is widely present in a number of fine chemicals and 
biologically active agents such as dyes, herbicides, agrochemicals, pharmaceuticals, and 
natural products. Benzonitriles are traditionally prepared from diazo compounds via the 
Sandmeyer reaction.
33
 An alternative process is the Rosenmund-von Braun reaction from aryl 
halides in the presence of excessive cuprous cyanide.
34
 In 1973, Sakakibara and his coworkers 
demonstrated the first palladium-catalyzed cyanation of aryl halides using potassium cyanide 
as cyanide source (Scheme 16).
35
 
 
Scheme 16. Pd-catalyzed cyanation of aryl halides. 
Transition metal complexes of the platinum group, especially palladium or nickel complexes 
are the most efficient catalysts for cyanation reactions (Scheme 17). The commonly used 
cyanating reagents consist of metal cyanide salts or complexes such as NaCN, KCN, CuCN, 
Zn(CN)2, (RO)2BCN, and K4[Fe(CN)6].
36
 Direct oxidative cyanation reactions of 
CHAPTER 1 
11 
hydrocarbons in the presence of an appropriate oxidant were also established in the past 
decade. A directing group bearing an adjacent heteroatom dramatically promotes the 
cyanation, and organo cyanides such as trimethylsiylcyanide, NCTS, BrCN, TsCN, 
isocyanides, acetonitrile and DMF represent the most efficient cyanating reagents for C–H 
bond activation processes.
37
 
 
Scheme 17. Cyanation reactions. 
1.1.1.7 Direct arylation via C–H bond activation 
In the presence of an appropriate metal catalyst, the C–H bond of an arene could be cleaved, 
replacing of the hydrogen atom by an organo electrophile or a metallic nucleophile, resulting 
in the formation of a new C–C bond (Scheme 18).38 From the economical and ecological 
standpoint, the direct arylation of hydrocarbons is particularly attractive to organic chemists, 
since this provides a versatile pathway to biaryl compounds. A rapidly growing number of 
reports contribute to the development of C–H bond activation chemistry.39 
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Scheme 18. Cross-coupling of arenes with aryl electrophiles or aryl organometallic reagents. 
 
Scheme 19. Intramolecular and intermolecular coupling of an arylmetal halide complex with 
an arene. 
A great diversity of mechanisms for the direct arylation processes are postulated. In general, 
such coupling reactions are initiated by or involve the oxidative addition of aryl halides to a 
metal catalyst, forming an arylmetal halide complex. This organometallic species is then 
coupled with another arene or heteroarene at the position where the C–H bond is cleaved. As 
depicted in Scheme 19, six general pathways have been proposed: (i) an electrophilic 
substitution on the arene by the metal species (SEAr);
40
 (Scheme 19, ii) a concerted SE3 
process facilitated by a base;
41
 (Scheme 19, iii) –bond metathesis 42  or a concerted 
metallation-deprotonation;
43
 (Scheme 19, iv) a Heck-type insertion on the arene, either 
through a formal anti-hydride elimination or by several isomerizations followed by a syn -
hydride elimination;
44
 (Scheme 19, v) an direct oxidative addition of the arene C–H bond;45 
(Scheme 19, vi) a process in that a second metal-aryl species is involved.
46
 The mechanistic 
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details for each catalytic system depend on the substrate, transition metal, solvent, base, and 
ligand. Arylation reactions of arenes bearing a directing group which can form a five or six 
membered ring through the coordination of oxygen or nitrogen to the transition metal may 
occur via even complicated mechanisms, involving several organometallic species. 
 
Scheme 20. Pd, Ru and Rh intermediates in the direct arylation processes. 
Many transition metals can catalyze the direct arylation of arenes. Complexes of Pd, Ru and 
Rh are the most versatile and widely used catalysts for these processes.
47
 The reactions 
catalyzed by palladium complexes occur through a mechanism involving Pd(0) and Pd(II) 
intermediates, while the reactions using hypervalent aryl iodine reagents as electrophiles are 
expected to proceed via a catalytic cycle containing Pd(II) and Pd(IV) species (Scheme 20, 
i).
48
 Ruthenium-catalyzed cross-coupling reactions of arenes with aryl halides or sulfonates 
are also believed to undergo a catalytic cycle involving Ru(II) and Ru(IV) intermediates 
(Scheme 20, ii).
49
 However, a mechanism involving Ru(0) and Ru(II) is also proposed when 
the arenes are coupled with arylboronic esters (Scheme 20, iii).
50
 As for the rhodium-
catalyzed direct arylations, a catalytic cycle containing a combination of Rh(I) and Rh(III) 
intermediates is proposed (Scheme 20, iv).
51
  
Recently, the use of the first-row transition metals in the direct arylation of arenes and 
heteroarenes has also been reported. In contrast to the late transition metals, Fe, Cu and Ni 
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catalysts are abundant and less expensive, making their use in organic synthesis more 
attractive.
52
  
 
Scheme 21. Fe and Ni intermediates in the direct arylation reactions. 
Both aryl halides and arylmetallic reagents have been used in iron-catalyzed direct arylation 
reactions. The coupling of arenes with aryl halides is proposed to involve an SET (single-
eletron-transfer) process, in which an aryliron(III) radical species is generated from an iron(II) 
species and aryl iodide (Scheme 21, i).
53
 The iron-catalyzed arylation of activated arenes and 
alkenes by using organozinc and Grignard reagents respectively were also established 
(Scheme 21, ii). The mechanism of the iron-catalyzed arylation of arenes with arylzinc 
compounds remains unclear at this stage,
54
 while the couplings of alkenes bearing directing 
groups are thought to occur via either the reductive elimination of a five-membered 
metallacylce (Scheme 21, ii)
55
 or the Heck-type carbometallation followed by -hydride 
elimination (Scheme 21, iii).
56
 
In the Ni-catalyzed arylation of heteroarenes, the acidic C–H bonds could be cleaved by 
LiO(tBu) forming a heteroaryllithium compound, which undergoes transmetallation with the 
in situ generated arylnickel halide complex to form the corresponding diaryl-nickel species 
followed by the reductive elimination giving the biaryls and nickel(0) catalyst (Scheme 21, 
iv).
57
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In contrast to the routinely established Pd-catalyzed ortho-arylation of arenes containing 
directing groups, the use of a copper catalyst allows the direct arylation at the meta-position 
of arenes and indoles.
58
 The mechanism involves a highly electrophilic Cu(III)-aryl species 
generated from a hypervalent aryliodium reagent, activating the aromatic ring sufficiently to 
permit an anti-oxy-cupration of the carbonyl group of an acetamide across the 2,3 positions on 
the arene ring (Scheme 22). 
 
Scheme 22. Cu-catalyzed meta-arylation of phenyl acetamide. 
Controlling the regioselectivity in the direct cross-coupling reaction of unreactive arenes still 
remains as a big challenge, although unprecedented achievement have been made in the past 
two decades. Conventionally, the arenes or heteroarenes that undergo direct arylation contain 
either a directing group (DG) or an eletron bias controlled by an eletron-withdrawing or 
eletron-donationg group for directing the coupling to a specific C–H bond (Figure 1).  
 
Figure 1. The hydrogens of arenes and heteroarenes those are susceptible to cleavage. 
The introduction of directing groups allows the activation of the C–H bonds on the ortho 
positions, frequently resulting in the formation of ortho-diarylated byproducts, which can be 
suppressed by blocking one of the ortho-positions or bulky substituents in one of the meta-
positions. The installations and removal of these directing groups cause additional synthetic 
steps. In the direct coupling of arenes or heteroarenes without directing groups, the 
regioselectivity is highly dependent on the substrates’ inherent electronic properties. As 
shown in Figure 1, high regioselectivity in the directing couplings can be easily achieved for 
heteroarenes containing only one acidic C–H bonds, such as benzoxazole, benzothiazole and 
benzimidazole. However, most of the arenes and heteroarenes contain more than one reactive 
C-H bonds. As for these compounds, the regioselectivies have been partially obtained in 
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certain cases by changing the reaction solvent, adding co-catalysts, or by conducting the 
reaction with more sterically hindered catalysts or sterically congested substrates. 
1.1.1.8  Oxidative cross-coupling via C–H bond activation 
The oxidative coupling of two hydrocarbons by simultaneously activating two different 
carbon-hydrogen bonds is a straightforward approach to the C–C bond formations In the late 
1960s, Fujiwara and his co-workers reported a series of seminal work on the synthesis of aryl 
olefins from arenes and alkenes.
59
 Although a stoichiometric amounts of palladium salts are 
required for the complete transformation, the catalytic coupling could also be realized with 
oxidants, such as Cu(OAc)2 or O2 (Scheme 23). 
 
Scheme 23. Direct arylation of olefins. 
 
Scheme 24. Mechanism of the Fujiwara coupling reaction. 
As depicted in Scheme 24, the coupling process is initiated by the activation of the C–H bond 
of an arene to form an aryl palladium intermediate, to which the olefin can coordinate. 
Subsequent carbopalladation of the olefin leads to an alkyl palladium complex that undergoes 
syn--hydride elimination, affording the arylated olefins. The palladium(II) catalyst is 
regenerated through the oxidation of palladium(0) species after the reductive elimination. An 
oxidant in stoichiometric quantity is required for the completion of the catalytic cycle. 
Commonly used reagents include copper salts, silver salts, benzoquinone, O2, K2S2O8, and 
peroxides.  
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Since the arene substrates often contain multiple C–H bonds, the control of the 
regioselectivity becomes a challenging task for organic chemists. In the early studies, the 
regioselectivity was regulated by the electronic nature of the substrates chosen.
 60
 Nowadays, 
the ortho-selective alkenylation of aromatic rings could be easily achieved by the introduction 
of a directing group prior to the coupling reaction (Scheme 25).
61
 
 
Scheme 25. Selective oxidative alkenylation of arenes containing directing groups. 
More recently, the oxidative cross-coupling of two simple arenes have also been realized. As 
shown in Figure 2, the coupling partners are usually electron-rich arenes, arenes bearing 
directing groups such as pyridine, amides, carbamates, and other aza-rings, and pyridine N-
oxides, and arenes containing strong electron-withdrawing groups.
62
 
 
Figure 2. Coupling partners in tandem direct arylations. 
A general mechanism for the Pd-catalyzed tandem direct arylation is depicted in Scheme 26. 
A diaryl palladium intermediate is formed after subsequent activation of two different C–H 
bonds. After reductive elimination, the corresponding biaryl is generated along with the Pd(0) 
species which is finally re-oxidized to the initial Pd(II) catalyst. However, the mechanisms of 
the direct coupling of two C–H bonds can differ greatly from each other, depending on the 
reaction conditions and substrates chosen. An alternative mechanism involves the Pd(II) and 
Pd(IV) intermediates, especially when strong oxidants such as persulfate salts
63
 are used in 
the coupling reactions. 
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Scheme 26. General mechanism for tandem direct arylation. 
1.1.2 Coupling reactions forming Carbon–heteroatom bonds 
Carbon(sp
2
)-heteroatom bonds occur frequently in complicated molecules and therefore their 
construction is one of the most important tasks for organic chemists. The classic method 
involving the copper-mediated cross-coupling of aryl halides and heteroatom nucleophiles 
was developed by Ullmann in the 1900s.
64
 Substantial efforts with the aim to improve the 
efficiency and compatibility have been done to this coupling reaction.
65
 Nowadays, the 
Ullmann-type coupling reactions allow the carbon-heteroatom bond formations at much 
milder conditions compared to the prototypes and only catalytic copper salt is usually required 
for the transformations (Scheme 27).
66
 
 
Scheme 27. Ullmann-type cross-couplings. 
The general mechanism of the copper-catalyzed cross-couplings to form aromatic C–X bonds 
involves Cu(I) and Cu(III) intermediates (Scheme 28).
67
 The coupling reaction occurs by the 
formation of an organocopper complex though the anion exchange between a halide and a 
heteroatom ligand, followed by the oxidative addition of the aryl halide to form an arylcopper 
complex. This Cu(III) intermediate undergoes reductive elimination releasing the coupling 
product and the initial Cu(I) halide complex. 
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Scheme 28. General mechanism for Ullmann-type coupling reaction. 
The Pd-catalyzed cross-coupling reactions of aryl halides and sulfonates with heteroatom 
nucleophiles in the presence of a stoichiometric amount of a strong base were established by 
Buchwald and Hartwig in the mid-1990s (Scheme 29).
68
 Compared to the copper-catalyzed 
protocol, the palladium-catalyzed variant allows the C–N and C–O bond formations under 
milder reaction conditions and therefore shows higher functional group tolerance.
69
 Moreover, 
by applying the appropriate ligands, unreactive organo electrophiles such as aryl chlorides,
70
 
aryl tosylates,
71
 even aryl meslyates
72
 can be coupled with amines or alcohols. 
 
Scheme 29. Buchwald-Hartwig cross-couplings. 
 
Scheme 30. General mechanism for Buchwald-Hartwig coupling reaction. 
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As dipected in scheme 30, the cross-coupling reaction between amines and aryl halides starts 
with the formation of an aryl palladium halide complex (a) through the oxidative addition of 
the aryl halide to the palladium(0) catalyst. An aryl palladium amide (d) is then formed via 
either deprotonation of the palladium-coordinated amine (b) by a strong base or the 
protonation of the palladium-alkoxide intermediate (c) by the amine. After reductive 
elimination of this aryl palladium-amido complex, the corresponding arylamine product is 
finally formed along with the regeneration of the palladium(0) catalyst. 
1.2 Carboxylic acids and their derivatives in coupling reactions 
Conventionally, C–C bond can be efficiently and conveniently constructed via the cross-
coupling reactions between organometallic reagents and aryl halides or pseudohalides in the 
presence of transition metal catalysts. However, these traditional metal-catalyzed coupling 
reactions suffer from using stoichiometric amounts of organometallic compounds which are 
usually prepared from organohalogen compounds after several synthetic steps.
7-14
  
C–C bond can be alternatively formed through the cross-coupling reactions of hydrocarbons 
containing acidic C–H bonds with carbon eletrophiles or even hydrocarbons. The synthetic 
strategies involving C–H bond activation draw on high atom economy, whereas the protocols 
frequently require pre-embedded directing groups in order to achieve high regioselectivity. 
Although traceless directing C–H bond transformations have been developed recently, they 
can only be applied for specific substrates.
73
 
Another important alternative to the construction of carbon frameworks involves the transition 
metal-catalyzed decarboxylative cross-coupling of carboxylic acids with organo electrophiles 
or nucleophiles under redox or oxidative conditions (Scheme 31). 
 
Scheme 31. Decarboxylative cross-couplings. 
Decarboxylative cross-coupling reactions have recently emerged as a powerful methodology 
for the regioselective construction of C–C and C–heteroatom bonds.74 The key advantage over 
traditional cross-coupling reactions is that they draw on stable and easily available carboxylic 
acids as sources of carbon nucleophiles rather than expensive and sensitive organometallic 
reagents. Within the last decade, a rapidly growing number of decarboxylative reactions have 
been discovered including decarboxylative Heck reactions, allylations, redox-neutral cross-
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coupling reactions, oxidative coupling reactions, C–H arylations, homo-couplings, and Chan-
Lam-type reactions. 
Carboxylic acids can be versatile starting materials for many important building blocks in 
addition to the traditional synthetic strategies (Scheme 32). In principle, a carboxylic acid can 
undergo cross-coupling with a carbon eletrophile or a heteroatom-nucleophile, affording a 
new C–C or C–heteroatom bond (I). When an carboxylic acid undergoes decarboxylative 
homocoupling, the corresponding biaryl, bialkenyl or bialkynyl compound will be formed (II). 
The protodecarboxylation of a carboxylic acid can also ocurr, yielding a hydrocarbon (III). 
When the carboxyl group is used as a directing group, the adjacent C–H bod can be activated, 
foriming a new C–C or C–heteroatom bond at the ortho-position of the molecule (IV).75 If 
necessary, this new carboxylic acid can further undergo the three afore-mentioned 
decarboxylative processes, affording the demanding products (V, VI and VII). 
 
Scheme 32. Synthetic strategies involving decarboxylative coupling reactions. 
1.2.1  Decarboxylative couplings forming C–C bonds 
In classic organic synthesis, alkylation of -ketoesters and other active methylene compounds 
followed by decarboxylation is a useful route to -alkylated ketones or esters (Scheme 33).76 
The decarboxylation step occurs either via a zwitterionic tautomer in which the carbonyl is 
protonated and the carboxyl group is deprotonated (I),
77
 or trhough the Krapcho process 
involving the reaction of esters with alkali metal salt (II).
78
  
Upon heating, allylic -keto esters can be converted into ,-unsaturated ketones via a 
decarboxylative Claisen rearrangement (Scheme 34). This reaction was discovered by Carroll 
in 1940,
79
 and many different variations have been disclosed especially after 1990. Recent 
developments of this reaction focused on the low-temperature processes through modification 
of the precursor -keto esters and the high syn/anti selectivities.80 
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Scheme 33. Preparation of -alkylated ketones or esters via tandem alkylation and 
decarboxylation. 
 
Scheme 34. Decarboxylation process in Carroll rearrangement. 
In 1966, Nilsson described the first biaryl synthesis via metal-mediated decarboxylative 
coupling of aryl carboxylic acid with aryl iodide (Scheme 35).
81
 The rationale of this reaction 
is based on the assumption that the Ullmann-type biaryl synthesis and the copper-catalyzed 
decarboxylation of aromatic acids proceed via a common intermediate.  
 
Scheme 35. Copper-mediated decarboxylative cross-coupling of aromatic carboxylic acids 
with aryl iodides. 
Although this new coupling reaction demonstrated the feasibility of the use of carboxylic 
acids as coupling partners in biaryls synthesis, this reaction suffers from using excessive 
amount of copper catalyst, expensive aryl iodides and high reaction temperatures. Having 
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been seen as a typical variant of the Ullmann-type couplings, the copper-mediated 
decarboxylative cross-coupling reaction has not received much attention until the recent 
establishment of the catalytic processes. 
In 1980, Tsuji
82
 and Saegusa
83
 independently developed the palladium-catalyzed 
decarboxylative allylation reactions (Scheme 36). In the presence of palladium catalysts, the 
-keto allyl esters undergo decarboxylation via a carboxylate-palladium-allyl complex to 
form the ,-unsaturated ketones.  
 
Scheme 36. Pd-catalyzed Tsuji-Saegusa decarboxylative allylation. 
Compared to the Carroll rearrangement, the palladium-catalyzed decarboxylative allylation 
occurs via different mechanisms and takes place readily under much milder condition. Since 
its discovery, the decarboxylative allylations have received significant attention by organic 
chemists, while the substrate scope of the current methods is limited to the acidic 
hydrocarbons.
84
 The further improvement of decarboxylative allylation includes the 
exploration of a wide variety of nucleophiles and the development of a broader scope of 
asymmetric allylation is also required. 
In 1997, Steglich reported a seminal Heck-type intramolecular arylation reaction involving 
the decarboxylative palladation of pyrrolyl carboxylic acid in the total synthesis of lamellarin 
G (Scheme 37).
85
  
 
Scheme 37. Decarboxylative palladation of pyrrolyl carboxylic acid. 
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The reaction was proposed to occur through a -heteroatom-subsituted olefin insertion by the 
aryl palladium bromide complex followed by the concerted reductive elimination and 
decarboxylation (Scheme 38).
86
 
 
Scheme 38. Proposed mechanism for the intramolecular Heck-type decarboxylative arylation. 
1.2.1.1  Cross-coupling of carboxylic acids with alkenes 
The first palladium-catalyzed oxidative Heck-type decarboxylative cross-coupling reaction 
was disclosed by Myers in 2002 (Scheme 39).
87
 In the presence of palladium catalyst, ortho-
substituted carboxylic acids undergo decarboxylation to form aryl palladium (II) species 
which insert into the alkene double bond to generate an alkyl palladium (II) complex. After -
hydride elimination of this palladium intermediate, the arylated olefin is formed along with 
the palladium (0) species, which is oxidized by silver salt to regenerate the palladium (II) 
catalyst (Scheme 40).
88
  
 
Scheme 39. Decarboxylative Heck-type couplings. 
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Scheme 40. Mechanism of the oxidative Heck olefination of aryl carboxylic acids. 
In the oxidative Heck-type decarboxylative cross-coupling reactions, the costly aryl iodides or 
bromides are supplanted by inexpensive aryl carboxylic acids.
89
 Thus, this new synthetic 
method provides an effective alternative to the synthesis of arylated olefins. However, the use 
of stoichiometric amounts of silver salts are required in order to reoxidize the resulting 
palladium (0) species. In an analogous protocol, Su and his coworkers demonstrated that 
benzoquinone and molecular oxygen are sufficient to reoxidize the palladium (Scheme 41).
90
 
 
Scheme 41. Pd-catalyzed decarboxylative olefination using BQ or O2 as oxidant. 
In 2005, Scheidt and his coworkers
91
 discovered that in the presence of catalytic amount of 
thiazolium-derived zwitterions, the -keto carboxylates could be readily converted into 
reactive carbonyl ainons which undergo conjugate addition to substituted ,-unsaturated 2-
acyl imidazoles in a buffered protic environment. The decarboxylative addition process offers 
a convenient approach to valuable 1,4-dicarbonyl compounds under mild conditions (Scheme 
42). 
 
Scheme 42. Conjugate addition -keto carboxylates to alkenes. 
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The authors proposed a reaction pathway which is similar to the benzoin-type process 
involving thiamine-dependent enzymes (Scheme 43). A tetrahedral intermediate is generated 
through the interaction of a thiazolium ylide with an -keto carboxylate. The 
enanamine/carbon nucleophile species is then formed after the loss of CO2. The electron-rich 
enamine undergoes conjugate addition to the unsaturated electrophile followed by a 
deprotonation of the resulting tertiary alcohol, releasing the corresponding ketone and the 
thiazolium catalyst.  
 
Scheme 43. Proposed reaction pathway for the decarboxylative conjugate addition. 
 
Scheme 44. Rh-catalyzed decarboxylative processes. 
Recently, Zhao and his coworkers developed Rh-catalyzed decarboxylative couplings of 
aromatic carboxylic acids with electron-deficient olefins (Scheme 44).
92
 In the presence of Rh 
catalysts, different decarboxylative processes of aryl carboxylic acids, particularly 
polyfluorobenzoic acids could be easily achieved by the choice of specific phosphine ligands. 
For instance, by using the bidentate ligand DPPP, the decarboxylation of aryl carboxylic acids 
proceeds smoothly, giving the corresponding arenes in high yields. The in situ generated aryl 
rhodium complex resulting from decarboxylation of the aryl carboxylic acid could either 
undergo -hydride elimination forming the Heck-Mizoroki product or hydrolysis of the 
rhodium enolate intermediate, affording the conjugate addition product. The selectivity is 
highly controlled by the different phosphine ligands, namely BINAP and DIOP. As a 
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sacrificial hydrogen acceptor, the respective acrylate is required in stoichiometric quantity 
(Scheme 45). 
 
Scheme 45. Proposed mechanism for the Rh-catalyzed decarboxylative couplings. 
1.2.1.2  Cross-coupling of carboxylic acids with organo halides or pseudohalides 
In 2006, Gooßen et al. reported the first catalytic biaryl synthesis via the decarboxylative 
cross-coupling of aromatic carboxylic acids with aryl bromides (Scheme 46).
93
 Two 
complementary protocols were developed for the catalytic transformations. The first catalyst 
system containing stoichiometric amounts of copper salt allows the decarboxylative coupling 
of most ortho-substituted aromatic carboxylic acids with aryl bromides to proceed at 120 °C, 
while the second variant, where both metal catalysts were employed in only catalytic 
quantities requires a higher reaction temperature of 160 °C and remains limited to 2-
nitrobenzoic acids.  
 
Scheme 46. Pd/Cu-catalyzed decarboxylative biaryls synthesis. 
The bimetallic catalyst system consists of a copper salt and a palladium precatalyst. As 
depicted in Scheme 47, the copper salt catalyzes the decarboxylation of aromatic carboxylic 
acids to generate an aryl copper intermediate. The aryl moiety is then transferred to an aryl 
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palladium halide complex generated in situ from the oxidative addition of aryl halide onto the 
palladium (0) catalyst, forming an aryl-palladium-aryl species. Reductive elimination releases 
the biaryl product and regenerates the initial palladium (0) catalyst. 
 
Scheme 47. Mechanism for the decarboxylative cross-couplings. 
This Pd/Cu-catalyzed decarboxylative biaryl synthesis has been seen as an important 
milestone in decarboxylative cross-coupling reactions. The traditional transition metal-
catalyzed biaryl syntheses such as Kumada-Corriu, Suzuki-Miyaura, Negishi, Stille, Hiyama 
reactions have inherent disadvantages, namely the requirement of expensive and sensitive 
organometallic reagents. In contrast, the decarboxylative cross-coupling reactions utilize 
carboxylic acids as the nucleophilic coupling partners, which are inexpensive, stable in air, 
and available in wide structural variety. Therefore, the decarboxylative coupling reactions 
serve as an attractive alternative to the traditional transition metal-catalyzed coupling 
reactions, providing convenient and efficient methodologies for the C–C and C–heteroatom 
bond formations.
94
 
Another protocol for the decarboxylative cross-coupling of aromatic carboxylic acids with 
aryl iodides consists of catalytic amounts of PdCl2 and AsPh3 along with excessive silver 
carbonate (Scheme 48).
95
 However, this catalytic transformation is lacking of generality 
applicability. Moreover, the fact that large quantities of expensive silver salts are required for 
the transformation limits its synthetic utility and makes the reaction uneconomic. 
 
Scheme 48. Pd-catalyzed decarboxylative coupling of aryl iodides using stoichiometric 
amount of silver salts as additives. 
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The replacement of aromatic carboxylic acids with -keto carboxylic acids leads to a 
straightforward approach to the corresponding ketones
96
 and esters
97
 via a carbonyl umpolung 
tactic (Scheme 49). Unlike the conventional Friedel-Crafts acylations, these decarboxylative 
processes produce regiospecific ketones and esters without using any organometallic reagents. 
 
Scheme 49. Ketone and ester syntheses via carbonyl umpolung. 
The aryl chlorides have also been demonstrated to be amenable to the decarboxylative cross-
coupling reactions (Scheme 50, i).
98
 Although the aryl C–Cl bond is much stronger compared 
to the corresponding C–Br bond,99 the combination of palladium catalyst and an electron-rich 
and sterically hindered phosphine ligand JohnPhos allows the success of oxidative addition of 
palladium onto the aryl chlorides furnishing the decarboxylative coupling process. However, 
the decarboxylative cross-coupling of aryl bromides and chlorides are both limited to specific 
carboxylic acids, particularly the ortho-substituted benzoic acids. This is resulted from the 
competition between halide ions and carboxylates in the coordiantion of the copper 
catalyst.
100
  
 
Scheme 50. The use of aryl chlorides and sulfonates in decarboxylative couplings. 
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When the aryl halides are superceded by aryl triflates bearing weekly coordinating ions, a 
much broader range of benzoates is amenable to the decarboxylative cross-coupling reactions 
(ii).
101
 The coupling of aryl tosylates was also realized by using the Buchwald ligand X-Phos 
(iii).
102
 However, the use of less inexpensive and more robust aryl Mesylates as the 
electrophiles in the decarboxylative coupling is still challenging in this field. 
After an intensive investigation of the protodecarboxylation of aromatic carboxylic acids 
carried out in the Gooßen group,
103
 silver has been proved to be an effective decarboxylation 
catalyst which allows the protodecarboxylation of most benzoic acids already at 120 °C.
104
 
The combination of palladium and silver catalysts leads to a new protocol for the 
decarboxylative cross-coupling of aromatic carboxylic acids with aryl triflates at an 
unprecedentedly low temperature 130 °C (Scheme 51).
105
  
 
Scheme 51. Pd/Ag-catalyzed decarboxylative coupling. 
Polyfluorobenzoic acids are particularly reactive in the presence of several transition metals. 
Besides Rhodium, copper
106
 and palladium
107
 catalysts are also demonstrated to be effective 
for the decarboxylative cross-coupling of fluorinated aromatic carboxylic acids with aryl 
halides (Scheme 52). DFT calculations showed that the oxidative addition represents the rate-
determining step in the Cu-catalyzed decarboxylative coupling, whereas the decarboxylation 
step is the rate-limiting step in the Pd-catalyzed version. 
 
Scheme 52. Polyfluorobenzoates in decarboxylative cross-couplings. 
 
Scheme 53. Decarboxylative coupling of pentafluorobenzoate with 1- bromoadamantane. 
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In the presence of a copper catalyst, 1-bromoadamantane could be also coupled with 
pentafluorobenzoate, affording the corresponding tertiary alkyl arene (Scheme 53).
106
 
Allyl arenes could also be easily accessed via the decarboxylative cross-coupling of aromatic 
carboxylic acids with allylic halides (Scheme 54).
108
 The mechanism involves a sequent 
Heck-type insertion of Ar-PdL2(OAc) into the double bond and -halide elimination. 
 
Scheme 54. Decarboxylatvie cross-coupling of aromatic carboxylic acids with allylic halides. 
In 2006, Bilodeau and Forgione disclosed the first Pd-catalyzed decarboxylative cross-
coupling of five-membered heterocyclic carboxylic acids with aryl halides (Scheme 55).
109
  
 
Scheme 55. Decarboxylatvie cross-coupling reaction between heteroaromatic carboxylic 
acids and aryl halides. 
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Scheme 56. Proposed mechanism for the decarboxylatvie cross-coupling of heteroaromatic 
carboxylic acids with aryl halides. 
This new transformation possesses obvious advantages over the C–H bond direct arylation, 
due to the low regioselectivity of the latter reaction system. Unlike for aryl carboxylic acids, 
the coupling process of heteroaryl surrogates with aryl halides proceeds via electrophilic 
palladation pathways (Scheme 56, paths B and C) instead of direct decarboxylation, which 
can be excluded based on the unequivocal observation of 2,3-diarylation byproducts (path 
A).
110
 
The decarboxylative cross-coupling of carboxyindoles with aryl halides has also been 
elaborated by Miura (Scheme 57).
111
 The direct synthesis of 2,3-diarylindoles involves 
sequential ortho- and ipso-decarboxylative arylation processes. 
 
Scheme 57. Decarboxylatvie cross-coupling of carboxyindoles with aryl halides. 
More recently, the use of 2-picolinic acid as a nucleophilic partner in decarboxylative cross-
coupling reactions has also been developed by Wu and his coworkers (Scheme 56).
112
 2-
Arylpyridines are the one of the most important heterocyclic structural motifs and their 
syntheses are definitely of great interest for organic chemists. However, due to the instability 
and the synthetic difficulty of 2-pyridyl organometallics,
113
 2-arylpyridines are hard to access 
from traditional metal-catalyzed cross-coupling reactions. Therefore this decarboxylative 
process not only provides an efficient and new route to this important class of substrates, but 
also has been endowed with highly synthetic utility by using simple and inexpensive 2-
picolinic acid as the coupling partner. 
 
Scheme 58. Decarboxylatvie cross-coupling of 2-picolinic acid with aryl halides. 
Besides the aromatic and heteroaromatic carboxylic acids, the alkenyl and alkynyl carboxylic 
acids are also amenable to decarboxylative cross-coupling reactions. In Gooßen’s seminal 
report,
93
 cinnamic acid has been successfully coupled with aryl bromides affording stilbenes 
in almost quantative yields. In Wu’s protocol, a broad variety of cinnamic acids was coupled 
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with various aryl iodides yielding the corresponding 1,2-diaryl olefins in the presence of 
catalytic amounts of PdCl2 and stoichiometric amounts of Ag2CO3 (Scheme 59, i).
114
 In 2010, 
Miura demonstrated the decarboxylative coupling between cinnamic acids and vinyl bromides 
(Scheme 59, ii).
115
 
 
Scheme 59. Decarboxylatvie cross-coupling of cinnamic acids with aryl/alkenyl halides. 
In 2008, Lee et al. developed a convenient protocol for the synthesis of unsymmetrically 
substituted diaryl alkynes by applying propiolic acid in the conventional Sonogashira reaction 
(Scheme 60, i).
116
 The carboxylate group remains intact after the Sonogashira coupling and 
undergoes a subsequent decarboxylative cross-coupling of the arylpropiolic acid with another 
aryl halide leading to the final diaryl alkynes. In another protocol, Wu and his coworkers 
demonstrated the palladium-catalyzed decarboxylative cross-coupling of alkynyl carboxylic 
acids with aryl chlorides and benzyl halides by using X-Phos (Scheme 60, ii).
117
 In addition to 
the palladium catalyst system, the copper-catalyzed decarboxylative cross-coupling of alkynyl 
carboxylic acids with aryl halides have also been realized (Scheme 60, iii).
118
 However, there 
is controversy over the mechanisms that the transformation is initiated with the formation of 
the terminal alkynes from the proto-decarboxylation of the substituted propiolic acids 
followed by the Sonogashira coupling. 
 
Scheme 60. The use of alkynyl carboxylic acids in cross-couplings. 
GENERAL INTRODUCTION 
34 
Activated aliphatic carboxylic acids containing electron-withdrawing groups on their -
positions such as cyano,
119
 pyridyl,
120
 or nitroaryl,
121
 could also be used as nucleophiles in 
decarboxylative cross-coupling reactions. These auxiliary functional groups facilitate the 
decarboxylation steps (Scheme 61). 
 
Scheme 61. Decarboxylatvie cross-coupling of aliphatic carboxylic acids with aryl halides. 
1.2.1.3  Cross-coupling of carboxylic acids with alkynes 
In 2010, Jiao and his coworkers described the copper-catalyzed decarboxylative cross-
coupling of substituted propiolic acids with terminal alkynes, from which the unsymmetric 
conjugated diynes are readily approached (Scheme 62).
122
 However, the reaction scope is 
limited to electron-rich substrates, and the yields need to be improved. 
 
Scheme 62. Decarboxylative cross-coupling between substituted propiolic acids and terminal 
alkynes. 
More recently, Li and his coworkers demonstrated the synthesis of internal alkynes through 
decarboxylative alkynylation of aliphatic carboxylic acids with the electrophilic alkynylating 
agents, namely, ethynylbenziodoxolones (Scheme 63).
123
 As a typical radical reaction, the 
mechanism involves an SET (single eletron transfer) process (Scheme 63).  
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Scheme 63. Decarboxylatvie cross-coupling between aliphatic carboxylic acids and 
ethynylbenziodoxolones. 
In 2009, Li and coworkers developed the copper-catalyzed decarboxylative cross-coupling of 
-amino acids with terminal alkynes in the presence of tert-butyl peroxide, leading to 
propargyl amines (Scheme 64).
124
 Other activated hydrocarbons such as indoles, nitromethane 
could also be used in this decarboxylative coupling process, generating indolyl pyrrolidines 
and piperidines, and -nitroamines respectively.  
 
Scheme 64. Decarboxylatvie cross-coupling of -amino acids with terminal alkynes. 
The catalytic transformation starts with the oxidative decarboxylation of -amino acids to 
form an imine-type intermediate, which reacts with copper acetylide generating an alkynyl 
copper imidate. The organocopper species undergoes intramolecular nucleophilic addition to 
release the desired products and regenerate the copper catalyst (Scheme 65).  
 
Scheme 65. Mechanism of decarboxylative cross-coupling of -amino acids. 
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The decarboxylative cross-coupling of carboxylic acids with internal alkynes has been 
described recently. For instance, Glorius et al. disclosed the palladium-catalyzed 
intermolecular decarboxylative coupling of 2-phenylbenzoic acids with alkynes (Scheme 
66).
125
 The reaction could be seen as an intermolecular formal [4+2] annulation yielding the 
corresponding phenanthrene derivatives. The mechanistic investigation indicated that the 
reaction initiates with either decarboxylation or carboxylate-directed C–H bond activation. 
The subsequent carbopalladation of the alkynes leads to a vinyl palladium aryl species, which 
undergoes reductive elimination to release the product and palladium catalyst. 
 
Scheme 66. Decarboxylative cross-coupling of 2-phenylbenzoic acids with internal alkynes. 
In a related protocol, heteroaryl carboxylic acids such as indole-3-carboxylic acids, pyrrole-, 
benzofuran-, and furancarboxylic acids were coupled with two molecules of internal alkynes, 
affording the corresponding condensed heteroaromatic compounds such as carbazoles, indoles, 
dibenzofuran and benzofuran derivatives are prepared in only on step (Scheme 67).
126
 
 
Scheme 67. Decarboxylative coupling of heteroaromatic carboxylic acids with alkynes. 
CHAPTER 1 
37 
1.2.1.4  Cross-coupling of carboxylic acids with organometallic reagents 
The carboxylate moiety is often used as a nucleophile in cross-coupling reactions, so that an 
oxidant is essential for the coupling reaction between a carboxylic acid and an organometallic 
compound. However, most oxidants are scavengers for the decarboxylation steps. As a result, 
only a few examples of decarboxylative cross-coupling between carboxylic acids and 
organometallic reagents have been developed up to the present day. Among the oxidants 
employed, silver salts are most effective, since they not only serve as an efficient oxidant for 
palladium (0) to palladium (II), but also facilitate the decarboxylation of most of aromatic 
carboxylic acids. For example, Loh et al. reported the palladium-catalyzed decarboxylative 
cross-coupling of alkynyl carboxylic acids with arylboronic acids, in which Ag2O was used as 
an oxidant (Scheme 68, i).
127
 
 
Scheme 68. Decarboxylative cross-coupling between carboxylic acids and arylboron reagents. 
Recently, the decarboxylative coupling of aromatic carboxylic acids with arylboronic esters 
was developed by the group of Liu (Scheme 68, ii).
128
 The decarboxylation of -
oxocarboxylic acids occurs readily at room temperature in the presence of K2S2O8, to the 
extent that the combination of palladium catalysts and K2S2O8 allows the coupling of 
oxocarboxylic acids with organoborates (Scheme 68, iii).
129
 
1.2.1.5  Decarboxylative couplings involving C–H bond activation 
In the past decades, C–H activation have received much attention from organic chemists and a 
plethora of new reactions involving this concept have been invented in order to achieve high 
atom economy. On the view of sustainable organic synthesis, decarboxylative couplings 
provide an efficient alternative to the traditional metal-catalyzed cross-couplings that require 
organometallic reagents. Therefore, the combination of C–H activation and decarboxylative 
couplings becomes an urgent and interesting topic for organic chemists.  
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In 2009, Crabtree and his coworkers disclosed the first palladium-catalyzed decarboxylative 
dehydrogenative cross-coupling of aromatic acids with activated arenes by using t-Bu-XPhos 
(Scheme 69, i).
130
 An intramolecular variant was later developed by Glorius, in which 2-
phenoxybenzoic acids were chosen as the starting materials, affording the corresponding 
dibenzofurans as products (Scheme 69, ii).
131
 The proposed mechanism involves the 
formation of an aryl-Pd(II) intermediate formed from the decarboxylative metallation, and a 
palladacycle generated through the intramolecular C–H activation. The reductive elimination 
of this palladacyle releases the desired product and the palladium (0) catalyst, which is then 
oxidized to Pd(II). 
 
Scheme 69. Decarboxylative dehydrogenative cross-couplings. 
 
Scheme 70. Decarboxylative fluorenone synthesis. 
More recently, Greaney et al. reported the silver-catalyzed intramolecular decarboxylative 
fluorenone synthesis (Scheme 70).
132
 In the presence of a silver(I) catalyst and stoichiometric 
amounts of K2S2O8, the aroylbenzoic acid undergoes oxidative decarboxylation to generate an 
aryl radical, followed by cyclization to afford the fluorenone product. 
In 2009, Larrosa et al. described the palladium-catalyzed intermolecular decarboxylative 
dehydrogenative cross-couping of electro-deficient aromatic carboxylic acids with substituted 
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indoles (Scheme 71, i).
133
 It is notable that the arylation takes place regioselectively at the C-3 
postion of indole. Su and coworkers found that the regioselectivity of the decarboxylative 
arylation of indoles is highly depended on the electronic nature of the aromatic carboxylic 
acids. The benzoic acids bearing electron-donating groups give the 2-arylated indoles 
(Scheme 71, ii),
134
 while the electron-poor ones lead to the 3-arylated products (Scheme 71, 
iii). 
 
Scheme 71. Regio-selective arylation of indoles by using aromatic carboxylic acids. 
The intermolecular decarboxylative cross-couplings between aryl or heteroaryl carboxylic 
acids and acidic hydrocarbons such as azoles,
135
 thiophenes,
136
 polyfloruoarenes,
137
 and 
nitroethane
138
 have been developed by the groups of Greaney, Tan and Su (Scheme 72). 
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Scheme 72. Decarboxylative C–H cross-couplings. 
More recently, Mao
139
 and Liu
140
 independently reported the development of copper-
catalyzed oxidative decarboxylative couplings involving an sp
3
 C–H bonds activation in the 
presence of peroxides such as TBHP (Scheme 73, i) or DTBP (ii). These reactions are 
proposed to proceed via radical addition-elimination of aryl-substituted vinyl carboxylic acids. 
 
Scheme 73. Copper-catalyzed decarboxylative alkenylation of sp
3
 C–H bonds with cinnamic 
acids. 
Arenes bearing directing groups such as amide and pyridine are well known to easily undergo 
C–H activation at the ortho position, followed by functionalization in the presence of 
palladium or other transition metal catalysts. However, the combination of this strategy and 
decarboxylative processes is problematic, as the decarboxylation of most carboxylic acids is 
inhibited under oxidative conditions. In 2010, Ge reported the first example of an amide-
directing C–H activation and acylation by using -oxocarboxylic acids as acylating reagents 
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(Scheme 74, i).
141
 Unlike aromatic carboxylic acids, the decarboxylation of -oxocarboxylic 
acids could be even facilitated by the peroxides employed as oxidants in the protocol. 
However, changing the directing group to pyridine leads to a high-temperature process (ii),
142
 
probably due to the higher energy barrier of the C–H activation in the 2-phenyl pyridine 
systems compared to the acetanilide system. 
 
Scheme 74. Directed C–H activation and decarboxylative couplings. 
1.2.1.6  Other decarboxylative couplings forming C–C bonds 
Two identical or different aromatic carboxylic acids could also react with each other, 
affording symmetric or unsymmetric biaryls, respectively. As a side reaction, the homo-
coupling of carboxylic acids is always problematic in the development of decarboxylative 
coupling reactions. 
 
Scheme 75. Decarboxylative homo- and cross-coupling of two carboxylic acids. 
The first full account for the homo-coupling of aromatic carboxylic acids was described by 
Larrosa in 2008 (Scheme 75, i).
143
 Silver salts serve both as decarboxylation catalysts and as 
oxidants for the in situ generated Pd(0) species. Similar to the aromatic carboxylic acids, the 
homocoupling of alkynyl carboxylic acids has also been disclosed (Scheme 75, ii).
144
 More 
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recently, the cross-coupling of two different carboxylic acids was independently developed by 
the groups of Tan
145
 and Su (Scheme 75, iii).
146
 
 
Scheme 76. Decarboxylative addition to aldehydes and imines. 
Organometallic species generated via decarboxylation of carboxylic acids can undergo 
nucleophilic addition to carbon-carbon or carbon-heteroatom multibonds. Such 
decarboxylative addition reactions of aromatic (Scheme 76, i),
147
 aliphatic carboxylic acids
148
 
(Scheme, ii, iii and iv) to aldehydes and imines have been developed fro specific substrates, 
but no general method has been reported up to the present day. 
Recently, Miura et al. described the decarboxylative addition of cinnamic acids to internal 
alkynes, accompanyed with the coupling of aryl iodides (Scheme 77).
149
 The reaction is 
initiated with the oxidative addition of aryl iodide to a palladium (0) catalyst, forming an aryl 
halide species which undergoes insertion into the internal alkyne, generating the vinyl 
palladium halide intermediate. An alkenyl carboxylic acid reacts with this palladium species 
to form a vinyl palladium carboxylate intermediate, followed by the decarboxylation releasing 
the final product and the palladium catalyst. 
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Scheme 77. Decarboxylative addition of aromatic carboxylic acids to alkynes. 
In 2010, Larhed et al. disclosed the Pd-catalyzed decarboxylative ketone synthesis via the 
decarboxylative addition of aromatic carboxylic acids to nitriles (Scheme 78).
150
 Compared to 
the aforementioned decarboxylative acylations involving carbonyl unpolungs, this protocol 
avoids using expensive oxo-carboxylic acids, but requires high catalyst loading.  
 
Scheme 78. Decarboxylative addition of aromatic carboxylic acids to nitriles. 
1.2.2  Decarboxylative couplings forming C–heteroatom bonds 
1.2.2.1  Decarboxylative couplings forming C–halide bonds 
When aliphatic and ,-unsaturated carboxylic acids are treated with bromine in the presence 
of silver(I)-,
151
 thallium(I)-
152
 or mercury(II) salts,
 153
 the corresponding alkyl or vinyl 
bromides one carbon atom shortened were obtained (Scheme 79). This is so called 
Hunsdiecker reaction, which is still one of the most useful methods for the synthesis of 
organohalide compounds.  
 
Scheme 79. Hunsdiecker halogenative decarboxylation. 
The mechanism involves organic radical intermediates. Taking the decarboxylative 
bromination as a typical example, the silver carboxylate reacts with bromine to form the acyl 
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hypohalite, which undergoes fragmentation to generate the carboxylate radical along with a 
bromo radical. The radical decarboxylation leads to the formation of an alkyl radical which 
recombines with the bromo radical, affording the terminal bromide. 
New decarboxylative halogenating reagents include PhI(OAc)2,
154
 t-BuOX,
155
 XeF2,
156
 and 
LiX
157
 have been explored during the last century in order to avoid the use of heavy metals. In 
the Barton modifications, the carboxylic acids were first transferred into thiohydroxamates, 
which can easily undergo halogenative decarboxylation via thermal or photolytic 
decomposition in halogen donor solvents such as BrCl3, CHI3, and CCl4 (Scheme 80).
158
  
 
Scheme 80. Barton’s conditions for decarboxylative halogenation. 
Recently, Gandelman et al. reported a metal-free and general iododecarboxylation of both 
aliphatic and aromatic carboxylic acids (Scheme 81).
159
 The key to achieve the full 
conversions is the use of commercially available 1,3-diiodo-5,5-dimethylhydantoin (DIH) 
under irradiative conditions. The reaction begins with the homolytic cleavage of the N–I bond 
in the amide resulting in an N-based radical, followed by abstraction of the carboxylic acid 
hydrogen atom to form an acyloxyl radical. The radical decarboxylation takes place to give 
the R-radical, which can be iodinated with another molecule of the N-iodoamide. 
 
Scheme 81. Gandelman’s decarboxylative iodination. 
In 2010, Wu and coworkers described the silver-catalyzed decarboxylative chlorination and 
bromination of aromatic carboxylic acids (Scheme 82, i). The authors used copper(II) halides 
as the halogen source and silver carbonate as the decarboxylation catalyst. In Larrosa’s 
approach of the same transformation, a stoichiometric amount of silver and gold salts is 
required in order to generate an aryl gold species, which is halogenated by NXS (ii). Both 
protocols are limited to electron-deficient benzoic acids. 
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Scheme 82. Transition metal-catalyzed decarboxylative halogenations. 
More recently, Li et al. demonstrated the silver-catalyzed decarboxylative chlorination and 
fluorination of aliphatic carboxylic acids by using t-butyl hypochlorite and Selectfluor as the 
halogenating reagents (Scheme 83).  
 
Scheme 83. Silver-catalyzed decarboxylative halogenations. 
 
Scheme 84. Proposed mechanisms of silver-catalyzed decarboxylative halogenations. 
While the authors proposed that a binuclear chloro-tert-butoxy-bridged Ag(II) complex 
intermediate, the details of the mechanism still seem unclear. According to the authors, a 
subsequent ligand exchange leads to the formation of the silver carboxylate complex, from 
which the carboxyl radical is formed. It is supposed to undergo fast decarboxylation to 
generate the alkyl radical. In the final step, the alkyl chloride is released through the 
nucleophilic attack at the chloro ligand of the binuclear silver complex (Scheme 84, i). In the 
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decarboxylative fluorination process, the reaction begins with the formation of an Ag(III)–F 
intermediate via oxidative addition. A carboxyl radical is then formed through single electron 
transfer (SET), followed by a fast decarboxylation forming the alkyl radical, which abstracts 
the fluorine of Ag(II)–F to afford the aryl fluoride product (ii). 
1.2.2.2  Decarboxylative couplings forming C–N and C–O bonds 
It is well-known that allylic carbonates and carbamates undergo thermal decarboxylative 
rearrangement under harsh conditions.
160
 While the transition metal-catalyzed regio- and 
stereospecific decarboxylative allylic etherification and amination have been well documented 
(Scheme 85),
84
 intermolecular decarboxylative C–N and C–O cross-coupling of aryl, alkenyl, 
and alkynyl carboxylic acids have been rarely reported. 
 
Scheme 85. Metal-catalyzed decarboxylative allylic amination, etherification and selenation. 
In 2010, Jiao et al. reported the first Cu-catalyzed decarboxylative amidation of propiolic 
acids under oxidative conditions (Scheme 86).
161
 The reaction condition is rather simple and 
the use of air as the oxidant advances this catalytic transformation towards being a useful 
approach to ynamides. In the proposed mechanism, copper(II) carboxylate is firstly formed, 
followed by a fast decarboxylation, generating an alkynyl copper complex. Nucleophilic 
attack by an amide affords the alkynyl-Cu-amidate intermediate, which undergoes reductive 
elimination, releasing the corresponding ynamide. The formed copper(0) catalyst is then 
reoxidized by oxygen to restart the catalytic cycle. 
 
Scheme 86. Proposed methanism of the Cu-catalyzed decarboxylative amidation of propiolic 
acids. 
CHAPTER 1 
47 
More recently, Mainolfi et al. developed the first decarboxylative cross-coupling between 
aromatic carboxylic acids and amides (Scheme 87).
162
 Using a simple copper(II)-
phenanthroline catalyst system, the ortho-substituted benzoic acids undergo decarboxylative 
coupling with various N-nucleophiles affording the corresponding N-arylated amides. 
 
Scheme 87. Cu-catalyzed decarboxylative amidation of aromatic carboxylic acids. 
The authors proposed a similar mechanism to the decarboxylative amidation of propiolic 
acids (Scheme 88). An equilibrium between the Cu(II) and Cu(III) complexes may exist, 
because the reductive elimination of an aryl Cu(III) intermediate is more favorable. A 
pathway involving a tandem protodecarboxylation / ortho C–H amidation can be excluded, 
since the cross-coupling of nitrobenzene and 2-pyrrolidionone does not proceed under the 
optimized reaction conditions. 
 
Scheme 88. Proposed mechanism of the Cu-catalyzed decarboxylative amidation of aromatic 
carboxylic acids. 
Besides the C–N bond formation, the decarboxylative C–O cross-coupling has been recently 
established by Gooßen et al.
163
 As shown in scheme 89, the use of alkyl orthosilicates or aryl 
borates as the O-nucleophiles under aerobic conditions allows the convenient construction of 
alkyl and aryl diaryl ethers from readily available aromatic carboxylic acids. The bimetallic 
catalyst system consists of a silver(I) salt and a copper(II) salt, which are responsible for the 
decarboxylation and Chan-Evans-Lam coupling,
164
 respectively. An arylsilver(I) species 
generated from the decarboxylation cycle undergoes transmetallation with the copper(II) 
catalyst, forming an an arylcopper species where a standard Chan-Evans-Lam catalytic cycle 
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is then initiated. This arylcooper(II) intermediate is oxidized to the arylcopper(III) species, 
followed by a nucleophilic attack of the O-nucleophiles affording the ether product and the 
copper(I) sepcies, which is then oxidized to the initial copper(II) catalyst. 
 
Scheme 89. Ag/Cu-catalyzed decarboxylative etherification. 
In addition to the ipso-decarboxylative etherification, a decarboxylative ortho-alkoxylation 
process was later developed by our group (Scheme 90).
165
 This process proceeds via 
carboxylate-directed ortho C–H functionalization followed by protodecarboxylation. Using 
carboxylate as a traceless directing group, the original substitution pattern is altered in a 
defined way: meta-substituted aryl ethers arise from para- and ortho-substituted benzoates, 
and para-substituted aryl ethers from meta-substituted benzoates (Scheme 91). 
 
Scheme 90. Carboxylate-directed C–H alkoxylation with concomitant protodecarboxylation. 
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Scheme 91. Formal meta- and para-selective direct alkoxylation. 
1.2.2.3  Decarboxylative couplings forming C–S, C-Se, and C–P bonds 
Carboxylic acids could also be coupled with other heteroatom-nucleophiles forming the 
corresponding C–S, C-Se, and C–P bonds under oxidative conditions. In 2009, Liu et al. 
demonstrated the first example of a decarboxylative C–S coupling of carboxylic acids with 
mercaptans and disulfides (Scheme 92).
166
 In the presence of a bimetallic Pd(II)/Cu(II) 
catalyst system, both alkyl and aryl thiols could be coupled with various carboxylic acids 
affording the corresponding aryl or alkenyl sulfides in good to excellent yields. A 
stoichiometric amount of Cu(OH)2CO3 is required for the transformation, because the in situ 
generated Pd(0) species needs to be reoxidized to the initial Pd(II) catalysts by the Cu(II) salt. 
 
Scheme 92. Decarboxylative C–S coupling. 
In a related protocol, Becht established the expedient synthesis of diaryl sulfides and selenides 
from the decarboxylative cross-coupling of 2,6-dialkoxybenzoic acids and diaryl disulfides 
and diaryl diselenide (Scheme 93).
167
 A bimetallic catalyst system consisting of Pd(TFA)2 and 
Ag2CO3 was used at a lower reaction temperature, while the substrates are limited to the 
ortho-disubstituted aryl carboxylic acids.  
 
Scheme 93. Decarboxylative C–S and C–Se coupling. 
In a subsequent report, Liu et al. disclosed the copper-catalyzed decarboxylative cross-
coupling of arylpropiolic acids with thiols (Scheme 94).
168
 The highly stereospecific Z-vinyl 
sulfides are easily accessed under their optimal conditions. However, the reaction probably 
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proceeds via a sequential protodecarboxylation and nucleophilic addition of the thiols to aryl 
alkynes. 
 
Scheme 94. Decarboxylative alkynyl carboxylic acids with thiols. 
Decarboxylative C–P couplings of alkenyl and alkynyl carboxylic acids, as well as amino 
acids with R
1
R
2
P(O)H compounds were recently developed by the group of Yang (Scheme 
95).
169
 They presented three complementary protocols, for sp
2
-, sp-, and sp
3
-C–COOH 
substrates, from which a number of alkenyl, alkynyl and alkyl phosphine oxides are readily 
accessed without the need of the corresponding halocarbon precursors.  
 
Scheme 95. Decarboxylative C–P couplings. 
In all these three approaches, silver salts serve as decarboxylation catalysts, generating the 
organonuleophiles for the coupling reactions. The alkenyl and alkyl phosphine oxides are 
released from the corresponding organo-copper-phosphonyl species generated through the 
transmetallation from the organosilver species. In the reaction of the alkynyl carboxylic acids, 
an additional palladium catalyst is required to accomplish the transformation by an 
intertwined transmetallation from organo-copper and -silver intermediates. 
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1.3 Outline of the thesis 
In the previous subchapters, we have reviewed the most important developments of transition 
metal-catalyzed cross-coupling reactions, as well as the newly emerged decarboxylative 
couplings in the past decades. Compared to the well-developed traditional coupling reactions 
involving the inevitable use of expensive and delicate organometallic reagents, the 
decarboxylative cross-coupling is still in its infancy. However, the decarboxylative cross-
coupling reactions possess both economical and ecological advantages over traditional 
couplings, since carboxylic acids are inexpensive and commercially available in a large 
structural diversity. Moreover, they are air stable, easy to handle, and are preparatively 
accessible by a large number of well-established methods. Notably, decarboxylative couplings 
generate the new C–C and C–X bonds in incredibly high regioselectivities, because the 
coupling reactions usually take place only at the positions bearing carboxylic acid groups. 
In the past decade, decarboxylative coupling reactions have become powerful methodologies 
for the C–C and C–heteroatom bond formations. However, there are still many blind spots for 
the organic chemists to explore. For instance, the reaction temperatures of redox-neutral 
decarboxylative cross-couplings are still too high, limiting their preparative applications. 
Another challenge in the field of decarboxylative coupling chemistry is to allow the use of 
inexpensive and robust carbon electrophiles such organo mesylates and esters. 
The purpose of this thesis is to investigate the cross-coupling reactions between carboxylic 
acids and eletrophiles for the regioselective constructions of Csp
3
-Csp
2
, and Csp
2
-Csp
2
 bonds. 
In the following chapters, several important organic building blocks such as aryl acetates, 
diaryl acetates, imines, ketones, biaryls, styrenes and polysubstituted alkenes are successfully 
accessed from carboxylic acids and their derivatives by the means of C–H activation and 
decarboxylative cross-couplings. 
In chapter 2, we will describe the synthesis of aryl acetates via palladium-catalyzed 
dealkoxycarbonylative coupling of malonates with aryl halides (Scheme 96). The goal of this 
project is to develop an efficient and practical protocol for the synthesis of aryl acetate, 
especially for sterically demanding arylacetates in an economical and ecologically benign way. 
Two challenges arouse from this project, namely the effective coupling between malonates 
and aryl halides and the subsequent decarboxylation leading to the final aryl acetates. We will 
demonstrate our efforts to solve these problems through deliberately designing and intricate 
optimization of the coupling reactions. 
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Scheme 96. Synthesis of aryl acetates. 
In chapter 3, we will reveal an effective approach to -diaryl acetates from the cross-coupling 
of simple acetic acid derivatives and aryl halides (Scheme 97). Although the metal-catalyzed 
cross-coupling of enolates with aryl halides has been well investigated by many research 
groups, all the involving protocols require extremely strong bases such as LDA, MHMDS, 
and MO
t
Bu (M = Li, K, Na) in order to abstract the hydrogen from the -position of the 
carbonyl compounds. However, the use of such expensive and air-sensitive bases dramatically 
limits the functional tolerance and the preparative applications. A new catalyst system that 
allows the C–H activation of the -position of the carbonyl compounds by using mild bases is 
definitely an emergent task for organic chemists. 
 
Scheme 97. Synthesis of -diaryl acetates. 
In chapter 4, we describe the one-pot synthesis of azomethines and ketones from 
oxocarboxylic acids, amines and aryl halides via a low-temperature decarboxylative process 
(Scheme 98). Our strategy is based on the previously developed method involving the 
decarboxylative cross-coupling of oxocarboxylic acids and aryl halides from which aryl 
ketones were obtained. The amines employed will probably undergo fast condensation with 
the oxocarboxylic acids to form the -iminocarboxylates, which would be able to undergo 
decarboxylation at a much lower reaction temperature. Once the imines are formed, they can 
be readily in situ converted into the corresponding ketones by hydrolysis, or amines by 
reduction. However, the introduction of amines to the previous reaction system may probably 
lead to several problems such as the interactions between the amines and aryl halides, and the 
instability of the in situ formed -iminocarboxylates. These challenges will be overcome 
through systematic investigations. 
 
Scheme 98. Decarboxylative synthesis of azomethines and ketones. 
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In chapter 5, we will disclose the decarboxylative cross-coupling between aromatic carboxylic 
acids and simple but extremely robust organo methanesulfonate (Scheme 99). The scope of 
organo electrophiles in the decarboxylative cross-coupling reaction has covered aryl halides, 
aryl triflates, and aryl tosylates. However, the use of inexpensive and more robust aryl 
mesylates as eletrophiles in the decarboxylative coupling reactions is still challenging. The C–
O bond in aryl mesylates is particularly strong, so that only a few catalyst systems are capable 
of activating them. Two commonly used catalyst systems are the Nickel catalysts complexed 
with trialkylphosphines and palladium catalysts combined with eletron-rich and sterically 
hindered phosphine ligands. However, due to the incompatibility of nickel catalysts with 
decarboxylative couplings, we have no other choice to establish a new catalyst system based 
on palladium and efficient phosphine ligands. In this project, we will break this bottleneck 
through developing a new class of imidazolyl phosphine ligands. We will also demonstrate 
that how these unique ligands facilitate the transmetallation from organocopper to palladium 
catalysts to the extent that the coupling of carboxylic acids with aryl mesylates is smoothly 
accomplished. 
 
Scheme 99. The use of aryl/alkenyl mesylates in decarboxylative couplings. 
In chapter 6, we will describe our efforts against lowering the reaction temperature of the 
redox-neutral decarboxylative cross-coupling of aromatic carboxylic acids and aryl triflates 
(Scheme 100). The standard reaction temperature for the Pd/Cu-catalyzed neutral-redox 
decarboxylative cross-coupling between aryl carboxylic acids and organo eletrophiles is 
above 170 °C. The employing of a bimetallic Pd/Ag catalyst system allows the coupling of 
aryl triflates to occur at 130 °C. Our objective of this project is to further reduce the reaction 
temperature especially for the Pd/Cu catalyst system through developing unique phosphine 
ligands which are specific for the catalyst system. However, both of decarboxylation and 
transmetallation steps require elevated temperature to overcome the energy barriers. This 
project was carried out in the close collaboration with the group of Thiel. In this chapter, we 
will demonstrate how the Thiel’s phosphine ligands influence the decarboxylative coupling 
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process in such a way that a balance between the decarboxylation and transmetallation is 
established, so that the reaction could proceed efficiently at a temperature as low as 100 °C. 
 
Scheme 100. Low-temperature decarboxylative cross-couplings. 
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2.1 Introduction 
Many biologically active compounds belong to the substrate class of aryl and 
heteroarylacetice acid derivatives. Examples are auxins acting as phytohormonal growth 
regulators,
1
 as well as analgesics and nonsteroidal anti-inflammatory drugs (NSAIDs) (Figure 
1).
2 , 3
 The development of mild and efficient synthetic methods for the introduction of 
methylenecarboxyl groups into functionalized molecules is thus of great interest. 
 
Figure 1. Examples of auxins and nonsteroidal anti-inflammatory drugs. 
Traditional methods for the preparation of aryl acetic acids include the hydrolysis of benzyl 
cyanides (Scheme 1, I),
4
 the carbonylation of benzyl halides with metal catalysts (II),
5
 and the 
electrocatalytic carboxylation of benzyl chlorides (III).
6
 However, these processes have 
inherent disadvantages. For example, neither benzyl cyanides nor benzyl halides are available 
in great structural variety.
7
 Moreover, toxic carbon monoxide is required in carbonylation 
reactions, while electrocatalytic carboxylations require an elaborate reaction setup. 
As modern alternatives, transition metal-catalyzed cross-coupling reactions between aryl 
halides and Reformatsky reagents,
8
 tin,
9
 copper,
10
 and other enolates (IV),
11
 or ketene acetals 
(V) have been developed.
12
 Among these reactions, the palladium-catalyzed couplings 
between aryl halides and enolates developed by Buchwald
13
 and Hartwig
14
 (VI) are 
particularly straightforward, but the deprotonation of acetic acid esters requires strong and 
expensive bases, such as alkali metal hexamethyldisilazides or tert-butoxides. A broader 
range of functional groups is tolerated when using stabilized ketene derivatives or zinc 
enolates as the coupling partners.
15
 The inverse approach, namely the coupling of -
bromoacetic acid derivatives with arylboronic acids (VII) is also compatible with many 
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functional groups, but not effective for sterically demanding substrates, and requires the use 
of costly boron reagents.
16
  
 
Scheme 1. Traditional and modern syntheses of arylacetic acids. 
An interesting but less well-known alternative strategy to obtain 2-arylalkanoic acids consists 
in an initial cross-coupling of malonates or -ketoesters with aryl halides, followed by 
dealkoxycarbonylation or retro-Claisen condensation of the thermally labile intermediates 
(Scheme 1, VIII).
17
 The coupling reaction is mediated by Pd
18
 and Cu catalysts.
19
 The 
advantage of this approach is that mild bases suffice to deprotonate the acidic -dicarbonyl 
compounds. This synthetic pathway is particularly practical if the dealkoxycarbonylation 
takes place in situ under the conditions of the cross-coupling. 
A plausible mechanism for the dealkoxycarbonylative cross-coupling of dialkyl malonates 
and aryl halides is depicted in Scheme 2.
20
 Oxidative addition of the aryl halide (2) to the 
Pd(0) complex (a) gives rise to the arylpalladium(II) halide complex (b). The halide 
substituent is then replaced by an enolate nucleophile (c) formed via deprotonation of 
malonate (1). Reductive elimination of dialkyl -aryl malonate (5) from the resulting 
palladium enolate complex (d) regenerates the Pd(0) complex, closing the catalytic circle for 
the palladium. At elevated temperatures, the dialkyl -aryl malonate (5) directly undergoes 
dealkoxycarbonylation, presumably via a nucleophilic addition-elimination sequence. A base 
or halide nucleophile adds to one of the ester carbonyl groups with formation of the adduct 6. 
In the subsequent elimination step, enolate 7, which is resonance-stabilized by the newly 
introduced aryl group, is liberated together with the haloformate 8. On quenching the reaction 
mixture with water, hydrolysis of these intermediates leads to the desired arylacetic acid ester 
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(3) along with an alcohol (4) and carbon dioxide. This mechanism was supported by 
observation of the evolution of carbon dioxide (trapped by lime water) and alcohol (detected 
by proton NMR) during the reaction. 
 
Scheme 2. Proposed mechanism for the palladium-catalyzed dealkoxycarbonylative cross-
coupling. 
Kondo reported that some aryl iodides and activated aryl bromides can be coupled this way 
with diethyl malonate in the presence of a Pd-catalyst and 10 equivalents of Cs2CO3.
21
 
However, it takes up to 76 h until the coupling and the subsequent dealkoxycarbonylation 
reach reasonable conversions. Çetinkaya et al. achieved higher yields within shorter reaction 
times for a range of aryl halides when employing especially synthesized palladium complexes 
with customized N-heterocyclic carbene ligands.
22
 However, these ligands are not 
commercially available and accessible only via multistep syntheses. De Koning et al. 
investigated -ketoesters as alternative substrates and successively reported a palladium- and 
a copper-catalyzed protocol for the arylation of acetoacetate esters followed by in situ 
deacetylation.
 23
 However, these protocols have a rather narrow scope, and the deacetylation 
step often does not proceed to completion.
 
We evaluated all known protocols in the context of the synthesis of ortho-substituted aryl 
acetates, which are important precursors for active substances in crop protection.
24
 However, 
only unsatisfactory yields were achieved in couplings of sterically demanding aryl halides, 
e.g., 2,6-dimethylphenyl bromide. We thus came to the conclusion that this appealing 
synthetic approach had not yet reached synthetic maturity. More effective catalyst systems 
involving commercially available components and inexpensive bases were clearly required to 
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advance this reaction into a broadly applicable, practical synthetic entry to the important 
substrate class of arylacetic acids. 
2.2 Results and discussion 
As a first step towards an effective reaction protocol for a dealkoxycarbonylative coupling of 
malonates, we investigated the dealkoxycarbonylation reaction of diethyl 4-tolylmalonate (5a) 
at 160 °C under various conditions (Table 1). We found that this compound, which would be 
the primary product of the desired cross-coupling between an aryl halide and diethyl malonate, 
is thermally rather unstable. In the presence of cesium carbonate and using polar solvents such 
as NMP, it rapidly decomposed with formation of multiple products. Only traces of the 
desired ethyl 4-tolyacetate were detected (entry 1). The selectivity of the 
dealkoxycarbonylation was substantially higher when using potassium phosphate as the base. 
However, the desired product was obtained in only 32% yield (entry 2). We next investigated 
less polar solvents, but did not achieve any higher yields. 
Table 1. Dealkoxycarbonylation of diethyl 4-tolylmalonate. 
 
Entry Base Additive Solvent Conv. [%] Yield [%] 
1 Cs2CO3 — NMP 100 4 
2 K3PO4 — NMP 57 32 
3 K3PO4 — DEM
[b]
 50 40 
4 Cs2CO3 — DEM 40 38 
5 K2CO3 — DEM 14 12 
6 KHCO3 — DEM 16 11 
7 K2CO3/KHCO3
[c]
 — DEM 18 5 
8 K3PO4 18-Crown-6 DEM 99 97 
9 — 18-Crown-6 DEM 2 2 
10 — — DEM 1 1 
11 K3PO4 18-Crown-6 NMP 42 42 
[a] Reaction conditions: 2a (0.50 mmol), base (1.4 mmol), additive (0.25 mmol), solvent 
(1.0 mL), 160 °C, 8h. Yields were determined by GC analysis, with n-tetradecane as internal 
standard. [b] Diethyl malonate. [c] K2CO3 (1.5 mmol), KHCO3 (1.5 mmol). 
We finally tested the substrate for the desired coupling reaction, diethyl malonate (DEM), as 
the solvent. This inexpensive, high-boiling compound possesses a moderate polarity, so that it 
partially dissolves inorganic bases (entries 3-10). We were pleased to see that the selectivity 
of the dealkoxycarbonylation improved under these conditions (entry 3). Not only the 
PRACTICAL SYNTHESIS OF 2-ARYLACETIC ACID ESTERS 
68 
expensive cesium carbonate (entry 4) but also the much less costly potassium phosphate 
effectively mediated the reaction (entry 3). In the presence of milder bases such as potassium 
carbonate (entry 5) or bicarbonate (entry 6), the dealkoxycarbonylation proceeds much more 
slowly. In an attempt to improve the solubility of potassium phosphate in the reaction solvent, 
we added catalytic quantities of 18-crown-6. This dramatically increased the efficiency of the 
dealkoxycarbonylation, and almost quantitative yields of the desired arylacetate 3a were 
obtained (entry 8). Control experiments confirmed that the crown ether or DEM solvent alone 
do not promote the reaction (entries 9 and 10), and that under these conditions, diethyl 
malonate is a more effective reaction solvent than even NMP (entry 11). 
Having thus found optimal conditions for the dealkoxycarbonylation, we next examined the 
cross-coupling step using the reaction of 4-bromotoluene (2a) and diethyl malonate as the 
model. We employed DEM as both substrate and solvent, and tested various palladium 
catalyst, ligand systems, and bases (Table 2). 
As the initial palladium catalyst, we used a combination of Pd(dba)2 and P(t-Bu)3 in the form 
of its air-stable, easy-to-handle HBF4 adduct. This catalyst is known to mediate the cross-
coupling of aryl halides and malonates. Even at the elevated temperature of 160 °C, the 
arylmalonate 5a remained the major product for most bases tested (Table 2, entries 1-6). Only 
cesium carbonate gave the dealkoxycarbonylated product 3a as the main product, albeit in 
low yield (entry 3). The selectivity changed dramatically when 18-crown-6 was added to the 
reaction mixture (entry 7). In combination with potassium bases, this additive strongly 
facilitated the dealkoxycarbonylation, and the arylmalonate was no longer detected. The 
highest yields of the arylacetate were achieved with potassium phosphate (entries 8 and 9). 
Control experiments revealed that ammonium salts (entries 11-13) were inferior as phase 
transfer catalysts, and that DMSO (entry 14), which is known to facilitate decarboxylation 
reactions,
25
 is not effective in this context. The presence of stoichiometric quantities of water 
has a negative effect on the reaction outcome (entry 15). We next evaluated various palladium 
precursors and phosphine ligands (entries 16-20). These experiments revealed that several 
palladium precursors can be employed, but none of them possesses a higher activity than 
Pd(dba)2. The choice of the phosphine is much more critical, and besides with P(t-Bu)3, we 
achieved reasonable yields only with JohnPhos (38%). Under the optimal conditions using 
Pd(dba)2 (0.5 mol%), P(t-Bu)3•HBF4 (1.1 mol%), K3PO4 (2.8 equiv.), and 18-crown-6 (0.5 
equiv.) in diethyl malonate (6.6 equiv.) at 160 
o
C, ethyl 4-tolylacetate 3a was formed in 88% 
yield within only 8 hours (entry 7). Not even traces of the malonate 5a were detected in the 
reaction mixture. 
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Table 2. Optimization of the dealkoxycarbonylative cross-coupling.
[a]
 
 
entry “Pd” Ligand Base Additive 
Yield [%] 
5a 3a 
1
[b]
 Pd(dba)2 P(t-Bu)3•HBF4 KHCO3 — 83 10 
2
[b]
 Pd(dba)2 P(t-Bu)3•HBF4 K2CO3 — 82 18 
3
[b]
 Pd(dba)2 P(t-Bu)3•HBF4 Cs2CO3 — 9 20 
4
[b]
 Pd(dba)2 P(t-Bu)3•HBF4 Na3PO4 — 90 1 
5
[b]
 Pd(dba)2 P(t-Bu)3•HBF4 K3PO4 — 47 38 
6 Pd(dba)2 P(t-Bu)3•HBF4 K3PO4 — 50 46 
7 Pd(dba)2 P(t-Bu)3•HBF4 K3PO4 18-Crown-6 0 88 
8 Pd(dba)2 P(t-Bu)3•HBF4 KHCO3 18-Crown-6 0 80 
9 Pd(dba)2 P(t-Bu)3•HBF4 K2CO3 18-Crown-6 0 75 
10 Pd(dba)2 P(t-Bu)3•HBF4 Cs2CO3 18-Crown-6 0 9 
11 Pd(dba)2 P(t-Bu)3•HBF4 K3PO4 TBAB 29 45 
12 Pd(dba)2 P(t-Bu)3•HBF4 K3PO4 TBAI 20 57 
13 Pd(dba)2 P(t-Bu)3•HBF4 K3PO4 TBAF
[c]
 17 55 
14 Pd(dba)2 P(t-Bu)3•HBF4 K3PO4 DMSO
[d]
 70 27 
15 Pd(dba)2 P(t-Bu)3•HBF4 K3PO4 H2O
[d]
 45 19 
16 Pd(OAc)2 P(t-Bu)3•HBF4 K3PO4 18-Crown-6 0 75 
17 [(allyl)PdCl]2 P(t-Bu)3•HBF4 K3PO4 18-Crown-6 0 71 
18 Pd(PPh3)2Cl2 P(t-Bu)3•HBF4 K3PO4 18-Crown-6 0 60 
19 Pd(dba)2 P(t-Bu)3 K3PO4 18-Crown-6 0 76 
20 Pd(dba)2 JohnPhos K3PO4 18-Crown-6 2 38 
[a] Reaction conditions: 1a (1.00 mmol), diethyl malonate (6.6 mmol), Pd-source (0.5 mol%), 
ligand (1.1 mol%), base (2.8 mmol), additive (0.5 mmol); entries 1-6: 150 °C, 16 h; entries 6-
20: 160 C, 8 h. [allylPdCl]2 = allylpalladium(II) chloride dimer; JohnPhos = (2-
biphenylyl)di-tert-butylphosphine. Yields were determined by GC analysis, with n-
tetradecane as internal standard. [b] Pd(dba)2 (1.0 mol%), P(t-Bu)3•HBF4 (2.2 mol%), bases 
(2.3 mmol). 
[c]
 Tetrabutylammonium fluoride hydrate. [d] 1.00 mmol. 
Having thus found an effective and practical protocol to prepare ethyl arylacetates, we next 
explored its scope by coupling a large variety of aryl halides with diethyl malonate under the 
previously optimized conditions. As shown in Table 3, the dealkoxycarbonylative cross-
coupling reaction proceeded very well for electron-rich aryl halides. In all cases, the 
dealkoxycarbonylated products were exclusively obtained in high yields. Various functional 
groups were tolerated in para- (2b-e), ortho- (2f), and meta- (2g) positions on the aryl ring.  
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Table 3. Reaction scope of substituted aryl halides
[a]
 
 
Substrate Product Yield [%] 
  
87 
  
94
[b]
 
  
96
[b]
 
  
95 
  
86 
  
88
[c]
 
  
93 
  
93 
  
91 
  
94 
  
83
[b]
 
  
89
[b]
 
  
68 
  
88 
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Substrate Product Yield [%] 
  
89 
  
15
[d,e]
 
  
15
[d,f]
 
[a] Reaction conditions A: 1, 9 or 10 (1.00 mmol), Pd(dba)2 (0.5 mol%), P(t-Bu)3•HBF4 
(1.1 mol%), diethyl malonate (6.6 mmol), 18-Crown-6 (0.5 mmol), K3PO4 (2.8 mmol), 
160 °C, 8 h. Isolated yields. [b] 12 h. [c] 170 °C, 12h. [d] GC yields. [e] 48% of the m-xylene 
was detected. [f] 20 % of benzonitrile was detected. 
2-Bromonaphthalene (2h) and 9-bromophenanthrene (2i), as well as 3-bromothiophene as an 
example of an electron-rich heteroaryl bromide (2j), were also converted in excellent yields. 
The new protocol can be applied also to the coupling of aryl chlorides and iodides (9a and 
10a). 4-Chlorophenyl bromide (2k) underwent coupling at both halides to give the 
corresponding diester in good yield within a short time. Due to the good ability of the catalyst 
to activate aryl chlorides, no differential reaction of the Cl- and Br-groups was observed. 
Under the reaction conditions, unprotected carboxylic acid groups (2l) are converted into the 
corresponding ethyl esters, presumably via transesterification with the diethyl malonate 
present in excess, or condensation with the ethanol liberated during the 
dealkoxycarbonylation step. In analogy, phenolic OH-groups were converted into the ethyl 
ethers (2m). 
However, the performance limit of this protocol was reached for sterically hindered substrates 
such as 2-bromo-m-xylene 2n, and for electron-deficient aryl halides such as 4-
bromobenzonitrile 2p. In both cases, dehalogenation of the aryl halides was the major side 
reaction, and the products were obtained in unsatisfactory yields. 
These results indicate that the reaction protocol is effective mainly for the coupling of 
electron-rich aryl halides. For these substrates, the dealkoxycarbonylation proceeds slowly 
compared to the cross-coupling, so that it needs to be facilitated by the most effective 
mediator, namely the combination of potassium phosphate and 18-crown-6. In contrast, the 
decarboxylation proceeds more rapidly than the cross-coupling for electron-deficient as well 
as sterically demanding aryl halides.
26
 For these substrates, the bases and conditions must be 
adjusted such that the cross-coupling step proceeds with optimal selectivity, so as to avoid the 
undesired dehalogenation reactions.
27
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In order to find an alternative set of conditions which is more favorable for sterically hindered 
substrates, we used the reaction of 2-bromo-m-xylene 2n with diethyl malonate as a model to 
reevaluate various reaction conditions. The results are summarized in Table 4. Under none of 
the conditions tested, the malonate was detected in significant quantities, confirming that in 
contrast to the previous model reaction of 2a, the decarboxylation step is not critical for this 
sterically demanding substrate. Under the previous reaction conditions, the arylacetate 3n was 
obtained in low yields, along with large amounts of m-xylene resulting from 
protodehalogenation (entry 1). Without 18-crown-6, the yield was similarly unsatisfactory 
(entry 2). 
Table 4. Optimization for 2-bromo-m-xylene.
[a]
 
 
Entry Base [equiv.] Additive  
Yield[%] 
5n 3n 
1 K3PO4 (2.8) 18-Crown-6 0 15
[b]
 
2 K3PO4 (2.8) — 1 12 
3 K2CO3 (2.8) — 1 54
[c]
 
4 Cs2CO3 (2.8) — 0 31 
5 KHCO3 (2.8) — 0 14
[d]
 
6 K3PO4 (1.5)/KHCO3 (1.5) — 0 51 
7 K2CO3 (1.5)/KHCO3 (1.5) — 0 80 
8 Na2CO3 (1.5)/KHCO3 (1.5) — 0 19 
9 K2CO3 (2.0)/KHCO3 (1.0) — 0 65 
10 K2CO3 (1.0)/KHCO3 (2.0) — 0 54 
[a] Reaction conditions: 2n (1.00 mmol), Pd(dba)2 (0.5 mol%), P(t-Bu)3•HBF4 (1.1 mol%), 
base (2.8-3.0 mmol), additive (0.5 mmol), diethyl malonate (6.6 mmol), 160 °C, 8 h. Yields 
were determined by GC analysis, with n-tetradecane as internal standard. [b] 48 % of m-
xylene was detected.
 
[c] 32 % of m-xylene was detected.
 
[d] 32 % of 2n and 17% of m-xylene 
were detected. 
The yields improved substantially when employing carbonate bases (entries 3 and 4). A 
systematic study revealed that the optimal base consists of a 1:1 mixture of potassium 
carbonate and bicarbonate. The desired arylacetate 3n was detected in 80% yield with the 
adapted conditions (entry 7). Control experiments confirmed that a 1:1 ratio between K2CO3 
and KHCO3 is crucial for the selectivity of cross-coupling vs. protodehalogenation (entries 9-
10). The origin of the cooperative effect of these two bases is still unclear. 
CHAPTER 2 
73 
Table 5. Reaction scope of sterically hindered and electron-deficient substrates
[a]
 
 
Substrate Product Yield [%] 
  
81 
  
83 
  
70 
  
77 
  
93 
  
93 
  
95 
  
82 
  
73 
  
60 
  
77 
  
88 
  
73 
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Substrate Product Yield [%] 
  
87 
  
70 
  
16
[b,c]
 
[a] Reaction conditions B: 2 or 9 (1.00 mmol), Pd(dba)2 (0.5 mol%), P(t-Bu)3•HBF4 
(1.1 mol%), diethyl malonate (6.6 mmol), K2CO3 (1.5 mmol), KHCO3 (1.5 mmol), 160 °C, 
8 h. Isolated yields. [b] GC yield. [c] 82 % of malonate product 5a was detected by GC. 
This second protocol was also effective in the coupling of the electron-deficient substrate 2p 
(70% yield), which gave only 15% using the protocol optimized for electron-rich compounds. 
Encouraged by these spot checks, we explored the scope of the new conditions for various 
aryl halides (Table 5). 
The results confirm that the second set of conditions is superior for the coupling of sterically 
demanding and electron-deficient aryl bromides. The protodehalogenation was largely 
suppressed, and a good range of arylacetates was obtained in high yields. Common 
functionalities such as cyano, ester, benzoyl, trifluoromethyl, acetyl, and nitro groups were 
tolerated (3p-w). We were delighted to find that the conditions were also suitable for the 
conversion of aryl chlorides into the corresponding aryl acetates. 
Test reactions confirmed that the protocols used in Tables 3 and 5 are complementary to each 
other. The first, which involves potassium phosphate in combination with 18-crown-6 as the 
base, is highly effective for the coupling of electron-rich aryl halides but gives low yield for 
electron-deficient or sterically demanding substrates (Table 3, 3n and 3p). In contrast, the 
second, which is based on a potassium carbonate / bicarbonate mixture, allows the coupling of 
electron-poor and sterically demanding aryl halides, but is less effective for the coupling of 
electron-rich substrates (Table 5, 3a). 
2.3 Conclusions 
A new palladium catalyst system was developed that allows the convenient synthesis of 
diversely functionalized arylacetates from readily available aryl halides and diethyl malonate 
in the presence of mild bases. The reaction proceeds via the arylation of diethyl malonate with 
formation of diethyl 2-arylmalonates. These intermediates directly undergo a 
dealkoxycarbonylation to give arylacetic acid esters along with CO2 and ethanol. The 
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dealkoxycarbonylation step proceeds rapidly for electron-deficient and sterically demanding 
derivatives, but is much slower for electron-rich 2-arylmalonates. 
Two complementary reaction protocols were necessary to provide a general synthetic entry to 
alkyl 2-arylacetates. The optimal conditions for the coupling of electron-rich aryl halides 
involve Pd(dba)2 (0.5%) / P(t-Bu)3•HBF4 (1.1%) as the catalyst and 18-crown-6 (0.5 equiv.) / 
potassium phosphate (2.8 equiv.) as the base. This base / crown ether combination is essential 
for a quantitative dealkoxycarbonylation. 
In contrast, electron-deficient and sterically demanding aryl halides are best coupled in the 
absence of crown ether, using a 1:1 potassium carbonate / bicarbonate mixture as the base. 
This way, the competing protodehalogenation of the aryl halides, otherwise a major side 
reaction, is effectively suppressed. 
Overall, the new protocols, characterized by the use of commercially available, easy-to-
handle catalysts and mild bases as well as a high functional group tolerance, have decisively 
advanced the dealkoxycarbonylative cross-coupling of aryl halides and dialkyl malonates 
towards being a general and practical synthetic entry to the important substrate class of 
arylacetic acid derivatives. 
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3.1 Introduction 
The synthesis of diarylacetic acid derivatives is of considerable interest since many of these 
molecules display unique biological and pharmaceutical activities. For example, adiphenine is 
a parasympatholytic drug which acts as a smooth muscle relaxant in the treatment of 
hypermotility and spasms of the genitourinary and gastrointestinal tracts (Figure 1),
1
 
asimadoline is a potent -opioid receptor agonist that has been investigated as a possible 
treatment for irritable bowel syndrome,
2
 and 4-DAMP is a muscarinic acetylcholine receptor 
antagonist with selectivity for the M3 and M5 subtypes.
3
  
 
Figure 1. Biologically important diaryl acetic acid derivatives. 
A known synthesis of diarylacetic acid derivatives employs diaryliodonium salts as arylating 
reagents. Carbonanions generated from various carbonyl compounds could be arylated at their 
-position with diaryl iodonium salts. In 1963, Forgione4 disclosed the synthesis of diaryl 
acetates via the -arylation of 2-arylacetic esters with diphenyliodonium chloride (Scheme 1, 
I and II). Treating Meldrum’s acid with stable alkali base and diaryliodonium halides, the 
corresponding isopropylidene diarylmalonates were also easily prepared (III).
5
 These 
methods provided an efficient access to the diarylacetate compounds, whereas they suffer 
from extremely low atom economy due to the formation of a huge amount of waste.
6
  
In the last several decades, the transition metal-catalyzed cross-coupling reactions have 
emerged as powerful methods for C-C and C-heteroatom bond formations. Under palladium 
catalysis, aryl acetates could readily react with aryl halides forming the diaryl acetates (IV).
7
 
However, this method required expensive and hard-to-handle bases such as MHDMS. In 2004, 
Periasamy
8
 discovered the titanium-catalyzed arylation of aryl acetates using tertiary 
arylamines (V). Recently, Wang
9
 reported the catalysis-free arylation of -diazocarbonyl 
compounds with boroxines (VI). However, the preparative utility of these strategies is 
hampered by the limited availability of the required starting materials. 
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Scheme 1. Previous methods for the synthesis of diaryl acetates. 
In this respect, the diarylation of acetic acid esters with aryl halides appeared to be a more 
attractive approach, as these substrate classes are available in great structural variety at low 
cost.
10
 However, in contrast to 2-arylacetates [2-phenyl acetate: pKa(DMSO) = 22.7] or alkyl 
ketones [acetone: pKa(DMSO) = 26.5],
11
 simple acetic acid esters are much harder to deprotonate 
[ethyl acetate: pKa(DMSO) = 29.5],
12
 so that the use of expensive and hard-to-handle bases such 
as MHMDS (M = K or Na), LDA, or alkali metal alkoxides seems to be unavoidable in 
arylation processes of these compounds.
13
  
Our strategy to overcome this key limitation, which significantly hampers the preparative 
applicability of ester arylations, consisted in employing a co-catalyst that allows the 
deprotonation of simple acetic acid esters by mild bases by stabilizing the resulting enolates. 
The Sonogashira coupling
14
 can be seen as the archetype of a reaction in which a co-catalyst 
enables the deprotonation of an otherwise relatively inert C-H-bond. Due to the high stability 
of the intermediate copper acetylides, the Pd/Cu-catalyzed coupling of terminal alkynes with 
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aryl halides proceeds in the presence of carbonate or amine bases and is thus compatible with 
most common functional groups.  
 
Scheme 2. Proposed mechanism. 
We believed that a similar concept might also work for -arylation reactions.15 The proposed 
mechanism is outlined in Scheme 2. In the first step, the alkyl acetate coordinates to the 
copper species a via its carbonyl group. This should acidify the -protons so that they can be 
removed with a weak base with formation of a stable copper enolate complex c. Under 
liberation of copper halide species a, the enolate moiety is then transferred to arylpalladium(II) 
complex e generated via an oxidative addition of the aryl halide to the coordinatively 
unsaturated palladium complex d.  
The arylacetate 5 is released from species f via reductive elimination, regenerating the 
original palladium species d. This initial product should be much more reactive than the 
starting material [ethyl phenylacetate: pKa(DMSO) = 23.6],
16
 so that one would expect it to 
immediately undergo a second arylation leading to the desired product 6.  
3.2 Results and discussion 
In search for a catalyst system that would allow implementing this reaction concept, we 
evaluated the arylation of ethyl acetate with 4-bromotoluene in the presence of a palladium / 
tert-butyl phosphine catalyst system (Table 1, entries 1-3). We chose this Pd catalyst as the 
starting point on the basis that it has successfully been employed in -arylations of enolates. 
No arylation product was observed in the presence of simple carbonate or phosphate bases, 
which was expected as they are less basic than ester enolates by several orders of magnitude 
(pKa of HCO3

 = 10.3, pKa of HPO4
2
 = 12.3).
17
 Instead, solely homo-coupling product 7aa of 
the aryl bromide was formed. However, as soon as catalytic amounts of copper halides were 
introduced into the reaction system, arylated products were formed (entries 4-6).  
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Table 1. Optimization of reaction conditions.
[a]
 
 
Entry Cu source Base Solvent 
Yield (%)
[b]
 
5aa 6aa 7aa 
1 — Cs2CO3 DMF 0 0 9 
2 — K2CO3 DMF 0 0 8 
3 — K3PO4 DMF 0 0 34 
4 CuI K3PO4 DMF 1 13 19 
5 CuBr K3PO4 DMF 0 10 29 
6 CuCl K3PO4 DMF 1 8 29 
7 CuI/Phen
[c]
 K3PO4 DMF 2 28 1 
8 CuBr/Phen
[c]
 K3PO4 DMF 0 35 2 
9 CuCl/Phen
[c]
 K3PO4 DMF 2 19 1 
10 8a K3PO4 DMF 3 49 2 
11 8b K3PO4 DMF 1 45 3 
12 8c K3PO4 DMF 2 66 3 
13 8d K3PO4 DMF 1 60 4 
14 8e K3PO4 DMF 1 32 26 
15 8f K3PO4 DMF 0 24 28 
16 8g K3PO4 DMF 0 55 2 
17 8h K3PO4 DMF 0 63 4 
18 8i K3PO4 DMF 2 35 2 
19 8c K3PO4 DMA 1 61 0 
20 8c K3PO4 NMP 10 17 3 
21 8c K3PO4 Toluene 0 1 0 
22 8c Cs2CO3 DMF 11 23 0 
23 8c K2CO3 DMF 0 0 0 
24 8c
[d]
 K3PO4 DMF 39 11 0 
25
[e]
 8c K3PO4 DMF 0 54 12 
26
[f]
 8c K3PO4 DMF 2 86 2 
27
[g]
 8c K3PO4 DMF 7 43 8 
28
[h]
 8c K3PO4 DMF 0 0 0 
  
   
 
  
 
[a] Reaction conditions: 4-bromotoluene (0.5 mmol), ethyl acetate (2.5 mmol), Pd(OAc)2 
(1.0 mol%), P(t-Bu)3•HBF4 (2.2 mol%), Cu source (1.2 mol%), base (1.5 mmol), solvent 
(2.0 mL), 110 C, 24 h. [b] Yields were determined by GC analysis, with n-tetradecane as 
internal standard. [c]
 
1,10-Phenanthroline (2.4 mol%). [d] 3.6 mol%. [e] Pd(OAc)2 
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(3.0 mol%), P(t-Bu)3•HBF4 (3.6 mol%). [f] Pd(OAc)2 (2.0 mol%), P(t-Bu)3•HBF4 (2.4 mol%), 
8c (2.4 mol%). [g] Without P(t-Bu)3•HBF4. [h] Without Pd(OAc)2 and P(t-Bu)3•HBF4. 
The selectivity of the reaction dramatically increased when 1,10-phenanthroline was added to 
the copper catalyst, but the conversion still remained unsatisfactory (entries 7-9). This was 
substantially improved by introducing the copper(I) phenanthroline phosphine complex 8a as 
the co-catalyst. We then synthesized various related copper complexes (8b-h) and tested their 
catalytic activities (entries 11-17).
18
 This study revealed that copper(I) complexes (entries 10-
17) are more effective than copper(II) complex (entry 18), particularly when they contain a 
bromide counterion. Mixed PPh3-phenanthroline and PPh3-bipyridine ligands were similarly 
effective, whereas phosphine-free complexes did not give good results. The highest yields 
were thus obtained with [Cu(phen)PPh3Br] 8c (entry 12). We next screened various bases and 
solvents and found that amides such as DMF and DMA are particularly effective reaction 
solvents (entries 12 and 19-21). Among the bases tested, potassium phosphate gave the best 
results. The less basic cesium carbonate led to the desired products with low conversion and 
selectivity (entry 22), and potassium carbonate was almost ineffective (entry 23). 
The ratio between copper and palladium catalysts has a strong influence on the ratio between 
mono- and diarylated products. The best results are obtained at a 1/1.2 ratio. Increasing the 
Cu/Pd ratio leads to the monoarylated acetate 5aa as the major product (entry 24), whereas at 
lower Cu/Pd ratio larger amounts of the homo-coupling byproducts were formed (entry 25).  
Control experiments confirmed that the palladium is indispensable (entries 27 and 28) in this 
transformation
19
 and that t-butylphosphine is the most effective ligand for the palladium 
catalyst (Table 2). Under optimal reaction conditions (2.0 mol% of Pd(OAc)2, 2.2 mol% of 
P(t-Bu)3•HBF4, and 2.4 mol% of [Cu(phen)PPh3Br], 3.0 equiv. of K3PO4, DMF, 110 
o
C), the 
desired diarylation product was finally obtained in 86% yield along with only trace quantities 
of the monoarylated product 5aa and the homocoupling product 7aa (entry 26). 
We next explored the scope of the new protocol (Table 3). We thus treated n-butyl acetate and 
ethyl acetate with various aryl halides. In all cases, the diarylacetates were obtained in good to 
excellent yields. Electron-rich and electron-poor aryl bromides were successfully coupled, 
and many functional groups were tolerated, including esters, ethers, thioethers, nitriles, and 
amines. Under the mild reaction conditions, 4-bromochlorotoluene reacted exclusively at the 
bromine atom leaving the chloro-substituent intact (6ag).  
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Table 2. Screening of palladium source and ligands.
[a]
 
 
Entry Pd source Ligand 
Yield (%)
b
 
5aa 6aa 7aa 
1 Pd(OAc)2 P(t-Bu)3•HBF4 2 66 3 
2 Pd(OTFA)2 P(t-Bu)3•HBF4 2 56 5 
3 Pd(acac)2 P(t-Bu)3•HBF4 14 50 0 
4 Pd(dba)2 P(t-Bu)3•HBF4 13 2 0 
5 PdBr2 P(t-Bu)3•HBF4 5 62 0 
6 Pd(OAc)2 PPh3 22 16 0 
7 Pd(OAc)2 P(n-Bu)3•HBF4 17 10 0 
8 Pd(OAc)2 
 
20 17 3 
9 Pd(OAc)2 
 
13 12 5 
10 Pd(OAc)2 
 
5 56 5 
11 Pd(OAc)2 
 
3 43 4 
12 Pd(OAc)2 
 
10 13 5 
[a] Reaction conditions: 4-bromotoluene (0.5 mmol), ethyl acetate (2.5 mmol), Pd source 
(1 mol%), ligand (2.2 mol%), [Cu(Phen)PPh3Br] (1.2 mol%), base (1.5 mmol), solvent 
(2.0 mL), 110 C, 24 h. [b] Yields were determined by GC analysis, with n-tetradecane as 
internal standard. 
The successful conversion of 3-bromopyridine demonstrates that N-heterocycles are also 
compatible with this reaction (6ao). Sterically hindered aryl bromides were found to be less 
reactive but gave high yields at slightly increased catalyst loadings and extended reaction 
times (6al). 
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Table 3. Pd/Cu-catalyzed diarylation of acetate esters
[a]
 
 
Substrate Product R  Yield (%)
[b]
 
 
 
Et 
 
n-Bu 
6aa 
 
6ba 
86 
 
81 
 
 
Et 
 
n-Bu 
6ab 
 
6bb 
90 
 
89 
 
 
Et 
 
n-Bu 
6ac 
 
6bc 
93 
 
85 
 
 
Et 
 
n-Bu 
6ad 
 
6bd 
84 
 
83
[c]
 
 
 
Et 
 
n-Bu 
6ae 
 
6be 
74 
 
51 
 
 
Et 
 
n-Bu 
6af 
 
6bf 
94 
 
87 
 
 
Et 
 
n-Bu 
6ag 
 
6bg 
65 
 
77 
 
 
Et 
 
n-Bu 
6ah 
 
6bh 
87 
 
50 
 
 
Et 
 
n-Bu 
6ai 
 
6bi 
55 
 
57 
 
 
Et 
 
n-Bu 
6aj 
 
6bj 
90 
 
91 
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Substrate Product R  Yield (%)
[b]
 
 
 
Et 6ak 69 
 
 
Et 6al 70
[c,d]
 
 
 
Et 
 
n-Bu 
6am 
 
6bm 
82 
 
73 
 
 
Et 
 
n-Bu 
6an 
 
6bn 
82 
 
81 
 
 
Et 
 
n-Bu 
6ao 
 
6bo 
74 
 
75 
[a] Reaction conditions: Aryl halide 1-3 (1.00 mmol), ester 2 (5.00 mmol), Pd(OAc)2 
(2 mol%), P(t-Bu)3•HBF4 (4.4 mol%), 8c (2.4 mol%), K3PO4 (3.00 mmol), DMF (4.0 mL), 
110 C, 24 h. [b] Isolated yields. [c] 48 h. [d] Pd(OAc)2 (3 mol%), P(t-Bu)3•HBF4 (6.6 mol%), 
8c (3.6 mol%). 
This method was not restricted to aryl bromides. Aryl chlorides and iodides also reacted 
smoothly with ethyl acetate affording the corresponding diarylated products in moderate to 
good yields (Scheme 3). In the reaction of the electron-deficient aryl chlorides such as 2h, the 
monoarylated product 5ah was not detected. However, for the electron-rich 4-chlorotoluene 
(2a), the diarylation product was obtained in only 33% yield, accompanied by a large amount 
of monoarylated product 5aa. For this type of electrophiles, a selective monoarylation process 
might be feasible. 
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Scheme 3. Cross-ouplng of ethyl acetate with aryl chlorides and iodides. [a] 33 % of 
monoarylated product was detected. [b] 20 % of starting material was detected. [c] K3PO4 
(4.00 mmol). 
In order to shed some light on the reaction mechanism, we performed a control experiment in 
which ethyl 2-arylacetate, the expected intermediate in this reaction, was treated with phenyl 
bromide in the presence of the catalyst system (Scheme 4). The second arylation proceeded 
cleanly within a short time, and the product was even formed in good yield in the absence of 
the copper co-catalyst. In contrast, the first arylation step does not proceed without the copper 
co-catalyst (Table 1, entries 1-3). This experiment confirms that the second arylation step 
proceeds more readily than the first. Even under forcing conditions and using a large excess 
of aryl bromides, we never observed more than trace quantities of triarylated compounds. This 
can be explained with the steric bulk of the corresponding enolates, which appears to hinder 
their coordination to the palladium complex. 
 
Scheme 4. Pd-Catalyzed arylation of ethyl -phenyl acetate. 
3.3 Conclusions 
A bimetallic palladium/copper catalyst system was found to effectively promote the 
diarylation of alkyl acetates with aryl halides under unprecedentedly mild conditions. The 
new diarylation method represents a convenient and generally applicable synthesis of alkyl 
diarylacetates. The discovery that the ester -proton could be activated by catalytic amounts 
of copper species to the extent that it can be removed by a relatively weak base potentially 
opens up new opportunities for the design of various related coupling reactions with C-H 
functionalization. Further insights into the mechanism, reaction scope, and the transfer to 
other substrate classes are still desirable. 
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4.1 Introduction 
Azomethines are valuable intermediates in organic syntheses. As illustrated in Scheme 1, a 
wide range of amines
1
 and other nitrogen-containing molecules
2
 can be synthesized from 
azomethines. The reduction of imines is one of the most widely used strategies for the 
preparation of amines.
3
 α-Branched amines (e.g. allylic, propargylic, α-alkylated and arylated 
amines) can be obtained by addition of organometallic nucleophiles such as organolithium, -
copper, -zinc, or -magnesium reagents to the imine moiety.
4
 
 
 
Scheme 1. Products accessible from imine synthons. 
Azomethines can also be used as substrates for aza-Diels-Alder,
4e
 Mannich
5
 and aza-Morita-
Baylis-Hillman (aza-MBH) reactions.
6
 Their hydrolysis leads to the formation of ketones.
7
 
Moreover, imino groups can serve as directing groups in C-H activation reactions.
8
 In 
addition, azomethines are used as ligands, e.g., for Fe-based olefin polymerization catalysts.
9
 
A direct, yet modular access to this class of intermediates based on easily available reagents, 
in which all three substituents could independently be varied, is thus of high interest.  
As depicted in Scheme 2, various methods for the synthesis of azomethines have been 
reported. Traditionally, they are prepared by the condensation of a carbonyl functionality with 
a primary amine (Scheme 2, pathway I),
10
 the addition of organometallic reagents to nitriles 
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(II),
11
 or the arylation of nitriles under Friedel-Crafts conditions (III).
12
 Examples of modern 
transition metal-catalyzed syntheses include the hydroamination of alkynes catalyzed by Ru, 
Rh, Au or Ti (IV),
13
 the ruthenium-catalyzed oxidative coupling of aldimines and boronates 
(V),
14
 the palladium-catalyzed addition of arenes or boronic acids to nitriles (II or III)
15
 and 
the dehydrogenative coupling of alcohols and amines.
16
 However, none of these syntheses is 
fully modular since the products result from combinations of only two reagents. The benefit 
of multicomponent reactions is that they allow the generation of greater molecular diversity in 
a single step.
17
 However, to the best of our knowledge, the Pd-catalyzed cross-coupling of 
aryl halides, isonitriles, and organometallic reagents is the only known synthesis that allows 
an independent variation of all three substituents of the azomethine (Scheme 2, VI).
18
 
Unfortunately, the low availability, toxicity and bad odour of the isonitriles limit the practical 
utility of this synthetic strategy.  
  
 
Scheme 2. Synthetic entries to azomethines. 
In the most widely-used azomethine synthesis, the condensation of amines with ketones, two 
of the three substituents of the final product originate from the ketone building block. Ketones 
are usually assembled via Friedel-Crafts acylation of arenes (VII),
19
 couplings of 
organometallic species with carboxylic acid derivatives, e.g., Weinreb amides (VIII)
20
 or acid 
chlorides (IX),
21
 or carboxylic acids activated in situ with anhydrides
22
 or coupling reagents.
23
 
Further synthetic entries to ketones include the coupling of acyl anion equivalents (X), e.g. 
cyanohydrins,
24
 acetals,
25
 dithianes or hydrazones,
26
 with carbon electrophiles, as well as the 
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insertion of C-C multiple bonds into the aldehyde C-H bonds. However, all these approaches 
to the aryl ketones are not effective sufficient for the preparative applications. 
In the context of our work on decarboxylative cross-coupling reactions, we have recently 
communicated an alternative aryl ketones synthesis. It involves the generation of acyl 
nucleophiles via the decarboxylation of α-oxocarboxylates at a copper catalyst and their in 
situ coupling with aryl halides at a palladium co-catalyst. (Scheme 3, top).
27
 The key 
advantage of this and related decarboxylative couplings,
28
 which have successfully been used 
e.g. in the synthesis of biaryls,
29 , 30
 vinyl arenes,
31
 allyl derivatives,
32
 esters,
33
 and aryl 
ketones,
34
 is that they draw on easily available carboxylic derivatives rather than sensitive 
organometallic reagents as sources of carbon nucleophiles.  
 
Scheme 3. Decarboxylative synthesis of ketones and azomethines. 
We envisioned that a mechanistically related decarboxylative cross-coupling between α-
iminocarboxylates and aryl halides should also be possible (Scheme 3, bottom). If the α-
iminocarboxylates could be generated directly in the reaction mixture from α-oxocarboxylates 
salts and primary amines, this would represent a highly modular one-pot azomethine synthesis 
starting from three independently variable, broadly available and easy-to-handle components. 
The mechanistic basis for our desired decarboxylative azomethine synthesis is outlined in 
Scheme 4. We reasoned that upon mixing the α-oxocarboxylate 1 with the primary amine 2, at 
least a fraction of the molecules might condense via the hemiaminal to the α-
iminocarboxylate 5. Once inside the coordination sphere of the copper catalyst, either of these 
carboxylates should lose CO2 more readily than the α-oxocarboxylate due to the higher 
stability of imidoyl over acyl anions.
35,36
 At a reaction temperature well below that required 
for the decarboxylation of copper α-oxocarboxylates, the α-iminocarboxylate complex b 
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should already extrude CO2 resulting in the selective formation of the imidoyl copper 
complex c. In the transmetallation step, the imidoyl residue should be transferred onto the 
arylpalladium halide e, regenerating the initial copper halide species a. The arylpalladium 
species e itself arises from the oxidative addition of the aryl halide 3 to the second catalyst 
component, the low-valent palladium(0) species d. The desired azomethine product 4 would 
be liberated from complex f via reductive elimination, regenerating the original palladium 
species d and closing the catalytic cycle.  
 
Scheme 4. Mechanistic outline of the targeted imine / ketone synthesis. 
The Pd/Cu-catalyzed decarboxylative coupling of α-oxocarboxylates with aryl bromides 
requires very forcing conditions, i.e. 170 °C for 16h.
37
 If the above decarboxylative synthesis 
of azomethines indeed proceeded at substantially reduced temperatures, it would be useful 
also for the synthesis of aryl ketones 6. Rather than decarboxylative coupling α-
oxocarboxylates 1 themselves, they could be converted in situ into more reactive α-
iminocarboxylates 5 using an inexpensive amine 2, then react to the azomethines 4, and 
finally be hydrolyzed to the ketones 6 (Scheme 4, dotted arrow). Overall, the role of the amine 
would be that of a recyclable “organocatalyst” that would help reducing the activation barrier 
of the decarboxylation step.
38
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4.2 Results and discussion 
4.2.1 Decarboxylative coupling of -imino carboxylates and aryl bromides 
The first step towards the desired azomethine synthesis was to study the decarboxylative 
coupling of preformed α-iminocarboxylates with aryl halides. We attempted to synthesize α-
iminocarboxylate salts by stirring α-oxocarboxylic acids with amines in methanol and, once 
the reaction was complete, deprotonated the resulting α-iminoacids with potassium tert-
butoxide. However, the condensation step did not go to completion for aliphatic amines, and 
most of the products did not crystallize.  
Table 1. Optimization of the reaction conditions.
[a]
 
 
Entry Ligand Additive Yield (%)
[b]
 
1 P(o-Tol)3 
— 
5 
2 P(o-Tol)3 Mg(OTf)2 62 
3 P(o-Tol)3 3Å MS 27 
4 dppf 3Å MS 40 
5 dppf Mg(OTf)2 68 
6 dppf Mg(OTf)2, 3Å MS 85 
[a] Reaction conditions: 1.2 mmol 5a, 1.0 mmol 3a, 15 mol% CuBr, 15 mol% 1,10-
phenanthroline, 1 mol% Pd(F6-acac)2, 0.5 mol% dppf or 1 mol% P(o-Tol)3, 5 mol% 
Mg(OTf)2 when applicable, 200 mg 3Å molecular sieves (MS), 2 mL NMP, 130 °C, 16 h. 
dppf = 1,1’-bis(diphenylphosphinyl)ferrocene. [b] Yields determined by GC analysis using n-
tetradecane as the internal standard. 
In contrast, (N-[4-(dimethylamino)phenyl]imino)phenylacetate (5a) was directly obtained in 
high yields and crystalline form. Thus, we chose the reaction of 5a with 4-bromotoluene (3a) 
as a model for optimizing the decarboxylative cross-coupling step, using the solvent and 
catalyst system optimized for the decarboxylative ketone synthesis, i.e. 1 mol% Pd(F6-acac)2, 
2 mol% P(o-Tol)3, 15 mol% CuBr, and 15 mol% 1,10-phenanthroline.
27
 After stirring the 
reaction mixture for 16 h at 170 °C in N-methylpyrrolidinone (NMP)/quinoline, the desired 
azomethine 4aaa was isolated in an almost quantitative yield as a mixture of stereoisomers. 
Encouraged by this finding, we lowered the reaction temperature to 130 °C and studied the 
reaction systematically (Table 1). Control experiments confirmed that at this low reaction 
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temperature, the decarboxylative coupling between α-oxocarboxylates and aryl halides does 
not proceed at all. In contrast, the azomethine product 4aaa was formed in detectable amounts 
at this temperature (entry 1). 
The addition of Lewis acids, and of Mg(OTf)2 in particular, was found to strongly facilitate 
the reaction (entry 2). This finding can be rationalized by a coordination of Lewis acid to the 
nitrogen atom of the iminocarboxylate, thereby reducing the electron-density in the α-position 
to the carboxylate group, and thus, enhancing the decarboxylation rate. The beneficial effect 
of molecular sieves (entry 3) can be attributed to their Lewis acidity, but may also result from 
their ability to remove trace amount of water from the reaction mixture, thereby precluding a 
hydrolysis of the starting material. Among the ligands tested, 
bis(diphenylphosphinyl)ferrocene (dppf) gave the best results (entries 4 and 5). In 
combination with Mg(OTf)2 and molecular sieves as additives, the azomethine product 4aaa 
was formed in 85 % yield (entry 6). The only side reaction observed was a 
protodecarboxylation of the iminocarboxylate 5a, leading to the aldimine. Control 
experiments revealed that under the above reaction conditions, this aldimine does not react 
with the aryl bromide 3a with formation of azomethine 4aaa, which confirms that the product 
is indeed formed via a decarboxylative coupling rather than via protodecarboxylation 
followed by Heck-type reaction. 
We next examined the scope of this optimized protocol with regard to the electrophilic 
coupling partner by treating iminocarboxylate 5a with various aryl bromides 3 (Table 2). In 
all cases, the azomethines 4 were obtained in moderate to good yields. Both electron-rich (3a-
f) and electron-poor (3g-j) aryl bromides were successfully coupled, and many functional 
groups were tolerated, including amino, keto, cyano, ester and trifluoromethyl residues. Under 
the mild reaction conditions, 1-bromo-4-chlorobenzene (3l) reacted exclusively at the bromine 
atom while leaving the chlorine intact. The successful conversion of 3-bromopyridine (3m) 
demonstrates that nitrogen heterocycles are also compatible with this reaction. Only for the 
sterically crowded aryl bromide 3n an unsatisfactory yield was obtained. 
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Table 2. Scope of the imine synthesis from preformed α-iminocarboxylate 5a.[a] 
 
Product Yield (%)
[b]
 Product Yield (%)
[b]
 
 
85 
 
82 
 
64 
 
50 
 
58 
 
53 
 
57 
 
77 
 
70 
 
82 
 
75 
 
86 
 
84 
 
10 
[a] Reaction conditions: 1.2 mmol 5a, 1.0 mmol aryl bromide 3, 15 mol% CuBr, 15 mol% 
1,10-phenanthroline, 1 mol% Pd(F6-acac)2, 1 mol% dppf, 5 mol% Mg(OTf)2, 200 mg 3Å 
molecular sieves, 2 mL NMP, 130 °C, 16 h. PDP = 4-(dimethylamino)phenyl. [b] Isolated 
yields. 
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4.2.2 Development of a one-pot azomethine synthesis 
With optimized conditions for the decarboxylative cross-coupling in hand, we focused on the 
development of a one-pot protocol for the synthesis of azomethines from α-oxocarboxylates 1, 
amines 2 and aryl halides 3 without prior isolation of the α-iminocarboxylates 5. The key 
challenge was that the condensation step would now have to proceed under non-acidic 
conditions. This implies that the amine has to react with a carbonyl atom adjacent to a 
negatively charged carboxylate group. An NMR experiment revealed that when heating 
potassium phenyloxoacetate (1a), cyclohexylamine (2b) and molecular sieves in methanol for 
several hours, appreciable amounts (80%) of the iminocarboxylate 5b are formed, but still, 
20% of potassium phenyloxoacetate (1a) remain present (Figure 1).  
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Figure 1. Mixture of -oxocarboxylate, cyclohexylamine and molecular sieves in methanol-
d4 (resulting in 20% of -oxocarboxylate and 80% of -iminocarboxylate) 
This confirms that the condensation step is rather slow. For a successful one-pot azomethine 
synthesis, the water released in the imine condensation step would have to be continuously 
trapped, and the reaction would have to be performed at a temperature too low for 
decarboxylation of the α-oxocarboxylate salts present in the reaction mixture. This way, it 
should be possible to avoid the competing protodecarboxylation and the formation of aryl 
ketones. Indeed, when we heated a mixture of potassium phenyloxoacetate (1a), 4-
(dimethylamino)aniline (2a) and 4-bromotoluene (3a) in the presence of molecular sieves and 
the previously optimized catalyst system for 16 h to 130 °C, the desired azomethine product 
4aaa was detected in 60% yield. We next evaluated whether the reaction would also work 
with those amines, whose α-iminocarboxylates we had been unable to isolate, and found that 
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they gave even better results (Table 3). For cyclohexylamine (2b), the corresponding 
azomethine 4aba was formed in almost quantitative yield. 
Table 3. Evaluation of primary amines in the three-component coupling.
[a]
 
 
Product Yield (%)
[b]
 Product Yield (%)
[b]
 
 
60 
 
96 
 
87 
 
70 
 
62 
 
75 
[a] Reaction conditions: 0.6 mmol 1a, 0.6 mmol amine 2, 0.5 mmol 3a, 15 mol% CuBr, 
15 mol% 1,10-phenanthroline, 1 mol% Pd(F6-acac)2, 1 mol% dppf, 5 mol% Mg(OTf)2, 
100 mg 3Å molecular sieves, 1 mL NMP, 130 °C, 16 h. [b] Isolated yields. 
Based on these findings, we decreased the reaction temperature to 100 °C, shortened the 
reaction time to 6 h, and re-optimized the catalyst system using cyclohexylamine (2b) as the 
amine component.  
Upon mixing all reaction components in the presence of molecular sieves, the desired 
azomethine product 4a was obtained in moderate yields already after 6 h at 100 °C (Table 4, 
entry 1). The main side reaction was a protodecarboxylation under formation of the aldimine. 
Control experiments revealed that both palladium and copper are essential for this reaction 
(entries 2-4). In an attempt to optimize the yield, we first varied the copper and palladium 
catalysts. Copper(I) bromide was found to be the most effective copper source, with other 
copper salts lower yields were obtained (entries 5-10). The presence of 1,10-phenanthroline as 
a ligand for the copper is beneficial (entries 11-12). The choice of the palladium precursor 
was found to have only a limited effect on the reaction outcome (entries 13-20). The key 
towards achieving higher yields was the choice of the phosphine ligand. Moderately electron-
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rich triarylphosphines such as tri(p-methoxyphenyl)phosphine (entry 22), and chelating 
phosphines with a large bite angle such as 1,1'-diphenylphosphinoferrocene (dppf, entry 24), 
gave best results. Trialkylphosphines and less electron-rich triarylphosphines were less 
effective (entries 25-27). Among the solvents tested, the polar aprotic N-methylpyrrolidone 
(NMP) was found to be optimal. Using quinoline as the solvent, even higher yields were 
detected, but the separation of the azomethine product from the basic amine proved to be 
laborious (entry 28). Similarly high yields were achieved with NMP after increasing the 
reaction time to 16 h (entry 31). The presence of molecular sieves was crucial for achieving 
high yields, but for this substrate combination, Lewis acids were no longer required (entries 
32-33). With the optimized catalyst system (1 mol% Pd(F6-acac)2, 1 mol% dppf, 15 mol% 
CuBr, 15 mol% 1,10-phenanthroline, 3 Å molecular sieves, NMP), azomethine 4aba was 
formed in 92% yield at 100 °C as a mixture of stereoisomers.  
Table 4. Optimization of the one-pot three-component azomethine synthesis.
[a]
 
 
Entry Cu source Pd source Ligand Solvent Yield (%)
[b]
 
1 CuBr Pd(F6-acac)2 P(o-Tol)3 NMP 49 
2 — Pd(F6-acac)2 P(o-Tol)3 NMP 0 
3 — Pd(F6-acac)2 dppf NMP 0 
4 CuBr — — NMP 0 
5 CuI Pd(F6-acac)2 P(o-Tol)3 NMP 43 
6 Cu2O Pd(F6-acac)2 P(o-Tol)3 NMP 5 
7 CuCl2 Pd(F6-acac)2 P(o-Tol)3 NMP 20 
8 CuI Pd(F6-acac)2 dppf NMP 59 
9 Cu2O Pd(F6-acac)2 dppf NMP 6 
10 CuCl2 Pd(F6-acac)2 dppf NMP 31 
11 CuBr Pd(F6-acac)2 P(o-Tol)3 NMP 14
[c]
 
12 CuBr Pd(F6-acac)2 dppf NMP 36
[c]
 
13 CuBr PdCl2 P(o-Tol)3 NMP 51 
14 CuBr Pd(OAc)2 P(o-Tol)3 NMP 38 
15 CuBr Pd(acac)2 P(o-Tol)3 NMP 42 
16 CuBr Pd(dba)2 P(o-Tol)3 NMP 48 
17 CuBr PdCl2 dppf NMP 75 
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Entry Cu source Pd source Ligand Solvent Yield (%)
[b]
 
18 CuBr Pd(OAc)2 dppf NMP 54 
19 CuBr Pd(acac)2 dppf NMP 68 
20 CuBr Pd(dba)2 dppf NMP 68 
21 CuBr Pd(F6-acac)2 — NMP 27 
22 CuBr Pd(F6-acac)2 P(p-MeOC6H4)3 NMP 38/82
[d]
 
23 CuBr Pd(F6-acac)2 binap NMP 69 
24 CuBr Pd(F6-acac)2 dppf NMP 81 
25 CuBr Pd(F6-acac)2 dppb NMP 77 
26 CuBr Pd(F6-acac)2 PCy3 NMP 37 
27 CuBr Pd(F6-acac)2 PPh3 NMP 43 
28 CuBr Pd(F6-acac)2 dppf quinoline 93 
29 CuBr Pd(F6-acac)2 dppf DMF 43 
30 CuBr Pd(F6-acac)2 dppf DMPU 5 
31 CuBr Pd(F6-acac)2 dppf NMP 92
[d]
 
32 CuBr Pd(F6-acac)2 dppf NMP 75
[e]
 
33 CuBr Pd(F6-acac)2 dppf NMP 25
[f] 
[a] Reaction conditions: 1.2 mmol 1a, 1.2 mmol 2b, 1.0 mmol 3a, 15 mol% Cu cat., 15 mol% 
1,10-phenanthroline, 1 mol% Pd cat., 2 mol% ligand (1 mol% for bidentate ligands), 200 mg 
3Å molecular sieves, 2 mL NMP, 100 °C, 6 h. dba = dibenzylideneacetone, binap = 2,2’-
bis(diphenylphosphinyl)-1,1’-binaphthyl, dppf = 1,1’-bis(diphenylphosphinyl) ferrocene, 
dppb = 1,4-bis(diphenylphosphinyl)butane. [b] Yields were determined by GC analysis using 
n-tetradecane as the internal standard. [c] without 1,10-phenanthroline. [d] 16 h. [e] Mg(OTf)2 
(5 mol %) was used as Lewis acid. [f] 3Å molecular sieves is replaced by Mg(OTf)2 
(5 mol %). 
We next explored the scope of the one-pot reaction under the optimized conditions (1 mol% 
Pd(F6-acac)2, 1 mol% dppf, 15 mol% CuBr, 15 mol% 1,10-phenanthroline, 3Å molecular 
sieves, NMP, 100 °C, 16 h). As can be seen in Table 5, various aryl bromides 3 were 
successfully coupled with potassium aryl- or alkyl--oxoacetates 1 and primary amines 2. 
Electron-rich (3a-e) and electron-deficient substrates bearing cyano (3h), ester (3i), 
trifluoromethyl (3j) or nitro (3r) groups gave similarly high yields. Heteroaryl bromides such 
as 3-bromopyridine (3m) and 3-bromothiophene (3t) also gave good results. When starting 
from 4-bromobenzaldehyde (3q), the aldehyde group reacted with the amine to the 
corresponding imine. Thus, 2.2 equivalents of the primary amine were employed, and the 
product was isolated in the form of the corresponding imine 4abq.  
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Table 5. Substrate scope of the one-pot three-component imine synthesis.
[a]
 
 
Product Yield (%)
[b]
 Product 
Yield 
(%)
[b]
 Product 
Yield 
(%)
[b]
 
 
91 
(61)
[c]
 
 
90 
 
92 
 
85 
 
86 
 
93 
 
58 
 
66 
 
54
[d]
 
 
95 
 
83 
 
65 
 
57 
 
94 
 
91 
 
46 
 
85 
 
62 
 
34 
 
94 
 
89 
 
71 
 
53 
 
66 
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Product Yield (%)
[b]
 Product 
Yield 
(%)
[b]
 Product 
Yield 
(%)
[b]
 
 
45
[e]
 
 
(46)
 
[e,g]
 
 
87 
 
64 
 
94
[f]
 
 
60
[f]
 
 
66
[f]
 
 
73
[f]
 
 
53
[f]
 
 
75
[f]
 
 
(16)
[f,g]
   
[a] Reaction conditions: 1.2 mmol α-oxocarboxylate 1, 1.2 mmol primary amine 2, 1.0 mmol 
aryl bromide 3, 15 mol% CuBr, 15 mol% 1,10-phenanthroline, 1 mol% Pd(F6-acac)2, 1 mol% 
dppf, 200 mg 3Å molecular sieves, 2 mL NMP, 100 °C, 16 h. [b] Isolated yields. [c] From 4-
chlorotoluene. [d] 2.2 equiv. of amine. [e] 36 h. [f] 130 °C. [g] Yield determined by GC 
analysis using n-tetradecane as the internal standard. 
The use of the electron-rich, sterically demanding phosphine 2-(dicyclohexylphosphino)-
2’,4’,6’-triisopropylbiphenyl instead of dppf allows extending the reaction from aryl bromides 
to aryl chlorides. This is exemplified by the synthesis of 4aba from 4-chlorotoluene. 
Variation of the -oxocarboxylate substrate 1 showed that aryl- α-oxocarboxylates with 
electron-rich (1b,c,h) or electron-poor ring substituents (1d,e) as well as 
heteroarenecarboxylates (1f,g) were all smoothly converted. For the aliphatic α-
oxocarboxylate 1i, longer reaction times were required. The synthesis of enolizable 
azomethines is also possible (4jba) but their isolation in pure form via distillation proved to 
be troublesome. For such compounds, a different workup procedure has to be developed, or 
they have to be used without further purification. 
The amine component is also variable (2a-i). For both linear and branched aliphatic amines, 
good yields were obtained. In order to convert electron-rich anilines (2a,d,h,i), the reaction 
temperatures had to be increased to 130 °C. The performance limit of the current system is 
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reached with the electron-deficient aniline 2j. For even less electron-rich anilines, no 
conversion was observed, which may be due to their low reactivity in imine condensation 
reactions. 
4.2.3 Reduction of the azomethine into the corresponding amine 
Considering that the reduction of azomethines to secondary amines is an important synthetic 
application, we investigated this reaction using compound 4aba, a typical example of the 
products accessible by our new synthetic method. We tested various reaction conditions 
(Table 6) and found that the highest yields of the amine 7a are obtained when the azomethine 
is treated either with a 3:1 mixture of sodium borohydride and aluminium chloride (entry 4), 
or with lithium aluminium hydride (entry 5) in THF. 
Table 6. Optimization of the reduction step.
[a]
 
 
Entry Reducing agent Solvent T (°C) Yield (%)
[b]
 
1 LiAlH4 THF 40
 
0 
2 LiAlH4/AlCl3 THF 40 66 
3 NaBH4 THF 60 4 
4 NaBH4/AlCl3 THF 60 97 
5 LiAlH4 THF 60 100 
6 H2/ Pt/C EtOH 80 44 
7 H2/ Pd/C EtOH 80 0
[c]
 
[a] Reaction conditions: 1 mmol 4aba, 2 mL solvent, 16 h. [b] Yields determined by GC 
analysis using n-tetradecane as the internal standard. [c] the deaminated product was obtained 
in 91 % yield. 
Due to the steric hindrance and low polarity of the C=N bond in the ketimine group, a 
reaction temperature of 60 °C is required. Hydrogenation over a heterogeneous platinum 
catalyst (10 bar H2, 5 mol% Pt/C, EtOH, 80 °C) was less effective, and with palladium 
catalysts, deaminated product was obtained predominantly. 
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4.2.4 Application of the decarboxylative -imino carboxylate coupling to the 
synthesis of aryl ketones 
Since the synthesis of azomethines was found to proceed in such high yields at temperatures 
well below those required for the synthesis of ketones via decarboxylative coupling of α-
oxocarboxylates 1, we decided to develop a one-pot synthesis of ketones via intermediate 
formation of azomethines (Scheme 5). In this process, the α-oxocarboxylate salts 1 would 
need to be converted into α-iminocarboxylates 5, these would have to be coupled under 
decarboxylation with aryl halides 3, and the resulting azomethines 4 would have to be 
hydrolyzed to the ketones 6. By lowering the decarboxylation barrier with added amine, the 
reaction temperatures might be dramatically reduced, thus minimizing thermal degradation of 
sensitive substrates. 
 
Scheme 5. Decarboxylative synthesis of ketones and azomethines. 
Since the basic azomethines 4 would no longer need to be separated from the reaction 
medium, it should now be possible to use quinoline as the solvent (Table 4, entry 4). In 
addition to its beneficial effect on the reaction rate, it should easily be removed along with the 
amine mediator in an acidic work-up. We used cyclohexylamine (2b) as the amine mediator, 
as it is inexpensive and the corresponding α-iminocarboxylates had proven to be particularly 
reactive towards decarboxylation. After stirring a mixture of potassium phenyloxoacetate (1a), 
cyclohexylamine (2b), and 4-bromotoluene (3a) in the presence of molecular sieves and the 
previously optimized catalyst system (1 mol% Pd(F6-acac)2, 1 mol% dppf, 15 mol% CuBr, 
15 mol% 1,10-phenanthroline, 3Å molecular sieves) in quinoline at 100 °C for 10 h, GC-
analysis revealed that the azomethine intermediate 4aba had formed in quantitative yield. The 
reaction was allowed to cool slightly, a mixture of 2M HCl and THF (1:1, 3 mL) was added, 
and the reaction was stirred for one hour at 80 °C to completely hydrolyze the azomethine 
intermediate. After acidic work-up, ketone 6a was isolated in 97% overall yield. 
Having thus identified an effective protocol for the synthesis of ketones, we next investigated 
its scope. As can be seen from the examples in Table 7, a wide range of diversely substituted 
aryl ketones are accessible in good to excellent yields. The reaction works equally well for 
aryl bromides bearing electron-donating and -withdrawing groups. In all cases, better 
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conversions are achieved using the new amine-mediated protocol than the previously reported 
direct decarboxylative coupling of α-oxocarboxylate salts.[27] The mild reaction conditions 
even allowed synthesizing 4-nitrobenzophenone (6e) in 65% yield, a compound that was 
obtained only in traces using the previous protocol.
[27]
  
Table 7. Substrate scope of the one-pot ketone synthesis.
[a]
 
 
Product Yield (%)
[b]
 Product Yield (%)
[b]
 
 
97 
 
87 
 
95 
 
94 
 
65 
 
88 
 
92 
 
97 
 
91 
 
42 
 
55 
 
71 
 
60 
 
30 
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Product Yield (%)
[b]
 Product Yield (%)
[b]
 
 
73 
 
85
[c]
 
 
44
[c]
 
 
7
[d]
 
[a] Reaction conditions: 1.2 mmol α-oxocarboxylate 1, 1.2 mmol primary amine 2, 1.0 mmol 
aryl bromide 3, 15 mol% CuBr, 15 mol% 1,10-phenanthroline, 1 mol% Pd(F6-acac)2, 1 mol% 
dppf, 200 mg 3Å molecular sieves, 2 mL quinoline, 100 °C, 10 h; quenching with 3 mL of 
2 M HCl / THF (1:1), 80 °C, 1 h. [b] Isolated yields. [c] 36 h. [d] Yield determined by GC 
analysis using n-tetradecane as the internal standard. 
The advantages of the new protocol are visible for heterocyclic derivatives: in the coupling of 
both 3-bromothiophene and 3-bromopyridine, the corresponding aryl ketones 6h and 6i were 
now isolated in 97% and 91% rather than 50% and 57%, respectively. Moreover, the new 
protocol for the first time allows the decarboxylative coupling of vinyl halides, as 
demonstrated by the synthesis of 6j. 
The reaction is also broadly applicable to the α-oxocarboxylate substrates. Aryl α-
oxocarboxylates with electron-rich and electron-poor substituents were smoothly converted, 
and even heterocyclic derivatives gave high yields. The conversion of aliphatic α-
oxocarboxylates is also possible, but requires longer reaction times. Even the enolizable 
ketone 6p was obtained in 85% yield after 36 h. The limit of the current catalyst system was 
reached with the sterically crowded substrate 2,4,6-trimethylphenyloxoacetate. 
4.3 Conclusions 
In summary, we have developed a highly modular, one-pot three-component protocol for the 
synthesis of diversely substituted azomethines via decarboxylative coupling, starting from 
simple potassium α-oxocarboxylates, primary amines and various aryl halides. This new 
procedure, which is mediated by a bimetallic copper/palladium catalyst, shows a remarkable 
substrate scope and excellent functional group tolerance. All three substituents in the 
azomethine products can be individually varied. A wide range of valuable imines is thus 
accessible in high yields at 100 °C, an unprecedentedly low temperature for redox-neutral 
decarboxylative cross-couplings. In combination with an in situ hydrolysis of the azomethines, 
the new reaction can be used also for the synthesis of ketones from α-oxocarboxylate salts and 
aryl halides in the presence of cyclohexylamine. In this process, the inexpensive amine 
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mediator serves to reduce the reaction temperature of the decarboxylation step by 
intermediate imine condensation. The concept of lowering the temperature of decarboxylative 
couplings of α-oxocarboxylates by performing them in the presence of amines should open up 
new opportunities also for related decarboxylation transformations of α-oxocarboxylates, e.g., 
1,2- and 1,4-additions, allylations or arylations with C-H activation. 
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5.1 Introduction 
Redox-neutral decarboxylative cross-couplings mediated by Cu/Pd or Ag/Pd bimetallic 
catalyst systems proved to have a particularly broad scope with regards to both carboxylates 
and carbon electrophiles. In this reaction variant, the decarboxylation step is mediated by a 
Cu(I) 1  or Ag(I) catalyst, 2  while a Pd-complex catalyzes the coupling with a carbon 
electrophile. Whereas aryl bromides and iodides can be converted with very simple ligand 
systems,
3
 the activation of aryl chlorides,
4
 triflates
5
 and tosylates
6
 requires the use of 
sophisticated catalyst systems containing electron-rich, bulky phosphine ligands. However, all 
attempts to develop decarboxylative couplings of the notoriously hard-to-activate 
methanesulfonates (mesylates) as carbon electrophiles have failed so far (Scheme 1). 
 
Scheme 1. Decarboxylative cross-coupling of aryl/alkenyl mesylates. 
5.1.1  Activation of aryl and alkenyl mesylates 
Aryl and alkenyl mesylates are particularly attractive carbon electrophiles for preparative- or 
industrial-scale syntheses, since they have the lowest molecular weight of all sulfonate 
leaving groups. They are easily accessible by esterification of broadly available phenols or 
enolates with inexpensive mesyl chloride or anhydride (Scheme 2), often in substitution 
patterns different to related organohalides.
7
 Aryl and alkenyl mesylates are comparably stable 
against air and moisture, which makes them easy to store and handle. Their use in cross-
coupling reactions is, therefore, desirable from economical, ecological and practical 
standpoints. 
 
Scheme 2. Accesses to aryl/alkenyl mesylates. 
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However, the higher basicity of mesylates in comparison with e.g., triflates or even tosylates 
results in a particularly stable C–O bond (Figure 1)8 that can only be cleaved with only a few 
extremely active cross-coupling catalysts.
 
 
 
Figure 1. A comparison on the leaving-group activity of commonly used sulfonate groups, 
based on the pKa value of their conjugate acids. 
 
Scheme 3. Ni-catalyzed Suzuki-Miyaura reaction of aryl mesylates using Zn as reductant. 
In 1995, Percec
9
 reported the first example of cross-coupling of arylboronic acids with aryl 
mesylates, employing nickel or palladium catalysis. Using nickel complexes as the catalysts, 
the activated aryl mesylates were converted to the corresponding biaryls in high yields, 
whereas the Pd-catalyzed coupling of aryl mesylates could not give comparable results even 
when employing Pd(dppf)2Cl2 and Pd(PPh3)4, which were the most effective catalysts for 
Suzuki-Miyaura reactions at that time. As a stronger nucleophile compared to Pd(0), Ni(0) is 
sufficiently nucleophilic to undergo oxidative addition with aryl mesylates, especially when 
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the catalyst is supported by electron-rich phosphines ligands such as dppf or PCy3. However, 
these protocols often require stoichiometric amounts of zinc or other reductants such as n-
BuLi
10
 and NaH
11
 for the generation of Ni(0) (Scheme 3). Recent developments have allowed 
the coupling of aryl mesylates in Suzuki-Miyaura cross-coupling reactions in the absence of 
reducing agents, using a high excess of of phosphine ligands (normally 4 equivalents) 
(Scheme 4). 
 
Scheme 4. Ni-catalyzed reductant-free Suzuki-Miyaura reaction of aryl mesylates. 
In the past two decades, aryl sulfonates have been successfully used as carbon electrophiles in 
a array of Ni-catalyzed cross-coupling reactions, including homocoupling, Kumada-coupling, 
Negishi-coupling, Suzuki-coupling, C–S coupling, borylation, and cyanation (Scheme 5).12 
 
Scheme 5. Ni-catalyzed cross-couplings of aryl/alkenyl mesylates. 
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Although the Ni-catalyzed cross-coupling reaction of aryl mesylates has been established and 
elaborated since the mid-1990s, the same coupling reactions with the use of palladium 
catalyst had not been discovered until early 2000s due to the difficulty in the oxidative 
addition of aryl mesylates onto palladium catalysts. The breakthrough was recently achieved 
by the development of electron rich and sterically demanding phosphine ligands. Many 
research groups including Fu,
13
 Hartwig,
14
 Buchwald,
15 
Beller,
16
 Verkade,
17
 and Kwong,
 18
 
have made substantial contributions to the new generation of effective ligands capable of 
activating unreactive carbon electrophiles (Figure 2). 
 
Figure 2. Recent developments on effective phosphine ligands. 
In 2008, Kwong
18
 reported the first general Pd-catalyzed Suzuki coupling of aryl mesylates 
by using an indolyl phosphine ligand CM-Phos. This catalyst system also proved amenable to 
other coupling reactions including Buchwald-Hartwig amination,
19
 Sonogashira reaction,
20
 
Hiyama reaction,
21
 cyanation,
22
 CH arylation,
23
 borylation (Scheme 6).
24
  
DECARBOXYLATIVE CROSS-COUPLING OF MESYLATES 
118 
 
Scheme 6. CM-Phos as a versatile ligand for palladium in cross-couplings of aryl mesylates. 
Palldium catalyst combined with Buchwald’s ligands, namely, X-Phos and Brett-Phos 
(Scheme 7) also showed a high catalytic ability for the activation of aryl and alkenyl 
mesylates. In 2008, Wu reported the Hiyama coupling of aryl mesylates with aryl silanes, 
using a catalyst system consisting of Pd(OAc)2 and X-Phos.
25
 In 2009, Ackermann disclosed 
the first palladium-catalyzed direct arylation of heteroarenes using aryl sulphonates.
26
 The 
catalyst system consisting of Pd(OAc)2 and X-Phos allowed the smoothly coupling of 1,2,3-
triazoles with aryl tosylates and a few eletron-deficient aryl mesylates. Replacing the 
heteroarenes with pyridine N-oxides, a range of aryl mesylates could be coupled giving the 
corresponding biaryls in moderate to good yields.
27
 The combination of Pd(OAc)2 and X-Phos 
also proved to be an efficient catalyst system for the Stille reaction of aryl mesylates.
28
 In 
2009, Buchwald disclosed that BrettPhos was also an excellent phosphine ligand for 
activating aryl mesylates in Suzuki-Miyaura coupling reactions.
29
 Recently, Molander 
reported the first Pd-catalyzed C(sp2)–C(sp3) Suzuki-coupling of aryl- and heteroaryl 
mesylates using X-Phos.
30
 In 2008, Buchwald et al. found that Brett-Phos ligand was highly 
effective for the palladium-catalyzed amination of aryl mesylates with primary amines.
31
 
Using the similar catalyst system, the first example of N-arylation of amides using aryl 
mesylates was also reported by Buchwald and co-workers in 2011.
32
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Scheme 7. Buchwald ligands for palladium in cross-couplings of aryl mesylates. 
Whereas palladium-catalyzed carbonylation of aryl halides with carbon monoxide has been 
well documented, the first example of alkoxycarbonylation of aryl mesylates was developed 
by the research group of Buchwald recently using a catalyst system of Pd(OAc)2 and a 
chelating ligand 1,3-bis(dicyclohexylphosphanyl)propane (dcpp) (Scheme 8).
33
 
 
Scheme 8. Pd-catalyzed alkoxycarbonylation of aryl mesylates. 
5.1.2 Mechanistic considerations of decarboxylative coupling of mesylates 
In decarboxylative couplings, the use of mesylates is a particular challenge because 
transmetallations are known to proceed only from copper or silver to palladium but not to 
nickel, precluding the use of this catalyst metal.
6
 Moreover, particularly electron-rich ligands, 
which might promote the oxidative addition of aryl/alkenyl mesylates onto palladium 
catalysts, tend to interfere with the decarboxylation catalyst.
4,5
 
In search for an effective catalyst system for the desired decarboxylative arylation of 
mesylates, we chose the reaction of potassium ortho-nitrobenzoate (1a) with 2-naphthyl 
mesylate (2a) as a model. The desired biaryl (3aa) was formed only in trace amounts when 
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using phenanthroline/copper decarboxylation catalyst in combination with various palladium 
complexes, among them the state-of-the-art catalysts for other mesylate cross-couplings. 
Neither Kwong’s CM-Phos, nor Buchwald’s S-Phos or Brett-Phos systems proved to be 
effective (Table 1, entries 1-3). 
In the coupling reaction using the CM-Phos ligand, significant amounts of 
protodecarboxylation products were observed, indicating that this ligand does not inhibit the 
decarboxylation step. As its ability to activate aryl mesylates is well-documented, we 
reasoned that the transmetallation from copper to palladium must be the critical step in the 
overall catalytic process depicted in Scheme 9.
34
  
 
Scheme 9. Mechanism of the decarboxylative cross-coupling of aryl/alkenyl mesylates. 
5.2 Results and discussion 
5.2.1 Ligands designing and synthesis 
In the Stille reaction, where the transmetallation step is often limiting, it has been found that 
the use of less strongly -donating tri-2-furylphosphine rather than triphenylphosphine 
enhances reaction rates by two orders of magnitude.
35
 This ligand features a potentially 
coordinating heteroatom in close proximity to the phosphorus, which enhances -back-
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donation. It has also been reported that only one phosphine should be present in 
transmetallations to palladium.
36
  
 
Scheme 10. Synthesis of imidazolyl phosphines. 
As a lead structure for ligand design, we thus chose a benzoimidazolyl skeleton rather than 
the indolyl system of CM-Phos. The syntheses of benzoimidazolyl phosphines were first 
reported by Altenbach.
37
 Kwong recently used them in Suzuki couplings of aryl mesylates.
38
 
This ligand class should have a reduced -donor strength and provide an enhanced -back-
donation. Moreover, the second nitrogen atom in the imidazole moiety could also offer a 
weakly coordinating group that may aid an associative transmetallation step. Therefore we 
synthesized an array of imidazolyl phosphines via a sequence of cyclization, alkylation and 
phosphonation reactions (Scheme 10). 
5.2.2  Development of decarboxylative cross-coupling of aryl mesylates 
Having synthesized a series of imidazolyl phosphine ligands, we started our investigation with 
the evaluation of their activities in the decarboxylative cross-coupling reactions of aryl 
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mesylates. In the cross-coupling reaction of 1a with 2a, the new ligands L1-15 directly 
proved to be effective (Table 1). A clear trend was visible for the influence of the phosphorus 
substituents (L1-3). Moderately bulky, electron-rich dicyclohexyl phosphine showed the 
highest activity (L3), whereas tert-butyl or phenyl groups were less effective. As substituent 
on the imidazole nitrogen (R
3
), more sterically demanding groups such as phenyl (L4), 
isopropyl (L5) or methoxymethyl (L6) had a beneficial effect. When increasing the 
substitution on the phosphorus-bound aryl ring using alkoxy-groups in the manner of a Brett-
Phos ligand (R
2
=OMe, L7), the yields dropped. Increasing the electron density of the 
benzoimidazole nitrogens by methyl substituents (R
4
) further improved the yields (L10). A 
tetrahydrobenzoimidazole fragment (L8), which would also have a high electron density on 
the nitrogens, was nearly as effective as L10. Further optimization of the N-substituents (R
3
) 
on the final ligand core led to another step-up in the yields (L13-16), with n-octyl being the 
most effective residue. 
Table 1. Study of ligand performance in the decarboxylative coupling of aryl mesylates.
[a]
 
 
Ligand Yield (%)
[b]
 Ligand Yield (%)
[b]
 
X-Phos 2 
 L1 
6 Brett-Phos 2 
CM-Phos 3
[b]
 
 L2 
11 
 L3 
14 
 L4 
18 
 L5 
19 
 L6 
16 
 L7 
10 
 L8 
7 
 L9 
13 
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Ligand Yield (%)
[b]
 Ligand Yield (%)
[b]
 
 L10 
19 
 L11 
16 
 L12 
18 
 L13 
20 
 L14 
19 
 L15 
22 
 L16 
21   
[a] Reaction conditions: 1a (0.3 mmol), 2a (0.6 mmol), Pd(acac)2 (5.0 mol%), L (7.5 mol%), 
Cu2O (2.5 mol%), 1,10-phenanthroline (5.0 mol%), NMP (2.0 mL), 170 °C, 16 h; Yields 
determined by GC analysis using n-tetradecane as the internal standard. Cy = cyclohexyl, iPr 
= isopropyl, tBu = tert-butyl. [b] 50 % of protodecarboxylation product was observed. 
The crystal structure of the optimal catalyst system, obtained from L15 and Pd(PhCN)2Cl2, is 
shown in Figure 3.
39
 The palladium center is coordinated with both amino and phosphino 
groups in a distorted square-planar geometry. Compared to the Pd-Cσ bond in the Pd-CM-
Phos complex (1.986 Å),
19
 the Pd-N bond is longer (2.0415 Å) confirming the targeted labile 
chelating coordination mode. 
 
Figure 3. Crystal structure of Pd-L15. Hydrogen atoms haven been omitted for clarity. 
Selected bond distance [Å] and angles [°]: Pd(1)-N(1) 2.0415 (16), Pd(1)-P(1) 2.2393 (5), 
Pd(1)-Cl(1) 2.3796 (5), Pd(1)-Cl(2) 2.2897 (5), N(1)-Pd(1)-P(1) 82.97(5), Cl(2)-Pd(1)-Cl(1) 
91.158(18). 
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The reaction conditions were systematically optimized with the goal of improving the yields 
by minimizing the competing protodecarboxylation and sulfonate cleavage with formation of 
2-naphthol,
40
 using the easy-to-handle, solid ligand L10 (Table 2). A major step-up in yields 
to 68% was achieved by changing the solvent to a 1:3 mixture of NMP and mesitylene (entry 
7). Changing to Pd(dba)2 as the Pd-precursor, the protodecarboxylation was completely 
suppressed (entry 9). Further screening experiments confirmed that Pd(dba)2 and Cu2O are the 
most effective precatalysts (entries 8-13, 16-18). A silver catalyst is also compatible with the 
new catalyst system, but showed inferior catalytic activities (entries 14-15). Among the 
investigated nitrogen-containing ligands (entries 19-22), the best results were obtained with 
3,4,7,8-tetramethyl-1,10-phenanthroline. Control experiments revealed that the 
decarboxylative coupling reaction requires both palladium and copper to proceed (entries 23-
24). Under these optimized conditions, the use of ligand L15, a viscous oil, still made a 
positive difference. Up to 79% yield was obtained with the catalyst generated in the reaction 
solution (entry 25), and almost quantitative yields were obtained using the preformed complex 
PdCl2-L15 (entry 26). The reaction is easy to perform also in a laboratory microwave reactor 
(entry 27). 
Having thus found an effective and easy-to-perform reaction protocol, we next investigated its 
scope. Various aromatic carboxylate salts were successfully coupled with 2-naphthyl mesylate 
using a catalyst system generated in situ from Pd(dba)2 (5 mol%), L15 (12 mol%), Cu2O (2.5 
mol%), 3,4,7,8-tetramethyl-1,10-phenanthroline (5 mol%) within 30 minutes at 180 °C in a 
laboratory microwave reactor. 
Table 2. Optimization of the decarboxylative mesylate coupling.
[a]
 
 
Entry [Pd] L [Cu] / [Ag] L’ solvent 
Yield [%] 
3aa 4a 
1 Pd(acac)2 L10 Cu2O 1,10-phen NMP 19 40 
2 Pd(acac)2 L10 Cu2O 1,10-phen DMF 9 37 
3 Pd(acac)2 L10 Cu2O 1,10-phen DMSO 0 50 
4 Pd(acac)2 L10 Cu2O 1,10-phen Diglyme 41 31 
5 Pd(acac)2 L10 Cu2O 1,10-phen Mesitylene 52 22 
6 Pd(acac)2 L10 Cu2O 1,10-phen NMP/Mes (1/1) 39 41 
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Entry [Pd] L [Cu] / [Ag] L’ solvent 
Yield [%] 
3aa 4a 
7 Pd(acac)2 L10 Cu2O 1,10-phen NMP/Mes (1/3) 68 25 
8 Pd(acac-F6)2 L10 Cu2O 1,10-phen NMP/Mes (1/3) 67 22 
9 Pd(dba)2 L10 Cu2O 1,10-phen NMP/Mes (1/3) 75 0 
10 PdBr2 L10 Cu2O 1,10-phen NMP/Mes (1/3) 70 0 
11 PdCl2 L10 Cu2O 1,10-phen NMP/Mes (1/3) 73 0 
12 Pd(OAc)2 L10 Cu2O 1,10-phen NMP/Mes (1/3) 66 21 
13 Pd(PhCN)2Cl2 L10 Cu2O 1,10-phen NMP/Mes (1/3) 70 29 
14 Pd(dba)2 L10 Ag2CO3 1,10-phen NMP/Mes (1/3) 30 0 
15 Pd(dba)2 L10 Ag2CO3 2,6-lutidine NMP/Mes (1/3) 20 0 
16 Pd(dba)2 L10 CuI
[b]
 1,10-phen NMP/Mes (1/3) 75 0 
17 Pd(dba)2 L10 CuBr
[b]
 1,10-phen NMP/Mes (1/3) 61 0 
18 Pd(dba)2 L10 CuCl
[b]
 1,10-phen NMP/Mes (1/3) 70 0 
19 Pd(dba)2 L10 Cu2O NO2-phen NMP/Mes (1/3) 45 38 
20 Pd(dba)2 L10 Cu2O bathophen NMP/Mes (1/3) 70 0 
21 Pd(dba)2 L10 Cu2O Bipy NMP/Mes (1/3) 66 0 
22 Pd(dba)2 L10 Cu2O Me4-phen NMP/Mes (1/3) 77 0 
23 Pd(dba)2 L10 — — NMP/Mes (1/3) 0 0 
24 — — Cu2O 1,10-phen NMP/Mes (1/3) 0 66 
25 Pd(dba)2 L15 Cu2O Me4-phen NMP/Mes (1/3) 79 0 
26 PdCl2-L15 — Cu2O Me4-phen NMP/Mes (1/3) 87 0 
27
[c]
 PdCl2-L15 — Cu2O Me4-phen NMP/Mes (1/3) 90 0 
[a] Reaction conditions: 1a (0.3 mmol), 2a (0.45 mmol), [Pd] (5.0 mol%), L (7.5 mol%), [Cu] 
or [Ag] (2.5 mol%), L’ (5.0 mol %), 170 °C, 5 h; Yields determined by GC analysis using n-
tetradecane as the internal standard. 1,10-phen = 1,10-phenanthroline; NMP = N-methyl 
pyrrolidine; Mes = mesitylene; Me4-phen. = 3,4,7,8-tetramethyl-1,10-phenanthroline; NO2-
phen. = 5-nitro-1,10-phenanthroline; Bathophen = 4,6-diphenyl-1,10-phenanthroline; Bipy = 
2,2´-bipyridine. [b] 5.0 mol%. [c] Microwave conditions: 180 °C / 100 W / 30 min. 
As illustrated in Table 3, various ortho-substituted arenecarboxylic acid salts were converted 
into the corresponding biaryls in high yields (3aa-3ea). Even the highly sterically demanding 
substrate 1g, resulted in moderate yields. The ortho-methoxybezoate salt was also converted 
but in low yield (3ha). When pentafluorobenzoate salt (1f) was used, the desired product was 
obtained in only 5% yield, whereas the diaryl ether (3faꞌ) was obtained as a major product. 
We reasoned that this reaction probably proceeds via a nucleophilic substitution of the para-
fluoride by in situ formed 2-naphthol,
41
 followed by protodecarboxylation. Heterocyclic 
carboxylates were smoothly transformed into biaryls in moderate to high yields (3ia-3la). 
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However, the meta-nitrobenzoate 1n could not be converted and control experiments 
confirmed that the decarboxylation step was completely impeded by the phosphine ligand. 
Further experiments revealed that besides 2-naphthyl, other aryl mesylates could also be 
coupled, albeit in moderate yields (3ab-3ae). 
Table 3. Decarboxylative coupling of aryl and heteroaryl carboxylates with aryl mesylates.
[a]
 
 
Product  Yield [%] Product  Yield [%] 
3aa 
 
86 3ja 
 
73 
3ba 
 
88 3ka 
 
50 
3ca 
 
85 3la 
 
62 
3da 
 
84 3na 
 
0 
3ea 
 
80
[b]
 3ab 
 
27 
3fa′ 
 
43
[b, c]
 3ac 
 
26
[e,f]
 
3ga 
 
50
[b]
 3ad 
 
28
[e,f]
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Product  Yield [%] Product  Yield [%] 
3ha 
 
17
[d]
 3ae 
 
35
[e,f]
 
3ia 
 
45    
[a] Reaction conditions: 1 (0.5 mmol), 2 (0.75 mmol), Pd(dba)2 (5.0 mol%), L15 (12.0 mol%), 
Cu2O (2.5 mol%), 3,4,7,8-tetramethyl-1,10-phenanthroline (5.0 mol%), NMP (1.0 mL), 
mesitylene (3.0 mL), W at 180 °C / 100 W / 30 minutes; isolated yields of two identical runs. 
[b] 1/2 ratio = 2:1. [c] 5 % of the decarboxylative product was detected by GC. [d] GC yield. 
[e] NMP/mesitylene = 1:5. [f] Pd(acac)2 was used. 
5.2.3 Development of decarboxylative cross-coupling of alkenyl mesylates 
Since alkenyl mesylates are easily accessible by esterification of enolates in substantially 
greater structural diversity than alkenyl halides, their utilities in the cross-coupling reactions 
are of even higher interest than that of aryl mesylates. The corresponding aryl alkenes, 
especially the polysubstituted olefin products are otherwise difficult to access by Mizoroki-
Heck reaction,
42
 because the essential cis-Pd-H elimination pathway is often not feasible 
(Scheme 10).
43
  
 
Scheme 10. Mechanism of the Mizoroki-Heck reaction. 
This problem arises especially when the cyclic alkenes are used as the coupling partners. For 
instance, the coupling reaction of 1-iodo-2-nitrobenzene with 6,7-dimethoxy-1,2-
DECARBOXYLATIVE CROSS-COUPLING OF MESYLATES 
128 
dihydronaphthalene proceed slowly even at 140 °C, resulting in 29 % of yield after 16 hours 
(Scheme 11).
44
  
 
Scheme 11. Heck reaction of cyclic alkenes. 
Common methods for the synthesis of polysubstituted olefins include carbonyl olefinations,
45
 
Suzuki reactions
46
 and other coupling reactions.
47
 One of the most efficient processes to 
access this substrate class is the Suzuki cross-coupling reaction of boron reagents with alkenyl 
halides or pseudohalides. However, these protocols suffer from the use of stoichiometric 
quantities of expensive and sensitive organometallic reagents. 
We were pleased to find that only minor adjustments were necessary to extend our new 
reaction concept to the alkenyl mesylates (Table 4). All the common palladium precursors 
showed high catalytic activities in the decarboxylative coupling reaction of aryl carboxylate 
1a with alkenyl mesylate 5a (Table 3-13), and among them Pd(OAc)2, Pd(dba)2 and 
[Pd(allyl)Cl]2 gave the best results. Further screening of the copper catalysts and the amine 
ligands revealed that Cu2O combined with 2,2’-bipyridine remained as the most active 
decarboxylation catalyst. 
Table 4. Optimization of the decarboxylative coupling reaction with alkenyl mesylate.
[a]
 
 
Entry [Pd] [Cu] L’ Time (h) 
Yield (%) 
6aa 4a 
1
[b]
 Pd(dba)2 Cu2O 1,10-phen 0.5 72 0 
2 Pd(dba)2 Cu2O 1,10-phen 16 56 10 
3 Pd(dba)2 Cu2O 1,10-phen 5 72 0 
4 Pd(acac)2 Cu2O 1,10-phen 5 68 15 
5 Pd(acac-F6)2 Cu2O 1,10-phen 5 73 0 
6 Pd(dba)2 Cu2O 1,10-phen 5 79 0 
7 PdBr2 Cu2O 1,10-phen 5 64 15 
8 PdCl2 Cu2O 1,10-phen 5 74 14 
9 Pd(OAc)2 Cu2O 1,10-phen 5 79 0 
10 Pd(OTFA)2 Cu2O 1,10-phen 5 78 0 
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Entry [Pd] [Cu] L’ Time (h) 
Yield (%) 
6aa 4a 
11 Pd(PhCN)2Cl2 Cu2O 1,10-phen 5 74 13 
12 Pd(COD)Cl2 Cu2O 1,10-phen 5 75 14 
13 [Pd(allyl)Cl]2 Cu2O 1,10-phen 5 78 0 
14 Pd(OAc)2 Cu2O 1,10-phen 3 78 15 
15 Pd(OAc)2 Cu2O 1,10-phen 1 80 15 
16 Pd(OAc)2 CuI 
[c]
 1,10-phen 1 69 7 
17 Pd(OAc)2 CuBr 
[c]
 1,10-phen 1 78 16 
18 Pd(OAc)2 CuCl 
[c]
 1,10-phen 1 80 0 
19 Pd(OAc)2 Cu(PPh3)(Phen)Br
 [c]
 — 1 60 19 
20 Pd(OAc)2 Cu2O 
 
1 69 23 
21 Pd(OAc)2 Cu2O 
 
1 79 15 
22 Pd(OAc)2 Cu2O 
 
1 76 19 
23 Pd(OAc)2 Cu2O 2,2ꞌ-bipyridine 1 85 0 
24 Pd(OAc)2 Cu2O 
 
1 72 20 
25 Pd(OAc)2 Cu2O 
 
1 75 0 
26 Pd(OAc)2 Cu2O 
 
1 69 30 
27 Pd(OAc)2 Cu2O  
1 71 0 
[a] Reaction conditions: 1a (0.3 mmol), 5a (0.45 mmol), [Pd] (5.0 mol%), L10 (12.0 mol%), 
Cu2O (2.5 mol%), L’ (5 mol%), NMP (1.0 mL), mesitylene (3.0 mL), 170 °C. Yields 
determined by GC analysis using n-tetradecane as the internal standard.
 
[b] Microwave 
conditions: 180 °C / 100 W / 30 min. [c] 5.0 mol%. 
Other active imidazolyl phosphine ligands were also tested in this reaction, and L8 with 
electron-withdrawing chloro-substituents on the benzoimidazolyl backbone was most 
effective as ligand for the palladium (Table 5). With the catalyst system generated in situ from 
Pd(OAc)2/L8 and Cu2O/2,2-bipyridine, a broad array of arenecarboxylate salts were coupled 
with various alkenyl mesylates in high yields within only 1h (Table 6). Among the products 
are several that would be hard to access otherwise, for example tetrasubstituted olefins or 
vinyl arenes. 
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Table 5. Screening with ligands under optimal conditions.
[a]
 
 
Ligand Yield (%) Ligand Yield (%) 
 L8 
90 
 L9 
80 
 L10 
85 
 L11 
68 
 L12 
87 
 L13 
81 
 L14 
73 
 L15 
75 
 L16 
72   
[a] Reaction conditions: 1a (0.3 mmol), 5a (0.45 mmol), Pd(OAc)2 (5.0 mol%), L 
(12.0 mol%), Cu2O (2.5 mol%), 2, 2’-bypyridine (5 mol%), NMP (1.0 mL), mesitylene 
(3.0 mL), 170 °C, 1h. Yields determined by GC analysis using n-tetradecane as the internal 
standard. 
The scope of the decarboxylative coupling of alkenyl mesylates was shown in Table 6. An 
array of different aryl as well as heterocyclic carboxylates was successfully converted under 
the optimized conditions (6aa-6ja). Sterically demanding carboxylates (1f-g, 1j) were also 
transferred into the corresponding products in low to moderate yields (6fa-6ga, 6ja). The 
pentafluorobenzoate salt was smoothly coupled without any observation of the corresponding 
ether formation (6fa). The reaction is also broadly applicable with regard to the alkenyl 
mesylates. The most simple vinyl mesylate (5g) was also transferred into ortho-nitrostyrene in 
54% yield (6ag). This might provide another economical and practical way to access such 
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strong electron deficient styrenes. The main procedures for the synthesis of ortho-nitrostyrene 
include Suzuki or Stille coupling of special vinyl reagents,
48
 Heck coupling,
49
 
semihyrogenation of alkynes,
50
 and Wittig reaction.
51
 These methods suffered from either low 
turnover frequencies or expensive and toxic reagents. Less sterically hindered vinyl mesylates 
such as 5b and 5c showed high activity towards the decarboxylative coupling (6ab and 6ac), 
whereas the ratio of E- and Z-isomers of the stilbene was slightly increased after the reaction 
(6ac). However, when the relatively electron-deficient vinyl mesylate bearing trifluoromethyl 
substituent (5i) was employed in the optimal conditions, only the corresponding ester product 
was obtained in low yield (6aiʹ). Internal alkenyl mesylates regardless of the aryl-(5d) or 
alkyl-substituted olefins (5e-f) were smoothly converted in moderate to good yields (6ad-6af). 
Even conjugated alkenyl mesylates were converted in moderate yields (6ah). No experiments 
have yet been performed with stereo-isomerically pure alkenyl mesylates, but when starting 
from E/Z mixtures, it appears as if the ratio between E and Z configurated products increases 
slightly in the course of the reaction.  
Table 6. Decarboxylative coupling of aryl and heteroaryl carboxylates with alkenyl 
mesylates.
[a]
 
 
Product  Yield [%] Product  Yield [%] 
6aa 
 
86 6ab 
 
83 
6ba 
 
82 6ac 
 
86
[b]
 
6ca 
 
84 6ad 
 
40
[c,d]
 
6ma 
 
83 6ae 
 
63 
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Product  Yield [%] Product  Yield [%] 
6da 
 
85 6af 
 
73 
6ea 
 
80 6ag 
 
54
[e]
 
6fa 
 
22 6ah 
 
21
[f]
 
6ga 
 
42 6aiʹ 
 
21
[e]
 
6ja 
 
54    
[a] Reaction conditions: 1 (0.5 mmol), 5 (0.75 mmol), Pd(OAc)2 (5.0 mol%), L8 (12.0 mol%), 
Cu2O (2.5 mol%), 2,2’-bypyridine (5.0 mol%), NMP (1.0 mL), mesitylene (3.0 mL),  C, 
1h; isolated yields of two identical runs. [b] E/Z-isomers = 2.8:1 (E/Z-isomers of starting 
material = 2.3:1) [c] 1/5 ratio = 2:1. [d] E/Z-isomers = 1:2 (E/Z-isomers of starting material = 
1:3.2). [e] 1/5 ratio = 1:3. [f] 1/5 ratio = 1.5:1. 
5.3 Conclusions 
In summary, the use of customized imidazolyl phosphines for the first time allows the use of 
aryl and alkenyl mesylates in decarboxylative cross-coupling reactions. This is a decisive step 
in leading this relatively young reaction concept to synthetic maturity. The variation of the 
ligands allowed us to identify two complementary protocols for the coupling of aryl and 
alkenyl mesylates respectively. Both methods show high efficiencies and functional group 
tolerance. This important discovery will open up new opportunities for a rapid development in 
this field, although the first protocol is restricted to activated aryl mesylates. The coupling of 
multi-substituted alkenyl mesylates is of particular interest, as it provides a convenient access 
to polysubstituted olefins that are otherwise hard to synthesize. Further optimization of the 
catalyst system with the goal of increasing the substrate scope, lowering the reaction 
temperatures and performing fully stereo-retentive cross-couplings of isomerically pure 
alkenyl mesylates are still desirable. 
CHAPTER 5 
133 
 
5.4 References 
 
1  a) L. J. Gooßen, F. Manjolinho, B. A. Khan, N. Rodríguez, J. Org. Chem. 2009, 74, 
2620-2623; b) L. J. Gooßen, W. R. Thiel, N. Rodríguez, C. Linder, B. Melzer, Adv. 
Synth. Catal. 2007, 349, 2241-2246. 
2  a) L. J. Gooßen, N. Rodríguez, C. Linder, P. P. Lange, A. Fromm, ChemCatChem 2010, 
2, 430-442; b) L. J. Gooßen, C. Linder, N. Rodríguez, P. P. Lange, A. Fromm, Chem. 
Commun. 2009, 7173-7175. 
3  a) F. Collet, B. Song, F. Rudolphi, L. J. Gooßen, Eur. J. Org. Chem. 2011, 6486-6501; 
b) F. Rudolphi, B. Song, L. J. Gooßen, Adv. Synth. Catal. 2011, 353, 337-342; c) L. J. 
Gooßen, F. Rudolphi, C. Oppel, N. Rodríguez, Angew. Chem. Int. Ed. 2008, 47, 3043-
3045. 
4   L. J. Gooßen, B. Zimmermann, T. Knauber, Angew. Chem. Int. Ed. 2008, 47, 7103-
7106. 
5  a) L. J. Gooßen, N. Rodríguez, C. Linder, J. Am. Chem. Soc. 2008, 130, 15248-15249; b) 
L. J. Gooßen, C. Linder, N. Rodríguez, P. P. Lange, Chem. Eur. J. 2009, 15, 9336-9349. 
6  L. J. Gooßen, N. Rodríguez, P. P. Lange, C. Linder, Angew. Chem. Int. Ed. 2010, 49, 
1111-1114. 
7  P. J. Stang, M. Hanack, L. R. Subramnian, Synthesis 1982, 85-126. 
8  Ionization Constants of Organic Acidsin Solution (Eds.: E. P. Serjeant, B. Dempsey), 
Pergamon, Oxford, UK, 1979 (IUPAC Chemical Data Series No. 23). 
9  V. Percec, J.-Y. Bae, B. H. Hill, J. Org. Chem. 1995, 60, 1060-1065. 
10  M. Ueda, A. Saitoh, S. Oh-tani, N. Miyaura, Tetrahedron, 1998, 54, 13079-13086. 
11  J.-G. Lei, M.-H. Xu, G.-Q. Lin, Synlett 2004, 2364-2368 
12  B. M. Rosen, K. W. Quasdorf, D. A. Wilson, N. Zhang, A.-M. Resmerita, N. K. Garg, 
V. Percec, Chem. Rev. 2011, 111, 1346-1416 
13 A. F. Littke, G. Fu, Angew. Chem. Int. Ed. 1998, 37, 3387-3388. 
14 B. C. Hamann, J. F. Hartwig, J. Am. Chem. Soc. 1998, 120, 7369-7370. 
15  J. P. Wolfe, S. L. Buchwald, Angew. Chem. Int. Ed. 1999, 38, 2413-2416. 
16 a) A. Zapf, A. Ehrentraut, M. Beller, Angew. Chem. Int. Ed. 2000, 39, 4153-4155. b) A. 
Zapf, M. Beller, Chem. Eur. J. 2004, 10, 2983-2990. 
17 S. Urgaonkar, J.-H. Xu, J. G. Verkade, J. Org. Chem. 2003, 68, 8416-8423. 
18  C. M. So, C. P. Lau, F. Y. Kwong, Angew. Chem., Int. Ed. 2008, 47, 8059-8063. 
19  C. M. So, Z. Zhou, C. P. Lau, F. Y. Kwong, Angew. Chem. Int. Ed. 2008, 47, 6402-
6406. 
20  P. Y. Choy, W. K. Chow, C. M. So, C. P. Lau, F. Y. Kwong, Chem. Eur. J. 2010, 16, 
9982-9985. 
21  C. M. So, H. W. Lee, C. P. Lau, F. Y. Kwong, Org. Lett. 2008, 11, 317-320. 
22  P. Y. Yeung, C. M. So, C. P. Lau, F. Y. Kwong, Angew. Chem. Int. Ed. 2010, 49, 8918-
8922. 
23  C. M. So, C. P. Lau, F. Y. Kwong, Chem. Eur. J. 2011, 17, 761-765. 
24  W. K. Chow, C.M. So, C. P. Lau, F. Y. Kwong, Chem. Eur. J. 2011, 17, 6913–6917. 
25  L. Zhang, J. Qing, P. Yang, J. Wu, Org. Lett. 2008, 10, 4971-4974. 
26  L. Ackermann, A. Althammer, S. Fenner, Angew. Chem. Int. Ed. 2009, 48, 201-204. 
27  L. Ackermann, S. Fenner, Chem. Commun. 2011, 47, 430-432. 
28  J. R. Naber, B. P. Fors, X. X. Wu, J. T. Gunn, S. L. Buchwald, Heterocycles, 2010, 80, 
1215–1226. 
29  B. Bhayana, B. P. Fors, S. L. Buchwald, Org. Lett. 2009, 11, 3954-3957. 
30  G. A. Molander, F. Beaumard, Org. Lett. 2011, 13, 1242-1245. 
 
DECARBOXYLATIVE CROSS-COUPLING OF MESYLATES 
134 
 
31  B. P. Fors, D. A. Watson, M. R. Biscoe, S. L. Buchwald, J. Am. Chem. Soc. 2008, 130, 
13552-13554. 
32  K. Dooleweerdt, B. P. Fors, S. L. Buchwald, Org. Lett. 2010, 12, 2350-2353. 
33  R.H. Munday, J. R.Martinelli, S. L. Buchwald, J. Am. Chem. Soc. 2008, 130, 2754-2755 
34  The DFT calculation indicates that the transmetalation step is crucial for the 
decarboxylative coupling reaction. This manuscript is under preparation in our group. 
35  a) V. Farina, B. Krishnan, J. Am. Chem. Soc. 1991, 113, 9585-9595; b) V. Farina, S. 
Kapadia, B. Krishman, C. Wang, L. S. Liebeskind, J. Org. Chem. 1994, 59, 5905-
5911.c) A. L. Casado, P. Espinet, J. Am. Chem. Soc. 1998, 120, 8978-8985; c) A. L. 
Casado, P. Espinet, A. M. Gallego, J. Am. Chem. Soc. 2000, 122, 11771-11782. 
36  L. J. Gooßen, D. Koley, H. L. Hermann, W. Thiel, J. Am. Chem. Soc. 2005, 127, 11102-
11114. 
37  A. Figge, H. J. Altenbach, D. J. Brauer, P. Tielmann, Tetrahedron: Asymmetry 2002, 13, 
137-144. 
38  a) K. H. Chung, C. M. So, S. M. Wong, C. H. Luk, Z. Zhou, C. P. Lau, F. Y. Kwong, 
Chem. Commun. 2012, 48, 1967-1969; b) S. M. Wong, C. M. So, K. H. Chung, C. P. 
Lau, F. Y. Kwong, Eur. J. Org. Chem. 2012, 4172-4177. 
39  CCDC 904069 contains the supplementary crystallographic data for this paper. These 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre 
via www.ccdc.cam.ac.uk/data_request/cif. 
40  D. S. Plich, E. J. Lavoie, M. Kaul, A. Parhi, PTC Int. Appl. WO2010083436, 2010. 
41  a) D. T. Gryko, D. Wyrostek, A. Nowak-Król, K. Abramczyk, M. K. Rogacki, Synthesis 
2008, 4028-4032; b) Y. Zhang, J. Wen, J. Fluor. Chem. 1991, 52, 333-340. 
42  For reviews, see: a) J. Ruan, J. Xiao, Acc. Chem. Res. 2011, 44, 614-626; b) W. Cabri, I. 
Candiani, Acc. Chem. Res. 1995, 28, 2-7. 
43  K. Maeda, E. J. Farrington, E. Galardon, B. D. John, J. M. Brown, Adv. Syn. Catal. 
2002, 344, 104-109. 
44  Y. Yu, S. K. Singh, A. Liu, T.-K. Li, L. F. Liu, E. J. LaVoie, Bioorg. Med. Chem. 2003, 
11, 1475-1491. 
45  For reviews, see: a) B. E. Maryanoff, A. B. Reitz, Chem. Rev. 1989, 89, 863-927; b) A. 
Fürstner, Chem. Rev. 1999, 99, 991-1045; c) O. G. Kulinkovich, A. de Meijere, Chem. 
Rev. 2000, 100, 2789-2834; d) L. F. van Staden, D. Gravestock, D. J. Ager, Chem. Soc. 
Rev. 2002, 31, 195-200; e) R. Dumeunier, I. E. Marko, in Modern Carbonyl Olefination, 
Wiley-VCH, Weinheim, 2004, pp. 104-150. 
46  a) P. Y. Wong, W. K. Chow, K. H. Chung, C. M. So, C. P. Lau, F. Y. Kwong, Chem. 
Commun. 2011, 47, 8328-8330; b) L, Xu, B.-J. Li, Z.-H. Wu, X.-Y. Lu, B.-T. Guan, B.-
Q. Wang, K.-Q. Zhao, Z.-J. Shi, Org. Lett. 2010, 12, 884-887; c) C.-L. Sun, Y. Wang, X. 
Zhou, Z.-H. W, B.-J. Li, B.-T. Guan, Z.-J. Shi, Chem. Eur. J. 2010, 16, 5844-5847; d) C. 
M. So, C. P. Lau, A. S. C. Chan, F. Y. Kwong, J. Org. Chem. 2008, 73, 7731-7734. 
47  a) H. Zhou, Y.-H. Xu, W.-J. Chung, Angew. Chem. Int. Ed. 2009, 48, 5355-5357; b) H. 
Zhou, W.-J. Chung, Y.-H. Xu, T.-P. Loh, Chem. Commun. 2009, 3472-3474; c) E. 
Shirakawa, Y. Imazaki, T. Hayashi, Chem. Lett. 2008, 37, 654-655; d) F.-L. Yang, X.-T. 
Ma, S.-K. Tian, Chem. Eur. J. 2012, 18, 1582-1585; e) N. Handler, G. Brunhofer, C. 
Studenik, K. Leisser, W. Jaeger, S. Parth, T. Erker, Bioorg. Med. Chem. 2007, 15, 6109-
6118; f) S. Some, J. K. Ray, M. G. Banwell, M. T. Jones, Tetrahedron Lett. 2007, 48, 
3609-3612; g) D. Tanaka, A. G. Myers, Org. Lett. 2004, 6, 433-436; h) B. Scheiper, M. 
Bonnekessel, H. Krause, A. Früstner, J. Org. Chem. 2004, 69, 3943-3949; i) A. 
Meurling, Chemica Scripta, 1987, 27, 349-354; j) T. L. Gilchrist, R. J. Summersell, 
Tetrahedron Lett. 1987, 28, 1469-1472. 
48  a) T. M. Gøgsig, L. S. Søbjerg, A. T. Lindhardt, K. L. Jensen, T. Skrydstrup, J. Org. 
Chem. 2008, 73, 3404-3410; b) L. Joucla, G. Cusati, C. Pinel, L. Djakovitch, 
 
CHAPTER 5 
135 
 
Tetrahedron Lett. 2008, 49, 4738-4741; c) Y. Yabe, T. Maegawa, Y. Monguchi, H. 
Sajiki, Tetrahedron, 2010, 66, 8654-8660.  
49  S. E. Denmark, C. R. Butler, Org. Lett. 2006, 8, 63-66. 
50  Y. Takahashi, N. Hashimoto, T. Hara, S. Shimazu, T. Mitsudome, T. Mizugaki, K. 
Jitsukawa, K. Kaneda, Chem. Lett. 2011, 40, 405-407. 
51  H. Lebel, M. Davi, S. Díez-González, S. P. Nolan, J. Org. Chem. 2007, 72, 144-149. 
 
  
Chapter 6 
 
 
 
Low-Temperature Decarboxylative Cross-Coupling Reactions 
Promoted by Customized Pyrimidinyl Phosphine Ligands 
 
 
 
 
 
 
 
 
 
 
 
 
 
LOW-TEMPERATURE DECARBOXYLATIVE CROSS-COUPLINGS 
138 
6.1 Introduction 
Within the last decades, significant developments have advanced the decarboxylative cross-
coupling reactions towards being powerful alternatives for regiospecific C-C and C-
heteroatom bond formations.
1
 Although substantial efforts made in the past several years 
strongly broaden the applications of decarboxylative cross-coupling reactions in a wide 
spectrum of coupling reactions, their practical applicability is still limited by relatively high 
reaction temperatures, especially in the case of redox-neutral process, which represents one of 
the most efficient and versatile methods for the C-C bond formations (Scheme 1). 
 
Scheme 1. Decarboxylative coupling reactions. 
In oxidative decarboxylative cross-coupling reactions, due to the use of excessive oxidants, 
often Ag2CO3, which can also serve as a decarboxylation catalyst, the reaction temperatures 
could be somewhat reduced to around 120 °C. The only one exception involves the oxidative 
decarboxylative cross-coupling of N-phenylacetamides with oxocarboxylic acids (Scheme 2).
2
 
In the presence of stoichiometric amounts of a strong oxidant, (NH4)2S2O8, oxocarboxylic 
acids readily undergo decarboxylation at room temperature, generating acylating reagents for 
the in situ formed amide-direct palladacycle. However, when changing the directing group to 
pyridine, the similar decarboxylative dehydrogenative cross-couplings occurred at 120 °C.
3
 
 
Scheme 2. Pd-catalyzed oxidative decarboxylative coupling of oxocarboxylic acids with 
arenes bearing directing groups. 
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In chapter 4, we have described a breakthrough to lower the reaction temperature by 
introducing a primary amine into the reaction mixture, in which case the activation barrier of 
decarboxylation step would be reduced by the in situ formed -iminocarboxylates (Scheme 
3).
4
 This new strategy employed allows us to conduct the decarboxylative cross-coupling of 
oxocarboxylic acids with aryl halides at 100 °C, that is 70 °C lower than the formerly reported 
protocol, whereas it is only applicable to -oxocarboxylic acids.5 
 
Scheme 3. Access to ketones and imines by Pd/Cu-catalyzed decarboxylative cross-couplings. 
Although a few examples involving the low-temperature oxidative decarboxylative coupling 
reactions have been developed, they are only applicable to specific substrates, in which 
certain directing groups need to be pre-embeded. Moreover, all these methods suffer from 
using expensive oxidants in excessive quantities, resulting in low functional-group tolerance. 
By contrast, the redox-neutral decarboxylative processes normally require bimetallic catalysts 
in both catalytic quantities. In the above chapters, we have shown that redox-neutral 
decarboxylative cross-coupling reactions mediated by Pd/Cu
6
 and Pd/Ag
7
 bimetallic catalyst 
systems have a particularly broad substrate scope and high functional-group tolerance in both 
coupling partners. In this context, the key challenge currently facing us is to establish a new 
catalyst system that allows the redox-neutral decarboxylative cross-coupling reactions to 
proceed efficiently at much lower temperatures. 
6.2  Mechanistic considerations 
In redox-neutral decarboxylative coupling reactions, a copper or silver catalyst is required to 
release carbon nucleophiles by the extrusion of CO2. These organometallic fragments are 
transmetallated to the palladium catalyst, where their couplings with aryl electrophiles take 
place (Scheme 4). The difficulties in the decarboxylation and transmetallation steps strongly 
influence the rate of the whole coupling process. 
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Scheme 4. Mechanism of the neutral-redox decarboxylative cross-coupling reactions. 
During the mechanistic studies carried out in our group, we have demonstrated that the 
decarboxylation constitutes the rate determining step in most cases.
8
 In the presence of a 
coper-phenanthroline complex, the decarboxylation of most of the aromatic carboxylic acids 
occurs efficiently at temperatues above 170 °C (Scheme 5),
9
 and as a result the 
decarboxylative coupling process takes place normally at temperatures within a range of 170-
190 °C.
10
 The development of an effective decarboxylation catalyst appeared to be an obvious 
task with the goal of achieving low-temperature redox-neutral decarboxylative coupling 
reactions. 
 
Scheme 5. Redox-neutral decarboxylative reactions using copper as decarboxylation co-
catalysts. 
DFT calculations led us to find a silver-based catalyst with improved protodecarboxylation 
activity at temperatures as low as 80 °C (Scheme 6).
11
 A new catalyst system consisting of a 
silver co-catalyst with a palladium salt was thus developed, that allows the decarboxylative 
cross-coupling of aryl carboxylic acids with aryl triflates to occur readily at 130 °C, which is 
50 °C higher than the protodecarboxylation in the case of the coupling reactions starting from 
2-nitrobenzoic acid, indiating that the transmetallation step is crucial to the whole catalytic 
transformation.
12
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Scheme 6. Redox-neutral decarboxylative reactions using silver as decarboxylation co-
catalysts. 
Our DFT calculations
13
 also show that gold catalyst is even more effective for the 
protodecarboxylation compared to silver. Recently, this hypothesis was verified by the 
research groups of Nolan
14
 and Larrosa (Scheme 7),
15
 however, the resulting C–Au bond in 
the aryl gold intermediates is extremely strong to the extent that the transfer of these aryl gold 
species to other metal catalysts is greatly hampered. Palladium
16 
 and rhodium
17
 could also 
facilitate the protodecarboxylation, albeit restricted to specific substrates such as polyfluoro- 
and dimethoxy-aryl carboxylic acids. 
 
Scheme 7. Gold-catalyzed protodecarboxylation of aromatic carboxylic acids. 
Although the Pd/Ag-catalyzed redox-neutral decarboxylative cross-coupling reactions could 
proceed at only 130 °C, all the attempts towards a further decline of reaction temperatures 
based on the improvement of decarboxylation catalyst have all failed so far. Our aim in this 
project is to develop a new catalyst system that allows efficient cross-couplings of 
(hetero)aryl carboxylic acids with aryl halides or pseudohalides at an unprecedentedly low 
reaction temperature. 
In the presence of silver and coper catalysts, decarboxylation of 2-nitrobenzoic acid occurs 
readily at temperatues as low as 80 °C and 120 °C (Scheme 8), repectively. However, their 
efficient cross-coupling reactions with aryl halides or pseudohalides take place only when the 
reaction temperature reaches 130 °C for silver, and 170 °C for copper. These big differences 
again imply that the transmetallation step might be the actual rate determing step in the 
decarboxylative coupling reactions that start from 2-nitrobenzoic acid.
18
 It is noteworthy that 
the difficulty of this step will, even be incressed at low reaction temperatures.
19
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Scheme 8. Protodecarboxylation and decarboxylative coupling of 2-nitrobenzoic acid. 
Therefore, the solution to achieve low-temperature decarboxylative cross-couplings will not 
only lie in the development of more efficient decarboxylation catalysts, but also depends on 
the improvement of the coupling catalysts. A balance between the decarboxylation and 
transmetallation has to be established in such a way that both of these two steps would be 
facilitated at a low temperature. 
Our investigation on the ligand effects in the transmetallction step in chapeter 5 indicates that 
the transmetallation step can be accelerated by employing a specific phosphine ligand that 
features a potentially coordinating heteroatom in close proximity to the phosphorus, which 
enchances -back-donation. We envisage that a modification of such phosphine ligand by 
introducting a multi-nitrogen-donor moiety that could also offer a potentially coordinationg 
site to a copper catalyst would probably bring the two metal catalysts sufficiently close to 
each other, resulting in a positive impact on both decarboxylation and transmetallation 
processes (Figure 1). 
 
Figure 1. A potential ligand model for both decarboxylation and coupling catalysts. 
In search of a potential candidate which would facilitate both decarboxylation and 
transmetallation, the pyrimidinyl phosphine ligands developed by the group of W. R. Thiel 
fullfill these criteria (Figure 2). These heterocyclic phosphines feature a pyrimidinyl moiety, 
containing multiple nitrogen donor atoms, along with a 2-heteroarylphenyl phospino group, 
which could coordinate to the copper and palladium atoms respectively. These new ligands 
have achieved highly catalytic activites for the Pd-catalyzed Suzuki-Miyaura cross-coupling 
of aryl boronic acids with aryl halides (Scheme 9).
20
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Figure 2. Pyrimidinyl phosphine ligands developed by Thiel. 
 
Scheme 9. Application of Thiel ligands in Suzuki-Miyaura reactions. 
6.3 Results and discussion 
We started our investigation by employing four typical Thiel phosphine ligands in the 
decarboxylative cross-coupling of 2-nitrobenzoate (1a) with 4-chlorophenyl triflate (2a) at 
different temperatures (Table 1). These pyrimidinyl phosphines showed highly catalytic 
activities comparable to the standard ligand P(p-Tol)3 at elevated temperatures such as 150 °C 
and 170 °C. However, the differences become obvious when the reactions were conducted at 
110 °C. Using the Thiel ligands, especially L2 and L3, we still observed quantative yields of 
the desired products, while only small quantities were detected when using P(p-Tol)3. Below 
90 °C, P(p-Tol)3 was completely inactive, whereas L1-L3 could still give satisfactory results. 
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Table 1. Preliminary study on the decarboxylative coupling by using Thiel ligands.
[a]
 
 
Entry L 
Yield (%) 
90 °C (24h) 110 °C (24h) 150 °C (2h) 170 °C (2h) 
1 P(p-Tol)3 0 25 92 91 
2 L1 27 69 90 88 
3 L2 21 97 85 85 
4 L3 18 92 95 95 
5 L4 0 37 46 57 
[a] Reaction conditions: 0.5 mmol of potassium carboxylate, 1 mmol of triflate, 5 mol% Cu2O, 
10 mol% 1,10-phenanthroline, 2 mol% PdI2, 6 mol% L, 2.0 mL of NMP, 150 °C, 2 h; 170 °C, 
1 h, GC yield without calibration. 
The fact that the decarboxylative cross-coupling of 2-nitrobenzoate with 4-chlorophenyl 
triflate readily occurs at temperatures as low as 90 °C encouraged us to further optimize the 
reaction conditions at 100 °C (Table 2). This transformation could still undergo slowly when 
the 1,10-phenanthroline was excluded (entries 5-7), while the reaction was completely 
inhibited when the preformed copper complex [CuPhenPPh3Br] was used instead of Cu2O 
(entries 8-10). These results indicate that there is no fast ligand exchange within the reaction 
mixture. The real decarboxylation catalyst involves a copper complex which probably 
contains both 1,10-phenanthroline and the pyrimidinyl phosphine ligands. 
The ratio of the two substrates is crucial for the reaction, and the yield was increased by using 
an excessive amount of benzoate 1a (Table 2, entries 12-13). Other pyrimidinyl phosphines 
were also investigated for the catalytic reaction (entries 14-20). Yields were much lower when 
using the sterically congested ligand L5 (entry 14). All ligands containing an NH group turned 
out to be less effective than the ones bearing tertiary amino nitrogen atom (entries 15-19). 
However, among these secondary amino substituted phosphines, the electron-rich ones 
(entries 15-16, 19) showed higher catalytic activities compared to those ligands containing 
electron-withdrawing groups (entries 17-18). Silver co-catalysts for the decarboxylation were 
also compatible with these new ligands, but are less effective (entries 21-22). Changing PdI2 
to Pd(acac)2 led to further improved results (entries 23-24), while replacing the phenyl 
substituent in the phosphino moiety by a p-tolyl group did not significantly affect the 
observed yield (entry 24). 
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Table 2. Optimization of the low-temperature decarboxylative cross-couplings.
[a]
 
 
Entry [Pd] L [Cu] / [Ag] L’ Yield [%] 
1 PdI2 P(p-Tol)3 Cu2O 1,10-phen 16 
2 PdI2 L1 Cu2O 1,10-phen 37 
3 PdI2 L2 Cu2O 1,10-phen 40 
4 PdI2 L3 Cu2O 1,10-phen 30 
5 PdI2 L1
[b]
 Cu2O — 20 
6 PdI2 L2
[b]
 Cu2O — 20 
7 PdI2 L3
[b]
 Cu2O — 11 
8 PdI2 L1
[b]
 [CuPhenPPh3Br]
[c]
 — 0 
9 PdI2 L2
[b]
 [CuPhenPPh3Br]
[c]
 — 0 
10 PdI2 L3
[b]
 [CuPhenPPh3Br]
[c]
 — 0 
11 PdI2 P(p-Tol)3 Cu2O 1,10-phen 23 
12 PdI2 L1 Cu2O 1,10-phen 60 
13 PdI2 L2 Cu2O 1,10-phen 65 
14 PdI2 L5 Cu2O 1,10-phen 5 
15 PdI2 L7 Cu2O 1,10-phen 37 
16 PdI2 L8 Cu2O 1,10-phen 48 
17 PdI2 L9 Cu2O 1,10-phen 29 
18 PdI2 L10 Cu2O 1,10-phen 26 
19 PdI2 L11 Cu2O 1,10-phen 45 
20 PdI2 L12 Cu2O 1,10-phen 21 
21 PdCl2
[d]
 L1
[e]
 Ag2CO3 2,6-lutidine
[f]
 41 
22 PdCl2
[d]
 L2
[e]
 Ag2CO3 2,6-lutidine
[f]
 18 
23 Pd(acac)2 L2 Cu2O 1,10-phen 82 
24 Pd(acac)2 L6 Cu2O 1,10-phen 77 
[a] Reaction conditions: 1a / 2a = 1:1.5 (entries 1-10), 1a / 2a = 1:1.5 (entries 11-23), [Pd] 
(2.0 mol%), L (6.0 mol%), [Cu] or [Ag] (5.0 mol%), L’ (10.0 mol%), NMP (2.0 mL), 100 °C, 
24 h; Yields determined by GC analysis using n-tetradecane as the internal standard. 1,10-
phen = 1,10-phenanthroline; NMP = N-methyl pyrrolidine. [b] 15.0 mol%. [c] 10.0 mol%. [d] 
3.0 mol%. [e] 9.0 mol%. [f] 20.0 mol%. 
We next investigated the influence of the decarboxylation co-catalysts on the low-temperature 
decarboxylative cross-coupling process (Table 3). Different copper catalyst precursors, along 
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with the common chelating nitrogen ligands were screened under the preliminarily optimized 
conditions. CuBr showed a catalytic activity similar to Cu2O (entry 3), while CuCl was less 
effective (entry 2). All the preformed copper complexes gave rather low yields, presumably 
due to the lack of the coordination sites for the pyrimidinyl phosphine ligands (entries 4-6). 
As for the tested chelating nitrogen ligands, the phenanthroline type showed higher activities 
(entries 7-10). However, ligands containing strong electron withdrawing groups such as NO2 
led to extremely poor yield (entry 7). 
Table 3. Screening of copper sources and their supporting ligands.
[a]
 
 
Entry [Cu]] L’ Yield [%] 
1 Cu2O 1,10-phen 82 
2 CuCl 1,10-phen 60 
3 CuBr 1,10-phen 80 
4 [CuPhenPPh3Cl]
[b]
 — 29 
5 [CuPhenPPh3Br]
[b]
 — 20 
6 [CuPhen(PPh3)2NO2]
[b]
 — 15 
7 Cu2O 
 
9 
8 Cu2O 
 
72 
9 Cu2O 
 
66 
10 Cu2O 
 
17 
[a] Reaction conditions: 1a / 2a = 1:1.5, Pd(acac)2 (2.0 mol%), L2 (6.0 mol%), [Cu] 
(5.0 mol%), L’ (10.0 mol%), NMP (2.0 mL), 100 °C, 24 h; Yields determined by GC analysis 
using n-tetradecane as the internal standard. [b] 10.0 mol%. 
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Several commonly used solvents for decarboxylative cross-couplings have also been 
employed in our low-temperature process (Table 4). The unpolar solvent mesitylene was not 
compatible with this transformation due to the poor solubility of benzoate (entry 2), whereas 
the introduction of NMP could dramatically improve the yields (entries 4-5). Other more 
polar solvents such as quinoline, DMF, DMSO and diglyme could be used for the catalytic 
reaction, albeit resulting in lower yields (entries 3, 6-8). The fact that the coupling reaction 
could even take place with moderate yields in the presence of small quantities of water 
indicates that the transmetallation step is greatly facilitated by the new pyrimidinyl phosphine 
ligands, so that the hydrolytic cleavage of the aryl copper species was suppressed (entry 9). 
Table 4. Screening of solvent.
[a]
 
 
Entry Solvent Yield [%] 
1 NMP 82 
2 mesitylene 0 
3 quinoline 57 
4 NMP / mesitylene (1 / 2) 8 
5 NMP / mesitylene (2 / 1) 68 
6 NMP / DMF (3 / 1) 73 
7 NMP / DMSO (3 / 1) 67 
8 NMP / diglyme (3 / 1) 53 
9 NMP
[b]
 60 
[a] Reaction conditions: 1a / 2a = 1:1.5, Pd(acac)2 (2.0 mol%), L2 (6.0 mol%), Cu2O 
(5.0 mol%), 1,10-phenantrholine (10.0 mol%), NMP (2.0 mL), 100 °C, 24 h; Yields 
determined by GC analysis using n-tetradecane as an internal standard. [b] 2 equivalents of 
water were added to the reaction mixture. 
In order to shed more light on the mechanism of this low-temperature decarboxylative 
coupling reaction, we tested the reaction with preformed palladium complexes prepared by Dr. 
Saeid Farsadpour from the group of Prof. Thiel (Table 5). These palladium complexes have 
proved to be efficient for the Suzuki-Miyaura coupling of arylbronic acids with aryl halides 
even at room temperature. When our reactions were conducted using palladium precursors 
and phosphine ligands separately, a clear trend could be perceptible: L1 > L3 > L7 (entries 1-
3). However, this tendency was completely lost when the preformed palladium complexes 
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were used under the same reaction conditions, and only traces of the desired products were 
detected (entries 4-6). These results further imply that the new pyrimidinyl phosphine ligands 
are probably part of a complicated complex which bridges palladium and copper species. 
Table 5. Control experiments with different Pd complexes as catalysts.
[a]
 
 
Entry [Pd] L [Cu]] L’ Yield [%] 
1 PdCl2 L1 Cu2O 1,10-phen 79 
2 PdCl2 L3 Cu2O 1,10-phen 40 
3 PdI2 L7 Cu2O 1,10-phen 37 
4 
PdCl2-L1 
— Cu2O 1,10-phen 10 
5 
 PdCl2-L3 
— Cu2O 1,10-phen 9 
6 
 PdCl2-L7 
— Cu2O 1,10-phen 9 
[a] Reaction conditions: 1a / 2a = 1:1.5, [Pd] (2.0 mol%), L (6.0 mol%), [Cu] (5.0 mol%), L’ 
(10.0 mol%), NMP (2.0 mL), 100 °C, 24 h; Yields determined by GC analysis using n-
tetradecane as the internal standard. 
The new catalyst system is not restricted to aryl triflates. The internal vinyl triflate 2b was 
also smoothly converted into the corresponding product in quantative yield (Scheme 10). 
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Scheme 10. Decarboxylative cross-coupling of benzoate with vinyl triflate. 
6.4 Conclusions and outlook 
In summary, we have developed a new catalyst system that for the first time allows the 
decarboxylative coupling at only 100 °C, which is 70 °C lower than the standard process. A 
new class of pyrimidinyl phosphine ligands developed by the group of Thiel plays a 
prominent role in the low-temperature process, in which a complicated Pd/Cu bimetallic 
complex bridged by the ligand might be formed. Several preformed palladium complexes 
containing the new ligands were employed in the coupling reactions, albeit resulting in 
extremely low yields. These control experiments further imply that a complicated Pd-Cu 
complex bridiging by the pyrimidinyl phosphines is probably formed in the reaction. After 
systematic optimization of the reaction conditions, the decarboxylative cross-coupling of 2-
nitrobenzoate with 4-chlorophenyl triflate could readily occur at 100 °C, forming the 
corresponding biaryl in almost quantative yield. Moreover, the optimal conditions are also 
applicable to vinyl triflates. This is of great interest, since the alkenyl triflates are accessible in 
broader diversity than the corresponding halides. The full investigation of a wide range of 
(hetero)aryl carboxylic acids along with aryl and alkenyl triflates is subject to research in our 
group (Scheme 10). 
 
Scheme 10. Decarboxylative coupling of (hetero)aryl carboxylates with aryl / alkenyl triflates. 
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In this thesis, applications of carboxylic acids and their derivatives in transition metal-
catalyzed cross-coupling reactions were explored. In five related projects, several 
synthetically useful methods for the sustainable synthesis of important organic building 
blocks such as aryl acetates, diaryl acetates, imines, ketones, biaryls, styrenes and poly-
substituted alkenes through the activation of carboxylic acids and their derivatives were 
successfully established (Scheme 1). 
 
Scheme 1. Carboxylic acids and their derivatives in cross-coupling reactions. 
In the fist project, an efficient and practical protocol for the synthesis of arylacetate esters 
through the dealkoxycarbonlative cross-coupling reaction between aryl halides and malonates 
was developed (Scheme 1, i). In addition to arylacetates, a straightforward approach to the -
diarylacetates from acetic acid esters was then developed in the second project (ii). Activation 
of the -proton of esters by a copper catalyst allowed the deprotonation of esters even in the 
presence of mild bases. In the rest part of this thesis, several important achievements in 
decarboxylative cross-coupling reactions were demonstrated (iii-vi). The addition of a 
primary amine into the coupling reaction of -oxocarboxylic acids and aryl halides led to an 
unprecedented low-temperature redox-neutral decarboxylative coupling process, providing a 
green and efficient method for the preparation of azomethines (iii). A minor modification of 
this protocol allowed us to easily access the corresponding ketones (iv). The decarboxylative 
coupling of robust aryl mesylates as well as polysubstituted alkenyl mesylates using our 
customized imidazolyl phosphine ligands was also realized, further expanding the scope of 
carbon electrophiles in decarboxylative coupling reactions (v). Variation of the ligands led to 
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two complementary protocols, providing the corresponding biaryls and polysubstituted olefins 
in high yields. In the end, an important breakthrough in redox-neutral decarboxylative 
coupling reactions was achieved (vi). The use of a new class of pyrimidinyl phosphine ligands 
developed by the group of W. R. Thiel dramatically reduced the reaction temperatures of 
decarboxylative couplings between aromatic carboxylic acids and aryl or alkenyl triflates. The 
new catalyst system for the first time allowed the efficient decarboxylative biaryls synthesis at 
only 100 °C. 
Dealkoxycarbonylative coross coupling of malonates (i) 
In the first project, a new and convenient entry to pharmaceutically and biologically important 
arylacetates was developed. In this protocol, aryl malonates serve as both solvent and starting 
materials. Our strategy involves the cross-coupling of malonates between aryl halides, 
followed by the alkoxydecarbonylation of the arylated malonate intermediates. A new catalyst 
system that not only allows the efficient coupling reaction, but also facilitates the subsequent 
decarboxylation step is thus required. 
The dealkoxycarbonylation step proceeds rapidly for electron-deficient and sterically 
demanding derivatives, but is much slower for electron-rich 2-arylmalonates. Two 
complementary reaction protocols were necessary to provide a general synthetic entry to alkyl 
2-arylacetates. The optimal conditions for the coupling of electron-rich aryl halides involve 
Pd(dba)2 (0.5 mol%) / P(t-Bu)3•HBF4 (1.1 mol%) as the catalyst and 18-crown-6 (0.5 equiv.) / 
potassium phosphate (2.8 equiv.) as the base. This base / crown ether combination is crucial 
for a quantitative dealkoxycarbonylation (Scheme 2). 
 
Scheme 2. Dealkoxycarbonylative coupling of malonates with electron-rich aryl halides. 
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In contrast, electron-deficient and sterically demanding aryl halides were efficiently coupled 
in the absence of crown ether, using a 1:1 potassium carbonate / bicarbonate mixture as the 
base (Scheme 2). This way, the competing protodehalogenation of the aryl halides, otherwise 
a major side reaction, was effectively suppressed.  
Diarylation of alkyl acetates (ii) 
In a related project, a straightforward approach to diarylacetates through the Pd/Cu-catalyzed 
di--arylation of simple acetic acid esters was then developed. The precedent synthetic 
methods mainly focused on the arylation of 2-arylacetic acids and their derivatives. The 
diarylation of acetic acid esters with aryl halides appeared to be an attractive approach, since 
these substrates are available in great structural variety at low cost. However, in contrast to 2-
arylacetates (ethyl 2-phenylacetate: pKa(DMSO) = 22.7), simple acetic acid esters are much 
harder to deprotonate (ethyl acetate: pKa(DMSO) = 29.5), so that the use of expensive and hard-
to-handle bases such as MHMDS (M = K or Na), LDA, or alkali metal alkoxides seems to be 
unavoidable in arylation processes of these compounds.  
A new catalyst system consisting of a palladium catalyst and a copper complex enabling the 
the use of mild base for the deprotonation of non-activated esters was therefore developed. 
The addition of catalytic quantities of a phenanthroline copper phosphine complex stabilized 
the enolate intermediate to the extent that even mild bases were sufficient to promote the 
conversion of these esters into copper enolates. These intermediates could then be coupled 
with aryl halides at a palladium catalyst under regeneration of the copper co-catalyst. 
After intricate catalyst development, a catalyst system consisting of the phenanthroline copper 
phosphine catalyst Cu(phen)PPh3Br (2.4 mol%), and a palladium co-catalyst (Pd(OAc)2 
(2.2 mol%) / P(t-Bu)3•HBF4 (4.4 mol%) was found to be most effective (Scheme 3). It 
allowed the coupling of alkyl acetates with various aryl halides in the presence of potassium 
phosphate. These are unprecedentedly mild conditions for the arylation of simple esters. 
Control experiments confirm that the copper and palladium catalysts are both required for the 
first arylation step, whereas the second arylation proceeds much faster and does not require 
the copper co-catalyst. The discovery that the -C–H bond of simple esters could be activated 
by catalytic amounts of copper species in the presence of mild base is likely to open up new 
opportunities for the design of related coupling reactions with C-H functionalization. 
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Scheme 3. Di--arylation of simple alkyl acetic acid esters. 
Decarboxylative imine and ketone synthesis (iii) 
In the third project, a one-pot low-temperature decarboxylative process for the convenient 
preparation of azomethines and ketones from oxocarboxylic acids was developed. Via 
condensation with primary amines, -oxocarboxylates (which decarboxylate only at 170 °C) 
were converted into the corresponding -iminocarboxylates, which lost CO2 at much lower 
temperatures (80-100 °C). The coupling of the intermediately formed imidoyl anion 
equivalents led to the formation of azomethines. To validate this hypothesis, a stable 
preformed -iminocarboxylate was thus prepared and used directly for the decarboxylative 
coupling reactions. Various aryl halides were successfully converted into the corresponding 
imines in good yields at only 130 °C, which is already 40 °C lower than the previous protocol 
(Scheme 4).  
 
Scheme 4. Synthesis of azomethines from preformed -iminocarboxylate. 
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The further optimization of the reaction conditions led to an efficient one-pot protocol that 
allowed the convenient assembly of three easily available building blocks into synthetically 
valuable azomethines (Scheme 5). In contrast to most other synthetic approaches to this 
substance class, all three substituents could thus independently be varied. The decarboxylative 
redox-neutral cross-coupling reactions for the first time occurred at 100 °C. This 
unprecedented tandem imine condensation / decarboxylative coupling reaction of -
oxocarboxylates opens up new opportunities for the design of various other decarboxylative 
transformations, including arylations with C-H activation, 1,2- and 1,4-additions, and 
allylation reactions. 
 
Scheme 5. Decarboxylative one-pot imine synthesis. 
In addition to the imine synthesis, a variety of ketones was readily accessed via a minor 
adjustment of the previous protocol (Scheme 6). Moreover, when the imine was treated with a 
3:1 mixture of sodium borohydride and aluminium chloride, the corresponding amine could 
be easily obtained.  
 
Scheme 6. Low-temperature decarboxylative one-pot ketone synthesis. 
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Decarboxylative coupling of aryl and alkenyl mesylates (iv) 
With the help of a new class of imidazolyl phosphine ligands, a breakthrough in neutral-redox 
decarboxylative cross-coupling reactions was achieved, for the first time utilized extremely 
unreactive aryl methanesulfonates (mesylates) as carbon electrophiles. Aryl and alkenyl 
mesylates are particularly attractive carbon electrophiles for applications in both laboratory 
synthesis and large-scale manufacturing processes, since they are easily accessible at low cost 
by esterification of the corresponding phenols and carbonyl enolates with inexpensive 
methanesulfonyl chlorides or anhydrides. These small, stable, inexpensive but rather 
unreactive sulfonates are economically and ecologically advantageous in comparison to the 
large p-toluenesulfonates or the expensive trifluormethanesulfonates. However, there are only 
a few ligand systems which permit the use of these compounds in transition metal catalysis. 
Prior to our experiments with 2-benzimidazolyl-aryl phosphines, all the attempts to achieve a 
decarboxylative coupling of aryl mesylates turned out to be in vain. Our ligands, together with 
Pd originating from Pd(dba)2, are capable of activating aryl mesylates and, at the same time 
permit a transmetallation from copper to palladium.  
A series of benzoimidazolyl phosphines was thus synthesized and applied in the 
decarboxylative coupling of aromatic carboxylic acids with aryl mesylates. After intricate 
optimizations of the reaction parameters, a bimettalic Pd/Cu catalyst system containing a 
customized benzoimidazolyl phosphine for the palladium precursor and a bidentate nitrogen-
chelating ligand for copper salt was thus developed (Scheme 7). 
 
Scheme 7. Decarboxylative cross-coupling of aromatic carboxylic acids with aryl mesylates. 
By employing the dichloro-substituted benzoimidazolyl phosphine ligand, our new reaction 
concept was successfully extended to the alkenyl mesylates (Scheme 8). The decarboxylative 
cross-coupling of mesylates described herein provides a convenient access to a broad array of 
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products, including tetrasubstituted alkenes and vinyl arenes, which are hard to access by 
other means.  
 
Scheme 8. Decarboxylative cross-coupling of aromatic carboxylic acids with alkenyl 
mesylates. 
Low-temperature decarboxylative couplings (v) 
In the last project, the temperature bottleneck of redox-neutral decarboxylative cross-coupling 
reactions was finally overcome. Unlike the low-temperature one-pot decarboxylative process 
using an additional amine as the additive described in chapter 4, the strategy used herein was 
to lower the energy barrier of both decarboxylation and transmetallation steps by rational 
ligand design and intricate reaction development. An ideal ligand class that features a 
combination of the chelating nitrogen moiety and the phosphino group, which is capable of 
complexing with both copper and palladium catalysts, would thus fit these criteria. In close 
collaboration with Prof. Thiel, a new catalyst system that for the first time allowed the 
decarboxylative coupling to occur at only 100 °C (70 °C lower than the standard process) was 
developed. The pyrimidinyl phosphine ligands developed by the group of Thiel played a 
prominent role on the low-temperature process, in which a complicated Pd/Cu bimetallic 
complex bridged by the ligand might be formed. The mechanistic details are still unkown at 
this stage. 
After systematic optimization of the reaction conditions, the decarboxylative cross-coupling 
of 2-nitrobenzoate with 4-chlorophenyl triflate could readily occur at 100 °C, forming the 
corresponding biaryl in almost quantative yield (Scheme 9, i). Moreover, the optimal 
conditions were also applicable to vinyl triflates (ii). This is of great interest, since the alkenyl 
triflates are accessible in broader diversity than the corresponding halides. The full 
investigation on a wide range of (hetero)aryl carboxylic acids along with aryl and alkenyl 
triflates is ongoing work in our group. 
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Scheme 9. Low-temperature decarboxylative cross-coupling of aromatic carboxylic acids 
with aryl and alkenyl triflates. 
Outlook  
Five related projects that make use of carboxylic acids and their dervativies as starting 
materials described in this thesis constitute several important discoveries in decarboxylative 
cross-coupling reactions. At this stage, we have successfully extended the carbon 
electrophiles unsed in decarboxylative cross-coupling reactions to simple, but unreactive 
mesylates by employing imidazolyl phosphine ligands, which greatly facilitate the 
transmetallation step. The next obvious challenge in the filed will be to further expand the 
scope of carbon eletrophiles to more robust carbon electrophiles such as aryl acetates, ethers, 
and even phenols (Scheme 10).  
 
Scheme 10. The use of various caron eletrophiles in decarboxylative couplings. 
However, the reactivity of aryl acetates and methoxylated aromatic compounds are 
exetremely lower compared to aryl mesylates, due to the dramatic increase in the basicity 
(Figure 1).
1
 With the help of transition metals including Ni,
2
 Pd,
3
 Ru,
4
 Rh,
5
 and Fe
6
, several 
research groups have successfully realized the activation of C–O bonds in aryl ethers and 
carboxylates, followed by a subsequent coupling process, providing new methodologies for 
C–C and C–heteroatom bond formations. 7  The key solution to achieve decarboxylative 
couplings of aryl acetates, ethers and even phenols will probably depend on the development 
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of novel and efficient ligands that permit the transmetallation from copper or sivler to one of 
those aforementioned metals. 
 
Figure 1. Various caron eletrophiles. 
Very recently, Cahiez et al.
8
 disclosed a low-temperature decarboxylative cross-coupling 
process (130 °C) by using aliphatic amines such as tetramethylethylenediamine (TMEDA) or 
hexamethylenetetra-amine (HMTA) as ligands instead of the aromatic heterocyclic amines 
(quinoline, phenanthroline) for the copper co-catalyst. This new finding represents another 
important route to low-temperature decarboxylative couplings by accelerating the rate of the 
decarboxylation step. We are optimistic that the border of the reaction temperature of 
decarboxylative coupling reactions will be further overcome by the combination of these 
aliphatic amines with our customized pyrimidyl phosphine ligands. 
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8.1 General Techniques 
8.1.1 Chemicals and Solvents 
All commercially available chemicals were used without any further purification. Air and 
moisture sensitive chemicals were stored under nitrogen or argon. Reaction vessels were 
usually charged with solid starting materials and reagents, evacuated (oil pump  10-3 mbar) 
to remove oxygen and moisture, then backfilled with nitrogen. Solvents and liquid reagents 
were added under an atmosphere of nitrogen. Solvents were purified following standard 
literature techniques and stored over 3Å molecular sieves. Inorganic salts such as KF, K2CO3, 
or K3PO4 were dried under vacuum at 120 °C for 3 hours and stored under nitrogen. Copper 
salts were dried under vacuum at 60 °C for 1 hour. 
8.2 Analytical Methods 
8.2.1 Thin Layer Chromatography 
TLC was performed using analytical silica gel plates 60 F254 and analytical neutral alumina 
plates by Polygram Alox N/UV254 by Merk and Macherey-Nagel. The silica gel (230-
400 mesh, 60 Å) used for column chromatography was purchased from Aldrich. 
8.2.2 Gas Chromatography 
For GC-analysis a Hewlett Packard 6980 chromatograph was used. The carrier gas was 
nitrogen with a flow rate of 149 mL/min (0.5 bar pressure). The temperature of the injector 
was 220 °C. The split-ratio was 1:100. For separation, an Agilent HP-5-column with 5 % 
phenyl-methyl-siloxane (30 x 320 μm x 1.0 μm, 100/ 2.3-30-300/ 3) was used. The following 
temperature program was implemented: starting temperature 60 °C (2 min), linear 
temperature increase (30 °C min
-1
) to 300 °C, end temperature 300 °C (13 min). 
8.2.3 Mass Spectroscopy 
Mass spectrometry was performed using a Varian Saturn 2100 T GC-MS. The ionization was 
done by EI AGC. The intensities of the signals are relative to the highest peak. For fragments 
with isotopes, only the most intensive peak of the isotope is given. High resolution mass 
spectra were acquired on a GC-MS-TOF spectrometer using EI-ionization (Waters). 
Electrospray ionization mass spectrometry (ESI-MS) was performed with a Bruker Esquire 
3000plus ion trap instrument. The ion source was used in positive electrospray ionization 
mode. Scan speed was 13000 m/z / s in normal resolution scan mode (0.3 FWHM / m/z), scan 
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range was at least 50 to 1500 m/z. All spectra were accumulated for at least one minute. 
Sample solutions in toluene at concentrations of 0.007 M were continuously infused into the 
ESI chamber at a flow rate of 4 μL/min using a syringe pump. Nitrogen was used as drying 
gas with a flow rate of 3.0 L/min at 300 °C. The solutions were sprayed at a nebulizer 
pressure of 4 psi (275.8 mbar) and the electrospray needle was typically held at 4.5 kV. The 
instrument was controlled by the Bruker Esquire Control 5.3 software, and data analysis was 
performed using Bruker Data Analysis 3.4 software. 
8.2.4 High-Performance Liquid Chromatography 
HPLC analysis was carried out using a Shimadzu HPLC equipped with a Merck KGaA 
reversed phase column LiChroCart©PAH C 18, with a particle diameter of 5 µm. The 
instrument was operated at a constant temperature of 60 °C and a pressure of 200 bar. 
Acetonitrile and water were used as eluents with a flow rate of 2 mL/min. Gradient: 15 % 
acetonitrile for 3 min linear increase to 85 % within 7 min, hold for 1 min, decrease to 15 % 
within 1 min. and hold for 50 seconds. 5 µL of sample were injected as standard amount into 
the Rheodyne. This amount can be varied manually through the Shimadzu sequence program 
Class-VP. 
8.2.5 Infrared Spectroscopy 
Infrared spectra were recorded with a Perkin-Elmer Fourier Transform Infrared Spectrometer 
FT/IR. Solids were thoroughly ground, and mixed with potassium bromide and pressed into a 
pellet. Liquids were measured as a thin film between sodium chloride plates. Absorbance 
bands are shown in wave numbers (cm
-1
). Intensities are abbreviated: vs (very strong), s 
(strong), m (medium), w (weak) and b (broad). 
8.2.6 Nuclear Magnetic Resonance Spectroscopy 
Proton-, fluorine-, phosphorus-, boron- and decoupled carbon-NMR spectra were recorded 
with a Bruker FT-NMR DPX 200, a DPX 400 and a Bruker Avance 600 spectrometer. The 
frequency and solvent used are described separately for each substance. Chemical shifts are 
given in units of the δ-scale in ppm. Shifts for 1H-spectra are calibrated to the proton signal of 
the solvent used (chloroform: 7.25 ppm, dimethyl sulfoxide: 2.50 ppm, methanol: 3.35 ppm, 
water: 4.75 ppm), for 
13
C-spectra respectively to the deuterated solvent (chloroform: 77.0 ppm, 
dimethyl sulfoxide: 37.7 ppm, methanol: 49.3 ppm). The atom numbering within products is 
not according to the IUPAC rules. The multiplicity of the signals is abbreviated by the 
following letters: Coupling constants are given in Hertz (Hz). Processing and interpretation 
EXPERIMENTAL SECTION 
164 
was performed with ACD/Labs 7.0 and ACD/Labs 12.0 software (Advanced Chemistry 
Development Inc.) 
Signals are abbreviated as s (singlet), d (doublet), dd (doublet of doublet), ddd (doublet of 
doublet of doublet), td (triplet of doublet), q (quartet), quin (quintet), sext (sextet), hept 
(heptet), m (multiplet), br (broad). 
8.2.7 Elemental Analysis 
CHNS-elemental analysis was performed with a Perkin-Elmer Elemental Analyzer EA 2400 
CHNS. 
8.2.8 Melting Point 
Melting points were measured in a glass capillary tube with a Mettler FP61 automatic 
measuring apparatus. 
8.3 High-throughput Experiments 
In order to perform a large number of experiments, a specially manufactured setup was used. 
All reactions were carried out in 20 mL headspace vials that were closed and clamped shut 
with aluminum caps fitted with a Teflon-coated butyl rubber septum (both commercially 
available at Macherey & Nagel).  
   
Figure 1. Aluminum block, magnetic stirrer and vacuum distributer 
In an 8 cm high round aluminum block, which fits on the hot plate of a regular laboratory 
heater in diameter, 10 of these 20 mL headspace vials can be tempered between 25°C and 
180 °C. An 11th smaller hole drilled in the middle of the block creates room to hold the 
thermometer of the heater. A similar setup was used for reactions in autoclaves, except that a 
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4 cm aluminum block containing 8 holes for 10 mL head space vials and a small hole for the 
thermometer. This aluminum block is designed to fit inside the autoclave. Figure 1 shows a 
magnetic stirrer, aluminum block and vacuum distributer (spider) (Fiture 1). 
To correctly evacuate and refill 10 reaction vessels with inert gas at the same time, special 
vacuum distributors were manufactured to be connected to the Schlenk-line. 
A steel tubing is linked to ten 3 mm Teflon tubes, which are equipped on the opposite end 
with adaptors for Luer-Lock syringe needles. The steel tubing can be connected to the 
Schlenk-line just like any other laboratory equipment by a steel olive and vacuum tubing. To 
perform 10 or more reactions in parallel, the following protocol was used. All solid 
substances were weighed in the reaction vessels, an oven-dried, hot 20 mm stir bar added and 
each vessel closed with a separate cap using flanging pliars. All 10 vessels were transferred to 
one of the aforementioned aluminum cases and evacuated using syringe needles connected to 
the vacuum steel tubing. 
The reaction vessels were evacuated and refilled with nitrogen. Using standard sterile and 
Hamilton syringes all liquid reagents, stock solutions of reagents and solvents were added and 
the vessels were evacuated and refilled with nitrogen 3 times. After removal of the needles, 
the aluminum case was tempered to the desired temperature. Every temperature description is 
the case temperature, which only differs by maximum 2 °C from the actual reaction media 
temperature. 
After the reaction time and subsequent cooling to room temperature, any over pressure was 
released with a needle and n-tetradecane was added as internal strandard with a Hamilton 
syringe. The reaction vials were opened carefully. 2 mL of ethyl acetate were added to dilute 
the reaction mixture, then mixed thoroughly with a disposable pipette to ensure a homogenous 
mixture. A 0.25 mL sample was collected and extracted with 2.5 mL of ethyl acetate and 
2 mL of aqueous 1M HCl solution (acidic work up) or saturated potassium bicarbonate 
solution (basic work up). The organic layer was filtered through a pipette filled with a cotton 
plug and NaHCO3 / magnesium sulfate (in case of acidic work up) or only MgSO4, directly 
into a GC-vial. After analyzing sample the GC and, if necessary GC-MS, the contents of all 
work-up and analysis vials were recombined and the product isolated using standard 
procedures, deposed on silica-gel and purified by flash chromatography using a Combi Flash 
Companion-Chromatography apparatus from Isco-Systems. 
The developed experimental setups and an electronic laboratory journal allowed a substantial 
amount of reactions to be performed during the course of this PhD. Approximately 4300 
reactions would have consumed a much longer time when using standard laboratory 
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techniques. Preparative reactions were performed mostly in standard laboratory oven-dried 
glass ware. The following experimental section describes all reaction procedures and 
observations mentioned in chapters 2-6. Yields are isolated yields unless explicitly mentioned. 
All compounds were analyzed by melting point (for solids), 
1
H-NMR, 
13
C-NMR, 
19
F-NMR 
(for fluorinated compounds), 
31
P-NMR (for phosphorous-containing compounds), GC-MS or 
ESI-MS, IR spectroscopy, and elemental analysis or HR-MS. 
8.4 Reactions under Microwave-Irradiation 
All microwave radiation experiments were carried out in a CEM-Discover® LabMate mono-
mode microwave apparatus equipped with an IntelliVent™ pressure control system and a 
vertically-focused IR temperature sensor. The reaction was monitored with CEM’s 
ChemDriver software. After the irradiation period, the reaction vessel was cooled rapidly (60-
120 sec) to ambient temperature by air jet cooling. 
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8.5 Practical Synthesis of 2-Arylacetic Acid Esters via Palladium-
Catalyzed Dealkoxycarbonylative Coupling of Malonates with Aryl Halides 
8.5.1 General Methods for the Synthesis of Ethyl 2-Arylacetates 
Method A: 
A 20 mL Schlenk tube equipped with a rubber cap and a stirrer bar was charged with aryl 
halides (1.00 mmol), bis(dibenzylideneacetone)palladium(0) (0.005 mmol), tri-tert-butyl-
phosphonium tetrafluoroborate (0.011 mmol), potassium phosphate (2.8 mmol), 18-crown-6 
(0.5 mmol) and diethyl malonate (6.6 mmol). The reaction vessel was evacuated and filled 
with nitrogen three times. The reaction mixture was stirred at 160 °C for 8-12 hours. After the 
reaction was complete, the mixture was cooled to room temperature and diluted with ethyl 
acetate. The resulting solution was washed successively with water (20 mL), saturated sodium 
bicarbonate solution (20 mL) and brine (20 mL), dried over MgSO4, filtered, and the solvents 
were removed in vacuo. Purification of the residue by column chromatography (SiO2, 
hexane/ethyl acetate gradient) gave the corresponding products. 
Method B: 
A 20 mL Schlenk tube equipped with a rubber cap and a stirrer bar was charged with aryl 
halides (1.00 mmol), bis(dibenzylideneacetone)palladium (0) (0.005 mmol), tri-tert-butyl-
phosphonium tetrafluoroborate (0.011 mmol), potassium carbonate (1.5 mmol), potassium 
bicarbonate (1.5 mmol) and diethyl malonate (6.6 mmol). The reaction vessel was evacuated 
and refilled with nitrogen three times. The reaction mixture was stirred at 160 °C for 8 hours. 
Upon completion, the reaction mixture was cooled and diluted with ethyl acetate. The solution 
was washed successively with water (20 mL), saturated sodium bicarbonate solution (20 mL) 
and then with brine (20 mL), dried over MgSO4, filtered, and the solvents removed in vacuo. 
Purification of the residue by column chromatography (SiO2, hexane/ethyl acetate gradient) 
gave the corresponding products. 
8.5.2 Synthesis of Aryl acetates 
 
Ethyl 2-(p-tolyl)acetate (2.2-3a) [CAS No. 14062-19-2] 
Compound 2.2-3a was synthesized according to general procedure A from diethyl malonate 
(1.0 ml, 6.6 mmol) and 4-bromotoluene (171 mg, 123 μL, 1.00 mmol) or 4-chlorotoluene 
(128 mg, 120 μL, 1.00 mmol) or 4-iodotoluene (218 mg, 1.00 mmol). After purification by 
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flash column chromatography (SiO2, ethyl acetate - hexane 5:95), 2.2-3a (155 mg, 87 %; 
148 mg, 83 %; 159mg, 89 %) was obtained as a colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.19 (d, J = 8.0 Hz, 2H), 7.14 (d, J = 8.0 Hz, 2H), 4.16 (q, J 
= 8.0 Hz, 2H), 3.58 (s, 2H), 2.34 (s, 3H), 1.26 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): δ = 171.8, 136.6, 131.1, 129.2, 129.1, 60.8, 41.0, 21.0, 14.2 ppm. EI-MS (70 eV), m/z 
(%): 178 (34) [M
+
], 106 (10), 105 (100). IR (NaCl): ν~  = 2980 (vs), 2927 (m), 1735 (vs), 1515 
(m), 1446 (m), 1367 (m), 1301 (m), 1253 (m), 1152 (m), 1032 (m), 809 (m) cm
-1
. EI-HRMS 
m/z calcd. for C11H14O2: 178.0094, m/z found: 178.1000. 
 
Diethyl 2-(p-tolyl)malonate (2.2-5a) [CAS No. 29148-27-4] 
Compound 2.2-5a was obtained as a byproduct in the synthesis of 2.2-3a.  
1
H-NMR (400 MHz, CDCl3): δ = 7.30 (d, J = 8.0 Hz, 2H), 7.18 (d, J = 8.0 Hz, 2H), 4.59 (s, 
1H), 4.26-4.16 (m, 4H), 2.36 (s, 3H), 1.27 (t, J = 8.0 Hz, 6H) ppm. 
13
C-NMR (100 MHz, 
CDCl3): δ = 168.3, 137.9, 129.8, 129.3, 129.1, 61.7, 57.6, 21.1, 14.0 ppm. EI-MS (70 eV), m/z 
(%): 250 (19) [M
+
], 178 (73), 177 (80), 150 (34), 149 (89), 132 (54), 105 (100) 77 (48). IR 
(NaCl): ν~ = cm
-1
. Anal. Calcd. for C14H18O4: C 80.56, H 7.51; found: C 80.77, H 7.20. 
 
Ethyl 2-(4-methoxyphenyl)acetate (2.2-3b) [CAS No. 14062-18-1] 
Compound 2.2-3b was synthesized according to general procedure A from diethyl malonate 
(1.0 ml, 6.6 mmol) and 4-bromoanisole (187 mg, 128 μL, 1.00 mmol). After purification by 
flash column chromatography (SiO2, ethyl acetate - hexane 10:90), 2.2-3b (183 mg, 94 %) 
was obtained as a light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.22 (d, J = 8.0 Hz, 2H), 6.87 (d, J = 8.0 Hz, 2H), 4.16 (q, J 
= 8.0 Hz, 2H), 3.80 (s, 3H), 3.56 (s, 2H), 1.26 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): δ = 171.8, 158.6, 130.1, 126.1, 113.9, 60.7, 55.1, 40.4, 14.1 ppm. EI-MS (70 eV), m/z 
(%): 194 (35) [M
+
], 121 (100), 91 (11), 78 (13), 77 (17). IR (NaCl): ν~ = 2980 (vs), 2935 (m), 
1734 (vs), 1612 (m), 1513 (s), 1465 (m), 1301 (m), 1247 (m), 1176 (m), 1154 (m), 1032 (m), 
820 (m) cm
-1
. Anal. Calcd. for C11H14O3: C 68.02, H 7.27; found: C 67.35, H 7.32. 
 
Ethyl 2-(4-(dimethylamino)phenyl)acetate (2.2-3c) [CAS-No. 17078-29-4] 
Compound 2.2-3c was synthesized according to general procedure A from diethyl malonate 
(1.0 ml, 6.6 mmol) and 4-bromo-N,N-dimethylaniline (200 mg, 1.00 mmol). After 
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purification by flash column chromatography (SiO2, ethyl acetate - hexane 10:90), 2.2-3c 
(199 mg, 96 %) was obtained as a light green oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.17 (d, J = 8.0 Hz, 2H), 6.71 (d, J = 8.0 Hz, 2H), 4.14 (q, J 
= 8.0 Hz, 2H), 3.52 (s, 2H), 2.93 (s, 6H), 1.26 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): δ = 172.2, 149.6, 129.7, 121.9, 112.7, 60.5, 40.6, 40.4, 14.1 ppm. EI-MS (70 eV), m/z 
(%): 208 (14), 207 (67) [M
+
], 134 (100), 118 (12). IR (NaCl): ν~ = 2980 (vs), 2935 (m), 1732 
(vs), 1615 (s), 1523 (vs), 1344 (m), 1255 (m), 1149 (m), 1032 (m), 947 (m), 809 (m) cm
-1
. 
Anal. Calcd. for C12H17NO2: C 69.54, H 8.27, N 6.76; found: C 68.52, H 8.02, N 6.65. 
 
Ethyl 2-(4-(methylthio)phenyl)acetate (2.2-3d) [CAS-No. 14062-27-2] 
Compound 2.2-3d was synthesized according to general procedure A from diethyl malonate 
(1.0 ml, 6.6 mmol) and 4-bromothioanisole (203 mg, 1.00 mmol). After purification by flash 
column chromatography (SiO2, ethyl acetate - hexane 5:95), 2.2-3d (199 mg, 95 %) was 
obtained as a white solid, M.p. 57-58 °C.  
1
H-NMR (400 MHz, CDCl3): δ = 7.25-7.18 (m, 4H), 4.14 (q, J = 8.0 Hz, 2H), 3.56 (s, 2H), 
2.46 (s, 3H), 1.24 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 171.5, 137.1, 
131.0, 129.7, 126.9, 60.7, 40.8, 16.0, 14.2 ppm. EI-MS (70 eV), m/z (%): 211 (16), 210 (100) 
[M
+
], 137 (88), 121 (9). IR (KBr): ν~ = 1730 (vs), 1495 (m), 1469 (m), 1366 (m), 1225 (m), 
1031 (m), 802 (s) cm
-1
. Anal. Calcd. for C11H14O2S: C 62.83, H 6.71, S 15.25; found: C 62.90, 
H 6.74, S 15.35. 
 
Ethyl 2-(4-fluorophenyl)acetate (2.2-3e) [CAS-No. 587-88-2] 
Compound 2.2-3e was synthesized according to general procedure A from diethyl malonate 
(1.0 ml, 6.6 mmol) and 1-bromo-4-fluorobenzene (175 mg, 110 μL, 1.00 mmol). After 
purification by flash column chromatography (SiO2, ethyl acetate - hexane 5:95), 2.2-3e 
(157 mg, 86 %) was obtained as a colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.26 (dd, J = 8.0 Hz, J = 4.0 Hz, 2H), 7.01 (t, J = 8.0 Hz, 
2H), 4.16 (q, J = 8.0 Hz, 2H), 3.59 (s, 2H), 1.26 (t, J = 8.0 Hz, 3H) ppm. 
19
F-NMR (376 MHz, 
CDCl3): δ = -115.9 (m, Ar-F) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 171.3, 161.9 (d, 
1
JC-F = 
245.4 Hz), 130.7 (d, 
3
JC-F = 7.1 Hz), 129.8 (d, 
4
JC-F = 3.0 Hz), 115.3 (d, 
2
JC-F = 22.2 Hz), 60.8, 
40.4, 14.1 ppm. EI-MS (70 eV), m/z (%): 182 (21) [M
+
], 109 (100). IR (NaCl): ν~ = 2982 (vs), 
2937 (m), 1735 (vs), 1604 (m), 1510 (s), 1368 (m), 1224 (m), 1155 (m), 1031 (m), 826 (m) 
cm
-1
. EI-HRMS m/z calcd. for C10H11FO2: 182.0743, m/z found: 182.0732. 
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Ethyl 2-(2-ethylphenyl)acetate (2.2-3f) [CAS-No. 105337-78-8] 
Compound 2.2-3f was synthesized according to general procedure A from diethyl malonate 
(1.0 ml, 6.6 mmol) and 1-bromo-2-ethylbenzene (185 mg, 139 μL, 1.00 mmol). After 
purification by flash column chromatography (SiO2, ethyl acetate - hexane 5:95), 2.2-3f 
(170 mg, 88 %) was obtained as a light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.27-7.16 (m, 4H), 7.56 (t, J = 8.0 Hz, 1H), 7.46 (t, J = 
8.0 Hz, 2H), 7.39 (d, J = 8.0 Hz, 2H), 4.17 (q, J = 8.0 Hz, 2H), 3.68 (s, 2H), 2.70 (q, J = 
8.0 Hz, 2H), 1.29-1.23 (m, 6H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 171.6, 142.5, 132.0, 
130.3, 128.4, 127.4, 125.9, 60.7, 38.5, 25.7, 14.8, 14.1 ppm. EI-MS (70 eV), m/z (%): 193 (4), 
192 (24) [M
+
], 146 (29), 119 (100), 91 (54), 77 (21). IR (NaCl): ν~ = 2980 (vs), 2935 (m), 1734 
(vs), 1615 (m), 1583 (w), 1513 (s), 1246 (s), 1032 (m), 821 (m) cm
-1
. Anal. Calcd. for 
C12H16O2: C 74.97, H 8.39; found: C 74.63, H 8.39. 
 
Ethyl 2-(3-methoxyphenyl)acetate (ASC-3g) [CAS-No. 35553-92-5] 
Compound 2.2-3g was synthesized according to general procedure A from diethyl malonate 
(1.0 ml, 6.6 mmol) and 3-bromoanisole (187 mg, 128 μL, 1.00 mmol). After purification by 
flash column chromatography (SiO2, ethyl acetate - hexane 10:90), 2.2-3g (180 mg, 93 %) 
was obtained as a light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.25 (t, J = 8.0 Hz, 1H), 6.91-6.81 (m, 3H), 4.17 (q, J = 
8.0 Hz, 2H), 3,81 (s, 3H), 3.60 (s, 2H), 1.27 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): δ = 171.4, 159.6, 135.5, 129.4, 121.5, 114.8, 112.5, 60.8, 55.1, 41.4, 14.1 ppm. EI-
MS (70 eV), m/z (%): 195 (7), 194 (50) [M
+
], 121 (100), 91 (37), 78 (17), 77 (26). IR (NaCl): 
ν~ = 2979 (vs), 1731 (vs), 1601 (s), 1586 (m), 1492 (m), 1368 (m), 1262 (m), 1031 (m), 870 
(m), 773 (m) cm
-1
. Anal. Calcd. for C11H14O3: C 68.02, H 7.27; found: C 68.05, H 7.42. 
 
Ethyl 2-(naphthalene-2-yl)acetate (2.2-3h) [CAS-No. 2122-70-5] 
Compound 2.2-3h was synthesized according to general procedure A from diethyl malonate 
(1.0 ml, 6.6 mmol) and 2-bromonaphthaline (207 mg, 1.00 mmol). After purification by flash 
column chromatography (SiO2, ethyl acetate - hexane 10:90), 2.2-3h (200 mg, 93 %) was 
obtained as a light yellow oil. 
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1
H-NMR (400 MHz, CDCl3): δ = 7.87-7.79 (m, 3H), 7.75 (s, 1H), 7.51-7.42 (m, 3H), 4.18 (q, 
J = 8.0 Hz, 2H), 3.79 (s, 2H), 1.27 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 
171.5, 133.4, 132.4, 131.6, 128.1, 127.9, 127.61, 127.58, 127.3, 126.0, 125.7, 60.9, 41.6, 
14.2 ppm. EI-MS (70 eV), m/z (%): 215 (10), 214 (57) [M
+
], 141 (100), 115 (31). IR (NaCl): 
ν~ = 2980 (vs), 2936 (m), 1734 (vs), 1601 (m), 1508 (m), 1368 (m), 1258 (m), 1159 (m), 1031 
(s), 859 (m), 818 (m), 802 (m). 759 (m), 742 (m) cm
-1
. EI-HRMS m/z calcd. for C14H14O2: 
214.0994; found: 214.0994 
 
Ethyl 2-(phenanthren-9-yl)acetate (2.2-3i) [CAS-No. 101723-22-2] 
Compound 2.2-3i was synthesized according to general procedure A from diethyl malonate 
(1.0 ml, 6.6 mmol) and 9-bromophennathrene (257 mg, 1.00 mmol). After purification by 
flash column chromatography (SiO2, ethyl acetate - hexane 5:95), 2.2-3i (240 mg, 91 %) was 
obtained as a white solid. M.p. 83-84 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 8.77-8.70 (m, 1H), 8.67 (d, J = 8.0 Hz, 1H), 8.06 (d, J = 
8.0 Hz, 1H), 7.86 (d, J = 8.0 Hz, 1H), 7.70-7.59 (m, 5H), 4.19 (q, J = 8.0 Hz, 2H), 4.11 (s, 
2H), 1.24 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 171.5, 131.5, 131.1, 
130.7, 130.2, 129.1, 128.8, 128.3, 126.8, 126.7, 126.6, 126.4, 124.4, 123.1, 122.4, 61.0, 39.8, 
14.1 ppm. EI-MS (70 eV), m/z (%): 265 (19), 264 (100) [M
+
], 192 (19), 191 (34), 190 (27), 
165 (14). IR (KBr): ν~ = 2982 (w), 1731 (vs), 1602 (m), 1495 (m), 1415 (m), 1365 (m), 1328 
(m), 1182 (s), 1151 (m), 1025 (m), 895 (m), 793 (m), 771 (m), 753 (m), 728 (m), 715 (m) cm
-
1
. Anal. Calcd. for C18H16O2: C 81.79, H 6.10; found: C 81.76, H 6.12. 
 
Ethyl 2-(thiophen-3-yl)acetate (2.2-3j) [CAS-No. 2122-70-5] 
Compound 2.2-3j was synthesized according to general procedure A from diethyl malonate 
(1.0 ml, 6.6 mmol) and 3-bromothiophene (163 mg, 94 μL, 1.00 mmol). After purification by 
flash column chromatography (SiO2, ethyl acetate - hexane 5:95), 2.2-3j (160 mg, 94 %) was 
obtained as a light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.29-7.26 (m, 1H), 7.14 (s, 1H), 7.04 (d, J = 8.0 Hz, 1H), 
4.16 (q, J = 8.0 Hz, 2H), 3.64 (s, 2H), 1.26 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): δ = 170.1, 133.7, 128.5, 125.6, 122.7, 60.9, 35.9, 14.1 ppm. EI-MS (70 eV), m/z (%): 
171 (10), 170 (58) [M
+
], 98 (22), 97 (100). R (NaCl): ν~ = 2979 (s), 2937 (m), 1733 (vs), 1464 
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(m), 1369 (m), 1259 (m), 1206 (m), 1155 (m), 1028 (m) cm
-1
. EI-HRMS m/z calcd. for 
C8H10O2S: 170.0402, m/z found: 170.0403. 
 
Diethyl 2,2′-(1,4-phenylene)diacetate (2.2-3k) [CAS-No. 36076-26-3] 
Compound 2.2-3k was synthesized according to general procedure A from diethyl malonate 
(1.0 ml, 6.6 mmol) and 1-bromo-4-chlorobenzene (191 mg, 1.00 mmol). After purification by 
flash column chromatography (SiO2, ethyl acetate - hexane 5:95), 2.2-3k (171 mg, 68 %) was 
obtained as a light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.23 (s, 4H), 4.13 (q, J = 8.0 Hz, 2H), 3.28 (s, 2H), 1.24 (t, J 
= 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 171.5, 132.9, 129.4, 60.8, 41.0, 
14.1 ppm. EI- MS (70 eV), m/z (%): 250 (21) [M
+
], 178 (20), 177 (100), 105 (32), 104 (40), 
91 (29), 78 (15), 77 (12). IR (NaCl): ν~ = 2983 (vs), 2938 (s), 1735 (vs), 1612 (m), 1368 (m), 
1277 (s), 1032 (s), 854 (m) cm
-1
. Anal. Calcd. for C14H18O4: C 67.18, H 7.25; found: C 66.93, 
H 7.12. 
 
Ethyl 2-(4-(ethoxycarbonyl)phenyl)acetate (2.2-3l) [CAS-No. 3516-89-0] 
Compound 2.2-3l was synthesized through an in situ esterification of the 
dealkoxycarbonylative cross-coupling product according to the general procedure A from 
diethyl malonate (1.0 ml, 6.6 mmol) and 4-bromobenzoic acid (201 mg, 1.00 mmol). After 
purification by flash column chromatography (SiO2, ethyl acetate - hexane 5:95), 2.2-3l 
(208 mg, 88 %) was obtained as a light yellow oil. 
Compound 2.2-3l was also synthesized according to the general procedure B from diethyl 
malonate (1.0 ml, 6.6 mmol) and ethyl 4-bromobenzoate (229 mg, 160 μL, 1.00 mmol) or 
ethyl 4-chlorobenzoate (185 mg, 156 μL, 1.00 mmol). After purification by flash column 
chromatography (SiO2, ethyl acetate - hexane 5:95), 2.2-3l (219 mg, 93 %; 208 mg, 88 %) 
was obtained as a light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 8.01 (d, J = 8.0 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 4.37 (q, J 
= 8.0 Hz, 2H), 4.16 (q, J = 8.0 Hz, 2H), 3.67 (s, 2H), 1.39 (t, J = 8.0 Hz, 3H), 1.25 (t, J = 
8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 170.8, 166.3, 139.1, 129.7, 129.2, 61.0, 
60.9, 41.3, 14.3, 14.1 ppm. EI-MS (70 eV), m/z (%): 237 (15), 236 (5) [M
+
], 208 (11), 191 
(39), 180 (13), 163 (100), 149 (18), 136 (25), 135 (47), 119 (13), 118 (18), 107 (40), 91 (24), 
90 (28), 89 (35), 77 (13). IR (NaCl): ν~ = 2983 (vs), 2938 (m), 1735 (vs), 1718 (vs), 1612 (m), 
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1368 (m), 1277 (s), 1106 (m), 1032 (s) cm
-1
. Anal. Calcd. for C13H16O4: C 66.09, H 6.83; 
found: C 66.07, H 6.96. 
 
Ethyl 2-(4-ethoxyphenyl)acetate (2.2-3m) [CAS-No. 40784-88-1] 
Compound 2.2-3m was synthesized through an in situ etherification of the 
dealkoxycarbonylative cross-coupling product according to the general procedure A from 
diethyl malonate (1.0 ml, 6.6 mmol) and 4-bromophenol (173 mg, 1.00 mmol). After 
purification by flash column chromatography (SiO2, ethyl acetate - hexane 5:95), 2.2-3m 
(186 mg, 89 %) was obtained as a light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.18 (d, J = 8.0 Hz, 2H), 6.84 (d, J = 8.0 Hz, 2H), 4.13 (q, J 
= 8.0 Hz, 2H), 4.00 (q, J = 8.0 Hz, 2H), 3.53 (s, 2H), 1.39 (t, J = 8.0 Hz, 3H). 1.24 (t, J = 
8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 171.9, 158.0, 130.2, 126.0, 114.5, 63.4, 
60.7, 40.5, 14.8, 14.1 ppm. MS (70 eV), m/z (%): 210 (29), 209 (20) [M
+
], 137 (100), 136 
(72), 107 (99), 106 (41), 91 (21), 89 (94), 78 (90). IR (NaCl): ν~ = 2979 (vs), 2935 (s), 1735 
(vs), 1613 (m), 1583 (m), 1513 (vs), 1246 (m), 1156 (m), 1032 (m), 922 (w), 822 (w) cm
-1
. 
Anal. Calcd. for C12H16O3: C 69.21, H 7.74; found: C 68.68, H 7.69. 
 
Ethyl 2-(2,6-dimethylphenyl)acetate (2.2-3n) [CAS-No. 105337-15-3] 
Compound 2.2-3n was synthesized according to general procedure B from diethyl malonate 
(1.0 ml, 6.6 mmol) and 2-bromo-m-xylene (185 mg, 134 μL, 1.00 mmol). After purification 
by flash column chromatography (SiO2, ethyl acetate - hexane 5:95), 2.2-3n (156 mg, 81 %) 
was obtained as a light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.11-7.03 (m, 3H), 4.16 (q, J = 8.0 Hz, 2H), 3.70 (s, 2H), 
2.35 (s, 6H), 1.26 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 171.2, 137.1, 
131.7, 128.0, 126.9, 60.6, 35.4, 20.2, 14.1 ppm. EI-MS (70 eV), m/z (%): 193 (9), 192 (37) 
[M
+
], 119 (100), 118 (51), 91 (27). IR (NaCl): ν~ = 2979 (vs), 1734 (vs), 1589 (m), 1472 (m), 
1445 (m), 1327 (m), 1246 (m), 1152 (s), 1031 (s), 769 (m) cm
-1
. Anal. Calcd. for C12H16O2: C 
74. 97, H 8.39; found: C 74.65, H 8.31. 
 
Ethyl 2-mesitylacetate (2.2-3o) [CAS-No. 5460-08-2] 
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Compound 2.2-3o was synthesized according to the general procedure B from diethyl 
malonate (1.0 ml, 6.6 mmol) and 2-bromomesitylene (199 mg, 153 μL, 1.00 mmol). After 
purification by flash column chromatography (SiO2, ethyl acetate - hexane 5:95), 2.2-3o 
(172 mg, 83 %) was obtained as a light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 6.89 (s, 2H), 4.17 (q, J = 8.0 Hz, 2H), 3.7 (s, 2H), 2.33 (s, 
6H), 2.29 (s, 3H), 1.27 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 171.4, 
136.9, 136.3, 128.8, 128.7, 60.6, 35.0, 20.8, 20.1, 14.1 ppm. EI-MS (70 eV), m/z (%): 207 (7), 
206 (42) [M
+
], 133 (100), 132 (39), 117 (12), 105 (15), 91 (14). IR (NaCl): ν~ = 2977 (vs), 
2919 (vs), 1734 (vs), 1613 (s), 1580 (m), 1485 (m), 1445 (m), 1157 (m), 1030 (s), 850 (s), 783 
(m) cm
-1
. Anal. Calcd. for C13H18O2: C 75.69, H 8.80; found: C 75.67, H 8.79. 
 
Ethyl 2-(4-cyanophenyl)acetate (2.2-3p) [CAS-No. 1528-41-2] 
Compound 2.2-3p was synthesized according to the general procedure B from diethyl 
malonate (1.0 ml, 6.6 mmol) and 4-bromobenzonitrile (182 mg, 1.00 mmol) or 4-
chlorobenzonitrile (139 mg, 1.00 mmol). After purification by flash column chromatography 
(SiO2, ethyl acetate - hexane 10:90), 2.2-3p (132 mg, 70 %; 145 mg, 77 %) was obtained as a 
white solid. M.p. 93 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.60 (d, J = 8.0 Hz, 2H), 7.38 (d, J = 8.0 Hz, 2H), 4.15 (q, J 
= 8.0 Hz, 2H), 3.66 (s, 2H), 1.24 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 
170.2, 139.4, 132.2, 130.1, 118.6, 111.1, 61.2, 41.3, 14.1 ppm. EI-MS (70 eV), m/z (%): 190 
(2), 189 (2) [M
+
], 161 (11), 145 (7), 117 (77), 116 (100), 90 (14), 89 (32). IR (NaCl): ν~ = 2230 
(s), 1735 (vs), 1609 (m), 1510 (m), 1471 (m), 1366 (m), 1343 (m), 1220 (s), 1172 (s), 1112 
(m), 1031 (s), 827 (s), 757 (s) cm
-1
. Anal. Calcd. for C11H11NO2: C 69.83, H 5.86, N 7.40; 
found: C 69.83 , H 6.00, N 7.25. 
 
Ethyl 2-(3-cyanophenyl)acetate (2.2-3q): [CAS-No. 210113-91-0] 
Compound 2.2-3q was synthesized according to general procedure B from diethyl malonate 
(1.0 ml, 6.6 mmol) and 3-bromobenzonitrile (182 mg, 1.00 mmol). After purification by flash 
column chromatography (SiO2, ethyl acetate - hexane 10:90), 2.2-3q (145 mg, 77%) was 
obtained as a white solid. M.p. 50 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.56 (s, 1H), 7.52 (dd, J = 12.0 Hz, J = 8.0 Hz, 2H), 7.41 (t, 
J = 8.0 Hz, 1H), 4.14 (q, J = 8.0 Hz, 2H), 3.62 (s, 2H), 1.24 (t, J = 8.0 Hz, 3H) ppm. 
13
C-
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NMR (101 MHz, CDCl3): δ = 170.3, 135.5, 133.8, 132.8, 130.7, 129.2, 118.5, 112.5, 61.2, 
40.6, 14.0 ppm. EI-MS (70 eV), m/z (%): 190 (2), 189 (4) [M
+
], 161 (17), 145 (5), 117 (83), 
116 (100), 90 (13), 89 (33). IR (KBr): ν~ = 2981 (w), 2229 (s), 1733 (vs), 1414 (m), 1369 (m), 
1340 (m), 1245 (s), 1168 (vs), 1028 (s), 865 (m), 817 (s), 746 (s), 686 (s) cm
-1
. Anal. Calcd. 
for C11H11NO2: C 69.83, H 5.86, N 7.40; found: C 69.60, H 5.83, N 7.33. 
 
Ethyl 2-(4-cyano-2-methylphenyl)acetate (2.2-3r) 
Compound 2.2-3r was synthesized according to general procedure B from diethyl malonate 
(1.0 ml, 6.6 mmol) and 4-bromo-3-methylbenzonitrile (200 mg, 1.00 mmol). After 
purification by flash column chromatography (SiO2, ethyl acetate - hexane 10:90), 2.2-3r 
(190 mg, 93 %) was obtained as a light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.49-7.41 (m, 2H), 7.28 (d, J = 8.0 Hz, 1H), 4.14 (q, J = 
8.0 Hz, 2H), 3.65 (s, 2H), 2.33 (s, 3H), 1.23 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): δ = 170.1, 138.3, 133.6, 130.9, 129.8, 118.8, 111.1, 61.2, 39.2, 19.4, 14.1 ppm. EI-
MS (70 eV), m/z (%): 204 (9), 203 (29) [M
+
], 157 (19), 131 (40), 130 (100), 129 (20), 104 
(16), 103 (37), 102 (12), 77 (23). IR (NaCl): ν~ = 2981 (vs), 2935 (s), 2229 (vs), 1731 (vs), 
1607 (m), 1569 (w), 1499 (m), 1367 (s), 1334 (s), 1256 (s), 1234 (s), 1216 (s), 1174 (s), 1162 
(s), 1030 (s), 886 (w), 838 (w), 808 (w), 788 (w) cm
-1
. Anal. Calcd. for C12H13NO2: H 6.45, C 
70.92, N 6.89; found: H 6.61, C 70.63, N 6.56. 
 
Ethyl 2-(4-benzoylphenyl)acetate (2.2-3t) [CAS-No. 24021-67-8] 
Compound 2.2-3t was synthesized according to general procedure B from diethyl malonate 
(1.0 ml, 6.6 mmol) and 4-bromobenzophenone (261 mg, 1.00 mmol). After purification by 
flash column chromatography (SiO2, ethyl acetate - hexane 5:95), 2.2-3t (255 mg, 95 %) was 
obtained as a white solid. M.p. 61 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.77 (t, J = 8.0 Hz, 4H), 7.56 (t, J = 8.0 Hz, 1H), 7.46 (t, J = 
8.0 Hz, 2H), 7.39 (d, J = 8.0 Hz, 2H), 4.16 (q, J = 8.0 Hz, 2H), 3.68 (s, 2H), 1.25 (t, J = 
8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 196.2, 170.8, 138.8, 137.5, 136.3, 132.3, 
130.3, 129.9, 129.2, 128.2, 61.1, 41.3, 14.1 ppm. EI-MS (70 eV), m/z (%): 269 (25), 268 (99) 
[M
+
], 196 (44), 195 (70), 192 (94), 168 (100), 105 (69), 89 (51), 77 (51). IR (KBr): ν~ = 2981 
(vs), 2935 (m), 1734 (vs), 1654 (vs), 1607 (s), 1578 (m), 1446 (m), 1277 (m), 1150 (m), 1029 
(m), 701 (s) cm
-1
. Anal. Calcd. for C17H16O3: C 76.10, H 6.01; found: C 75.99, H 6.07. 
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Ethyl 2-(4-(trifluoromethyl)phenyl)acetate (2.2-3u) [CAS-No. 721-63-1] 
Compound 2.2-3u was synthesized according to general procedure B from diethyl malonate 
(1.0 ml, 6.6 mmol) and 4-bromobenzotrifluoride (227 mg, 142 μL, 1.00 mmol) or 4-
chlorobenzotrifluoride (184 mg, 136 μL, 1.00 mmol). After purification by flash column 
chromatography (SiO2, ethyl acetate - hexane 10:90), 2.2-3u (190 mg, 82 %; 170 mg, 73 %) 
was obtained as a white solid. M.p. 37 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.59 (d, J = 8.0 Hz, 2H), 7.42 (d, J = 8.0 Hz, 2H), 4.17 (q, J 
= 8.0 Hz, 2H), 3.68 (s, 2H), 1.27 (t, J = 8.0 Hz, 3H) ppm. 
19
F-NMR (376 MHz, CDCl3): δ = 
62.6 (s, Ar-F) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 170.7, 138.1, 129.6, 129.4 (q, 
2
JC-F = 
32.3 Hz), 125.4 (q, 
3
JC-F = 4.0 Hz), 124.1 (q, 
1
JC-F = 272.7 Hz), 61.1, 41.0, 14.0 ppm. EI-MS 
(70 eV), m/z (%): 233 (7), 232 (5) [M
+
], 213 (14), 204 (18), 160 (23), 159 (100). IR (KBr): ν~ = 
2983 (vs), 2938 (s), 1735 (vs), 1619 (m), 1586 (w), 1420 (m), 1326 (vs), 1164 (s), 1124 (s), 
1067 (s), 1020 (m), 823 (w) cm
-1
. Anal. Calcd. for C11H11F3O3: C 56.90, H 4.77; found: C 
56.50, H 4.98. 
 
Ethyl 2-(4-acetylphenyl)acetate (2.2-3v) [CAS-No. 1528-42-3] 
Compound 2.2-3v was synthesized according to general procedure B from diethyl malonate 
(1.0 ml, 6.6 mmol) and 4-bromoacetophenone (199 mg, 1.00 mmol) or 4-chloroacetophenone 
(155 mg, 130 μL, 1.00 mmol). After purification by flash column chromatography (SiO2, 
ethyl acetate - hexane 15:85), 2.2-3v (150 mg, 73 %; 180 mg, 87 %) was obtained as a white 
solid. M.p. 61 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.90 (d, J = 8.0 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 4.14 (q, J 
= 8.0 Hz, 2H), 3.65 (s, 2H), 2.57 (s, 3H), 1.23 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): δ = 197.6, 170.7, 139.4, 135.9, 129.7, 128.5, 61.1, 41.3, 26.6, 14.1 ppm. EI-MS 
(70 eV), m/z (%): 207 (10) [M
+
], 191 (100), 163 (21), 133 (20), 118 (10), 105 (35), 89 (21). 
IR (KBr): ν~ = 1735 (vs), 1683 (s), 1607 (m), 1472 (m), 1368 (m), 1269 (m), 1110 (m), 1031 
(m), 957 (w) cm
-1
. Anal. Calcd. for C12H14O3: C 69.88, H 6.84; found: C 69.80, H 6.90. 
 
Ethyl 2-(4-nitrophenyl)acetate (2.2-3w) [CAS-No. 2122-70-5] 
Compound 2.2-3w was synthesized according to general procedure B from diethyl malonate 
(1.0 ml, 6.6 mmol) and 1-bromo-4-nitrobenzene (202 mg, 1.00 mmol) or 1-chloro-4-
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nitrobenzene (158 mg, 1.00 mmol). After purification by flash column chromatography (SiO2, 
ethyl acetate - hexane 15:85), 2.2-3w (125 mg, 60 %; 147 mg, 70 %) was obtained as a yellow 
solid. M.p. 61 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 8.18 (d, J = 8.0 Hz, 2H), 7.45 (d, J = 8.0 Hz, 2H), 4.16 (q, J 
= 8.0 Hz, 2H), 3.17 (s, 2H), 1.25 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 
170.1, 147.1, 141.4, 130.2, 123.7, 61.4, 41.0, 14.1 ppm. EI-MS (70 eV), m/z (%): 210 (29), 
209 (20) [M
+
], 137 (100), 136 (72), 107 (99), 106 (41), 91 (21), 89 (94), 78 (90). IR (KBr): 
ν~ = 2984 (m), 1734 (vs), 1604 (m), 1521 (s), 1348 (m), 1223 (m), 1174 (m), 1030 (m), 859 
(m), 807 (m), 718 (m) cm
-1
. Anal. Calcd. for C10H11NO4: C 57.41, H 5.30, N 6.70; found: C 
57.61, H 5.50, N 6.30. 
8.6 Palladium/Copper-Catalyzed Di--arylation of Acetic Acid Esters 
8.6.1 Preparation of Copper Complexes (3.2-8b-i) 
The copper complex precursors Cu(PPh3)3X were prepared according to literature 
precedures.
1
  
Synthesis of Cu(PPh3)3I [CAS-No. 15709-82-7] 
CuI (952 mg, 5 mmol) and triphenylphosphine (3.94 g, 15 mmol) was refluxed for 3h in 
chloroform (20 mL) and the hot, clear solution was filtered. On slow cooling and evaporation 
of the solvent, the products seperated as colourless crystals (4.6 g, 94%). M.p. 152-153 °C. IR 
(KBr): ν~ = 3052 (w), 1480 (s), 1434 (s), 1087 (s), 741 (s), 733 (s), 689 (vs) cm
-1
. Anal. Calcd. 
for C54H45CuIP3: H 4.64, C 66.36; found: H 4.72, C 66.14. 
Synthesis of Cu(PPh3)3Br [CAS-No. 15709-74-7] 
CuBr (2.87 g, 20 mmol) and triphenylphosphine (15.74 g, 60 mmol) was refluxed for 3h in 
chloroform (70 mL) and the hot, clear solution was filtered. On slow cooling and evaporation 
of the solvent, the products seperated as colourless crystals (16 g, 86%). M.p. 171-172°C. IR 
(KBr): ν~ = 3047 (w), 1480 (s), 1435 (s), 1090 (s), 741 (s), 734 (s), 692 (vs) cm
-1
.
 
Anal. Calcd. 
for C54H45CuBrP3: H 4.88, C 69.72; found: H 4.51, C 68.98. 
Synthesis of Cu(PPh3)3Cl [CAS-No. 15709-76-9] 
CuCl (495 mg, 5 mmol) and triphenylphosphine (3.94 g, 15 mmol) was refluxed for 3h in 
chloroform (20 mL) and the hot, clear solution was filtered. On slow cooling and evaporation 
of the solvent, the products seperated as colourless crystals (3.8 g, 86%). M.p. 169-170 °C. IR 
(KBr): ν~ = 3047 (w), 1480 (s), 1435 (s), 1092 (s), 744 (s), 734 (s), 692 (vs) cm
-1
.
 
Anal. Calcd. 
for C54H45CuClP3: C 73.22; H 5.12, found: C 72.41, H 5.10. 
The copper complexes [Cu(Phen)(PPh3)X] were prepared according to literature procedures.
2
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[Cu(Phen)(PPh3)I] (3.2-8b) [CAS-No. 25753-85-9] 
In an Erlenmeyer flask equipped with a Teflon-coated magnetic stirrer, 
tris(triphenylphosphine)copper(I) iodide (977 mg, 1 mmol) was added to chloroform (50 mL). 
After complete dissolution, 1,10-phenanthroline (180 mg, 1 mmol) was then added. The 
colorless solution immediately changed to orange. The contents of the flask were stirred for 
25 minutes at room temperature. Afterwards the solvent was removed under reduced pressure 
to afford an orange-yellow solid. Recrystallization was achieved by layering diethyl ether 
(40 mL) onto a solution of the solid in dichloromethane (20 mL), giving a bright yellow solid 
(530 mg, 84 %). M.p. 223-224 °C (decomposed). IR (KBr): ν~ = 3034 (w), 1478 (m), 1434 (s), 
1092 (s), 858 (s), 847 (s), 739 (m), 729 (m), 691 (vs) cm
-1
. Anal. Calcd. for C30H23CuIN2P: C 
56.93, H 3.66, N 4.43; found: C 56.53, H 3.78, N 4.43. 
 
[Cu(Phen)(PPh3)Br] (3.2-8c) [CAS-No. 25753-84-8] 
In an Erlenmeyer flask equipped with a Teflon-coated magnetic stirrer, 
tris(triphenylphosphine)copper(I) bromide (3.7 g, 4 mmol) was added to chloroform (100 mL). 
After complete dissolution, 1,10-phenanthroline (721 mg, 4 mmol) was then added. The 
colorless solution immediately changed to orange. The contents of the flask were allowed to 
stir for 25 minutes at room temperature. Afterwards the solvent was removed under reduced 
pressure to afford an orangeyellow solid. Recrystallization was achieved by layering diethyl 
ether (40 mL) onto a solution of the solid in dichloromethane (20 mL) giving a bright yellow 
solid (2.1 g, 90 %). M.p. 256-257 °C (decomposed). IR (KBr): ν~ = 3015 (w), 1509 (m), 1480 
(m), 1435 (m), 1425 (m), 1365 (m), 1217 (m), 1095 (m), 846 (s), 745 (s), 727 (s), 696 (vs) 
cm
-1
. Anal. Calcd. for C30H23CuBrN2P: C 61.50, H 3.96, N 4.78; found: C 61.44, H 4.05, N 
4.74. 
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[Cu(Phen)(PPh3)Cl] (3.2-8d) [CAS-No. 14751-81-6] 
In an Erlenmeyer flask equipped with a Teflon-coated magnetic stirrer, 
tris(triphenylphosphine)copper(I) chloride (3.7 g, 4 mmol) was added to chloroform (100 mL). 
After complete dissolution, 1,10-phenanthroline (721 mg, 4 mmol) was then added. The 
colorless solution immediately changed to orange. The contents of the flask were stirred for 
25 minutes at room temperature. Afterwards the solvent was removed under reduced pressure 
to afford an orangeyellow solid. Recrystallization was achieved by layering diethyl ether 
(40 mL) onto a solution of the solid in dichloromethane (20 mL), giving a bright yellow solid 
(2.1 g, 90 %). M.p. 248-249 °C (decomposed). IR (KBr): ν~ = 3014 (w), 1509 (w), 1480 (w), 
1434 (m), 1426 (m), 1365 (m), 1217 (m), 1096 (m), 845 (s), 745 (s), 727 (s), 696 (vs) cm
-1
. 
Anal. Calcd. for C30H23CuClN2P: C 61.50, H 3.96, N 4.78; found: C 61.44, H 4.05, N 4.74. 
 
[Cu(neocup)(PPh3)I] (3.2-8e) [CAS-No. 828935-28-0] 
In an Erlenmeyer flask equipped with a Teflon-coated magnetic stirrer, 
tris(triphenylphosphine)copper(I) iodide (977 mg, 1 mmol) was added to chloroform (50 mL). 
After complete dissolution, neocuproine (208 mg, 1 mmol) was then added. The colorless 
solution immediately changed to orange. The contents of the flask were allowed to stir for 
25 minutes at room temperature. Afterwards the solvent was removed under reduced pressure 
to afford an orangeyellow solid. Recrystallization was achieved by layering diethyl ether 
(40 mL) onto a solution of the solid in dichloromethane (20 mL) giving a yellow solid 
(560 mg, 85 %). M.p. > 300 °C (decomposed). IR (KBr): ν~ = 3053 (w), 1588 (m), 1500 (m), 
1480 (m), 1434 (s), 1373 (m), 1361 (m), 1090 (m), 870 (s), 753 (s), 740 (s), 692 (vs) cm
-1
. 
Anal. Calcd. for C32H27CuIN2P½ CH2Cl2: C 55.49, H 4.01, N 3.98; found: C 55.61, H 4.12, 
N 4.06. 
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[Cu(neocup)(PPh3)Br] (3.2-8f) [CAS-No. 391684-10-9] 
In an Erlenmeyer flask equipped with a Teflon-coated magnetic stirrer, 
tris(triphenylphosphine)copper(I) bromide (1.4 g, 1.5 mmol) was added to chloroform 
(50 mL). After complete dissolution, neocuproine (312 mg, 1.5 mmol) was then added. The 
colorless solution immediately changed to orange. The contents of the flask were stirred for 
25 minutes at room temperature. Afterwards the solvent was removed under reduced pressure 
to afford an orange-yellow solid. Recrystallization was achieved by layering diethyl ether 
(40 mL) onto a solution of the solid in dichloromethane (20 mL), giving a bright yellow solid 
(850 mg, 92 %). M.p. 276-277 °C. IR (KBr): ν~ = 3050 (w), 1587 (m), 1498 (m), 1480 (m), 
1434 (s), 1090 (m), 869 (s), 753 (s), 740 (s), 691 (vs) cm
-1
. Anal. Calcd. for C32H27CuBrN2P: 
C 62.60, H 4.43, N 4.56; found: C 62.50, H 4.61, N 4.63. 
The copper complexes [Cu(bpy)(PPh3)X] were prepared according to literature procedures.
3
 
 
[Cu(bpy)(PPh3)I] (3.2-8g) [CAS-No. 25753-82-6] 
A mixture of CuI (400 mg, 2.1 mmol), 2,2’-bipyridine (328 mg, 2.1 mmol), and PPh3 (551 mg, 
2.1 mmol) was stirred for 30 min in CH3CN. The starting materials dissolved to give an 
orange solution from which fine orange crystals of the compound precipitated (940 mg, 74 %). 
M.p. 215-216 °C (Lit.
3
 234-248 °C). IR (KBr): ν~ = 3053 (w), 3011 (w), 1592 (m), 1478 (m), 
1465 (m), 1434 (s), 1307 (m), 1093 (s), 757 (vs), 744 (vs), 693 (vs) cm
-1
. Anal. Calcd. for 
C28H23CuIN2P: C 55.23, H 3.81, N 4.60; found: C 51.27, H 3.66, N 4.56. 
 
[Cu(bpy)(PPh3)I] 3.2-8h [CAS-No. 25753-81-5] 
A mixture of CuI (400 mg, 2.1 mmol), 2,2’-bipyridine (301 mg, 2.1 mmol), and PPh3 (551 mg, 
2.1 mmol) was stirred for 30 min in CH3CN. The starting materials dissolved to give an 
orange solution from which fine orange crystals of the compound precipitated (830 mg, 74 %). 
M.p 217-218 °C (Lit.
3
 234-248 °C). IR (KBr): ν~ = 3053 (w), 3009 (w), 1591 (m), 1478 (m), 
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1465 (m), 1435 (s), 1307 (m), 1094 (s), 745 (vs), 694 (vs) cm
-1
. Anal. Calcd. for 
C28H23BrCuN2P: C 59.85, H 4.13, N 4.99; found: C 59.21, H 4.21, N 4.97. 
 
[Cu(bpy)(PPh3)I] (3.2-8i) [CAS-No. 199582-45-1] 
This compound was prepared according to literature methods.
4
 Copper(II) bromide (1.11 g, 
5 mmol) and 1,10-phenanthroline monohydrate (1.98 g, 10 mmol) were dissovled in 20 mL of 
MeOH/H2O (1:1, 20 mL) and the solution was refluxed for 2 h under stirring. Dark green 
crystallline precipitate was separated from the warm solution, washed with MeOH/H2O (1:1), 
chloroform, and diethyl ether. Recrystallization from MeOH/H2O (1:1) gave a green solid 
(2.64 g, 88 %). M.p. > 300 °C. IR (KBr): ν~ = 3490 (m), 3298 (w), 3231 (w), 1582 (w), 1515 
(m), 1426 (s), 1226 (m), 851 (vs), 721 (vs) cm
-1
. Anal. Calcd. for C24H18Br2CuN4O: C 47.90, 
H 3.01, N 9.31; found: C 47.98, H 3.17, N 9.35. 
8.6.2 General Procedure for the Pd/Cu-Catalyzed Diarylation 
An oven-dried 20 mL vessel equipped with a septum cap and a stirrer bar, was charged with 
potassium phosphate (636.8 mg, 3.0 mmol). The reaction vessel was evacuated and flushed 
with nitrogen three times. Subsequently, a solution of the corresponding aryl halide 
(1.0 mmol), alkyl acetate (5.0 mmol), palladium acetate (4.5 mg, 0.02 mmol), tri-tert-
butylphosphonium tetrafluoroborate (13.0 mg, 0.044 mmol), [Cu(Phen)(PPh3)Br] (14.0 mg, 
0.024 mmol) and the internal standard n-tetradecane (50 μL) in DMF (3 mL) was added via 
syringe. The resulting mixture was stirred at 110 °C for 24 h, and the crude reaction mixture 
was cooled, diluted with ethyl acetate. The solution was washed successively with water 
(20 mL) and brine (20 mL), dried over MgSO4, filtered, and the volatiles were removed in 
vacuo. The residue was purified by column chromatography (silica gel, hexane/ethyl acetate 
gradient) or Kugelrohr distillation in vacuo (180-250 °C, 3.0×10
-2
 mBar), yielding the 
corresponding products 3.2-6. 
8.6.3 Sythesis of Diaryl Acetates 
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Ethyl 2,2-di(p-tolyl)acetate (3.2-6aa) [CAS-No. 23597-04-8] 
Compound 3.2-6aa was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and 4-bromotoluene (171 mg, 126 μL, 1.0 mmol). After 
distillation, 3.2-6aa (115 mg, 86 %) was obtained as a white solid, m.p. 65 °C.
1
H-NMR 
(400 MHz, CDCl3): δ = 7.21 (d, J = 8.0 Hz, 4H), 7.13 (d, J = 8.0 Hz, 4H), 4.95 (s, 1H), 4.21 
(q, J = 8.0 Hz, 2H), 2.33 (s, 6H), 1.26 (t, J = 8.0 Hz, 3H) ppm; 
13
C-NMR (101 MHz, CDCl3): 
δ = 172.7, 136.7, 136.0, 129.2, 128.4, 61.0, 56.3, 21.0, 14.1 ppm; EI-MS (70 eV), m/z (%): 
296 (4) [M
+
], 195 (100), 180 (27), 165 (25); IR (KBr): ν~ = 2977 (m), 1732 (vs), 1508 (s), 1477 
(m), 1368 (m), 1277 (m), 1149 (s), 1020 (m), 806 (m), 777 (m), 755 (s) cm
-1
; Anal. Calcd. for 
C18H20O2: C 80.56, H 7.51; found: C 80.77, H 7.20. 
 
Ethyl 2,2-diphenylacetate (3.2-6ab) [CAS-No. 3468-99-3] 
Compound 3.2-6ab was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.66 mL, 5.0 mmol) and bromobenzene (157 mg, 105 μL, 1.0 mmol). After 
distillation, 3.2-6ab (108 mg, 90 %) was obtained as a white solid, m.p. 59 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.30-7.20 (m, 10H), 4.98 (s, 1H), 4.17 (q, J = 8.0 Hz, 2H), 
1.22 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 172.5, 138.7, 128.6, 128.5, 
127.2, 61.2, 57.1, 14.1 ppm. EI-MS (70 eV), m/z (%): 240 (11) [M
+
], 167 (100), 165 (40). IR 
(KBr): ν~ = 1728 (vs), 1597 (m), 1582 (m), 1511 (vs), 1490 (m), 1454 (s), 1369 (m), 1345 (m), 
1309 (m), 1277 (m), 1187 (m), 1021 (m), 744 (m), 707 (s) cm
-1
. EI-HRMS m/z calcd. for 
C16H16O2: 240.1150, m/z found: 240.1155. 
 
Ethyl 2,2-bis(4-methoxyphenyl)acetate (3.2-6ac) [CAS-No. 121090-64-0] 
Compound 3.2-6ac was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and 4-bromoanisole (187 mg, 126 μL, 1.0 mmol). After 
distillation, 3.2-6ac (140 mg, 93 %) was obtained as colorless oil. 
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1
H-NMR (400 MHz, CDCl3): δ = 7.22 (d, J = 8.0 Hz, 4H), 6.85 (d, J = 8.0 Hz, 4H), 4.91 (s, 
1H), 4.19 (q, J = 8.0 Hz, 2H), 3.78 (s, 6H), 1.25 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): δ = 173.0, 158.6, 131.3, 129.5, 113.9, 61.0, 55.4, 55.2, 14.1 ppm. EI-MS (70 eV), m/z 
(%): 300 (7) [M
+
], 227 (100), 196 (5), 169 (11). IR (NaCl): ν~ = 2956 (m), 2835 (s), 1733 (vs), 
1610 (vs), 1583 (m), 1511 (vs), 1463 (m), 1303 (m), 1250 (m), 1178 (m), 1152 (m), 1033 (m), 
833 (m), 812 (m) cm
-1
. Anal. Calcd. for C18H20O4: C 71.98, H 6.71; found: C 71.94, H 6.61. 
 
Ethyl 2,2-bis(4-(methylthio)phenyl)acetate (3.2-6ad) 
Compound 3.2-6ad was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and 4-bromothioanisole (203 mg, 1.0 mmol). After distillation, 
3.2-6ad (140 mg, 84 %) was obtained as colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.25-7.18 (m, 8H), 4.92 (s, 1H), 4.20 (q, J = 8.0 Hz, 2H), 
2.45 (s, 6H), 1.25 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 172.2, 137.4, 
135.4, 128.9, 126.7, 61.2, 55.9, 15.7, 14.1 ppm. EI-MS (70 eV), m/z (%): 333 (7), 332 (33) 
[M
+
], 259 (100), 165 (26). IR (NaCl): ν~ = 2979 (s), 2918 (s), 1732 (vs), 1596 (s), 1493 (s), 
1437 (s), 1152 (m), 1093 (m), 1028 (m), 1016 (m), 798 (s) cm
-1
. Anal. Calcd. for C18H20O2S2: 
C 65.02, H 6.06, S 19.29; found: C 64.83, H 5.66, S 18.97. 
 
Ethyl 2,2-bis(4-(dimethylamino)phenyl)acetate (3.2-6ae) [CAS-No. 74283-75-3] 
Compound 6ae was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and 4-bromo-N,N-dimethylaniline (200 mg, 1.0 mmol). After 
distillation, 6ae (120 mg, 74 %) was obtained as a blue solid, m.p. 72  C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.20 (d, J = 12.0 Hz, 4H), 6.70 (d, J = 12.0 Hz, 4H), 4.85 (s, 
1H), 4.20 (q, J = 8.0 Hz, 2H), 2.92 (s, 12H), 1.26 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR 
(101 MHz, CDCl3): δ = 173.5, 149.5, 129.1, 127.4, 112.6, 60.7, 55.3, 40.8, 14.2 ppm. EI-MS 
(70 eV), m/z (%): 327 (7), 326 (30) [M
+
], 253 (100), 237 (16), 165 (6). IR (KBr): ν~ = 2957 
(m), 1725 (vs), 1611 (vs), 1520 (vs), 1350 (s), 1154 (s), 1061 (s), 948 (s), 802 (s), 747 (m) cm
-
1
. Anal. Calcd. for C20H26N2O2: C 73.59, H 8.03, N 8.58; found: C 73.60, H 8.02, N 8.18. 
EXPERIMENTAL SECTION 
184 
 
Ethyl 2,2-bis(4-fluorophenyl)acetate (3.2-6af) [CAS-No. 386-99-2] 
Compound 3.2-6af was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and 4-fluorotoluene (175 mg, 110 μL, 1.0 mmol). After 
distillation, 3.2-6af (130 mg, 94 %) was obtained as colorless oil. 
19
F-NMR (376 MHz, CDCl3): δ = -115.2 (m, Ar-F) ppm. 
1
H-NMR (400 MHz, CDCl3): δ = 
7.19 (t, J = 8.0 Hz, 4H), 6.93 (t, J = 8.0 Hz, 4H), 4.89 (s, 1H), 4.13 (q, J = 8.0 Hz, 2H), 1.17 (t, 
J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 172.2, 162.0 (d, 
1
JC-F = 246.4 Hz), 
134.4 (d, 
4
JC-F = 4.0 Hz), 130.0 (d, 
3
JC-F = 8.1 Hz), 115.5 (d, 
2
JC-F = 21.2 Hz), 61.3, 55.4, 
14.1 ppm. EI-MS (70 eV), m/z (%): 277 (1), 276 (4) [M
+
], 203 (100), 201 (27), 183 (46). IR 
(NaCl): ν~ = 2983 (vs), 1734(vs), 1604 (vs), 1508 (vs), 1368 (s), 1228 (s), 1157 (s), 1028 (vs), 
837 (vs) cm
-1
. Anal. Calcd. for C16H14F2O2: C 69.56, H 5.11; found: C 69.74, H 5.27. 
 
Ethyl 2,2-bis(4-chlorophenyl)acetate (3.2-6ag) [CAS-No. 30738-51-3] 
Compound 3.2-6ag was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and 1-bromo-4-chlorobenzene (191 mg, 1.0 mmol). After 
distillation, 3.2-6ag (100 mg, 65 %) was obtained as a white solid, m.p. 86
 
°C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.29 (d, J = 8.0 Hz, 4H), 7.22 (d, J = 8.0 Hz, 4H), 4.93 (s, 
1H), 4.20 (q, J = 8.0 Hz, 2H), 1.25 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 
171.8, 136.8, 133.4, 129.8, 128.8, 61.5, 55.7, 14.1 ppm. EI-MS (70 eV), m/z (%): 310 (4) [M
+
, 
37
Cl], 308 (8) [M
+
, 
35
Cl], 237 (66), 235 (100), 202 (7), 200 (21), 165 (58). IR (KBr): ν~ = 2981 
(m), 1733 (vs), 1489 (vs), 1408 (s), 1368 (s), 1297 (s), 1270 (s), 1190 (s), 1155 (vs), 1091 (s), 
1015 (s), 851 (s), 805 (s), 776 (s) cm
-1
. Anal. Calcd. for C16H14Cl2O2: C 62.15, H 4.56; found: 
C 62.34, H 4.78. 
 
Diethyl 4,4'-(2-ethoxy-2-oxoethane-1,1-diyl)dibenzoate (3.2-6ah) 
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Compound 3.2-6ah was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and ethyl 4-bromobenzoate (229 mg, 160 μL, 1.0 mmol). After 
distillation, 3.2-6ah (168 mg, 87 %) was obtained as colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 8.00 (d, J = 8.0 Hz, 4H), 7.49 (d, J = 8.0 Hz, 4H), 4.36 (m, 
7H), 1.37 (t, J = 8.0 Hz, 6H), 1.26 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 
173.3, 166.1, 146.1, 130.3, 129.4, 127.3, 80.5, 63.4, 61.1, 14.3, 13.9 ppm. EI-MS (70 eV), m/z 
(%): 384 (1) [M
+
], 339 (12), 312 (29), 311 (100), 283 (8), 165 (21). IR (NaCl): ν~ = 2980 (s), 
1732 (s), 1718 (vs), 1607 (s), 1445 (m), 1417 (m), 1367 (s), 1275 (vs), 1105 (vs), 1021 (vs), 
863 (m), 759 (s), 711 (m) cm
-1
. EI-HRMS m/z calcd. for C22H24O6: 384.1573, m/z found: 
384.1554. 
 
Ethyl 2,2-bis(4-cyanophenyl)acetate (3.2-6ai) 
Compound 3.2-6ai was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and 4-bromobenzonitrile (182 mg, 1.0 mmol). After 
purification by column chromatography, 3.2-6ai (80 mg, 55 %) was obtained as a white solid, 
m.p. 94 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.62 (d, J = 8.0 Hz, 4H), 7.40 (d, J = 8.0 Hz, 4H), 5.07 (s, 
1H), 4.22 (q, J = 8.0 Hz, 2H), 1.24 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 
170.4, 142.5, 132.5, 129.3, 118.3, 111.8, 62.0, 56.7, 14.0 ppm. EI-MS (70 eV), m/z (%): 290 
(3) [M
+
], 246 (5), 218 (53), 217 (100), 190 (35). IR (KBr): ν~ = 2982 (m), 2229 (vs), 1736 (vs), 
1603 (s), 1499 (s), 1416 (m), 1334 (s), 1204 (s), 1161 (s), 1028 (s), 853 (s), 817 (s), 791 (s) 
cm
-1
. Anal. Calcd. for C18H14N2O2: C 74.47, H 4.86, N 9.65; found: C 74.09, H 4.95, N 9.61. 
 
Ethyl 2,2-di(m-tolyl)acetate (3.2-6aj) 
Compound 3.2-6aj was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and 3-bromotoluene (171 mg, 121 μL, 1.0 mmol). After 
distillation, 3.2-6aj (121 mg, 90 %) was obtained as colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.13 (t, J = 8.0 Hz, 2H), 7.05 (d, J = 8.0 Hz, 4H), 6.99 (d, J 
= 8.0 Hz, 2H), 4.87 (s, 1H), 4.13 (q, J = 8.0 Hz, 2H), 2.25 (s, 6H), 1.18 (t, J = 8.0 Hz, 
3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 172.6, 138.7, 138.1, 129.2, 128.4, 127.9, 125.6, 
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61.1, 57.0, 21.4, 14.1 ppm. EI-MS (70 eV), m/z (%): 268 (8) [M
+
], 196 (17), 195 (100), 180 
(29), 165 (27). IR (NaCl): ν~ = 2980 (m), 1735 (vs), 1605 (s), 1458 (m), 1157 (vs), 1032 (s), 
741 (m), 700 (m) cm
-1
. Anal. Calcd. for C16H14F2O2: C 80.56, H 7.51; found: C 80.22, H 7.49. 
 
Ethyl 2,2-bis(3-cyanophenyl)acetate (3.2-6ak) 
Compound 3.2-6ak was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and 3-bromobenzonitrile (182 mg, 1.0 mmol). After 
purification by column chromatography, 3.2-6ak (100 mg, 69 %) was obtained as colorless 
oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.60-7.50 (m, 6H), 7.47 (t, J = 8.0 Hz, 2H), 5.03 (s, 1H), 
4.23 (q, J = 8.0 Hz, 2H), 1.25 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 
170.5, 138.9, 132.9, 132.0, 131.4, 129.7, 118.2, 113.0, 62.0, 55.7, 14.0 ppm. EI-MS (70 eV), 
m/z (%): 291 (2) [M
+
], 246 (14), 218 (100), 217 (100), 191 (18), 190 (62). IR (NaCl): ν~ = 
2983 (s), 2230 (vs), 1732 (vs), 1601 (s), 1582 (s), 1482 (vs), 1176 (vs), 1027 (vs), 807 (s), 737 
(s), 687 (s) cm
-1
. EI-HRMS m/z calcd. for C18H14N2O2: 290.1055, m/z found: 290.1041. 
 
Ethyl 2,2-bis(2-methoxyphenyl)acetate (3.2-6al) 
Compound 3.2-6al was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and 2-bromoanisole (187 mg, 125 μL, 1.0 mmol). After 
purification by column chromatography, 3.2-6al (105 mg, 70 %) was obtained as a white solid, 
m.p. 87 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.28 (t, J = 8.0 Hz, 2H), 7.05 (d, J = 8.0 Hz, 2H), 6.92-6.88 
(m, 4H), 5.63 (s, 1H), 4.21 (q, J = 8.0 Hz, 2H), 3.81 (s, 6H), 1.25 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 173.3, 157.1, 129.2, 128.2, 126.8, 120.4, 110.4, 60.6, 55.4, 
44.8, 14.2 ppm. EI-MS (70 eV), m/z (%): 310 (6), 300 (32) [M
+
], 254 (16), 227 (61), 181 (24), 
165 (8), 121 (100), 91 (20). IR (KBr): ν~ = 2936 (m), 2837 (s), 1734 (vs), 1600 (s), 1587 (m), 
1491 (s), 1462 (s), 1438 (m), 1245 (s), 1182 (m), 1153 (m), 1029 (s), 753 (vs) cm
-1
. EI-HRMS 
m/z calcd. for C18H20O4: 300.1362, m/z found: 300.1358. 
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Ethyl 2,2-bis(4-methoxy-3-methylphenyl)acetate (3.2-6am) 
Compound 3.2-6am was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and 4-bromo-1-methoxy-2-methylbenzene (201 mg, 1.0 mmol). 
After purification by column chromatography, 3.2-6am (135 mg, 82 %) was obtained as 
colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.16-7.09 (m, 4H), 6.79 (d, J = 8.0 Hz, 2H), 4.88 (s, 1H), 
4.22 (q, J = 8.0 Hz, 2H), 3.82 (s, 6H), 2.22 (s, 6H), 1.28 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR 
(101 MHz, CDCl3): δ = 173.2, 156.8, 130.8, 130.7, 126.6, 109.8, 60.9, 55.5, 55.2, 16.3, 
14.1 ppm. EI-MS (70 eV), m/z (%): 328 (13) [M
+
], 256 (23), 255 (100), 240 (5), 225 (5). IR 
(NaCl): ν~ = 2949 (m), 2834 (s), 1731 (vs), 1609 (s), 1503 (vs), 1463 (m), 1254 (s), 1154 (m), 
1134 (s), 1033 (m), 888 (m), 815 (m) 750 (m) cm
-1
. EI-HRMS m/z calcd. for C20H24O4: 
328.1675, m/z found: 328.1661. 
 
Ethyl 2,2-di(2-naphthyl)acetate (3.2-6an) 
Compound 3.2-6an was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and 2-bromonaphthaline (207 mg, 1.0 mmol). After purification 
by column chromatography, 3.2-6an (140 mg, 82 %) was obtained as a white solid, m.p. 
81 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.90-7.80 (m, 8H), 7.53-7.45 (m, 6H), 5.39 (s, 1H), 4.31 (q, 
J = 8.0 Hz, 2H), 1.32 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 172.4, 136.1, 
133.3, 132.5, 128.3, 128.0, 127.6, 127.3, 126.8, 126.2, 126.0, 61.3, 57.3, 14.1 ppm. EI-MS 
(70 eV), m/z (%): 341 (13), 340 (44) [M
+
], 268 (23), 267 (100), 126 (5). IR (KBr): ν~ = 2982 
(w), 1728, 1596 (m), 1508 (s), 1448 (m),1363 (m), 1303 (s), 1179 (m), 1153 (m), 1031 (s), 
896 (s), 868 (s), 761 (s) cm
-1
. EI-HRMS m/z calcd. for C24H20O2: 340.1463, m/z found: 
300.1454. 
 
Ethyl 2,2-di(3-pyridinyl)acetate (3.2-6ao) 
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Compound 3.2-6ao was synthesized according to the general procedure from ethyl acetate 
(441 mg, 0.49 mL, 5.0 mmol) and 3-bromopyridine (158 mg, 97 μL, 1.0 mmol). After 
distillation, 3.2-6ao (90 mg, 74 %) was obtained as colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 8.56 (s, sH), 8.53 (d, J = 4.0 Hz, 2H), 7.66 (d, J = 8.0 Hz, 
2H), 7.27 (dd, J = 8.0, 4.0 Hz, 2H), 5.00 (s, 1H), 4.22 (q, J = 8.0 Hz, 2H), 1.25 (t, J = 8.0 Hz, 
3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 170.9, 149.7, 149.0, 135.8, 133.6, 123.6, 61.9, 
52.2, 14.0 ppm. EI-MS (70 eV), m/z (%): 243 (2), 242 (7) [M
+
], 169 (100). IR (NaCl): ν~ = 
2980 (m), 1734 (vs), 1575 (s), 1478 (s), 1425 (s), 1312 (m), 1156 (s), 1025 (vs), 713 (s) cm
-1
. 
EI-HRMS m/z calcd. for C14H14N2O2: 242.1055, m/z found: 242.1046. 
 
Butyl 2,2-di(p-tolyl)acetate (3.2-6ba) 
Compound 3.2-6ba was synthesized according to the general procedure from n-butyl acetate 
(581 mg, 0.66 mL, 5.0 mmol) and 4-bromotoluene (171 mg, 126 μL, 1.0 mmol). After 
distillation, 3.2-6ba (120 mg, 81 %) was obtained as colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.38 (d, J = 8.0 Hz, 4H), 7.29 (d, J = 8.0 Hz, 4H), 5.13 (s, 
1H), 4.31 (t, J = 8.0 Hz, 2H), 2.49 (s, 6H), 1.77 (quin, J = 8.0 Hz, 2H), 1.49 (sext, J = 8.0 Hz, 
2H), 1.06 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 172.8, 136.7, 136.0, 
129.2, 128.4, 64.9, 56.4, 30.5, 21.0, 19.0, 13.6 ppm. EI-MS (70 eV), m/z (%): 296 (3) [M
+
], 
196 (17), 195 (100), 180 (23), 165 (21). IR (NaCl): ν~ = 2959 (s), 2930 (m), 2872 (m), 1736 
(vs), 1512 (s), 1458 (m), 1307 (m), 1183 (m), 1150 (s), 1021 (s), 806 (m), 773 (m), 753 (m) 
cm
-1
. Anal. Calcd. for C20H24O2: C 81.04, H 8.16; found: C 81.43, H 7.94. 
 
Butyl 2,2-diphenylacetate (3.2-6bb) [CAS-No. 58538-94-6] 
Compound 6bb was synthesized according to the general procedure from n-butyl acetate 
(581 mg, 0.66 mL, 5.0 mmol) and 4-bromobenzene (157 mg, 105 μL, 1.0 mmol). After 
distillation, 6bb (120 mg, 89 %) was obtained as colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.30-7.15 (m, 10H), 4.98 (s, 1H), 4.11 (t, J = 8.0 Hz, 2H), 
1.56 (quin, J = 8.0 Hz, 2H), 1.27 (sext, J = 8.0 Hz, 2H), 0.84 (t, J = 8.0 Hz, 3H) ppm. 
13
C-
NMR (101 MHz, CDCl3): δ = 172.5, 138.7, 128.6, 128.5, 127.1, 65.0, 57.2, 30.5, 19.0, 
13.6 ppm. EI-MS (70 eV), m/z (%): 268 (2) [M
+
], 168 (15), 167 (100). IR (NaCl): ν~ = 2958 (s), 
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2871 (m), 1733 (vs), 1599 (s), 1584 (m), 1495 (s), 1453 (s), 1306 (m), 1188 (m), 1149 (m), 
743 (s), 700 (vs) cm
-1
. Anal. Calcd. for C18H20O2: C 80.56, H 7.51; found: C 80.51, H 7.23. 
 
Butyl 2,2-bis(4-methoxyphenyl)acetate (3.2-6bc) 
Compound 3.2-6bc was synthesized according to the general procedure from n-butyl acetate 
(581 mg, 0.66 mL, 5.0 mmol) and 4-bromoanisole (187 mg, 126 μL, 1.0 mmol). After 
distillation, 3.2-6bc (140 mg, 85 %) was obtained as light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.14 (d, J = 12.0 Hz, 4H), 6.77 (d, J = 8.0 Hz, 4H), 4.84 (s, 
1H), 4.06 (t, J = 8.0 Hz, 2H), 3.69 (s, 6H), 1.52 (quin, J = 8.0 Hz, 2H), 1.24 (sext, J = 8.0 Hz, 
2H), 0.81 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 173.0, 158.6, 131.2, 
129.5, 113.8, 64.9, 55.5, 55.1, 30.5, 19.0, 13.6 ppm. EI-MS (70 eV), m/z (%): 328 (2) [M
+
], 
228 (16), 227 (100), 196 (5). IR (NaCl): ν~ = 2958 (s), 2836 (m), 1731 (vs), 1609 (s), 1583 (m), 
1510 (vs), 1463 (m), 1249 (vs), 1177 (m), 1152 (m), 1034 (s), 831 (s) cm
-1
. Anal. Calcd. for 
C20H24O4: C 73.15, H 7.37; found: C 73.21, H 7.25. 
 
Butyl 2,2-bis(4-(methylthio)phenyl)acetate (3.2-6bd) 
Compound 3.2-6bd was synthesized according to the general procedure from n-butyl acetate 
(581 mg, 0.66 mL, 5.0 mmol) and 4-bromothioanisole (203 mg, 1.0 mmol). After purification 
by column chromatography, 3.2-6bd (150 mg, 83 %) was obtained as light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.25-7.18 (m, 8H), 4.91 (s, 1H), 4.14 (t, J = 8.0 Hz, 2H), 
2.45 (s, 6H), 1.59 (quin, J = 8.0 Hz, 2H), 1.30 (sext, J = 8.0 Hz, 2H), 0.88 (t, J = 8.0 Hz, 
3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 172.4, 137.4, 135.5, 128.9, 126.7, 65.1, 56.0, 
30.5, 19.0, 15.8, 13.6 ppm. EI-MS (70 eV), m/z (%): 361 (4), 360 (16) [M
+
], 260 (18), 259 
(100), 244 (5), 197 (6), 165 (16). IR (NaCl): ν~ = 2957 (m), 2920 (m), 2870 (m), 1731 (vs), 
1593 (s), 1493 (s), 1436 (vs), 1189 (m), 1153 (m), 1093 (s), 1015 (s), 806 (s) cm
-1
. EI-HRMS 
m/z calcd. for C20H24O2S2: 360.1218, m/z found: 360.1210. 
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Butyl 2,2-bis(4-(dimethylamino)phenyl)acetate (3.2-6be) 
Compound 3.2-6be was synthesized according to the general procedure from n-butyl acetate 
(581 mg, 0.66 mL, 5.0 mmol) and 4-bromo-N,N-dimethylaniline (200 mg, 1.0 mmol). After 
purification by column chromatography, 3.2-6be (90 mg, 51 %) was obtained as a yellow 
solid, m.p. 55 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.19 (d, J = 8.0 Hz, 4H), 6.69 (d, J = 8.0 Hz, 4H), 4.85 (s, 
1H), 4.13 (t, J = 8.0 Hz, 2H), 2.92 (s, 12H), 1.61 (quin, J = 8.0 Hz, 2H), 1.34 (sext, J = 8.0 Hz, 
2H), 0.90 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 173.6, 149.5, 129.1, 
127.5, 112.6, 64.6, 55.4, 40.6, 30.6, 19.1, 13.7 ppm. EI-MS (70 eV), m/z (%): 355 (3), 354 (13) 
[M
+
], 254 (20), 253 (100), 237 (16), 118 (4). IR (KBr): ν~ = 2928 (m), 1726 (vs), 1611 (s), 
1518 (s), 1443 (m), 1340 (s), 1144 (m), 1019 (s), 832 (s), 798 (s) cm
-1
. EI-HRMS m/z calcd. 
for C22H30N2O2: 354.2307, m/z found: 354.2310. 
 
Butyl 2,2-bis(4-fluorophenyl)acetate (3.2-6bf) 
Compound 3.2-6bf was synthesized according to the general procedure from n-butyl acetate 
(581 mg, 0.66 mL, 5.0 mmol) and 1-bromo-4-fluorobenzene (175 mg, 110 μL, 1.0 mmol). 
After distillation, 3.2-6bf (133 mg, 87 %) was obtained as colourless oil. 
19
F-NMR (376 MHz, CDCl3): δ = -115.2 (m, Ar-F) ppm. 
1
H-NMR (400 MHz, CDCl3): δ = 
7.29-7.24 (m, 4H), 7.01 (t, J = 8.0 Hz, 4H), 4.98 (s, 1H), 4.16 (t, J = 8.0 Hz, 2H), 1.60 (quin, J 
= 8.0 Hz, 2H), 1.31 (sext, J = 8.0 Hz, 2H), 0.89 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): δ = 172.3, 162.0 (d, 
1
JC-F = 247.5 Hz), 134.4 (d, 
4
JC-F = 3.0 Hz), 130.1 (d, 
3
JC-F = 
8.1 Hz), 115.5 (d, 
2
JC-F = 22.2 Hz), 65.2, 55.5, 30.5, 19.0, 13.6 ppm. EI-MS (70 eV), m/z (%): 
304 (1) [M
+
], 203 (100), 184 (35). IR (NaCl): ν~ = 2960 (s), 2934 (m), 2873 (m), 1735 (vs), 
1604 (vs), 1508 (vs), 1465 (m), 1228 (m), 1190 (m), 1157 (m), 1016 (s), 836 (s), 788 (m), 765 
(m) cm
-1
. Anal. Calcd. for C18H18F2O2: C 71.04, H 5.96; found: C 70.77, H 5.95. 
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Butyl 2,2-bis(4-chlorophenyl)acetate (3.2-6bg) [CAS-No. 42991-55-9] 
Compound 3.2-6bg was synthesized according to the general procedure from n-butyl acetate 
(581 mg, 0.66 mL, 5.0 mmol) and 1-bromo-4-chlorobenzene (191 mg, 1.0 mmol). After 
distillation, 3.2-6bg (130 mg, 77 %) was obtained as light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.29 (d, J = 8.0 Hz, 4H), 7.21 (d, J = 8.0 Hz, 4H), 4.94 (s, 
1H), 4.15 (t, J = 8.0 Hz, 2H), 1.59 (quin, J = 8.0 Hz, 2H), 1.31 (sext, J = 8.0 Hz, 2H), 0.89 (t, 
J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 171.8, 136.8, 133.4, 129.8, 128.8, 
65.4, 55.8, 30.5, 19.0, 13.6 ppm. EI-MS (70 eV), m/z (%): 310 (4), 309 (2) [M
+
], 308 (8), 237 
(66), 235 (100), 200 (21), 165 (58). IR (NaCl): ν~ = 2960 (vs), 2873 (m), 1732 (vs), 1595 (m), 
1491 (vs), 1465 (m), 1410 (s), 1300 (m), 1191 (s), 1154 (s), 1092 (vs), 1015 (vs), 800 (s), 775 
(m) cm
-1
. EI-HRMS m/z calcd. for C18H18Cl2O2: 336.0684, m/z found: 336.0673. 
 
Diethyl 4,4'-(2-butoxy-2-oxoethane-1,1-diyl)dibenzoate (3.2-6bh) 
Compound 3.2-6bh was synthesized according to the general procedure from n-butyl acetate 
(581 mg, 0.66 mL, 5.0 mmol) and ethyl 4-bromobenzoate (229 mg, 160 μL, 1.0 mmol). After 
purification by column chromatography, 3.2-6bh (102 mg, 50 %) was obtained as a colorless 
oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.99 (d, J = 8.0 Hz, 4H), 7.36 (d, J = 8.0 Hz, 4H), 5.10 (s, 
1H), 4.35 (q, J = 8.0 Hz, 4H) , 4.15 (t, J = 8.0 Hz, 2H), 1.58 (quin, J = 8.0 Hz, 2H), 1.36 (t, J 
= 8.0 Hz, 6H), 1.33-1.22 (m, 2H), 0.87 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): 
δ = 171.3, 166.1, 142.9, 129.9, 129.7, 128.6, 65.4, 61.0, 57.0, 30.4, 19.0, 14.3, 13.6 ppm. EI-
MS (70 eV), m/z (%): 412 (2) [M
+
], 367 (11), 312 (38), 311 (100), 283 (18), 238 (10), 165 
(30). IR (NaCl): ν~ = 2960 (s), 1718 (vs), 1608 (s), 1275 (vs), 1105 (vs), 1021 (s), 759 (s), 711 
(s) cm
-1
. EI-HRMS m/z calcd. for C24H28O6: 412.1886, m/z found: 412.1865. 
 
Butyl 2,2-bis(4-cyanophenyl)acetate (3.2-6bi) 
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Compound 3.2-6bi was synthesized according to the general procedure from n-butyl acetate 
(581 mg, 0.66 mL, 5.0 mmol) and 4-bromobenzonitrile (182 mg, 1.0 mmol). After 
purification by column chromatography, 3.2-6bi (90 mg, 57 %) was obtained as colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.62 (d, J = 8.0 Hz, 4H), 7.40 (d, J = 8.0 Hz, 4H), 5.08 (s, 
1H), 4.16 (t, J = 8.0 Hz, 2H), 1.58 (quin, J = 8.0 Hz, 2H), 1.26 (sext, J = 8.0 Hz, 2H), 0.87 (t, 
J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 170.4, 142.5, 132.5, 129.3, 118.3, 
111.8, 65.9, 56.8, 30.3, 18.9, 13.5 ppm. EI-MS (70 eV), m/z (%): 318 (1) [M
+
], 218 (100), 190 
(35). IR (NaCl): ν~ = 2960 (s), 2229 (vs), 1731 (vs), 1605 (s), 1503 (s), 1158 (s), 1020 (s), 820 
(m) cm
-1
. EI-HRMS m/z calcd. for C20H18N2O2: 318.1368, m/z found: 318.1360. 
 
Butyl 2,2-di(m-tolyl)acetate (3.2-6bj) 
Compound 3.2-6bj was synthesized according to the general procedure from n-butyl acetate 
(581 mg, 0.66 mL, 5.0 mmol) and 3-bromotoluene (171 mg, 121 μL, 1.0 mmol). After 
distillation, 3.2-6bj (135 mg, 91 %) was obtained as colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.14 (t, J = 8.0 Hz, 2H), 7.08-6.98 (m, 6H), 4.88 (s, 1H), 
4.09 (t, J = 8.0 Hz, 2H), 2.26 (s, 6H), 1.55 (quin, J = 8.0 Hz, 2H), 1.26 (sext, J = 8.0 Hz, 2H), 
0.83 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 172.3, 138.7, 138.1, 129.3, 
128.3, 127.9, 125.6, 64.9, 57.1, 30.5, 21.4, 19.0, 13.6 ppm. EI-MS (70 eV), m/z (%): 297 (3), 
296 (15) [M
+
], 196 (16), 195 (100), 180 (16), 165 (19). IR (NaCl): ν~ = 2959 (s), 2871 (m), 
1735 (vs), 1605 (s), 1588 (m), 1489 (m), 1458 (m), 1241 (m), 1162 (s), 741 (m), 699 (s) cm
-1
. 
Anal. Calcd. for C20H24O2: C 81.04, H 8.16; found: C 80.74, H 7.77. 
 
Butyl 2,2-bis(4-methoxy-3-methylphenyl)acetate (3.2-6bm) 
Compound 3.2-6bm was synthesized according to the general procedure from n-butyl acetate 
(581 mg, 0.66 mL, 5.0 mmol) and 4-bromo-1-methoxy-2-methylbenzene (201 mg, 1.0 mmol). 
After distillation, 3.2-6bm (130 mg, 73 %) was obtained as colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.12-7.06 (m, 4H), 6.76 (d, J = 8.0 Hz, 2H), 4.86 (s, 1H), 
4.14 (t, J = 8.0 Hz, 2H), 3.80 (s, 6H), 2.19 (s, 6H), 1.61 (quin, J = 8.0 Hz, 2H), 1.33 (sext, J = 
8.0 Hz, 2H), 0.90 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 173.3, 156.8, 
130.9, 130.8, 126.7, 126.6, 109.8, 64.8, 55.6, 55.3, 30.6, 19.0, 16.3, 13.6 ppm. EI-MS (70 eV), 
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m/z (%): 356 (6) [M
+
], 256 (19), 255 (100), 240 (4), 225 (4). IR (NaCl): ν~ = 2958 (m), 2931 
(m), 2836 (m), 1733 (vs), 1609 (s), 1505 (vs), 1464 (s), 1255 (s), 1134 (m), 1034 (m), 887 (m), 
813 (m) 750 (m) cm
-1
. EI-HRMS m/z calcd. for for C22H28O4: 356.1988; found: 356.1982. 
 
Butyl 2,2-di(2-naphthyl)acetate (3.2-6bn) 
Compound 3.2-6bn was synthesized according to the general procedure from n-butyl acetate 
(581 mg, 0.66 mL, 5.0 mmol) and 2-bromonaphthaline (207 mg, 1.0 mmol). After distillation, 
3.2-6bn (150 mg, 81 %) was obtained as a light yellow solid, m.p. 86 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.90-7.80 (m, 8H), 7.54-7.44 (m, 6H), 5.4 (s, 1H), 4.27 (t, J 
= 8.0 Hz, 2H), 1.67 (quin, J = 8.0 Hz, 2H), 1.38 (sext, J = 8.0 Hz, 2H), 0.92 (t, J = 8.0 Hz, 
3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 172.5, 136.1, 133.3, 132.5, 128.3, 127.9, 127.6, 
127.3, 126.9, 126.2, 126.0, 65.2, 57.4, 30.5, 19.0, 13.6 ppm. EI-MS (70 eV), m/z (%): 369 (5), 
368 (17) [M
+
], 268 (23), 267 (100). IR (KBr): ν~ = 2954 (m), 1717 (v)s, 1596 (s), 1507 (s), 
1458 (m), `1222 (vs), 1160 (m), 1059 (s), 1023 (s), 862 (s), 791 (m), 751 (s), 738 (s) cm
-1
. EI-
HRMS m/z calcd. for C26H24O2: 368.1776, m/z found: 368.1778. 
 
Butyl 2,2-di(3-pyridyl)acetate (3.2-6bo) 
Compound 3.2-6bo was synthesized according to the general procedure from n-butyl acetate 
(581 mg, 0.66 mL, 5.0 mmol) and 3-bromopyridine (158 mg, 97 μL, 1.0 mmol). After 
distillation, 3.2-6bo (100 mg, 74 %) was obtained as colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 8.54 (s, 2H), 8.51 (d, J = 4.0 Hz, 2H), 7.64 (d, J = 4.0 Hz, 
2H), 7.25 (dd, J = 4.0, 8.0 Hz, 2H), 5.00 (s, 1H), 4.14 (t, J = 8.0 Hz, 2H), 1.57 (quin, J = 
8.0 Hz, 2H), 1.27 (sext, J = 8.0 Hz, 2H), 0.85 (t, J = 8.0 Hz, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): δ = 170.9, 149.7, 149.0, 135.8, 133.5, 123.5, 65.7, 52.2, 30.3, 18.9, 13.5 ppm. EI-MS 
(70 eV), m/z (%): 270 (16) [M
+
], 226 (8), 170 (93), 169 (100). IR (NaCl): ν~ = 3032 (m), 2959 
(s), 2933 (m), 2873 (m), 1732 (vs), 1575 (s), 1479 (s), 1424 (vs), 1312 (s), 1190 (m), 1158 
(m), 1026 (s), 714 (s) cm
-1
. EI-HRMS m/z calcd. for C16H18N2O2: 270.1368, m/z found: 
270.1371. 
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8.7 Development of Decarboxylative Coupling Processes for the Synthesis 
of Azomethines and Ketones 
Synthesis of the potassium oxocarboxylates 
Potassium phenyloxoacetate, potassium (4-cyanophenyl)oxoacetate, potassium 2-
furyloxoacetate, potassium 2-thiophenyloxoacetate, potassium trimethylpyruvate and 
potassium 3-methyl-2-oxobutanoate were obtained by reaction of the commercially available 
carboxylic acids with potassium tert-butoxide in 2-propanol. Potassium (4-
methylphenyl)oxoacetate, potassium (4-chlorophenyl)oxoacetate, potassium (4-
methoxyphenyl)oxoacetate and potassium (2,5-dimethylphenyl)oxoacetate were obtained by 
Friedel-Crafts acylation of the corresponding commercially available arenes with ethyl oxalyl 
chloride in DCM, followed by ester hydrolysis with potassium hydroxide in 2-propanol. 
These starting materials were prepared by Dr. Felix Rudolph. 
 
Potassium (N-[4-(dimethylamino)phenyl]imino)-phenylacetate (4.2-5a) 
A mixture of phenyloxoacetic acid (751 mg, 5 mmol) and N,N-dimethyl-p-phenylendiamine 
(613 mg, 4.5 mmol) in 20 mL methanol was stirred for 16 h at 25 °C, filtered and washed 
with 5 mL of diethyl ether, yielding an orange solid (1178 mg). The solid was stirred with 
potassium tert-butoxide (493 mg, 4.39 mmol) in diethyl ether (20 mL) for 1 h at 25 °C, 
filtered and washed with diethyl ether (5 mL), affording potassium (N-[4-(dimethylamino)-
phenyl]imino)-phenylacetate (4.2-5a) as a yellow solid (1.29 g, 94 %). M.p. 220 °C 
(dcomposition) 
1
H-NMR (400 MHz, DMSO-d6): 7.85-7.91 (m, 2H), 7.32-7.37 (m, 3H), 7.12-7.17 (m, 2H), 
6.61-6.66 (m, 2H), 2.85 (s, 6H) ppm.
 13
C-NMR (151 MHz, DMSO-d6): 169.2, 166.5, 
147.5, 140.9, 137.8, 129.2, 127.9, 127.7, 122.8, 112.5, 40.6 ppm. IR (KBr): ν~ = 3356 (m, br), 
1597 (vs), 1509 (vs), 1395 (s), 1338 (m), 1316 (m), 1214 (s), 1134 (w), 1056 (w), 1012 (w), 
946 (w), 852 (m), 838 (m), 706 (m), 572 (w) cm
-1
. Anal. Calcd. for C16H15KN2O2: C 62.72, H 
4.93, N 9.14; found: C 61.98, H 5.04, N 9.14. 
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8.7.1 General Procedure for the Decarboxylative Cross-Coupling Reactions 
from Preformed -Iminocarboxylate 
An oven-dried 20 mL reaction vial was charged with potassium phenyl(N-[4-
(dimethylamino)phenyl]imino)acetate (5a, 1.2 mmol), copper (I) bromide (21.5 mg, 
150 µmol), palladium(II)-1,1,1,3,3,3-hexafluoroacetylacetonate (5.2 mg, 10 µmol), 1,1’-bis-
(diphenylphosphino)-ferrocene (5.7 mg, 10 µmol), magnesium trifluoromethane sulfonate 
(16.1 mg, 50 µmol) and ground 3 Å molecular sieves (200 mg). The reaction vessel was 
evacuated and flushed with nitrogen three times. Subsequently, a solution of the 
corresponding aryl halide (1.0 mmol) and the internal standard n-tetradecane (50 µL) in NMP 
(2 mL) was added via syringe. The resulting mixture was stirred at 130 
o
C for 16 h, diluted 
with saturated sodium bicarbonate solution (20 mL) and extracted repeatedly with 20 mL 
portions of ethyl acetate. The combined organic layers were washed with saturated sodium 
bicarbonate solution, water and brine, dried over MgSO4, filtered, and the solvent was 
removed under reduced vacuum. The crude product was purified by column chromatography 
on silica gel (hexane/ethyl acetate gradient). 
 
N,N-Dimethyl-N'-[(phenyl)-(4-tolyl)-methylene]-p-phenylenediamine (4.2-4aaa) 
Compound 4.2-4aaa was synthesized at 130 °C according to the general procedure from 4.2-
5a (368 mg, 1.20 mmol) and 4-bromotoluene (171 mg, 122 µl, 1.00 mmol). After purification 
by column chromatography (hexane/ethyl acetate 90:10), 4.2-4aaa (290 mg, 85 %) was 
obtained as orange solid, m.p. 99 °C. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers, approx. ratio 1.2:1): 7.58-7.62 
and 7.68-7.72 (2 m, 2H), 7.26-7.30 and 7.33-7.42 (2 m, 3H), 7.02-7.11 and 7.12-7.20 (2 m, 
4H), 6.65-6.72 (m, 2H), 6.51-6.60 (m, 2H), 2.87 and 2.85 (2 s, 6H), 2.38 and 2.34 (2 s, 
3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 Signal sets for E/Z-isomers): 166.3 and 166.0, 
147.26 and 147.22, 141.1,140.9, 140.8, 140.3, 138.1, 137.8, 137.4, 134.1, 130.0, 129.7, 129.6, 
129.07, 129.00, 128.77, 128.73, 128.1, 128.0, 123.14 and 123.08, 112.74 and 112.70, 40.86 
and 40.85, 21.38 and 21.37 ppm. EI-MS (70 eV): m/z (%): 343 (28), 342 (100) [M
+
], 341 (57), 
325 (22), 207 (30), 192 (20), 77 (23). IR (KBr): ν~ = 1607 (s), 1509 (vs), 1441 (m), 1351 (m), 
1226 (m), 1176 (m), 1166 (m), 1064 (w), 944 (m), 820 (vs), 776 (m), 704 (vs), 670 (m) cm
-1
. 
Anal. Calcd. for C22H22N2: C 84.04, H 7.05, N 8.91; found: C 83.94, H 7.15, N 8.93. 
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N,N-Dimethyl-N'-[(4-methoxyphenyl)-(phenyl)-methylene]-p-phenylenediamine (4.2-
4aab) 
Compound 4.2-4aab was synthesized at 130 °C according to the general procedure from 4.2-
5a (368 mg, 1.20 mmol) and 2-bromoanisole (187 mg, 126 µl, 1.00 mmol). After purification 
by column chromatography (hexane/ethyl acetate 80:20), 4.2-4aab (270 mg, 82 %) was 
obtained as orange solid, m.p. 119 °C. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers, approx. 1.7:1): 7.66-7.78 (m, 
2H), 7.36-7.49 (m, 1H), 7.26-7.48 (m, 2H), 7.08-7.23 (m, 2H), 6.80-6.97 (m, 2H), 6.66-6.78 
(m, 2H), 6.53-6.65 (m, 2H), 3.83 and 3.87 (s, 3H), 2.88 and 2.91 (2 s, 6H) ppm. 
13
C-NMR 
(101 MHz, CDCl3, 2 Signal sets for E/Z-isomers): 165.6 and 165.9, 161.3, 159.4, 147.1 
and 147.2, 141.0 and 141.2, 137.3, 133.2, 131.4, 130.6, 130.0, 129.6, 129.21, 129.15, 128.1, 
128.0, 123.0 and 123.1, 113.4, 112.7 and 112.8, 55.1 and 55.3, 40.9 ppm. EI-MS (70 eV): m/z 
(%): 332 (31), 331 (100), 330 (15) [M
+
], 254 (38), 208 (13), 77 (19), 40 (14). IR (KBr): ν~ = 
1653 (m), 1607 (s), 1559 (s), 1507 (vs), 1437 (m), 1260 (s), 1228 (s), 1166 (s), 1064 (m), 
1030 (s), 816 (vs), 702 (s), 670 (s), 662 (m), 540 (m) cm
-1
. Anal. Calcd. for C22H22N2O: C 
79.97, H 6.71, N 8.48; found: C 79.88, H 6.82, N 8.64. 
 
N,N-Dimethyl-N'-[(4-methylsulfanylphenyl)-(phenyl)-methylene]-p-phenylenediamine 
(4.2-4aac) 
Compound 4.2-4aac was synthesized at 130 
o
C according to the general procedure from 4.2-
5a (368 mg, 1.20 mmol) and 2-bromothioanisole (203 mg, 1.00 mmol). After purification by 
column chromatography (hexane/ethyl acetate 85:15), 4.2-4aac (220 mg, 64 %) was obtained 
as orange solid, m.p. 110 
o
C.  
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers): 7.64-7.69 and 7.69-7.75 (2 m, 
2H), 7.26-7.36 and 7.37-7.47 (2 m, 3H), 7.08-7.13 and 7.23-7.26 (2 m, 2H), 7.14-7.21 (m, 
2H), 6.68-6.76 (m, 2H), 6.54-6.63 (m, 2H), 2.89 and 2.91 (2 s, 6H), 2.50 and 2.52 (2 s, 
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3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 Signal sets for E/Z-isomers): 165.2 and 165.5, 
147.3, 141.4, 140.9, 140.7, 140.6, 139.1, 137.15, 137.11, 133.45, 130.2, 130.1, 129.5, 129.3, 
129.1, 128.2, 128.10, 128.05, 125.3, 123.3, 123.1, 112.6 and 112.8, 40.8, 15.1 and 15.3 ppm. 
EI-MS (70 eV): m/z (%): 347 (33), 346 (100) [M
+
], 345 (11), 269 (23), 223 (12), 135 (19), 77 
(17). IR (KBr): ν~ = 1605 (s), 1549 (m), 1507 (vs), 1441 (m), 1338 (m), 1226 (m), 1164 (m), 
1122 (m), 1090 (s), 958 (m), 820 (vs), 702 (vs), 670 (w) cm
-1
. Anal. Calcd. for C22H22N2S: C 
76.26, H 6.40, N 8.08, S 9.25; found: C 76.09, H 6.24, N 8.15, S 9.18. 
 
N,N-Dimethyl-N'-[(4-(dimethylamino)phenyl)-(phenyl)-methylene]-p-phenylenediamine 
(4.2-4aad) 
Compound 4.2-4aad was synthesized at 130 °C according to the general procedure from 4.2-
5a (368 mg, 1.20 mmol) and 2-bromo-N,N-dimethylaniline (3200 mg, 1.00 mmol) After 
purification by column chromatography (hexane/ethyl acetate 80:20), 4.2-4aad (170 mg, 
50 %) was obtained as orange solid, m.p. 173 °C.  
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers, approx. 2.1:1): 7.61-7.69 and 
7.71-7.76 (2 m, 2H), 7.26-7.34 and 7.36-7.47 (2 m, 3H), 7.03-7.10 and 7.16-7.23 (2 m, 2H), 
6.52-6.84 (m, 6H), 2.99 and 3.04 (2 s, 6H), 2.87 and 2.91 (2 s, 6H) ppm. 
13
C-NMR (101 MHz, 
CDCl3, 2 Signal sets for E/Z-isomers): 166.1 and 166.7, 151.7, 150.1, 146.8 and 147.0, 
142.1, 141.8, 141.6, 137.8, 131.5, 130.4, 129.7, 129.6, 129.4, 128.2, 127.9, 127.8, 124.0, 
123.1, 122.9, 112.9 and 113.1, 111.0 and 111.1, 41.0, 40.1 and 40.2 ppm. EI-MS (70 eV): m/z 
(%): 344 (31), 343 (100) [M
+
], 342 (21), 328 (12), 266 (19), 208 (22), 77 (15). IR (KBr): ν~ = 
1617 (m), 1583 (s), 1507 (s), 1441 (m), 1369 (m), 1343 (m), 1320 (m), 1224 (s), 1198 (m), 
1164 (m), 1142 (m), 1058 (m), 942 (m), 914 (w), 816 (vs), 700 (s), 670 (m) cm
-1
. EI-HRMS 
m/z calcd. for C23H25N3: 343.2048; m/z found 343.2051. 
 
N,N-Dimethyl-N'-[(2-methoxyphenyl)-(phenyl)-methylene]-p-phenylenediamine (4.2-
4aae) 
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Compound 4.2-4aae was synthesized at 130 °C according to the general procedure from 4.2-
5a (368 mg, 1.20 mmol) and 2-bromoanisole (187 mg, 125 µl, 1.00 mmol). After purification 
by column chromatography (hexane/ethyl acetate 80:20), 4.2-4aae (190 mg, 58 %) was 
obtained as orange solid, m.p. 93 °C. 
1
H-NMR (400 MHz, CDCl3):  7.72-7.77 (m, 2H), 7.26-7.41 (m, 4H), 6.97-7.02 (m, 1H), 
6.83-6.92 (m, 2H), 6.71-6.76 (m, 2H), 6.51-6.57 (m, 2H), 3.59 (s, 3H), 2.84 (s, 6H) ppm. 
13
C-
NMR (101 MHz, CDCl3): 163.8, 156.9, 147.4, 141.3, 140.0, 130.0, 129.9, 129.6, 128.2, 
126.7, 122.2, 120.4, 112.5, 110.9, 55.3, 40.9 ppm. EI-MS (70 eV): m/z (%): 331 (25), 330 (97) 
[M
+
], 167 (21), 136 (100), 135 (69), 121 (23), 77 (25). IR (KBr): ν~ = 1605 (s), 1509 (vs), 
1485 (s), 1443 (s), 1345 (m), 1248 (s), 1228 (s), 1166 (m), 1108 (m), 1046 (w), 1022 (m), 956 
(m), 816 (m), 754 (s), 698 (s) cm
-1
. Anal. Calcd. for C22H22N2O: C 79.97, H 6.71, N 8.48; 
found: C 80.05, H 6.69, N 8.49. 
 
N,N-Dimethyl-N'-[(2-naphthyl)-(phenyl)-methylene]-p-phenylenediamine (4.2-4aaf) 
Compound 4.2-4aaf was synthesized at 130 °C according to the general procedure from 4.2-
5a (368 mg, 1.20 mmol) and 2-bromonaphthalene (207 mg, 1.00 mmol). After purification by 
column chromatography (hexane/ethyl acetate 85:15), 4.2-4aaf (185 mg, 53 %) was obtained 
as orange solid, m.p. 119 °C. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers, approx. 1.2:1): 7.99-8.02 and 
8.11-8.15 (2m, 1H), 7.35-7.56 and 7.71-7.93 (2m, 5H), 6.73-6.82 and 7.23-7.29 (2m, 2H), 
6.49-6.56 and 6.56-6.63 (2m, 1H), 2.86 and 2.91 (2 s, 6H) ppm. 
13
C-NMR (101 MHz, CDCl3, 
2 Signal sets for E/Z-isomers): 165.7 and 165.8, 147.4, 140.8, 140.7, 140.6, 138.0, 137.3, 
134.9, 134.3, 132.9, 132.8, 130.1, 129.9, 129.7, 129.3, 129.2, 128.9, 128.3, 128.2, 128.1, 
127.8, 127.7, 127.6, 127.1, 127.0, 126.6, 126.2, 126.1, 125.6, 123.3 and 123.4, 112.6 and 
112.7, 40.7 and 40.8 ppm. Ei-MS (70 eV): m/z (%): 352 (36), 351 (100), 349 (13) [M
+
], 274 
(19), 224 (16), 208 (15), 136 (30), 77 (20). IR (KBr): ν~ = 1605 (m), 1507 (s), 1441 (m), 1347 
(m), 1226 (m), 1180 (m), 1166 (w), 1116 (w), 1060 (w), 936 (w), 896 (w), 818 (vs), 750 (m), 
704 (vs) cm
-1
. Anal. Calcd. for C25H22N2: C 85.68, H 6.33, N 7.99; found: C 85.52, H 6.13, N 
7.96. 
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N,N-Dimethyl-N'-[(4-acetylphenyl)-(phenyl)-methylen]-p-phenylenediamine (4.2-4aag) 
Compound 4aag was synthesized at 130 °C according to the general procedure from 4.2-5a 
(368 mg, 1.20 mmol) and 1-bromo-4-chlorobenzene (199 mg, 1.00 mmol). After purification 
by column chromatography (hexane/ethyl acetate 80:20), 4aag (195 mg, 57 %) was obtained 
as reddish-brown solid, m.p. 111 °C. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers, approx. 1.1:1): 7.89-7.99 (m, 
2H), 7.67-7.74 and 7.80-7.85 (2 m, 2H), 7.27-7.47 (m, 4H), 7.15-7.19 (m, 1H), 6.66-7.76 (m, 
2H), 6.52-6.58 (m, 2H), 2.90 and 2.91 (2 s, 6H), 2.62 and 2.65 (2 s, 3H) ppm. 
13
C-NMR 
(101 MHz, CDCl3, 2 Signal sets for E/Z-isomers): 197.6 and 197.8, 164.2 and 164.7, 
147.5 and 147.7, 144.7, 142.3, 140.1, 140.0, 139.8, 137.8, 136.8, 136.5, 130.4, 129.9, 129.4, 
129.0, 128.8, 128.6, 128.4, 128.2, 128.1, 128.0, 123.1 and 123.6, 112.4 and 112.6, 40.6 and 
40.7, 26.6 and 26.8 ppm. EI-MS (70 eV): m/z (%): 344 (35), 343 (100) [M
+
], 342 (19), 282 
(19), 266 (23), 224 (24), 208 (35). IR (KBr): ν~ = 1683 (vs), 1607 (vs), 1511 (vs), 1443 (m), 
1399 (m), 1355 (s), 1264 (vs), 1230 (s), 1184 (m), 1062 (m), 954 (m), 822 (s), 708 (vs), 670 
(m), 604 (w), 592 (w) cm
-1
. Anal. Calcd. for C23H22N2O: C 80.67, H 6.48, N 8.18; found: C 
80.19, H 6.55, N 8.65. EI-HRMS m/z calcd. for C23H22N2O: 342.1732; m/z found: 342.1720. 
 
N,N-Dimethyl-N'-[(4-cyanophenyl)-(phenyl)-methylene]-p-phenylenediamine (4.2-4aah) 
Compound 4.2-4aah was synthesized at 130 °C according to the general procedure from 4.2-
5a (368 mg, 1.20 mmol) and 4-bromobenzonitrile (182 mg, 110 µl, 1.00 mmol). After 
purification by column chromatography (hexane/ethyl acetate 80:20), 4.2-4aah (250 mg, 
77 %) was obtained as red solid, m.p. 148 °C. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers): 7.61-7.65 and 7.82-7.87 (2 m, 
2H), 7.65-7.70 (m, 2H), 7.35-7.49 (m, 3H), 7.14-7.19 and 7.27-7.33 (2 m, 2H), 6.63-6.68 and 
6.71-6.76 (2 m, 2H), 6.52-6.58 (m, 2H), 2.92 (s, 6H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 
Signal sets for E/Z-isomers): 162.9 and 163.6, 147.7 and 148.0, 144.6, 142.2, 139.7, 139.4, 
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139.3, 136.4, 132.0, 131.8, 130.6, 130.3, 129.3, 129.2, 128.7, 128.6, 128.3, 123.8, 123.1, 
118.8, 118.4, 113.0, 112.5, 112.2, 112.0. 40.56 and 40.62 ppm. EI-MS (70 eV): m/z (%): 327 
(35), 326 (100), 325 (12) [M
+
], 249 (16), 224 (34), 208 (18), 77 (26), 51 (14). IR (KBr): ν~ = 
2227 (m), 1609 (s), 1513 (vs), 1443 (s), 1359 (s), 1318 (m), 1284 (w), 1230 (m), 1170 (m), 
1066 (w), 950 (m), 814 (s), 782 (m), 698 (s). Anal. Calcd. for C22H19N3: C 81.20, H 5.89, N 
12.91; found: C 81.24, H 5.85, N 12.97. 
 
N,N-Dimethyl-N'-[(4-(ethoxycarbonyl)phenyl)-(phenyl)-methylene]-p-phenylenediamine 
(4.2-4aai) 
Compound 4.2-4aai was synthesized at 130 °C according to the general procedure from 4.2-
5a (368 mg, 1.20 mmol) and ethyl 4-bromobenzoate (229 mg, 160 µl, 1.00 mmol). After 
purification by column chromatography (hexane/ethyl acetate 80:20), 4.2-4aai (260 mg, 70 %) 
was obtained as red solid, m.p. 81 °C. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers): 7.96-8.11 (m, 2H), 7.67-7.82 
(m, 2H), 7.15-7.48 (m, 5H), 6.66-6.78 (m, 2H), 6.52-6.60 (m, 2H), 4.36-4.47 (m, 2H), 2.895 
and 2.905 (2 s, 6H), 1.38-1.47 (m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 Signal sets for 
E/Z-isomers): 166.2 and 166.3, 164.5 and 164.9, 147.5 and 147.7 142.0, 140.2, 140.1, 
139.9, 136.9, 131.4, 130.3, 130.1, 129.6, 129.4, 129.3, 129.2, 128.84, 128.82, 128.5, 128.3, 
128.2, 123.1 and 123.5, 112.4 and 112.6, 61.05 and 61.09, 40.67 and 40.70, 14.3 ppm. EI-MS 
(70 eV): m/z (%): 373 (35), 372 (100) [M
+
], 344 (31), 299 (13), 223 (21), 135 (14), 77 (15).IR 
(KBr): ν~ = 2793 (w), 1719 (s), 1607 (m), 1507 (s), 1443 (m), 1272 (vs), 1228 (s), 1100 (vs), 
1014 (m), 958 (m), 820 (s), 782 (m), 710 (s) cm
-1
. Anal. Calcd. for C24H24N2O2: C 77.39, H 
6.49, N 7.52; found: C 77.37, H 6.48, N 7.51. 
 
N,N-Dimethyl-N'-[(4-(trifluoromethyl)phenyl)-(phenyl)-methylene)-p-phenylenediamine 
(4.2-4aaj) 
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Compound 4.2-4aaj was synthesized at 130 °C according to the general procedure from 4.2-
5a (368 mg, 1.20 mmol) and ethyl 4-bromo-4-(trifluoromethyl)benzene (227 mg, 142 µl, 
1.00 mmol). After purification by column chromatography (hexane/ethyl acetate 85:15), 4.2-
4aaj (303 mg, 82 %) was obtained as red solid, m.p. 117 °C. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers): 7.69-7.74 and 7.84-7.89 (2 m, 
2H), 7.58-7.68 (m, 2H), 7.27-7.52 (m, 4H), 7.16-7.22 (m, 1H), 6.67-6.78 (m, 2H), 6.54-6.61 
(m, 2H), 2.92 (s, 6H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 Signal sets for E/Z-isomers): 
163.9 and 164.2, 147.6 and 147.8, 141.0, 140.0, 139.9, 139.8, 133.5 (q, 1J (C,F)=approx. 
630 Hz), 130.2 and 131.5 (q, 
2
J (C,F)=32.7 and 32.1 Hz), 130.0, 129.4, 129.2, 128.8, 128.6, 
128.4, 128.2, 125.0 and 125.1 (q, 
3
J (C,F)=3.69 Hz), 123.1 and 123.5, 122.5 and 122.7, 112.4 
and 112.6, 40.6 and 40.7 ppm. 
19
F-NMR (376 MHz, CDCl3): -62.6 (s, 3F) ppm. EI-MS 
(70 eV): m/z (%): 369 (35), 368 (100) [M
+
], 291 (15), 223 (28), 135 (14), 77 (19), 42 (10). IR 
(KBr): ν~ = 1609 (s), 1507 (vs), 1443 (m), 1407 (m), 1351 (m), 1320 (vs), 1166 (s), 1128 (vs), 
1108 (s), 1064 (vs), 1014 (m), 960 (w), 948 (w), 860 (m), 818 (m), 706 (m), 678 (w) cm
-1
. 
Anal. Calcd. for C22H19F3N2: C 71.73, H 5.20, N 7.60; found: C 71.75, H 5.26, N 7.69. 
 
N,N-Dimethyl-N'-[(4-fluorophenyl)-(phenyl)-methylene]-p-phenylenediamine (4.2-4aak) 
Compound 4.2-4aak was synthesized at 130 °C according to the general procedure from 4.2-
5a (368 mg, 1.20 mmol) and 1-bromo-4-fluorobenzene (175 mg, 110 µl, 1.00 mmol). After 
purification by column chromatography (hexane/ethyl acetate 85:15), 4.2-4aak (240 mg, 
75 %) was obtained as orange solid, m.p. 95 °C. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers, approx. 1.1:1): 7.66-7.75 (m, 
2H), 7.26-7.35 and 7.35-7.46 (2m, 3H), 6.95-7.09 and 7.10-7.19 (2m, 4H), 6.64-6.72 (m, 2H), 
6.49-6.60 (m, 2H), 2.86 and 2.88 (2s, 6H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 Signal sets for 
E/Z-isomers): 164.6 and 165.0, 162.3 and 164.1 (d, 1J (C,F)=248.8 and 250.6 Hz), 147.4, 
140.6, 140.5, 140.4, 137.0, 133.1 and 136.7 (d, 
4
J (C,F)=3.7 and 2.8 Hz), 131.0 and 131.6 (2 d, 
3
J (C,F)=8.3 Hz), 130.2, 129.5, 129.0, 128.4, 128.1 and 128.2, 123.0 and 123.2, 115.0 and 
115.2 (2 d, 
2
J (C,F)=21.3 and 22.2 Hz), 112.6 and 112.7, 40.8 ppm. 
19
F-NMR (376 MHz, 
CDCl3, 2 Signal sets for E/Z-isomers): -110.8 and -112.1 (s, 1F) ppm. EI-MS (70 eV): m/z 
(%): 319 (29), 318 (100) [M
+
], 317 (15), 241 (28), 223 (19), 135 (23), 77 (22). IR (KBr): ν~ = 
1611 (m), 1595 (m), 1507 (vs), 1441 (m), 1353 (m), 1288 (m), 1224 (s), 1166 (m), 1064 (m), 
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958 (m), 846 (m), 806 (s), 690 (s), 534 (m) cm
-1
. Anal. Calcd. for C21H19FN2: C 79.22, H 6.01, 
N 8.80; found: C 79.22, H 6.39, N 8.90. 
 
N,N-Dimethyl-N'-[(4-chlorophenyl)-(phenyl)-methylene]-p-phenylenediamine (4.2-4aal) 
Compound 4.2-4aal was synthesized at 130 °C according to the general procedure from 4.2-
5a (368 mg, 1.20 mmol) and 1-bromo-4-chlorobenzene (175 mg, 110 µl, 1.00 mmol). After 
purification by column chromatography (hexane/ethyl acetate 80:20), 4.2-4aal (298 mg, 86 %) 
was obtained as orange solid, m.p. 127 °C. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers): 7.66-7.74 (m, 2H), 7.26-7.48 
(m, 5H), 7.11-7.19 (m, 2H), 6.67-6.74 (m, 2H), 6.52-6.62 (m, 2H), 2.90 and 2.92 (2s, 6H) 
ppm. 
13
C-NMR (101 MHz, CDCl3, 2 Signal sets for E/Z-isomers): 164.5 and 164.7, 147.4 
and 147.5, 140.4, 140.3, 140.2, 139.0, 136.8, 136.1, 135.6, 134.2, 131.1, 130.3, 129.4, 128.9, 
128.4, 128.3, 128.1, 123.1 and 123.3, 112.5 and 112.7, 40.7 and 40.8 ppm. EI-MS (70 eV): 
m/z (%): 337 (35), 336 (36), 335 (100), 334 (12) [M
+
], 258 (24), 224 (26), 136 (23), 77 (29). 
IR (KBr): ν~ = 1607 (m), 1507 (s), 1441 (m), 1339 (m), 1262 (vs), 1104 (vs), 1086 (vs), 1026 
(s), 820 (vs), 802 (vs), 708 (m). Anal. Calcd. for C21H19ClN2: C 75.33, H 5.72, N 8.37; found: 
C 75.01, H 5.82, N 8.46. 
 
N,N-Dimethyl-N'-[(phenyl)-(3-pyridyl)-methylene]-p-phenylenediamine (4.2-4aam) 
Compound 4.2-4aam was synthesized at 130 °C according to the general procedure from 4.2-
5a (368 mg, 1.20 mmol) and 3-bromopyridine (158 mg, 96.3 µl, 1.00 mmol). The crude 
product was purified by Kugelrohr distillation in vacuo (> 250 °C, 2.4×10
-2
 mbar), affording 
4.2-4aam (254 mg, 84 %) as red oil. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers): 8.60-8.64 and 8.81-8.85 (2m, 
1H), 8.38-8.42 and 8.51-8.54 (2m, 1H), 7.65-7.72 (m, 1H), 7.35-7.49 (m, 2H), 7.27-7.35 (m, 
2H), 7.20-7.24 and 8.03-8.08 (2m, 1H), 7.12-7.18 (m, 1H), 6.61-6.75 (m, 2H), 6.48-6.55 (m, 
2H), 2.86 and 2.87 (2s, 6H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 Signal sets for E/Z-isomers): 
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162.9 and 163.0, 150.6, 150.4, 150.2, 149.2, 147.6 and 147.7, 140.1, 139.8, 139.7, 137.1, 
136.2, 136.2, 135.9, 133.0, 130.5, 129.3, 128.8, 128.7, 128.6, 128.4, 128.3, 123.5, 122.96 and 
123.00, 112.4 and 112.7, 40.6 and 40.7 ppm. EI-MS (70 eV): m/z (%): 302 (27), 301 (100) 
[M
+
], 300 (21), 224 (21), 223 (31), 135 (29), 77 (30). IR (NaCl): ν~ = 1659 (s), 1613 (vs), 1503 
(vs), 1443 (vs), 1413 (s), 1351 (vs), 1228 (s), 1166 (s), 1062 (m), 1026 (m), 948 (s), 822 (s), 
752 (m), 706 (m) cm
-1
. EI-HRMS m/z calcd. for C20H19N3: 301.1579; m/z found: 301.1594. 
 
N,N-Dimethyl-N'-[(2-mesityl)-(phenyl)-methylene]-p-phenylenediamine (4.2-4aan) 
Compound 4.2-4aan was synthesized at 130 °C according to the general procedure from 4.2-
5a (368 mg, 1.20 mmol) and 2-bromo-mesitylene (199 mg, 153 µl, 1.00 mmol). GC-Yield: 
10 %. EI-MS (70 eV): m/z (%): 343 (27), 342 (100) [M
+
], 341 (55), 325 (21), 207 (29), 192 
(22), 77 (24). 
8.7.2 General Procedure for The One-pot-azomethine Synthesis 
An oven-dried 20 mL vessel was charged with potassium aryloxoacetate (1.20 mmol), 
copper(I) bromide (21.5 mg, 0.15 mmol), palladium(II) 1,1,1,3,3,3-hexafluoroacetylacetonate 
(5.2 mg, 0.01 mmol), 1,10-phenanthroline (27.0 mg, 0.15 mmol), 1,1'-bis-(diphenylphosphino) 
ferrocene (5.7 mg, 0.01 mmol) and 3 Å molecular sieves (200 mg). The reaction vessel was 
evacuated and flushed with nitrogen three times. Subsequently, a solution of the 
corresponding aryl halide (1.00 mmol), the amine (1.20 mmol) and the internal standard n-
tetradecane (50 L) in NMP (2 mL) was added via syringe. The resulting mixture was stirred 
at 100 °C for 16 h, diluted with saturated sodium bicarbonate solution (20 mL) and extracted 
repeatedly with 20 mL portions of ethyl acetate. The combined organic layers were washed 
with saturated sodium bicarbonate solution, water and brine, dried over MgSO4, filtered, and 
the volatiles were removed in vacuo. The residue was purified by Kugelrohr distillation in 
vacuo, yielding the corresponding azomethines. 
 
N-(Phenyl-p-tolyl-methylene)-cyclohexylamine (4.2-4aba) 
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Compound 4.2-4aba was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
4-bromotoluene (171 mg, 122 µL, 1.00 mmol). After distillation, 4.2-4aba (252 mg, 91 %) 
was obtained as pale yellow oil.  
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 1:1): 7.47-7.53 
and 7.56-7.64 (2m, 2H), 7.28-7.37 and 7.38-7.47 (2m, 3H), 7.14-7.19 and 7.23-7.28 (2m, 2H), 
7.04-7.09 and 7.10-7.14 (2m, 2H), 3.17-3.33 (m, 1H), 2.36 and 2.44 (2 s, 3H), 1.55-1.82 (m, 
7H), 1.10-1.34 (m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for stereoisomers): 
165.4 and 165.7, 140.6, 139.5, 137.6 and 137.7, 134.3, 129.4, 128.9, 128.6, 128.33, 
128.26, 128.2, 127.8, 127.6, 61.2 and 61.3, 34.0, 25.7, 24.4, 21.2 and 21.3 ppm. EI-MS 
(70 eV): m/z (%): 278 (100), 277 (38) [M
+
], 263 (21), 235 (21), 200 (30), 165 (36), 104 (29). 
IR (NaCl): ν~ = 3079 (m), 2923 (vs), 2851 (vs), 1659 (w), 1621 (s), 1607 (s), 1575 (m), 1567 
(m), 1507 (m), 1489 (m), 1445 (s), 1312 (s), 1288 (s), 1256 (m), 1182 (m), 1070 (m), 1028 
(m), 968 (s), 888 (m), 844 (w), 824 (m), 774 (m), 758 (m), 728 (m), 698 (s), 632 (w) cm
-1
. EI-
HRMS m/z calcd. for C20H23N: 277.1830; m/z found: 277.1819. 
 
N-((4-Methoxyphenyl)-phenyl-methylene)-cyclohexylamine (4.2-4abb) 
Compound 4.2-4abb was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
4-bromoanisol (187 mg, 126 µL, 1.00 mmol). After distillation, 4.2-4abb (263 mg, 90 %) was 
obtained as yellow oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 1.6:1): 7.54-
7.59 and 7.59-7.64 (2m, 2H), 7.29-7.40 and 7.40-7.51 (2m, 3H), 7.09-7.15 and 7.15-7.21 (2m, 
2H), 6.83-6.88 and 6.97-7.03 (2m, 2H), 3.82 and 3.90 (2s, 3H), 3.20 and 3.33 (2 qui, 
3
J 
(H,H)=7.1 Hz, 1H), 1.55-1.83 (m, 7H), 1.10-1.35 (m, 3H) ppm.
 13
C-NMR (101 MHz, CDCl3, 
2 signal sets for stereoisomers): 164.8 and 165.4, 159.2 and 160.8, 140.9, 137.6, 133.2, 
129.8, 129.5, 129.4, 129.1, 128.4, 128.2, 127.9, 127.6, 113.2 and 113.6, 61.2 and 61.3, 33.98 
and 34.02, 25.7, 24.4 ppm. EI-MS (70 eV): m/z (%): 294 (37), 293 (31), 292 (100) [M
+
], 264 
(22), 250 (32), 216 (69), 77 (24). IR (NaCl): ν~ = 2927 (vs), 2853 (s), 1651 (vs), 1599 (vs), 
1573 (s), 1507 (s), 1445 (s), 1417 (m), 1312 (s), 1282 (vs), 1256 (vs), 1172 (s), 1150 (s), 1072 
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(w), 1032 (s), 922 (m), 842 (m), 792 (w), 742 (m), 702 (s) cm
-1
. EI-HRMS m/z calcd. for 
C20H23NO: 293.1780; m/z found: 293.1762. 
 
N-((4-Methylsulfanylphenyl)-phenyl-methylene)-cyclohexylamine (4.2-4abc) 
Compound 4.2-4abc was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
4-bromothioanisol (203 mg, 1.00 mmol). After distillation, 4.2-4abc (285 mg, 92 %) was 
obtained as pale yellow oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 1.3:1): 7.58-
7.64 and 7.50-7.55 (2m, 2H), 7.37-7.48 (m, 2H), 7.27-7.37 (m, 2H), 7.06-7.12 and 7.12-7.19 
(2m, 3H), 3.16-3.32 (m, 1H), 2.44 and 2.53 (2 s, 3H), 1.54-1.85 (m, 7H), 1.09-1.35 (m, 3H) 
ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for stereoisomers): 164.7 and 164.8, 
140.2 and 140.5, 138.6, 136.9 and 137.1, 133.6, 129.4, 128.5, 128.2, 128.1, 127.8, 127.5, 
125.3 and 125.7, 61.1 and 61.2, 33.8, 25.6, 24.3, 15.24 and 15.17 ppm. EI-MS (70 eV): m/z 
(%): 310 (51), 309 (41) [M
+
], 308 (100), 266 (34), 262 (35), 254 (35), 165 (48). IR (NaCl): 
ν~ = 3077 (m), 2923 (vs), 2851 (vs), 2791 (w), 1619 (s), 1589 (s), 1551 (m), 1489 (s), 1445 (s), 
1397 (m), 1306 (m), 1286 (s), 1188 (m), 1112 (w), 1092 (s), 1068 (m), 1028 (w), 1014 (w), 
968 (m), 888 (w), 822 (m), 774 (m), 702 (m) cm
-1
. EI-HRMS m/z calcd. for C20H23NS: 
309.1551; m/z found: 309.1552. 
 
N-((4-(Dimethylamino)phenyl)-phenyl-methylene)-cyclohexylamine (4.2-4abd) 
Compound 4.2-4abd was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
4-brom-N,N-dimethylaniline (200 mg, 1.00 mmol). After distillation, 4.2-4abd (260 mg, 85 %) 
was obtained as orange oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 2:1): 7.48-7.55 
and 7.62-7.67 (2m, 2H), 7.28-7.36 and 7.37-7.48 (2m, 3H), 7.05-7.11 and 7.15-7.21 (2m, 2H), 
6.60-6.67 and 6.74-6.80 (2m, 2H), 3.18 and 3.46 (2qui, 
3
J (H,H)=7.1 Hz, 1H), 2.97 and 3.03 
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(2s, 6H), 1.54-1.84 (m, 7H), 1.09-1.36 (m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal 
sets for stereoisomers): 165.1 and 166.0, 149.9 and 151.2, 141.5, 138.0, 129.4, 129.1, 
129.0, 128.5, 128.4, 128.0, 127.7, 127.54, 127.48, 124.7, 111.1 and 111.4, 60.9 and 61.1, 40.1, 
34.1, 25.6 and 25.7, 24.40 and 24.43 ppm. EI-MS (70 eV): m/z (%): 307 (46), 306 (100) [M
+
], 
251 (48), 223 (55), 209 (46), 185 (69), 104 (55). IR (NaCl): ν~ = 2925 (vs), 2851 (s), 1593 (vs), 
1519 (s), 1481 (m), 1445 (m), 1357 (m), 1312 (m), 1292 (m), 1228 (m), 1218 (m), 1198 (m), 
1156 (m), 1066 (m), 968 (w), 948 (w), 908 (w), 888 (w), 822 (m), 756 (m), 704 (m) cm
-1
. EI-
HRMS m/z calcd. for C21H26N2: 306.2096; m/z found: 306.2090. 
 
N-((2-Methoxyphenyl)-phenyl-methylene)-cyclohexylamine (4.2-4abe) 
Compound 4.2-4abe was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
2-bromoanisol (187 mg, 125 µL, 1.00 mmol). After distillation, 4.2-4abe (251 mg, 86 %) was 
obtained as pale yellow oil. 
1
H-NMR (400 MHz, CDCl3): 7.63-7.68 (m, 2H), 7.37-7.44 (m, 1H), 7.28-7.36 (m, 3H), 
7.02-7.06 (m, 1H), 6.96-7.02 (m, 1H), 3.72 (s, 3H), 3.14 (m, 1H), 1.54-1.85 (m, 7H), 1.10-
1.36 (m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, additional signals for cyclohexane 
conformers): 162.4, 156.1, 140.0, 129.4, 129.3, 128.6, 127.8, 127.7, 126.3, 120.4, 110.8, 
62.0, 55.3, 33.7 and 33.4, 25.7, 24.4 ppm. EI-MS (70 eV): m/z (%): 294 (82), 293 (36), 292 
(100) [M
+
], 262 (48), 210 (41), 195 (42), 104 (35). IR (NaCl): ν~ = 2927 (vs), 2853 (vs), 1625 
(s), 1597 (s), 1579 (m), 1487 (s), 1461 (s), 1445 (s), 1290 (m), 1248 (s), 1180 (m), 1114 (m), 
1028 (s), 968 (m), 754 (s), 696 (s), 646 (w) cm
-1
. EI-HRMS m/z calcd. for C20H23NO: 
293.1780; m/z found: 293.1778. 
 
N-(2-Naphthyl-phenyl-methylene)-cyclohexylamine (4.2-4abf) 
Compound 4.2-4abf was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
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2-bromonaphthalene (207 mg, 1.00 mmol). After distillation, 4.2-4abf (292 mg, 93 %) was 
obtained as yellow oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 1.7:1): 8.09-
8.17 and 8.29-8.35 (2m, 2H), 7.41-7.56 and 7.72-7.80 (2m, 4H), 7.10-7.16 and 7.27-7.41 (2m, 
3H), 3.03-3.11 and 3.27 (m and qui, 
3
J (H,H)=7.0 Hz, 1H), 1.53-1.81 (m, 7H), 1.05-1.33 (m, 
3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for stereoisomers): 163.7 and 163.1, 
148.3, 147.6, 145.8, 144.2, 138.9, 136.0, 132.5, 130.3, 130.1, 129.1, 128.7, 128.2, 128.0, 
127.4, 126.7, 124.9, 123.7, 123.1, 61.8 and 61.7, 34.3, 33.8 and 33.7, 25.53 and 25.47, 24.7, 
24.1 ppm. EI-MS (70 eV): m/z (%): 314 (36), 313 (80) [M
+
], 312 (100), 256 (40), 230 (25), 
215 (39), 127 (30). IR (NaCl): ν~ = 3055 (m), 2925 (vs), 2851 (vs), 1657 (w), 1615 (s), 1595 
(m), 1575 (w), 1503 (w), 1489 (w), 1445 (s), 1347 (m), 1294 (m), 1234 (m), 1216 (w), 1198 
(w), 1118 (w), 1072 (w), 1028 (w), 966 (w), 900 (w), 862 (m), 820 (m), 752 (s), 706 (m) cm
-1
. 
EI-HRMS m/z calcd. for C23H23N: 313.1830; m/z found: 313.1815. 
 
N-[(1-Naphthyl)-(phenyl)-methylene]cyclohexylamine (4.2-4abo) 
Compound 4.2-4abo was synthesized at 100 °C according to the general procedure from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol), and 1-bromonaphthalene (3o, 207 mg, 140 µl, 1.00 mmol). After distillation, 4.2-
4abo (183 mg, 58 %) was obtained as orange oil. 
1
H-NMR (400 MHz, CDCl3, some split signals for the cyclohexane ring):  7.93-7.99 (m, 
2H), 7.64-7.72 (m, 3H), 7.56-7.63 (m, 1H), 7.50-7.56 (m, 1H), 7.40-7.46 (m, 1H), 7.26-7.40 
(m, 4H), 3.05-3.11 (m, 1H), 1.50-1.82 (m, 7H), 0.91-1.40 (m, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3, some split signals for the cyclohexane ring):  164.5, 140.1, 135.6, 133.3, 130.8, 
129.7, 128.3, 128.2, 128.1, 127.9, 126.5, 126.2, 125.6, 125.14, 125.08, 61.8, 33.8 and 33.7, 
25.6, 24.3 and 24.1 ppm. EI-MS (70 eV): m/z (%): 315 (30), 314 (100), 313 (81) [M
+
], 232 
(17), 231 (44), 216 (36), 128 (23). IR (NaCl): ν~ = 3057 (m), 2927 (vs), 2853 (s), 1619 (m), 
1505 (w), 1445 (m), 1286 (w), 1254 (w), 1214 (w), 1176 (w), 1026 (w), 960 (w), 800 (m), 
758 (m), 694 (w) cm
-1
. EI-HRMS m/z calcd. for C23H23N: 313.1830; m/z found: 313.1819. 
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N-(9-Phenanthryl-phenyl-methylene)-cyclohexylamine (4.2-4abp) 
Compound 4.2-4abp was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
9-bromophenanthrene (257 mg, 1.00 mmol). After distillation, 4.2-4abp (240 mg, 66 %) was 
obtained as yellow oil. 
1
H-NMR (400 MHz, CDCl3, some signals for the cyclohexane ring split): 8.73-8.86 (m, 
2H), 7.91-8.01 (m, 1H), 7.65-7.82 (m, 6H), 7.49-7.65 (m, 2H), 7.26-7.42 (m, 3H), 2.20-2.23 
and 3.17-3.30 (m, 1H), 1.47-1.90 (m, 7H), 0.90-1.41 (m, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3, some signals for the cyclohexane ring split): 164.2, 139.9, 134.4, 131.0, 130.2, 
129.8, 129.7, 128.9, 128.1, 128.0, 127.03, 126.98, 126.5, 125.8, 123.0, 122.6, 61.9, 33.7 and 
33.9, 25.6, 24.1 and 24.3 ppm. EI-MS (70 eV): m/z (%): 365 (42), 364 (100), 363 (90) [M
+
], 
282 (20), 281 (45), 266 (27), 55 (18). IR (NaCl): ν~ = 3059 (s), 2927 (vs), 2853 (s), 1621 (m), 
1595 (m), 1491 (m), 1447 (m), 1371 (w), 1316 (w), 1264 (w), 1176 (w), 1026 (w), 914 (w), 
886 (w), 848 (w), 748 (m), 722 (m), 694 (m) cm
-1
. EI-HRMS m/z calcd. for C27H25N: 
363.1987; m/z found: 363.1974. 
 
N-[4-(N-(Cyclohexylcarboximidoyl)phenyl)-(phenyl)-methylene]-cyclohexylamine (4.2-
4abq) 
Compound 4.2-4abq was synthesized at 100 °C according to the general procedure from 1a 
(226 mg, 1.20 mmol), cyclohexylamine (218 mg, 252 µl, 2.20 mmol), and 4-
bromobenzaldehyde (185 mg, 1.00 mmol). After distillation, 4.2-4abq (200 mg, 54 %) was 
obtained as yellow oil. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers, approx. 1.3:1): 8.29 and 8.38 
(2s, 1H), 7.63-7.69 and 7.75-7.86 (2m, 2H), 7.54-7.63 (m, 2H), 7.24-7.37 and 7.38-7.54 (2m, 
3H), 7.10-7.16 and 7.16-7.23 (2m, 2H), 3.12-3.29 (m, 2H), 1.50-1.89 (m, 14H), 1.05-1.45 (m, 
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6H) ppm. 
13
C-NMR (101 MHz, CDCl3, Signal sets for E/Z-isomers): 164.9 and 165.0, 
157.9 and 158.1, 142.0, 139.9, 139.4, 137.4, 137.1, 136.3, 129.6, 128.5, 128.3, 128.2, 128.1, 
128.0, 127.9, 127.7, 127.6, 127.5, 69.9 and 70.0, 61.4 and 61.5, 34.2 and 34.3, 33.8, 25.55 and 
25.58, 24.67 and 24.71, 24.3 ppm. EI-MS (70 eV): m/z (%): 374 (38), 372 (100) [M
+
], 296 
(90), 291 (29), 290 (97), 207 (29), 55 (60). IR (NaCl): ν~ = 2925 (vs), 2851 (s), 1641 (m), 
1485 (w), 1447 (m), 1381 (w), 1345 (w), 1294 (w), 1148 (w), 1068 (m), 1010 (w), 966 (w), 
888 (w), 854 (w), 830 (w), 820 (w), 776 (w), 756 (w), 696 (w) cm
-1
. EI-HRMS m/z calcd. for 
C26H32N2: 372.2565; m/z found: 372.2545. 
 
N-((4-Cyanophenyl)-phenyl-methylene)-cyclohexylamine (4.2-4abh) 
Compound 4.2-4abh was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
4-bromobenzonitrile (182 mg, 1.00 mmol). After distillation, 4.2-4abh (274 mg, 95 %) was 
obtained as pale yellow oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 2.2:1): 7.72-
7.79 and 7.65-7.71 (2m, 2H), 7.49-7.54 and 7.54-7.80 (2m, 2H), 7.41-7.49 (m, 2H), 7.09-7.15 
and 7.26-7.38 (2m, 3H), 3.03-3.11 and 3.24 (qui and m, 
3
J (H,H)=7.0 Hz, 1H), 1.51-1.80 (m, 
7H), 1.06-1.32 (m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for stereoisomers): 
163.3 and 163.9, 142.1 and 144.1, 136.0 and 139.0, 131.7 and 132.2, 130.0, 128.8, 128.63, 
128.55, 128.4, 128.05 and 128.12, 127.4, 118.3 and 118.7, 112.2 and 112.8, 61.6 and 61.7, 
33.7 and 33.8, 25.47 and 25.52, 24.1 and 24.2 ppm. EI-MS (70 eV): m/z (%): 289 (39), 288 
(40) [M
+
], 287 (100), 245 (35), 211 (47), 190 (61), 186 (84). IR (NaCl): ν~ = 3081 (m), 2927 
(vs), 2853 (vs), 2227 (s), 1623 (m), 1491 (w), 1447 (m), 1405 (w), 1288 (m), 1068 (w), 968 
(m), 850 (m), 756 (m), 706 (m) cm
-1
. EI-HRMS m/z calcd. for C20H20N2: 288.1626; m/z found: 
288.1629. 
 
Ethyl 4-(Cyclohexylimino-p-tolyl-methyl)-benzoate (4.2-4abi) 
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Compound 4.2-4abi was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
ethyl 4-bromobenzoate (229 mg, 160 µL, 1.00 mmol). After distillation, 4.2-4abi (277 mg, 
83 %) was obtained as pale yellow oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 1:1): 7.96-8.02 
and 8.13-8.20 (2m, 2H), 7.54-7.60 and 7.61-7.69 (2m, 2H), 7.30-7.41 and 7.41-7.51 (2m, 3H), 
7.12-7.20 and 7.24-7.30 (2m, 2H), 4.39 and 4.45 (2q, 
3
J (H,H)=7.2 Hz, 2H), 3.11-3.20 and 
3.23-3.32 (2m, 1H), 1.55-1.85 (m, 7H), 1.40 and 1.45 (2t, 
3
J (H,H)=7.2 Hz, 3H), 1.08-1.35 (m, 
3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for stereoisomers): 166.2, 164.6, 
144.3, 142.1, 139.6, 136.8, 131.1, 130.2, 129.8, 129.7, 129.2, 128.5, 128.3, 128.2, 128.1, 
127.7, 127.6, 61.7 and 61.6, 61.2 and 61.0, 33.8, 25.62 and 25.58, 24.3, 14.4 and 14.3 ppm. 
EI-MS (70 eV): m/z (%): 336 (53), 335 (41) [M
+
], 334 (96), 306 (63), 280 (31), 259 (100), 
104 (35). IR (NaCl): ν~ = 3079 (w), 2979 (m), 2927 (vs), 2853 (s), 1715 (vs), 1621 (m), 1445 
(m), 1403 (m), 1274 (vs), 1176 (m), 1102 (s), 1076 (w), 1022 (m), 968 (m), 852 (w), 780 (m), 
756 (m), 712 (m) cm
-1
. EI-HRMS m/z calcd. for C22H25NO2: 335.1885; m/z found: 335.1886. 
 
N-(Phenyl-(4-trifluoromethylphenyl)-methylene)-cyclohexylamine (4.2-4abj) 
Compound 4.2-4abj was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
4-bromobenzotrifluoride (227 mg, 142 µL, 1.00 mmol). After distillation, 4.2-4abj (215 mg, 
65 %) was obtained as red oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 1.4:1): 7.70-
7.80 (m, 2H), 7.54-7.63 (m, 2H), 7.43-7.51 (m, 2H), 7.13-7.21 and 7.28-7.41 (2m, 3H), 3.11-
3.20 and 3.30 (m and qui, 
3
J (H,H)=7.1 Hz, 1H), 1.56-1.84 (m, 7H), 1.13-1.36 (m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for stereoisomers): 163.9 and 164.2, 143.5, 
139.5, 132.5 (q, 
1
J (C,F) ca. 220 Hz), 131.2 (q, 
2
J (C,F)=32.4 Hz), 128.6, 128.4, 128.2, 128.1, 
127.5, 125.4 and 128.9 (2 q, 
3
J (C,F)=3.7 Hz), 61.5 and 61.6, 33.81 and 33.85, 25.57 and 
25.61, 24.20 and 24.23 ppm. 
19
F-NMR (376 MHz, CDCl3, 2 signal sets for stereoisomers): 
-62.7 and -62.6 (2 s, 3F) ppm. EI-MS (70 eV): m/z (%): 332 (100), 331 (27) [M+], 330 
(68), 288 (33), 276 (26), 254 (65), 165 (42). IR (NaCl): ν~ = 3081 (s), 2923 (vs), 2855 (vs), 
1667 (w), 1625 (s), 1615 (s), 1573 (m), 1447 (s), 1407 (s), 1326 (s), 1288 (s), 1170 (s), 1122 
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(s), 1066 (s), 1018 (s), 970 (m), 890 (w), 852 (m), 772 (m), 722 (m), 702 (m) cm
-1
. EI-HRMS 
m/z calcd. for C20H20F3N: 331.1548; m/z found: 331.1530. 
 
N-((4-Nitrophenyl)-phenyl-methylene)-cyclohexylamine (4.2-4abr) 
Compound 4.2-4abr was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
bromo-4-nitrobenzene (202 mg, 1.00 mmol). After distillation, 4.2-4abr (175 mg, 57 %) was 
obtained as orange oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 2:1): 8.06-8.17 
and 8.29-8.38 (2m, 2H), 7.40-7.58 and 7.65-7.80 (2m, 4H), 7.10-7.19 and 7.28-7.40 (2m, 3H), 
3.00-3.12 and 3.26 (qui and m, 
3
J (H,H)=7.1 Hz, 1H), 1.52-1.86 (m, 7H), 1.05-1.45 (m, 3H) 
ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for stereoisomers): 163.1 and 163.7, 
147.6 and 148.3, 144.2 and 145.8, 136.0 and 138.7, 130.1 and 132.5, 129.1, 128.7, 128.2, 
128.0, 127.4, 123.7, 123.1, 61.7 and 61.8, 33.70 and 33.74, 25.46 and 25.52, 24.1 ppm. EI-
MS (70 eV): m/z (%): 308 (40) [M
+
], 307 (100), 265 (57), 253 (44), 231 (93), 165 (51), 117 
(44), 55 (55). IR (NaCl): ν~ = 3077 (m), 2929 (vs), 2853 (vs), 1621 (m), 1599 (s), 1519 (s), 
1487 (m), 1447 (m), 1347 (s), 1314 (m), 1108 (m), 1068 (w), 1014 (w), 968 (m), 852 (m), 776 
(w), 736 (w), 704 (m) cm
-1
. EI-HRMS m/z calcd. for C19H20N2O2: 308.1525; m/z found: 
308.1523. 
 
N-((4-Chlorophenyl)-phenyl-methylene)-cyclohexylamine (4.2-4abl) 
Compound 4.2-4abl was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
bromo-4-chlorobenzene (175 mg, 110 µL, 1.00 mmol). After distillation, 4.2-4abl (280 mg, 
94 %) was obtained as pale yellow oil. 
1
H-NMR (400 MHz, CDCl3): 7.52-7.64 (m, 2H), 7.38-7.50 (m, 3H), 7.25-7.37 (m, 2H), 
7.09-7.19 (m, 2H), 3.16-3.30 (m, 1H), 1.54-1.84 (m, 7H), 1.10-1.35 ppm (m, 3H). 
13
C-NMR 
(101 MHz, CDCl3, 2 signal sets for stereoisomers): 164.1 and 164.2, 139.8, 138.7, 136.7, 
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135.5, 134.0, 131.3, 129.8, 129.6, 129.5, 129.0, 128.6, 128.4, 128.2, 128.0, 127.9, 127.4, 61.4 
and 61.3, 33.8, 25.6, 24.2 ppm. EI-MS (70 eV): m/z (%): 298 (73), 297 (38) [M
+
], 296 (100), 
254 (42), 220 (49), 165 (76), 104 (36). IR (NaCl): ν~ = 3079 (w), 2927 (vs), 2853 (vs), 1661 
(w), 1619 (s), 1589 (s), 1485 (s), 1445 (s), 1397 (m), 1286 (s), 1176 (w), 1090 (s), 1014 (m), 
968 (m), 888 (w), 838 (m), 774 (m), 746 (m), 728 (m), 704 (s) cm
-1
. EI-HRMS m/z calcd. for 
C19H20ClN: 297.1284; m/z found: 297.1280. 
 
N-(Phenyl-(3-pyridyl)-methylene)-cyclohexylamine (4.2-4abm) 
Compound 4.2-4abm was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
3-bromopyridine (158 mg, 96 µL, 1.00 mmol). After distillation, 4.2-4abm (240 mg, 91 %) 
was obtained as pale yellow oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 1.5:1): 8.64-
8.70 (m, 1H), 8.42-8.46 and 8.52-8.57 (2m, 1H), 7.27-7.57 and 7.90-7.96 (2m, 5H), 7.10-7.15 
and 7.18-7.24 (2m, 2H), 3.11-3.19 and 3.27 (m and qui, 
3
J (H,H)=7.0 Hz, 1H), 1.50-1.80 (m, 
7H), 1.06-1.31 (m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for stereoisomers): 
162.1 and 163.3, 150.3, 149.9, 149.5, 148.3, 139.7, 136.1, 135.7, 135.4, 135.2, 132.9, 
129.9, 128.6, 128.5, 128.2, 128.1, 127.5, 122.8 and 123.3, 61.3 and 61.6, 33.79 and 33.85, 
25.50 and 25.55, 24.2 ppm. EI-MS (70 eV): m/z (%): 264 (35) [M
+
], 263 (95), 221 (50), 187 
(64), 186 (100), 167 (43), 104 (35), 51 (35). IR (NaCl): ν~ = 2925 (vs), 2853 (vs), 1665 (w), 
1621 (m), 1585 (m), 1447 (m), 1413 (m), 1290 (m), 1194 (w), 1066 (w), 970 (w), 890 (w), 
774 (w), 756 (w), 706 (m) cm
-1
. EI-HRMS m/z calcd. for C18H20N2: 264.1626; m/z found: 
264.1626. 
 
N-[(Phenyl)-(2-pyridyl)-methylene]cyclohexylamine (4.2-4abs) 
Compound 4.2-4abs was synthesized at 100 °C according to the general procedure from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
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1.20 mmol), and 1-bromopyridine (158 mg, 96 µl, 1.00 mmol). After distillation, 4.2-4abs 
(123 mg, 47 %) was obtained as light yellow oil. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers, approx. 1.3:1):= 8.53-8.60 and 
8.69-8.76 (2m, 1H), 7.85-7.95 and 8.00-8.09 (2 m, 1H), 7.63-7.81 (m, 1H), 7.50-7.61 (m, 1H), 
7.36-7.50 (m, 2H), 7.12-7.24 and 7.26-7.36 (2 m, 3H), 3.07-3.18 and 3.25-3.37 (2 m, 1H), 
1.50-1.81 (m, 7H), 1.02-1.31 (m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 Signal sets for 
E/Z-isomers): 163.9 and 165.8, 156.3 and 157.8, 149.8, 149.0, 136.6, 136.1, 136.0, 130.9, 
129.7, 128.2, 128.11, 128.06, 128.0, 127.7, 123.6, 123.0, 122.9, 122.7, 61.4 and 61.6, 33.7, 
25.5, 24.29 and 24.33 ppm. EI-MS (70 eV): m/z (%): 264 (35) [M
+
], 222 (20), 221 (100), 208 
(23), 207 (19), 168 (21), 167 (17). IR (NaCl): ν~ = 2927 (vs), 2853 (s), 1665 (s), 1579 (m), 
1445 (m), 1433 (m), 1304 (m), 1282 (m), 1246 (m), 1162 (m), 994 (m), 970 (w), 940 (m), 744 
(w), 696 (m), 652 (w) cm
-1
. EI-HRMS m/z calcd. for C18H20N2: 264.1626; m/z found: 
264.1622. 
 
N-(Phenyl-(3-thienyl)-methylene)-cyclohexylamine (4.2-4abt) 
Compound 4.2-4abt was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 
3-bromothiophene (163 mg, 94 µL, 1.00 mmol). After distillation, 4.2-4abt (230 mg, 85 %) 
was obtained as pale yellow oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 2:1): 7.41-7.52 
and 7.60-7.69 (2 m, 4H), 7.31-7.41 (m, 1H), 7.19-7.31 (m, 2H), 6.97-7.02 and 7.02-7.10 (2m, 
1H), 3.17-3.30 and 3.32-3.45 (2m, 1H), 1.55-1.91 (m, 7H), 1.10-1.39 (m, 3H) ppm. 
13
C-NMR 
(101 MHz, CDCl3, 2 signal sets for stereoisomers): 161.0 and 161.1, 144.6, 140.5, 137.7 
and 137.0, 130.2, 129.5, 128.2, 128.1, 128.0, 127.9, 127.8, 127.2, 126.9, 125.5, 125.2, 123.9, 
60.8 and 61.7, 33.9 and 34.0, 25.60 and 25.63, 24.3 and 24.4 ppm. EI-MS (70 eV): m/z (%): 
270 (61), 269 (100) [M
+
], 268 (89), 226 (28), 192 (41), 171 (61), 110 (26). IR (NaCl): ν~ = 
3103 (w), 3079 (w), 3059 (m), 2923 (vs), 2853 (vs), 2791 (w), 2667 (w), 1613 (vs), 1597 (s), 
1491 (m), 1445 (vs), 1347 (m), 1276 (vs), 1176 (m), 1070 (s), 1030 (m), 966 (m), 890 (m), 
856 (s), 798 (s), 772 (s), 704 (vs) cm
-1
. EI-HRMS m/z calcd. for C17H19NS: 269.1238; m/z 
found: 269.1240. 
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N-[Bis-(4-tolyl)-methylene]-cyclohexylamine (4.2-4bba) 
Compound 4.2-4bba was synthesized at 100 °C according to the general procedure from 
potassium oxocarboxylate (243 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol), and 1-bromotoluene (171 mg, 123 µl, 1.00 mmol). After distillation, 4.2-4bba 
(80 mg, 62 %) was obtained as red oil. 
1
H-NMR (400 MHz, CDCl3): = 7.51-7.57 (m, 2H), 7.23-7.30 (m, 2H), 7.05-7.11 (m, 2H), 
7.11-7.17 (m, 2H), 3.30 (quint, 
3
J (H,H)=7.1 Hz, 1H), 2.44 (s, 3H), 2.36 (s, 3H), 1.57-1.84 (m, 
7H), 1.14-1.39(m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): = 165.4, 139.3, 137.9, 137.5, 
134.5, 128.8, 128.5, 128.2, 127.5, 61.1, 33.9, 25.6, 24.3, 21.2, 21.1 ppm. EI-MS (70 eV): m/z 
(%): 292 (32), 291 (39) [M
+
], 290 (100), 200 (85), 179 (34), 118 (37), 91 (31). IR (NaCl): ν~ = 
2919 (vs), 2853 (vs), 1659 (m), 1621 (s), 1605 (s), 1505 (s), 1447 (s), 1405 (m), 1310 (s), 
1292 (s), 1256 (m), 1180 (s), 1112 (m), 1068 (m), 1038 (w), 1020 (m), 968 (m), 932 (w), 890 
(w), 822 (m), 778 (m), 756 (m), 732 (m) cm
-1
. EI-HRMS m/z calcd. for C21H25N: 291.1987; 
m/z found: 291.1977. 
 
N-((4-Methoxyphenyl)-p-tolyl-methylene)-cyclohexylamine (4.2-4cba) 
Compound 4.2-4cba was synthesized according to the general procedure from potassium (4-
methoxyphenyl)oxoacetate (262 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 4-bromotoluene (171 mg, 123 µL, 1.00 mmol). After distillation, 4.2-4cba 
(105 mg, 34 %) was obtained as pale yellow oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 1.4:1): 7.49-
7.54 and 7.54-7.60 (2m, 2H), 7.04-7.17 and 7.24-7.30 (2m, 4H), 6.82-6.88 and 6.96-7.03 (2m, 
2H), 3.82 and 3.89 (2s, 3H), 3.21-3.35 (m, 1H), 2.37 and 2.46 (2s, 3H), 1.55-1.85 (m, 7H), 
1.13-1.36 (m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for stereoisomers): 
165.0 and 165.2, 160.7, 159.1, 139.4, 138.2, 137.5, 134.6, 133.5, 129.8, 129.7, 129.0, 
128.9, 128.5, 128.3, 127.6, 113.1 and 113.6, 61.1 and 61.2, 55.1 and 55.2, 33.99 and 34.04, 
25.7, 24.4, 21.2 and 21.3 ppm. EI-MS (70 eV): m/z (%): 308 (41), 307 (40) [M
+
], 306 (100), 
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264 (31), 252 (31), 250 (25), 91 (26). IR (NaCl): ν~ = 2925 (vs), 2851 (vs), 2053 (w), 1911 
(w), 1601 (vs), 1573 (s), 1505 (vs), 1447 (s), 1415 (m), 1310 (s), 1292 (s), 1248 (vs), 1176 (s), 
1158 (s), 1110 (m), 1068 (m), 1034 (s), 968 (s), 888 (m), 836 (s), 742 (m), 730 (m), 686 (w), 
630 (w) cm
-1
. EI-HRMS m/z calcd. for C21H25NO: 307.1936; m/z found: 307.1931. 
 
4-(Cyclohexylimino-p-tolyl-methyl)-benzonitrile (4.2-4dba) 
Compound 4.2-4dba was synthesized according to the general procedure from potassium (4-
cyanophenyl)oxoacetate (256 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) 
and 4-bromotoluene (171 mg, 123 µL, 1.00 mmol). After distillation, 4.2-4dba (285 mg, 
94 %) was obtained as colorless solid, m.p. 112.2 °C. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 3.4:1): 7.65-
7.71 and 7.71-7.78 (2m, 2H), 7.36-7.42 and 7.54-7.59 (2 m, 2H), 7.23-7.29 (m, 2H), 6.97-7.03 
and 7.09-7.15 (2m, 2H), 2.98-3.08 and 3.27 (m and qui, 
3
J (H,H)=7.0 Hz, 1H), 2.34 and 2.42 
(2s, 3H), 1.50-1.79 (m, 7H), 1.05-1.30 (m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal 
sets for stereoisomers): 163.2 and 164.1, 144.5, 142.4, 140.3, 138.5, 136.4, 133.0, 132.2, 
131.8, 129.3, 128.9, 128.5, 128.1, 127.5, 118.4 and 118.8, 112.1 and 112.7, 61.56 and 61.65, 
33.80 and 33.84, 25.5 and 25.6, 24.19 and 24.23, 21.27 and 21.33 ppm. EI-MS (70 eV): m/z 
(%): 305 (25), 303 (100), 302 (46) [M
+
], 288 (16), 202 (12), 201 (51), 132 (11). IR (NaCl): 
ν~ = 2927 (vs), 2853 (vs), 2227 (s), 1659 (w), 1621 (s), 1603 (m), 1507 (m), 1447 (m), 1403 
(m), 1310 (m), 1290 (m), 1198 (w), 1184 (w), 1112 (w), 1066 (w), 1020 (w), 968 (m), 910 
(m), 850 (m), 822 (m), 732 (s) cm
-1
. EI-HRMS m/z calcd. for C21H22N2: 302.1783; m/z found: 
302.1775. 
 
N-[(4-Chlorophenyl)-(4-tolyl)-methylene]cyclohexylamine (4.2-4eba) 
Compound 4.2-4eba was synthesized at 100 °C according to the general procedure from 
potassium oxocarboxylate (267 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol), and 4-bromotoluene (171 mg, 123 µl, 1.00 mmol). After distillation, 4.2-4eba 
(276 mg, 89 %) was obtained as colorless oil. 
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1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers, approx. 1.6:1): = 7.44-7.48 and 
7.50-7.56 (2m, 2H), 7.25-7.28 and 7.40-7.44 (2m, 2H), 7.00-7.05 and 7.07-7.15 und 7.22-7.25 
(3m, 4H), 3.13-3.30 (m, 1H), 2.35 and 2.43 (2s, 3H), 1.54-1.79 (m, 7H), 1.10-1.33 (m, 3H) 
ppm. 
13
C-NMR (101 MHz, CDCl3, 2 Signal sets for E/Z-isomers): = 164.1 and 164.5, 
139.1 and 139.8, 137.3 and 138.0, 135.5 and 135.9, 133.8 and 133.9, 129.6, 129.1, 128.7, 
128.6, 128.2, 128.0, 127.5, 61.3 and 61.4, 33.9, 25.6, 24.3, 21.2 and 21.3 ppm. EI-MS (70 eV): 
m/z (%): 312 (100), 311 (36), 310 (82) [M
+
], 268 (33), 256 (43), 200 (56), 179 (31). IR (NaCl): 
ν~ = 2927 (vs), 2853 (vs), 1659 (w), 1619 (s), 1589 (m), 1567 (m), 1509 (m), 1485 (s), 1447 
(m), 1397 (m), 1288 (m), 1174 (w), 1090 (m), 1068 (w), 1014 (m), 968 (m), 888 (w), 824 (m), 
792 (w), 756 (m), 732 (m) cm
-1
. EI-HRMS m/z calcd. for C20H22ClN: 311.1441; m/z found: 
311.1422. 
 
N-((2-Furyl)-p-tolyl-methylene)-cyclohexylamine (4.2-4fba) 
Compound 4.2-4fba was synthesized according to the general procedure from potassium 2-
furyloxoacetate (214 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 mmol) and 4-
bromotoluene (171 mg, 123 µL, 1.00 mmol). After distillation, 4.2-4fba (230 mg, 85 %) was 
obtained as brown oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 2.7:1): 7.47-
7.50 (m, 1H), 7.16-7.23 and 7.40-7.45 (2m, 2H), 7.05-7.11 and 7.11-7.14 (2m, 2H), 6.05-6.11, 
6.29-6.33 and 6.43-6.48 (3m, 2H), 3.13-3.24 and 3.63-3.75 (2m, 1H), 2.32 and 2.38 (2s, 3H), 
1.50-1.83 (m, 7H), 1.02-1.42 (m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for 
stereoisomers): 156.6, 155.0, 153.7, 146.2, 144.3, 142.8, 139.4, 138.2, 137.4, 132.5, 128.8, 
128.5, 128.4, 127.5, 115.0, 113.4, 111.0, 110.4, 60.8 and 61.8, 33.8 and 34.1, 25.4 and 25.6, 
24.47 and 24.51, 21.16 and 21.21 ppm. EI-MS (70 eV): m/z (%): 267 (55) [M
+
], 266 (89), 238 
(51), 224 (47), 176 (100), 142 (51), 115 (67). IR (NaCl): ν~ = 2925 (vs), 2851 (vs), 1649 (m), 
1643 (m), 1605 (s), 1509 (m), 1481 (m), 1463 (m), 1447 (s), 1302 (m), 1224 (w), 1182 (m), 
1152 (w), 1112 (w), 1066 (w), 1016 (m), 970 (m), 886 (m), 874 (w), 820 (m), 782 (m), 748 (s) 
cm
-1
. EI-HRMS m/z calcd. for C18H21NO: 267.1623; m/z found: 267.1617. 
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N-[(2-Thienyl)-(4-tolyl)-methylene]cyclohexylamine (4.2-4gba) 
Compound 4.2-4gba was synthesized at 100 °C according to the general procedure from 
potassium oxocarboxylate (233 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol), and 4-bromotoluene (171 mg, 123 µl, 1.00 mmol). After distillation, 4.2-4gba 
(150 mg, 53 %) was obtained as brown solid, m.p. 78 °C. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers, approx. 9:1): = 7.31-7.37 and 
7.50-7.56 (2 m, 1H), 7.24-7.39 and 7.44-7.48 (2 m, 2H), 7.10-7.16 (m, 2H), 6.90-6.95 and 
7.00-7.02 (2 m, 1H), 6.70-6.75 (m, 1H), 3.21 and 3.44-3.53 (qui and m, 
3
J (H,H)=7.1 Hz, 1H), 
2.37 and 2.44 (2s, 3H), 1.53-1.80 (m, 7H), 1.10-1.30 (m, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3, 2 Signal sets for E/Z-isomers): = 160.5, 147.9, 138.1, 133.6, 129.7, 128.9, 128.7, 
128.3, 127.5, 126.9, 60.7, 33.8 und 34.1, 25.6 und 25.7, 24.3 und 24.4, 21.3 ppm. EI-MS 
(70 eV): m/z (%): 283 (74) [M
+
], 282 (99), 250 (100), 240 (36), 192 (46), 186 (41), 171 (47). 
IR (NaCl): ν~ = 2921 (s), 2849 (s), 1601 (vs), 1445 (vs), 1429 (vs), 1290 (s), 1260 (s), 1230 (s), 
1108 (s), 1068 (vs), 1046 (s), 1018 (s), 842 (s), 818 (s), 804 (s), 780 (m), 700 (s) cm
-1
. EI-
HRMS m/z calcd. for C18H21NS: 283.1395; m/z found: 283.1391. 
 
N-((2,5-Dimethylphenyl)-p-tolyl-methylene)-cyclohexylamine (4.2-4hba) 
Compound 4.2-4hba was synthesized according to the general procedure from potassium 
(2,5-dimethylphenyl)oxoacetate (260 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 4-bromotoluene (171 mg, 123 µL, 1.00 mmol). After distillation, 4.2-4hba 
(200 mg, 66 %) was obtained as colorless solid, M.p. 87 °C. 
1
H-NMR (400 MHz, CDCl3): 7.45-7.51 (m, 2H), 7.08-7.17 (m, 4H), 6.81-6.84 (m, 1H), 
3.02-3.11 (m, 1H), 2.34 (s, 6H), 2.04 (s, 3H), 1.51-1.80 (m, 7H), 1.08-1.31 (m, 3H) ppm. 
13
C-
NMR (101 MHz, CDCl3, some signals for the cyclohexane ring split): 165.4, 139.5, 137.4, 
137.1, 135.0, 131.7, 129.8, 128.8, 128.7, 127.9, 127.8, 61.4, 33.7 and 33.8, 25.7, 24.37 and 
24.43, 21.0 and 21.3, 19.1 ppm. EI-MS (70 eV): m/z (%): 306 (52), 305 (13) [M
+
], 304 (76), 
292 (27), 291 (14), 290 (100), 55 (11). IR (NaCl): ν~ = 2919 (vs), 2855 (vs), 1667 (m), 1621 
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(s), 1605 (s), 1567 (m), 1503 (m), 1493 (m), 1447 (s), 1310 (m), 1296 (m), 1276 (m), 1258 
(m), 1178 (m), 1150 (m), 1066 (m), 1020 (w), 968 (m), 890 (w), 858 (w), 828 (m), 812 (m), 
786 (w), 760 (w) cm
-1
. EI-HRMS m/z calcd. for C22H27N: 305.2144; m/z found: 305.2131. 
 
N-(tert-Butyl-p-tolyl-methylene)-pentylamine (4.2-4ica) 
Compound 4.2-4ica was synthesized within 36 h according to the general procedure from 
potassium trimethylpyruvate (202 mg, 1.20 mmol), pentylamine (106 mg, 140 µL, 1.20 mmol) 
and 4-bromotoluene (171 mg, 123 µL, 1.00 mmol). After distillation, 4.2-4ica (63.0 mg, 26 %) 
was obtained as pale yellow oil. 
1
H-NMR (400 MHz, CDCl3): 7.14-7.18 (m, 2H), 6.81-6.86 (m, 2H), 2.97 (t, 
3
J 
(H,H)=7.2 Hz, 2H), 2.37 (s, 3H), 1.44-1.54 (m, 2H), 1.16-1.29 (m, 4H), 1.13 (s, 9H), 0.85 (t, 
3
J (H,H)=7.2 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): 178.1, 136.6, 134.9, 128.5, 
127.1, 55.2, 39.7, 30.7, 29.6, 28.5, 22.5, 21.2, 14.0 ppm. EI-MS (70 eV): m/z (%): 247 (30), 
245 (8) [M
+
], 188 (51), 119 (10), 118 (100), 91 (9), 41 (12). IR (NaCl): ν~ = 2953 (vs), 2927 
(vs), 2859 (s), 1637 (s), 1477 (m), 1461 (m), 1389 (w), 1359 (m), 1224 (w), 1196 (m), 1184 
(w), 1110 (w), 1040 (w), 990 (w), 972 (w), 824 (m), 786 (w), 730 (w) cm
-1
. EI-HRMS m/z 
calcd. for C18H27N: 245.2144; m/z found: 245.2130. 
 
N-(Phenyl-p-tolyl-methylene)-pentylamine (4.2-4aca) 
Compound 4.2-4aca was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), pentylamine (106 mg, 140 µL, 1.20 mmol) and 4-
bromotoluene (171 mg, 123 µL, 1.00 mmol). After distillation, 4.2-4aca (232 mg, 87 %) was 
obtained as orange-yellow oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers): 7.48-7.53 and 7.59-7.64 
(2m, 2H), 7.24-7.48 (m, 4H), 7.04-7.16 (m, 3H), 3.36 and 3.40 (2t, 
3
J (H,H)=7.0 and 7.2 Hz, 
2H), 2.35 and 2.42 (2s, 3H), 1.64-1.75 (m, 2H), 1.25-1.36 (m, 4H), 0.85-0.94 (m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for stereoisomers): 167.5 and 167.8, 139.8 and 
140.3, 137.9, 137.4, 137.2, 134.0, 129.9, 129.5, 129.0, 128.7, 128.3, 128.2, 128.0, 127.9, 
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127.79, 127.75, 53.8 and 53.9, 31.0, 29.7, 22.5, 21.2 and 21.3, 14.0 and 14.1 ppm. EI-MS 
(70 eV): m/z (%): 266 (32), 265 (100) [M
+
], 223 (20), 209 (74), 105 (71), 91 (45), 77 (22). IR 
(NaCl): ν~ = 2953 (s), 2927 (vs), 2857 (s), 1659 (w), 1621 (m), 1607 (m), 1445 (m), 1312 (m), 
1292 (m), 1182 (w), 1112 (w), 1072 (w), 1018 (w), 1002 (w), 938 (w), 924 (w), 824 (w), 776 
(w), 728 (w), 698 (m) cm
-1
. EI-HRMS m/z calcd. for C19H23N: 265.1830; m/z found: 265.1811. 
 
(+)-S-1-Phenyl-N-(phenyl-p-tolyl-methylene)-ethylamine (4.2-4aga) 
Compound 4.2-4aga was synthesized according to the general procedure from potassium 
phenyloxoacetate (226 mg, 1.20 mmol), L()-α-methylbenzylamine (147 mg, 94 µL, 
1.20 mmol) and 4-bromotoluene (171 mg, 123 µL, 1.00 mmol). After distillation, 4.2-4aga 
(191 mg, 64 %) was obtained as colorless oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 1:1): 7.72-7.79 
and 7.82-7.90 (2m, 2H), 7.42-7.50 and 7.50-7.62 (2 m, 7H), 7.31-7.42 (m, 2H), 7.23-7.31 (m, 
2H), 7.15-7.22 (m, 1H), 4.66-4.81 (2q, 
3
J (H,H)=6.4°Hz, 1H), 2.49 and 2.57 (2s, 2H), 1.70-
1.61 (q, 
3
J (H,H)=3.3 Hz, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for 
stereoisomers): 165.8 and 166.1, 146.2, 140.2, 139.9, 138.0, 137.3, 137.1, 133.9, 129.7, 
129.0, 128.6, 128.5, 128.4, 128.3, 128.21, 128.19, 128.1, 127.9, 127.6, 127.5, 126.6, 126.41, 
126.39, 61.2 and 61.3, 25.0, 21.2 and 21.3 ppm. EI-MS (70 eV): m/z (%): 300 (46), 299 (100) 
[M
+
], 285 (77), 181 (36), 165 (33), 105 (100), 77 (45). IR (NaCl): ν~ = 3025 (s), 2969 (s), 
2923 (m), 2889 (m), 2863 (m), 1737 (w), 1621 (vs), 1605 (s), 1491 (m), 1445 (s), 1312 (m), 
1290 (s), 1182 (m), 1114 (w), 1074 (m), 1030 (m), 1010 (m), 910 (m), 824 (m), 760 (m), 730 
(m), 698 (m) cm
-1
. Anal. Calcd. for C22H21N: C 88.25, H 7.07, N 4.68; found: C 87.97, H 6.94, 
N 4.70.  24589α = 18° (ethyl acetate). 
 
2,4-Dimethoxy-N-(phenyl-p-tolyl-methylene)-aniline (4.2-4aha) 
Compound 4.2-4aha was synthesized at 130 °C according to the general procedure from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), 2,4-dimethoxyaniline (184 mg, 171 µL, 
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1.20 mmol) and 4-bromotoluene (171 mg, 123 µL, 1.00 mmol). After distillation, 4.2-4aha 
(312 mg, 94 %) was obtained as brown oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 1.2:1): 7.64-
7.71 and 7.74-7.81 (2 m, 2H), 7.00-7.07, 7.12-7.27 and 7.33-7.46 (3 m, 7H), 6.49 and 6.51 (2 
s, 1H), 6.23-6.30 and 6.33-6.40 (2 m, 2H), 3.65, 3.67, 3.69, 3.71 (4 s, 6H), 2.30 and 2.39 (2 s, 
3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for stereoisomers): 169.3 and 169.6, 
156.57 and 156.60, 150.5 and 150.6, 140.6, 139.9, 138.1, 137.2, 136.9, 134.8, 134.6, 134.0, 
130.2, 129.3, 129.2, 128.8, 128.7, 128.6, 128.2, 128.1, 127.8, 127.4, 121.1 and 121.3, 103.6 
and 103.7, 98.9 and 99.0, 55.13, 55.15, 55.16 and 55.24, 21.2 and 21.3 ppm. EI-MS (70 eV): 
m/z (%): 333 (40), 332 (100), 331 (4) [M
+
], 317 (20), 302 (12), 255 (22), 241 (11), 182 (17). 
IR (NaCl): ν~ = 2870 (s), 2833 (vs), 1605 (vs), 1503 (vs), 1453 (vs), 1445 (s), 1306 (s), 1258 
(s), 1208 (s), 1158 (s), 1122 (s), 1036 (s), 960 (m), 828 (m), 700 (m) cm
-1
. EI-HRMS m/z 
calcd. for C22H21NO2: 331.1572; m/z found: 331.1568. 
 
N,N-Dimethyl-N'-(phenyl-p-tolyl-methylene)-p-phenylendiamine (4.2-4aaa) 
Compound 4aaa was synthesized at 130 °C according to the general procedure from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), N,N-dimethyl-p-phenylendiamine (163 mg, 
1.20 mmol) and 4-bromotoluene (171 mg, 123 µL, 1.00 mmol). After distillation, 4aaa 
(190 mg, 60 %) was obtained as orange solid, M.p. 99 °C. The spectroscopic data correspond 
with those reported above. 
 
N-[(Phenyl)-(4-tolyl)-methylene]-p-anisidine (4.2-4ada) 
Compound 4.2-4ada was synthesized at 130 °C according to the general procedure from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), p-anisidine (148 mg, 1.20 mmol), and 4-
bromotoluene (171 mg, 123 µl, 1.00 mmol). After distillation, 4.2-4ada (165 mg, 55 %) was 
obtained as orange oil. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers, approx. 1.1:1):= 7.62-7.68 and 
7.73-7.78 (2m, 2H), 7.18-7.31 and 7.36-7.48 (2m, 4H), 7.01-7.17 (m, 3H), 6.67-6.75 (m, 4H), 
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3.71 and 3.73 (2s, 2H), 2.34 and 2.41 (2s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 Signal 
sets for E/Z-isomers): = 167.6 and 167.8, 155.6 and 155.7, 144.4 and 144.5, 140.7, 140.2, 
138.3, 137.2, 136.7, 133.5, 130.3, 129.5, 129.4, 129.14, 129.08, 128.8, 128.6, 128.3, 128.0, 
127.9, 122.5, 122.4, 113.6 and 113.7, 55.2, 21.27 and 21.33 ppm. EI-MS (70 eV): m/z (%): 
302 (38), 301 (100) [M
+
], 287 (16), 225 (8), 224 (17), 210 (11), 179 (8). IR (NaCl): ν~ = 2929 
(m), 2833 (m), 1605 (vs), 1567 (s), 1503 (vs), 1443 (s), 1290 (s), 1242 (vs), 1220 (s), 1180 
(m), 1106 (m), 1036 (s), 960 (m), 832 (m), 778 (m), 700 (m) cm
-1
. EI-HRMS m/z calcd. for 
C21H19NO: 301.1467; m/z found: 301.1469. 
 
N-(Phenyl-p-tolyl-methylene)-o-anisidine (4.2-4aia) 
Compound 4.2-4aia was synthesized at 130 °C according to the general procedure from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), o-anisidine (148 mg, 135 µL, 1.20 mmol) 
and 4-bromotoluene (171 mg, 123 µL, 1.00 mmol). After distillation, 4.2-4aia (220 mg, 73 %) 
was obtained as yellow-orange oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 1.2:1): 7.73-
7.79 and 7.82-7.88 (2 m, 2H), 7.16-7.23, 7.23-7.32 and 7.40-7.54 (3m, 5H), 7.06-7.14 (m, 2H), 
6.91-7.01 (m, 1H), 6.75-6.85 (m, 2H), 6.62-6.70 (m, 1H), 3.73 and 3.75 (2s, 3H), 2.34 and 
2.46 (2s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 signal sets for stereoisomers): 169.6 
and 169.3, 149.5, 149.4, 141.2, 141.1, 140.8, 139.6, 138.4, 136.9, 136.6, 133.8, 130.4, 129.3, 
128.7, 128.5, 128.2, 127.4, 123.7, 121.0, 120.8, 120.4, 120.3, 110.9, 110.8, 55.2, 55.1, 21.3, 
21.2 ppm. EI-MS (70 eV): m/z (%): 303 (51), 302 (100), 301 (9) [M
+
], 287 (17), 271 (14), 225 
(17), 182 (40), 51 (15). IR (NaCl): ν~ = 2983 (m), 1731 (vs), 1607 (m), 1489 (m), 1373 (m), 
1246 (vs), 1112 (m), 1046 (s), 910 (m), 758 (s), 734 (s) cm
-1
. EI-HRMS m/z calcd. for 
C21H19NO: 301.1467; m/z found: 301.1472. 
 
N-(Phenyl-p-tolyl-methylene)-aniline (4.2-4aea) 
Compound 4.2-4aea was synthesized at 130 °C according to the general procedure from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), aniline (112 mg, 109 µL, 1.20 mmol) and 
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4-bromotoluene (171 mg, 123 µL, 1.00 mmol). After distillation, 4.2-4aea (144 mg, 53 %) 
was obtained as yellow oil. 
1
H-NMR (400 MHz, CDCl3, 2 signal sets for stereoisomers, approx. ratio 1.2:1): 7.69-
7.75 and 7.79-7.86 (2 m, 2H), 7.14-7.24, 7.24-7.35 and 7.41-7.55 (3 m, 7H), 6.92-7.01 and 
7.04-7.13 (2 m, 3H), 6.75-6.83 (m, 2H), 2.35 and 2.45 (2 s, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3, 2 signal sets for stereoisomers): 168.0 and 168.2, 151.3 and 151.4, 140.9, 139.9, 
138.4, 136.9, 136.3, 133.1, 130.5, 129.5, 129.4, 129.3, 129.2, 128.8, 128.5, 128.4, 128.3, 
128.0, 127.7, 122.89 and 122.91, 120.8 and 120.9, 21.3 and 21.4 ppm. EI-MS (70 eV): m/z 
(%): 272 (100), 271 (30) [M
+
], 257 (41), 195 (53), 181 (35), 180 (30), 77 (37). IR (NaCl): ν~ = 
3055 (s), 3025 (s), 2919 (m), 1617 (s), 1591 (vs), 1481 (m), 1445 (m), 1316 (m), 1292 (m), 
1220 (m), 1180 (w), 1142 (m), 1072 (w), 1026 (w), 958 (w), 832 (w), 764 (w), 696 (m) cm
-1
. 
EI-HRMS m/z calcd. for C20H17N: 271.1361; m/z found: 271.1350. 
 
4-chloro-N-[phenyl-(4-tolyl)-methylene]aniline (4.2-4afa) 
Compound 4.2-4afa was synthesized at 130 
o
C according to the general procedure from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), p-anisidine (156 mg, 1.20 mmol), and 4-
bromotoluene (171 mg, 123 µl, 1.00 mmol). After distillation, 4.2-4afa (229 mg, 75 %) was 
obtained as yellow oil. 
1
H-NMR (400 MHz, CDCl3, 2 Signal sets for E/Z-isomers, approx. 1.2:1):= 7.61-7.68 and 
7.71-7.79 (2 m, 2H), 7.17-7.34 and 7.36-7.51 (2 m, 2H), 7.05-7.15 (m, 4H), 6.96-7.03 (m, 1H), 
6.61-6.71 (m, 2H), 2.33 and 2.41 (2 s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3, 2 Signal sets 
for E/Z-isomers): = 168.8 and 169.0, 149.8 and 149.9, 141.3, 139.6, 138.8, 136.6, 136.0, 
132.8, 130.8, 129.5, 129.32, 129.28, 128.9, 128.7, 128.6, 128.52, 128.46, 128.25, 128.21, 
128.1, 128.0, 122.3 und 122.4, 21.3 and 21.4 ppm. EI-MS (70 eV): m/z (%): 307 (36), 306 
(33), 305 (100) [M
+
], 290 (34), 228 (42), 179 (41), 75 (43). IR (NaCl): ν~ = 3079 (m), 3055 
(m), 3025 (m), 2919 (m), 1605 (vs), 1481 (vs), 1445 (m), 1314 (s), 1296 (s), 1222 (s), 1182 
(m), 1142 (s), 1092 (s), 1010 (m), 960 (m), 834 (s), 774 (m), 722 (m), 702 (s), 670 (w) cm
-1
. 
EI-HRMS m/z calcd. for C20H16ClN: 305.0971; m/z found: 305.0951. 
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N-(Phenyl-p-tolyl-methylene)-4-trifluoromethylaniline (4.2-4aja) 
Compound 4.2-4aja was synthesized at 130 °C according to the general procedure from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), 4-trifluoroaniline (193 mg, 149 µL, 1.20 
mmol) and 4-bromotoluene (171 mg, 123 µL, 1.00 mmol). GC yield: 16 %. EI-MS (70 eV): 
m/z (%): 341 (38), 340 (100), 339 (22) [M
+
], 325 (33), 263 (57), 249 (22), 180 (45). 
8.7.3 General Procedure for the One-pot Ketone Synthesis 
An oven-dried 20 mL vessel was charged with potassium aryloxoacetate (1.20 mmol), 
copper(I) bromide (21.5 mg, 0.15 mmol), palladium(II) 1,1,1,3,3,3-hexafluoroacetylacetonate 
(5.2 mg, 0.01 mmol), 1,10-phenanthroline (27.0 mg, 0.15 mmol), 1,1'-bis-(diphenylphosphino) 
ferrocene (5.7 mg, 0.01 mmol) and 3 Å molecular sieves (200 mg). The reaction vessel was 
evacuated and flushed with nitrogen three times. Subsequently, a degassed solution of the 
corresponding aryl halide (1.00 mmol), the amine (1.20 mmol) and the internal standard n-
tetradecane (50 L) in quinoline (2 mL) was added via syringe. The resulting mixture was 
stirred at 100 °C for 10 h. Then, 3 mL of a 2 M HCl / THF (1:1) solution were added via 
syringe and the mixture was stirred at 80 °C for 1 h. After addition of 20 mL of 6 M HCl 
solution, the mixture was extracted three times with 20 mL portions of ethyl acetate. The 
combined organic layers were washed with saturated sodium bicarbonate solution, water and 
brine, dried over MgSO4, filtered, and the volatiles were removed in vacuo. The residue was 
purified by column chromatography (SiO2, hexane/ethyl acetate 80:20), affording the 
corresponding ketone. 
 
4-Methylbenzophenone (4.2-6a) [CAS-No. 134-84-9] 
The ketone 4.2-6a was synthesized according to the general procedure, starting from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 4-bromotoluene (175 mg, 126 µL, 1.00 mmol). 4-Methylbenzophenone 4.2-
6a was purified by column chromatography (SiO2, hexane/ethyl acetate 90:10) and isolated as 
a pale yellow solid (190 mg, 97 %). M.p. 55 °C. 
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1
H-NMR (400 MHz, CDCl3): 7.75-7.81 (m, 2H), 7.71 (d, 
3
J (H,H) = 8.2 Hz, 2H), 7.52-
7.58 (m, 1H), 7.42-7.48 (m, 2H), 7.26 (d, 
3
J (H,H) = 7.8 Hz, 2H), 2.42 ppm (s, 3H). 
13
C-NMR 
(101 MHz, CDCl3): δ = 196.2, 143.0, 137.9, 134.8, 132.0, 130.1, 129.7, 128.8, 128.1, 
21.5 ppm. EI-MS (70 eV), m/z (%): 196 (55) [M+], 181 (19), 119 (100), 105 (23), 91 (28), 77 
(24). IR (KBr): ν~ = 1654 (vs), 1604 (s), 1446 (m), 1408, 1317 (m), 1279 (s), 1176, 1149, 935 
(m), 840 (m), 785 (m), 732 (m), 699 (m), 602 cm
-1
. Anal. Calcd. for C12H14O: C 85.65, H 6.16; 
found: C 86.06, H 6.40. 
 
4-Methoxybenzophenone (4.2-6b) [CAS-No. 611-94-9] 
The ketone 4.2-6b was synthesized according to the general procedure, starting from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 4-bromoanisole (187 mg, 126 µL, 1.00 mmol). 4-Methoxybenzophenone 4.2-
6b was purified by column chromatography (SiO2, hexane/ethyl acetate 90:10) and isolated as 
a yellow oil (184 mg, 87 %). 
1
H-NMR (400 MHz, CDCl3): 7.80 (d, 
3
J (H,H) = 8.9 Hz, 2H), 7.73 (d, J = 7.2 Hz, 2H), 
7.53 (t, J = 7.3 Hz, 1H), 7.44 (t, J = 7.3 Hz, 2H), 6.93 (d, 3J (H,H) = 8.9 Hz, 2H), 3.84 (s, 3H) 
ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 195.3, 163.2, 138.3, 132.4, 131.7, 130.1, 129.6, 128.1, 
113.5, 55.3 ppm.MS (70 eV), m/z (%): 212 (60) [M+], 136 (12), 135 (100), 105 (9), 77 
(19), 51 (19). IR (NaCl): ν~ = 1654 (vs), 1599 (vs), 1508 (m), 1445 (m), 1317 (m), 1281 (s), 
1257 (vs), 1172 (s), 1148 (s), 1028 (s), 922 (m), 844 (m), 741 (m), 701 (m) cm
-1
. Anal. Calcd. 
for C15H14O2: C 79.62, H 6.24; found: C 79.42, H 5.93. 
 
2-Benzoylnaphthalene (4.2-6c) [CAS-No. 644-13-3] 
The ketone 4.2-6c was synthesized according to the general procedure, starting from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 2-bromonaphthalene (207 mg, 1.00 mmol). 2-Benzoylnaphthalene 4.2-6c was 
purified by column chromatography (SiO2, hexane/ethyl acetate 90:10) and isolated as a pale 
yellow solid (220 mg, 95 %). M.p. 83-84 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 8.29 (s, 1H), 7.88-7.99 (m, 6H), 7.61-7.66 (m, 2H), 7.52-
7.59 (m, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 196.7, 137.9, 135.2, 134.8, 132.3, 
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132.2, 131.8, 130.0, 129.4, 128.3, 128.3, 128.2, 127.8, 126.8, 125.7 ppm. EI-MS (70 eV), m/z 
(%): 232 (100) [M+], 231 (74), 155 (92), 127 (59), 105 (32), 77 (55), 51 (32). IR (KBr): ν~ = 
1655 (vs), 1622 (m), 1598 (m), 1446 (m), 1277 (vs), 1269 (vs), 1234 (s), 1115 (m), 920 (m), 
819 (s), 754 (vs), 696 (vs) cm
-1
. Anal. Calcd. for C17H12O: C 87.90, H 5.21; found: C 88.02, H 
4.96. 
 
4-Benzoylbenzonitrile (4.2-6d) [CAS-No. 1503-49-7] 
The ketone 4.2-6d was synthesized according to the general procedure, starting from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 4-bromobenzonitrile (182 mg, 1.00 mmol). 4-Benzoylbenzonitrile 4.2-6d was 
purified by column chromatography (SiO2, hexane/ethyl acetate 80:20) and isolated as a white 
solid (195 mg, 94 %). M.p. 114-115 °C. 
1
H-NMR (400 MHz, CDCl3): 7.88 (d, 
3
J (H,H) = 8.0 Hz, 2H), 7.78-7.81 (m, 4H), 7.63-
7.67 (m, 1H), 7.50-7.54 (m, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 195.0, 141.2, 136.3, 
133.3, 132.1, 130.2, 130.0, 128.6, 118.0, 115.6 ppm. EI-MS (70 eV), m/z (%): 207 (49) [M+], 
130 (23), 105 (100), 102 (21), 77 (50), 51 (28), 51 (21). IR (KBr): ν~ = 2227 (m), 1648 (vs), 
1595 (m), 1403 (m), 1311 (s), 1279 (vs), 856 (s), 735 (s), 694 (vs) cm
-1
. Anal. Calcd. for 
C14H9NO: C 81.14, H 4.38, N 6.76; found: C 81.39, H 4.21, N 6.74. 
 
4-Nitrobenzophenone (4.2-6e) [CAS-No. 1144-74-7] 
The ketone 4.2-6e was synthesized according to the general procedure, starting from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 1-bromo-4-nitrobenzene (202 mg, 1.00 mmol). 4-Nitrobenzo phenone 4.2-6e 
was purified by column chromatography (SiO2, hexane/ethyl acetate 85:15) and isolated as a 
pale yellow solid (148 mg, 65 %). M.p. 138-139 °C. 
1
H-NMR (400 MHz, CDCl3): 8.25 (d, 
3
J (H,H) = 7.4 Hz, 2H), 7.94 (d, 
3
J (H,H) = 7.4 Hz, 
2H), 7.81 (d, J = 8.2 Hz, 2H), 7.64-7.68 (m, 1H), 7.52-7.55 (m, 2H) ppm. 
13
C-NMR 
(101 MHz, CDCl3): δ = 194.7, 149.8, 142.8, 136.2, 133.4, 130.6, 130.0, 128.6, 123.5 ppm. EI-
MS (70 eV): m/z (%): 227 (26) [M
+
], 150 (12), 105 (100), 77 (46), 76 (15), 51 (19), 50 (23). 
IR (KBr): ν~ = 1651 (s), 1594 (m), 1511 (vs), 1446 (m), 1357 (s), 1317 (s), 1276 (s), 1146 (w), 
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1104 (m), 929 (m), 872 (m), 851 (m), 705 (vs), 691 (vs) cm
-1
. Anal. Calcd. for C13H9NO3: C 
68.72, H 3.99, N 6.16; found: C 68.72, H 3.67, N 6.15. 
 
4-Trifluoromethylbenzophenone (4.2-6f) [CAS-No. 728-86-9] 
The ketone 4.2-6f was synthesized according to the general procedure, starting from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 1-bromo-4-trifluoromethylbenzene (227 mg, 142 µL, 1.00 mmol). 4-
Trifluoromethylbenzophenone 4.2-6f was purified by column chromatography (SiO2, 
hexane/ethyl acetate 95:5) and isolated as a white solid (220 mg, 88 %). M.p. 116-117 °C. 
1
H-NMR (400 MHz, CDCl3):  7.91 (d, 
3
J (H,H) = 8.2 Hz, 2H), 7.76 - 7.83 (m, 4H), 7.62-
7.66 (m, 1H), 7.50 - 7.54 (m, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 195.5, 140.7 (d, J = 
1.8 Hz), 136.7, 133.5, 133.1 (q, 
2
J (C,F) = 32.7 Hz), 130.1, 130.0, 128.5, 125.3 (q, 
3
J (C,F) = 
3.7 Hz), 123.6 (q, 
1
J (C,F) = 272.6 Hz) ppm. 
19
F-NMR (376 MHz, CDCl3): -63.0 (s, 3F) 
ppm. EI-MS (70 eV), m/z (%): 250 (100) [M
+
], 173 (32), 145 (27), 105 (92), 77 (24), 51 (11). 
IR (KBr): ν~ = 1651 (s), 1597 (m), 1448 (m), 1409 (s), 1330 (vs), 1281 (s), 1168 (vs), 1110 
(vs), 1065 (vs), 1016 (s), 924 (s), 857 (vs), 715 (vs), 698 (vs) cm
-1
. Anal. Calcd. for C14H9F3O: 
C 67.20, H 3.63; found: C 66.93, H 3.58. 
 
4-Chlorobenzophenone (4.2-6g) [CAS-No. 134-85-0] 
The ketone 4.2-6g was synthesized according to the general procedure, starting from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 1-bromo-4-chlorobenzene (191 mg, 116 µL, 1.00 mmol). 4-
Chlorobenzophenone 4.2-6g was purified by column chromatography (SiO2, hexane/ethyl 
acetate 95:5) and isolated as a white solid (200 mg, 92 %). M.p. 76-77 °C. 
1
H-NMR (400 MHz, CDCl3): 7.76-7.79 (m, 4H), 7.59-7.63 (m, 1H), 7.46-7.52 (m, 4H) 
ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 195.5, 138.9, 137.2, 135.8, 132.6, 131.4, 129.9, 128.6, 
128.4 ppm. EI-MS (70 eV), m/z (%): 216 (93) [M+], 139 (86), 111 (31), 105 (100), 77 (44), 
51 (29), 50 (28). IR (KBr): ν~ = 1643 (vs), 1584 (m), 1483 (s), 1284 (m), 1089 (m), 854 (s), 
748 (vs) cm
-1
. Anal. Calcd. for C13H9ClO: C 72.07, H 4.19; found: C 71.81, H 4.16. 
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3-Benzoylthiophene (4.2-6h) [CAS-No. 6453-99-2] 
The ketone 4.2-6h was synthesized according to the general procedure, starting from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 3-bromothiophene (163 mg, 94 µL, 1.00 mmol). 3-Benzoylthiophene 4.2-6h 
was purified by column chromatography (SiO2, hexane/ethyl acetate 80:20) and isolated as 
yellow oil (182 mg, 97 %). 
1
H-NMR (400 MHz, CDCl3): = 7.91 (d, 
4
J (H,H) = 1.7 Hz, 1H), 7.83 (d, 
3
J (H,H) = 7.2 Hz, 
2H), 7.52-7.61 (m, 2H), 7.47 (t, J = 7.5 Hz, 2H), 7.36 ppm (dd, 
3
J (H,H) = 5.1 Hz, 
4
J (H,H) = 
3.1 Hz, 1H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 189.8, 141.3, 138.6 133.7, 132.2, 129.3, 
128.5, 128.3, 126.1 ppm. EI-MS (70 eV), m/z (%): 188 (100) [M
+
], 160 (7), 111 (96), 105 
(43), 83(10), 77 (34), 51 (23). IR (NaCl): ν~ = 3106 (s)), 1648 (vs), 1597 (s), 1509 (s), 1446 
(s), 1409 (s), 1387 (s), 1276 (vs), 1177 (m), 1137 (m), 1074 (m), 968 (m), 858 (s), 717 (vs), 
671 (s) cm
-1
. 
 
3-Benzoylpyridine (4.2-6i) [CAS-No. 5424-19-1] 
The ketone 4.2-6i was synthesized according to the general procedure, starting from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 3-bromopyridine (158 mg, 96 µL, 1.00 mmol). After addition of dilute 
sodium bicarbonate solution, the reaction mixture was extracted three times with 20 mL ethyl 
acetate. The combined organic layers were dried over magnesium sulfate, and the volatile 
components were removed at 130 °C and 2 x 10
-2
 mbar. The residue was purified by column 
chromatography (SiO2, hexane/ethyl acetate 80:20) to afford 3-benzoylpyridine 4.2-6i 
(166 mg, 91 %) as brown oil. 
1
H-NMR (400 MHz, CDCl3): = 8.92 (br s, 1H), 8.73 (br s, 1H), 8.02 (d, 
3
J (H,H) = 7.8 Hz, 
1H), 7.72 (d, 
3
J (H,H) = 7.0 Hz, 2H), 7.52-7.55 (m, 1H), 7.32-7.44 (m, 3H) ppm. 
13
C-NMR 
(101 MHz, CDCl3): δ = 194.7, 152.6, 150.7, 137.0, 136.5, 133.0, 129.9, 128.4, 123.3 ppm. EI-
MS (70 eV), m/z (%):183 (84) [M
+
], 182 (36), 106 (25), 105 (100), 77 (44), 51 (35). IR 
(NaCl): ν~ = 3057 (m), 1662 (vs), 1585 (vs), 1447 (s), 1415 (s), 1317 (m), 1284 (vs), 1026 (m), 
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922 (m), 784 (w), 714 (m), 654 (m) cm
-1
. Anal. Calcd. for C12H9NO: C 78.67, H 4.95, N 7.65; 
found: C 78.14, H 5.07, N 7.49. 
 
1,3-Diphenylprop-2-en-1-one (chalcone) (4.2-6j) [CAS-No. 94-41-7] 
The ketone 4.2-6j was synthesized according to the general procedure, starting from 
potassium phenyloxoacetate (226 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 2-bromovinylbenzene (183 mg, 129 µL, 1.00 mmol). Chalcone 4.2-6j was 
purified by column chromatography (SiO2, hexane/ethyl acetate 90:10) and isolated as yellow 
oil (88 mg, 42 %). 
1
H-NMR (400 MHz, CDCl3): 8.03 (d, 
3
J (H,H) = 7.8 Hz, 2H), 7.82 (d, 
3
J (H,H) = 15.7 Hz, 
1H), 7.62-7.65 (m, 2H), 7.48-7.60 (m, 4H), 7.40-7.42 (m, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): 190.4, 144.7, 138.1, 134.8, 132.7, 130.5, 128.9, 128.5, 128.4, 128.3, 122.0 ppm. 
EI-MS (70 eV): m/z (%): 208 (52) [M
+
], 207 (100), 131 (35), 103 (46), 77 (90), 51 (54), 50 
(33). IR (NaCl): ν~ = 1663 (s), 1605 (vs), 1573 (s), 1447 (m), 1336 (s), 1216 (s), 1016 (m), 
988 (m), 748 (vs), 688 (m) cm
-1
. CHN: C = 86.53 %, H = 6.00 %; calcd: C = 86.51 %, H = 
5.81 %. Anal. Calcd. for C15H12O: C 86.51, H 5.81; found: C 86.53, H 6.00. 
 
4,4’-Dimethylbenzophenone (4.2-6k) [CAS-No. 611-97-2] 
The ketone 4.2-6k was synthesized according to the general procedure, starting from 
potassium 4-methylphenyloxoacetate (243 mg, 1.20 mmol), cyclohexylamine (119 mg, 
137 µL, 1.20 mmol) and 4-bromotoluene (175 mg, 126 µL, 1.00 mmol). 4,4’-
Dimethylbenzophenone 4.2-6k was purified by column chromatography (SiO2, hexane/ethyl 
acetate 85:15) and isolated as a yellow solid (115 mg, 55 %). M.p. 72-73 °C. 
1
H-NMR (400 MHz, CDCl3): 7.62 (d, 
3
J (H,H) = 8.0 Hz, 4H), 7.19 (d, 
3
J (H,H) = 8.0 Hz, 
4H), 2.36 ppm (s, 6H, CH3). 
13
C-NMR (101 MHz, CDCl3): 196.2, 142.9, 135.2, 130.1, 
128.9, 21.6 ppm. EI-MS (70 eV): m/z (%): 210 (32) [M
+
], 120 (9), 119 (12), 91 (7), 89 (6). IR 
(KBr): ν~  = 1645 (vs), 1605 (vs), 1312 (m), 1277 (s), 1175 (s), 1145, 926 (m), 842 (m), 820 
(m), 747 (s), 680 (m), 577 (m) cm
-1
. Anal. Calcd. for C15H14O: C 85.68, H 6.71; found: C 
84.57, H 6.76. 
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4-Methoxy-4’-methylbenzophenone (4.2-6l) [CAS-No. 23886-71-7] 
The ketone 4.2-6l was synthesized according to the general procedure, starting from 
potassium 4-methoxyphenyloxoacetate (262 mg, 1.20 mmol), cyclohexylamine (119 mg, 
137 µL, 1.20 mmol) and 4-bromotoluene (175 mg, 126 µL, 1.00 mmol). 4-Methoxy-4’-
methylbenzophenone 4.2-6l was purified by column chromatography (SiO2, hexane/ethyl 
acetate 90:10) and isolated as a pale yellow solid (160 mg, 71 %). M.p. 89-90 °C.
 
1
H-NMR (200 MHz, CDCl3): 7.82 (d, 
3
J (H,H) = 8.8 Hz, 2H), 7.69 (d, 
3
J (H,H) = 8.1 Hz, 
2H), 7.28 (d, 
3
J (H,H) = 8.0 Hz, 2H), 6.97 (d, 
3
J (H,H) = 8.8 Hz, 2H), 3.89 (s, 3 H), 2.44 (s, 
3H) ppm. 
13
C-NMR (50 MHz, CDCl3): 195.2, 162.9, 142.4, 135.4, 132.3, 130.4, 129.9, 
128.8, 113.4, 55.4, 21.5 ppm. EI-MS (70 eV): m/z (%): 226 (63) [M
+
], 211 (14), 135 (100), 
119 (23), 91 (19), 77 (26). IR (KBr): ν~ = 1645 (s), 1596 (vs), 1505 (m), 1458 (m), 1315 (s), 
1259 (vs), 1168 (s), 1146 (s), 1114 (m), 1022 (m), 929 (m), 849 (m), 760 (s), 682 (m), 577 (m) 
cm
-1
. Anal. Calcd. for C15H14O2: C 79.62, H 6.24; found: C 79.42, H 5.93. 
 
(4-Methylbenzoyl)benzonitrile (4.2-6m) [CAS-No. 35776-95-5] 
The ketone 4.2-6m was synthesized according to the general procedure, starting from 
potassium 4-cyanophenyloxoacetate (256 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 4-bromotoluene (175 mg, 126 µL, 1.00 mmol). (4-
methylbenzoyl)benzonitrile 4.2-6m was purified by column chromatography (SiO2, 
hexane/ethyl acetate 90:10) and isolated as a white solid (132 mg, 60 %). M.p. 166-167 °C.
 
1
H-NMR (400 MHz, CDCl3): 7.86 (d, 
3
J (H,H) = 8.0 Hz, 2H), 7.79 (d, 
3
J (H,H) = 8.0 Hz, 
2H), 7.70 (d, 
3
J (H,H) = 8.0 Hz, 2H), 7.32 (d, 
3
J (H,H) = 8.0 Hz, 2H), 2.46 (s, 3H) ppm. 
13
C-
NMR (101 MHz, CDCl3): 194.7, 144.3, 141.6, 133.6, 2x 132.1, 2x 130.2, 2x 130.1, 2x 
129.3, 118.0, 115.3, 21.7 ppm. EI-MS (70 eV): m/z (%): 221 (44) [M
+
], 130 (10), 119 (100), 
102 (14), 91 (23), 65 (14). IR (KBr): ν~ = 2229 (w), 1648 (vs), 1603 (m), 1404 (w), 1312 (m), 
1282 (m), 1140 (w), 929 (w), 856 (m), 755 (s), 677 (m), 573 (w), 546 (w) cm
-1
. Anal. Calcd. 
for C15H11NO: C 81.43, H 5.01, N 6.33; found: C 80.96, H 5.01, N 6.25. 
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4-Chloro-4’-methylbenzophenone (4.2-6n) [CAS-No. 5395-79-9] 
The ketone 4.2-6n was synthesized according to the general procedure, starting from 
potassium 4-chlorophenyloxoacetate (267 mg, 1.20 mmol), cyclohexylamine (119 mg, 
137 µL, 1.20 mmol) and 4-bromotoluene (175 mg, 126 µL, 1.00 mmol). 4-Chloro-4’-
methylbenzophenone 4.2-6n was purified by column chromatography (SiO2, hexane/ethyl 
acetate 95:5) and isolated as a white solid (69 mg, 30 %). M.p. 127-128 °C. 
1
H-NMR (400 MHz, CDCl3): 7.60-7.67 (m, 4H), 7.37 (dd, 
3
J (H,H) = 8.2 and 1.6 Hz, 2H), 
7.21 (d, 
3
J (H,H) = 7.4 Hz, 2H), 2.36 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): 195.2, 
143.5, 138.5, 136.2, 134.5, 131.3, 130.1, 129.0, 128.5, 21.6 ppm. EI-MS (70 eV): m/z (%): 
230 (41) [M
+
], 195 (16), 139 (23), 119 (100), 111 (19), 91 (31), 65 (18). IR (KBr): ν~ = 1643 
(vs), 1605 (s), 1584 (m), 1286 (m), 1088 (m), 854 (s), 748 (vs) cm
-1
. 
 
2-Furyl-4-tolylketone (4.2-6o) [CAS-No. 13365-62-3] 
The ketone 4.2-6o was synthesized according to the general procedure, starting from 
potassium 2-furyloxoacetate (214 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 4-bromotoluene (175 mg, 126 µL, 1.00 mmol). 2-Furyl-4-tolylketone 4.2-6o 
was purified by column chromatography (SiO2, hexane/ethyl acetate 90:10) and isolated as 
yellow oil (135 mg, 73 %). 
1
H-NMR (400 MHz, CDCl3): 7.87 (d, 
3
J (H,H) = 8.12 Hz, 2H), 7.66 (s, 1H), 7.26 (d, 
3
J 
(H,H) = 7.3 Hz, 2H), 7.18 (d, 
3
J (H,H) = 3.4 Hz, 1H), 6.53-6.57 (m, 1H), 2.40 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): 182.1, 152.2, 146.7, 143.2, 134.4, 129.3, 128.9, 120.0, 
112.0, 21.5 ppm. EI-MS (70 eV): m/z (%): 186 (87) [M
+
], 171 (21), 158 (27), 119 (100), 95 
(17), 91 (45), 65 (24). IR (NaCl): ν~ = 3130 (w), 3031 (w), 2921 (w), 1643 (vs), 1607 (vs), 
1561 (s), 1463 (vs), 1389 (s), 1314 (s), 1300 (vs), 1226 (w), 1176 (s), 1148 (w), 1082 (w), 
1016 (m), 950 (m), 888 (m), 874 (s), 832 (w), 754 (s), 626 (w) cm
-1
. 
 
2,4’-Dimethylpropiophenone (4.2-6p) [CAS-No. 50390-51-7] 
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The ketone 4.2-6p was synthesized according to the general procedure, starting from 
potassium isopropyloxoacetate (185 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 1.20 
mmol) and 4-bromotoluene (175 mg, 126 µL, 1.00 mmol) for 36 hours at 100 °C. 2,4’-
Dimethylpropiophenone 4.2-6p was purified by column chromatography (SiO2, hexane/ethyl 
acetate 95:5) and isolated as colorless oil (138 mg, 85 %). 
1
H-NMR (400 MHz, CDCl3): 7.79 (d, 
3
J (H,H) = 8.0 Hz, 2H), 7.18 (d, 
3
J (H,H) = 8.0 Hz, 
2H), 3.43-3.50 (m, 1H), 2.33 (s, 3H), 1.14 (s, 3H), 1.12 (s, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): 204.1, 143.5, 133.6, 129.2, 128.4, 35.1, 21.5, 19.2 ppm. EI-MS (70 eV), m/z (%): 
162 (1) [M
+
], 119 (100), 91 (31), 65 (13).. IR (NaCl): ν~ = 2972 (s), 2931 (m), 1683 (vs), 1607 
(s), 1466 (m), 1458 (m), 1382 (m), 1229 (s), 1209 (m), 1161 (m), 977 (s), 829 (s), 745 (s) cm
-1
. 
 
2,2,4’-Trimethylpropiophenone (4.2-6q) [CAS-No. 30314-44-4] 
The ketone 4.2-6q was synthesized according to the general procedure, starting from 
potassium 3,3,3-trimethyl pyruvate (202 mg, 1.20 mmol), cyclohexylamine (119 mg, 137 µL, 
1.20 mmol) and 4-bromotoluene (175 mg, 126 µL, 1.00 mmol) for 36 hours at 100 °C. 2,2,4’-
Trimethylpropiophenone 4.2-6q was purified by column chromatography (SiO2, hexane) and 
isolated as colorless oil (78 mg, 44 %). 
1
H-NMR (400 MHz, CDCl3) δ = 7.62 (d, 
3
J (H,H) = 8.2 Hz, 2H), 7.11 (d, 
3
J (H,H) = 8.2 Hz, 
2H), 2.28 (s, 3H), 1.29 (s, 9H) ppm. 
13
C-NMR (100 MHz, CDCl3) δ = 207.1, 140.9, 135.0, 
128.3, 127.9, 43.5, 27.7, 20.9 ppm. EI-MS (70 eV), m/z (%): 176 (1) [M
+
], 120 (10), 119 
(100), 91 (8), 65 (6), 57 (5). IR (NaCl): ν~ = 1657 (vs), 1605 (vs), 1449 (m), 1310 (m), 1296 
(s), 1272 (s), 1170 (m), 1038 (w), 948 (w), 898 (m), 840 (w), 820 (w), 760 (m), 686 (w), 588 
(m), 562 (m) cm
-1
. 
 
2,4,4’,6-Tetramethylbenzophenone (4.2-6r) 
The ketone 4.2-6r was synthesized according to the general procedure, starting from 
potassium 2,4,6-trimethylphenyloxoacetate (276 mg, 1.20 mmol), cyclohexylamine (119 mg, 
137 µL, 1.20 mmol) and 4-bromotoluene (175 mg, 126 µL, 1.00 mmol). 2,4,4’,6-Tetramethyl 
benzophenone 4.2-6r was detected in 7 % yield (GC yield). 
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Synthesis of N-(phenyl(p-tolyl)methyl)cyclohexylamine (4.2-7a) 
A 20 mL vessel was charged with N-(phenyl-p-tolyl-methylene)-cyclohexylamine (4aba) 
(277 mg, 1.00 mmol), lithium aluminum hydride (120 mg, 3.00 mmol) and THF (2 mL). The 
resulting mixture was stirred at 60 °C for 16 h, diluted with saturated sodium bicarbonate 
solution (20 mL) and extracted repeatedly with 20 mL portions of ethyl acetate. The 
combined organic layers were washed with water and brine, dried over MgSO4, filtered, and 
the volatiles were removed in vacuo, yielding the product 4.2-7a as yellowish oil (262 mg, 
94 %). 
1
H-NMR (400 MHz, CDCl3): 7.23-7.30 (m, 2H), 7.12-7.20 (m, 4H), 7.03-7.09 (m, 1H), 
6.95-7.01 (m, 2H), 4.89 (s, 1H), 2.24-2.34 (m, 1H), 2.18 (s, 3H), 1.79-1.88 (m, 2H), 1.37-1.65 
(m, 3H), 1.20-1.36 (br, 1H), 0.91-1.13 (m, 5H) ppm. 
13
C-NMR (101 MHz, CDCl3): 144.9, 
141.8, 136.2, 129.0, 128.3, 127.2, 126.6, 63.3, 53.9, 33.9, 26.2, 25.1, 21.0 ppm. EI-MS 
(70 eV): m/z (%): 279 (5) [M
+
], 202 (29), 188 (14), 182 (23), 181 (100), 167 (17), 166 (26), 
165 (28). IR (NaCl): ν~ = 3021 (m), 2923 (vs), 2849 (vs), 1601 (w), 1509 (m), 1491 (m), 1449 
(s), 1339 (w), 1176 (w), 1110 (m), 1028 (w), 890 (w), 846 (w), 806 (m), 698 (m) cm
-1
. Anal. 
Calcd. for C20H25NHCl: C 76.05, H 8.30, N 4.43; found: C 75.91, H 8.39, N 4.32. EI-HRMS 
m/z calcd. for C20H25N: 279.1987; m/z found: 279.1976.  
8.8 Decarboxylative Cross-Coupling of Mesylates Catalyzed by 
Copper/Palladium with Customized Imidazolyl Phosphine Ligands 
8.8.1 Synthesis of Imidazolyl Ligands 
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2-(2-(Dicyclohexylphosphino)phenyl)-1-methyl-1H-indole (CM-Phos) 
CM-Phos was prepared according to the literature procedures.
5
 The white solid was obtained 
by recrystalization from acetone, m.p. 184-185 
o
C. 
1
H-NMR (200 MHz, CDCl3): δ = 7.72 (d, J = 6.0 Hz, 2H), 7.60-7.40 (m, 4H), 7.33 (d, J = 
6.0 Hz, 1H), 7.20 (t, J = 8.0 Hz, 1H), 6.48 (s, 1H), 3.59 (s, 3H), 2.40-1.60 (m, 12H), 1.50-0.80 
(m, 10H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 141.32, 141.27, 141.11, 140. 79, 137.23, 
137.03, 136.65, 132.60. 132.56, 131.98, 131.93, 128.18, 127.81, 127.67, 121.04, 120.05, 
119.30. 109.44, 103.28, 103.25, 30.83, 30.77, 27.27, 27.20, 26.38 (unresolved complex C-P 
splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ = -10.09 ppm. IR (KBr): ν~ = 
2923 (m), 2847 (m), 1467 (m), 1445 (s), 1385 (m), 1363 (w), 1339 (m), 1310 (m), 780 (m), 
770 (vs), 748 (vs), 732 (m), 670 (w) cm
-1
. Anal. Calcd. for C27H34NP: C 80.36, H 8.49, N 3.47; 
found: C 80.30, H 8.25, N 3.50. 
Synthesis of 5.2-L1-3. 
 
 
2-(2-Bromophenyl)-1H-benzimidazole [CAS No. 13275-42-8] 
To a mixture of 2-bromobenzoic acid (8.04 g, 40 mmol) and 1,2-phenylenediamine (4.83 g, 
44.7 mmol) were added polyphosphoric acid (56 g) and heated to 150 °C for 6 h. The reaction 
mixture was poured over crushed ice and kept in a refrigerator overnight. The resulting violet 
solid precipitate was filtered and added to 0.5 M Na2CO3 solution (500 mL), stirred for 
30 min and filtered. The yellow solid was dissolved in warm methanol (100 mL) and water 
(100 mL) was added dropwise to the previous solution within 1h. A light yellow solid (9.4 g, 
34.4 mmol, 86 %) was obtained after filteration and drying under vacuum overngiht. 
M.p. >300 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 12.81 (s, 1H), 7.82 (d, J = 4.0 Hz, 1H), 7.79 (d, J = 4.0 Hz, 
1H), 7.73 (d, J = 4.0 Hz, 1H), 7.58 (d, J = 4.0 Hz, 1H), 7.54 (t, J = 4.0 Hz, 1H), 7.45 (t, J = 
4.0 Hz, 1H), 7.26-7.23 (m, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 159.49, 143.26, 
134.54, 133.43, 132.44, 132.30, 131.38, 127.81, 122.73, 121.68, 121.61, 119.15, 111.65 ppm. 
EI-MS (70 eV), m/z (%): 275 (17), 274 (100) [M
+
], 273 (96), 272 (19), 193 (23), 166 (15). IR 
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(KBr): ν~ = 3566 (m), 3079 (w), 1441 (vs), 1405 (s), 1026 (m), 762 (m), 742 (vs), 728 (m) cm
-1
. 
Anal. Calcd. for C13H9BrN2: C 57.17, H 3.32, N 10.26; found: C 57.14, H 3.43, N 10.25. 
 
2-(2-Bromophenyl)-1-methyl-1H-benzimidazole [CAS No. 92152-36-8] 
2-(2-Bromophenyl)-1H-benzoimidazole (4.1 g, 15.0 mmol) was dissolved in a aqeuous 
solution of sodium hydroxide (50 %, 15 mL), and iodomethane (2.3 g, 1.0 mL, 16.5 mmol) 
was added dropwise to the previous solution. The reaction mixture was heat to reflux for 1 h, 
then cooled to room temperature. The resulted soltuion was diluted with water (100 mL), and 
the mixture was extracted with dichloromethane (3 x 30 mL). The combined organic layers 
were washed with water (30 mL), brine (30 mL), dried over MgSO4, and concentrated in 
vacuum. The residue was purified by column chromatography on silica gel (40 % ethyl 
acetate in hexane) to give a brown solid (4.04 g, 14.1 mmol, 94 %). M.p. 94.7 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.88-7.81 (m, 1H), 7.69 (dd, J = 1.1, 8.0 Hz, 1H), 7.53 (dd, 
J = 4.0, 8.0 Hz, 1H), 7.47-7.28 (m, 5H), 3.62 (s, 1H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 
152.33, 142.56, 135.29, 132.59, 132.17, 131.93, 131.25, 127.32, 123.59, 122.77, 122.18, 
119.89, 109.51, 30.65 ppm. ESI-MS (70 eV), m/z (%): 287, 289 [M+H]
+
. IR (KBr): ν~ = 3041 
(w), 2945 (w), 1643 (m), 1467 (s), 1449 (s), 1431 (s), 1387 (s), 1328 (m), 1284 (m), 1242 (m), 
1024 (s), 766 (vs), 754 (s), 742 (vs), 728 (s) cm
-1
. Anal. Calcd. for C14H11BrN2: C 58.56, H 
3.86, N 9.76; found: C 58.28, H 4.03, N 9.60. 
 
2-(2-(Diphenylphosphino)phenyl)-1-methyl-1H-benzimidazole (5.2-L1) 
2-(2-Bromophenyl)-1-methyl-1H-benzoimidazole (718 mg, 2.5 mmol) was dissolved in 
freshly distilled THF (15 mL) at room temperature under a nitrogen atmosphere. The solution 
was cooled to -78 °C in ethanol/liquid nitrogen bath. n-BuLi (1.6 mL, 1.6 M, 2.6 mmol) was 
added dropwise by syringe. After the reaction mixture was stirred for 30 min at -78 °C, 
chlorodiphenylphosphine (0.47 mL, 2.6 mmol) in THF (5 mL) was added dropwise by 
syringe. The reaction was stirred for 40 min at -78 °C and warmed to room temperature 
within 2 h, and then kept stirring for another 0.5 h. The reaction mixture was passed through a 
pad of celite and silica gel and washed with ethyl acetate. After the solvent was removed 
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under reduced pressure, the obtained yellow solid was purified by recrystallization from 
acetonitile to give a white solid (600 mg, 1.53 mmol, 61 %). M.p. 178-179 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.84-7.74 (m, 1H), 7.51-7.42 (m, 3H), 7.34-7.20 (m, 14H), 
3.38 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 153.15, 142.74, 140.21, 140.4, 136.39, 
136.27, 135.93, 135.65, 135.25, 134.01, 133.81, 133.56, 130.78, 130.74, 129.74, 128.68, 
128.55, 128.35, 128.28, 122.48, 121.99, 120.00, 109.30, 30.67; (unresolved complex C-P 
splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ = -11.04 ppm. ESI-MS 
(70 eV), m/z (%): 393.1 [M+H]
+
. IR (KBr): ν~ = 3064 (w), 3050 (w), 2940 (w), 1477 (w), 1458 
(m), 1436 (w), 1421 (m), 1376 (w), 1326 (m), 1281 (w), 1264 (w), 1243 (w), 1091 (w), 1080 
(w), 1069 (w), 1036 (w), 1025 (w), 819 (w), 739 (vs), 731 (s), 693 (vs) cm
-1
. Anal. Calcd. for 
C26H21N2P: C 79.58, H 5.39, N 7.14; found: C 79.33, H 5.59, N 7.18. 
 
2-(2-(Di-tert-butylphosphino)phenyl)-1-methyl-1H-benzimidazole (5.2-L2) 
2-(2-Bromophenyl)-1-methyl-1H-benzoimidazole (718 mg, 2.5 mmol) was dissolved in 
freshly distilled THF (15 mL) at room temperature under a nitrogen atmosphere. The solution 
was cooled to -78 °C in ethanol/liquid nitrogen bath. tert-Butyllithium (3.1 mL, 1.6 M, 
5.0 mmol) was added dropwise by syringe. After the reaction mixture was stirred for 30 min 
at -78 °C, CuCl (247 mg, 2.5 mmol) was added in one portion, and di-tert-
butylchlorophosphine (0.59 mL, 2.8 mmol) in THF (5 mL) was added dropwise by syringe. 
The reaction was stirred for 1 h at -78 °C and warmed to room temperature. The reaction 
mixture was treated with microwave in a sealed reaction vessel for 0.5 h at 140 °C. The 
resulted soltuion was diluted with ethyl acetate (50 mL), washed with ammonium solution (3 
x 30 mL). The aqueous solution was extracted with ethyl acetate (2 x 30 mL), and the 
combined organic layer was washed with brine (50 mL), dried over MgSO4 and concentrated 
in vacuum. The residue was purified by column chromatography on silica gel (30 % ethyl 
acetate in hexane) to give a white solid (375 mg, 1.06 mmol, 43 %). M.p. 184-185 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.97-7.93 (m, 1H), 7.82-7.78 (m, 1H), 7.55-7.42 (m, 3H), 
7.41-7.37 (m, 1H), 7.36-7.27 (m, 2H), 3.62 (s, 3H), 1.31-1.06 (m, 18H) ppm. 
13
C-NMR 
(101 MHz, CDCl3): δ = 155.08, 155.03, 142.90, 139.61, 139.26, 138.80, 138.51, 135.24, 
135.11, 135.08, 131.45, 131.37, 128.73, 128.37, 122.13, 121.71, 119.68, 109.44, 31.54, 31.39, 
31.29, 31.23, 30.18, 30.02; (unresolved complex C-P splittings were observed) ppm. 
31
P-
NMR (162 MHz, CDCl3): δ = 24.19 ppm. ESI-MS (70 eV), m/z (%): 391.1 [M+K]
+
. IR (KBr): 
EXPERIMENTAL SECTION 
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ν~ = 3049 (w), 2971 (w), 2948 (w), 2936 (w), 2888 (w), 2856 (w), 1469 (w), 1456 (w), 1446 
(w), 1435 (w), 1422 (w), 1386 (w), 1366 (w), 1359 (w), 1328 (w), 1281 (w), 1255 (w), 1240 
(w), 1174 (w), 1163 (w), 1124 (w), 1077 (w), 1040 (w), 780 (m), 738 (vs), 721 (w) cm
-1
. Anal. 
Calcd. for C22H29N2P: C 74.97, H 8.29, N 7.95; found: C 74.83, H 8.21, N 7.99. 
 
2-(2-(Dicyclohexylphosphino)phenyl)-1-methyl-1H-benzimidazole (5.2-L3) 
2-(2-Bromophenyl)-1-methyl-1H-benzoimidazole (2.87 g, 10 mmol) was dissolved in freshly 
distilled THF (30 mL) at room temperature under a nitrogen atmosphere. The solution was 
cooled to -78 °C in ethanol/liquid nitrogen bath. n-BuLi (7.5 mL, 1.6 M, 12 mmol) was added 
dropwise by syringe. After the reaction mixture was stirred for 30 min at -78 °C, 
chlorodicyclohexylphosphine (2.6 mL, 12 mmol) in THF (10 mL) was added dropwise by 
syringe. The reaction was stirred for 40 min at -78 °C and warmed to room temperature in 2h, 
and then kept stirring for another 0.5 h. The reaction mixture was passed through a pad of 
celite and silica gel and washed with ethyl acetate. After the solvent was removed under 
reduced pressure, the obtained yellow oil was purified by column chromatography on silica 
gel (10% ethyl acetate in hexane) to give a white solid (3.63 g, 9.0 mmol, 90 %). M.p. 163-
164 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.76-7.70 (m, 1H), 7.56 (d, J = 8.0 Hz, 1H), 7.48-7.34 (m, 
3H), 7.32-7.26 (m, 1H), 7.25-7.16 (2H), 3.48 (s, 3H), 1.90-1.45 (m, 12H), 1.23-0.88 (m, 10H) 
ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 154.55, 154.52, 142.66, 138.75, 138.43, 136.58, 
136.35, 135.13, 132.37, 132.35, 131.08, 131.01, 128.79, 128.65, 122.22, 121.70, 119.56, 
109.46, 33.30, 33.20, 30.84, 30.75, 29.91, 29.75, 29.07, 29.00, 27.18, 27.09, 27.05, 27.02, 
26.19 (unresolved complex C-P splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): 
δ = -7.81 ppm. ESI-MS (70 eV), m/z (%): 405.2 [M+H]+. IR (KBr): ν~ = 3047 (w), 2918 (s), 
2845 (m), 1446 (m), 1440 (m), 1426 (m), 1389 (w), 1327 (w), 1269 (w), 1232 (w), 1128 (w), 
1042 (w), 1029 (w), 1002 (w), 883 (w), 849 (w), 818 (w), 776 (m), 765 (m), 755 (m), 747 (vs), 
720 (w) cm
-1
. Anal. Calcd. for C26H33N2P: C 77.20, H 8.22, N 6.92; found: C 77.09, H 8.05, 
N 6.93. 
Synthesis of 5.2-L4 
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2-(2-bromophenyl)-1-isopropyl-1H-benzimidazole 
2-(2-Bromophenyl)-1H-benzoimidazole (2.0 g, 7.3 mmol) was dissolved in THF (40 mL) and 
cooled to 0 °C. NaH (586 mg, 60 %, suspension in mineral oil, 14.6 mmol) was added to the 
previous solution in one portion under 0 °C. After the cease of the extursion of H2, isopropyl 
bromide (1.8 mL, 19.3 mmol) was added dropwise and the reaction mixture was warmed to 
room temperature under kept stirring for another 1 h. The resulting mixture was washed with 
aqueous NaOH solution (10 %, 100 mL) and extracted with diethyl ether (3 x 30 mL). The 
combined organic layers were washed with brine dried over MgSO4, and concentrated in 
vacuum. The residue was purified by column chromatography on silica gel (40 % ethyl 
acetate in hexane) to give a mixture of product and starting material (1.58 g). The starting 
material could be removed by recrystallization from acetone to give a yellow oil (1.05 g, 
3.33 mmol, 46 %), which was directly used for the next step without further purification. 
 
2-(2-(Dicyclohexylphosphino)phenyl)-1-isopropyl-1H-benzimidazole (5.2-L4) 
2-(2-Bromophenyl)-1-isopropyl-1H-benzimidazole (501 mg, 1.6 mmol) was dissolved in 
freshly distilled THF (10 mL) at room temperature under a nitrogen atmosphere. The solution 
was cooled to -78 °C in an ethanol/liquid nitrogen bath. n-Butyllithium (1.2 mL, 1.6 M, 
1.9 mmol) was added dropwise by syringe. After the reaction mixture was stirred for 30 min 
at -78 °C, chlorodicyclohexylphosphine (0.4 mL, 1.75 mmol) in THF (5 mL) was added 
dropwise by syringe. The reaction was stirred for 1h at -78 °C and warmed to room 
temperature overnight. The reaction mixture was passed through a pad of celite and silica gel, 
and then washed with ethyl acetate. After the solvent was removed under reduced pressure, 
the residue was purified by column chromatography on silica gel (2 0% ethyl acetate in 
hexane) to give a light yellow solid, which was further purified by recrystallization from 
acetone giving a white solid (391 mg, 0.9 mmol, 57 %). M.p. 139-140 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.83-7.75 (m, 1H), 7.66-7.57 (m, 2H), 7.51 (dt, J = 4.0, 
8.0 Hz, 1H), 7.43 (t, J = 8.0 Hz, 1H), 7.40-7.35 (m, 1H), 7.29-7.20 (m, 2H), 4.25 (heptet, J = 
8.0 Hz, 1H), 2.25-2.10 (m, 1H), 1.85-1.51 (m, 14H), 1.48-0.97 (m, 13H) ppm. 
13
C-NMR 
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(101 MHz, CDCl3): δ = 153.80, 153.76, 143.70, 139.73, 139.40, 137.13, 136.91, 132.60, 
132.51, 132.47, 130.68, 130.61, 128.72, 128.46, 121.81, 121.36, 120.15, 119.94, 48.62, 35.59, 
35.42, 32.20, 32.09, 29.98, 29.81, 28.56, 27.51, 26.94, 26.45, 26.21, 21.55 (unresolved 
complex C-P splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ = -9.67 ppm. 
ESI-MS (70 eV), m/z (%): 433.3 [M+H]
+
. IR (KBr): ν~ = 3053 (w), 2919 (m), 2846 (m), 1445 
(m), 1427 (w), 1369 (m), 1282 (m), 1266 (w), 770 (m), 756 (w), 743 (vs), 724 (w) cm
-1
.Anal. 
Calcd. for C28H37N2P: C 77.74, H 8.62, N 6.48; found: C 77.36, H 8.32, N 6.40. 
Synthesis of 5.2-L5. 
 
 
2-(2-Bromophenyl)-1-phenyl-1H-benzimidazole [CAS No. 1173654-26-6] 
2-Bromobenzoic acid (8.04 g, 40 mmol) and N-phenyl-o-phenylenediamine (8.65 g, 46 mmol) 
were dissolved in polyphosphoric acid (56 g) and heated to 150 °C for 6 h. The reaction 
mixture was poured over crushed ice and kept in a refrigerator overnight. The resulting dark 
solution was neutralized with KOH, stirred for 30 minutes, extracted with dichlormethane (3 x 
100 mL), and the combined organic layers were washed with bine (200 mL), dried over 
MgSO4 and concentrated under vacuum. The residue was purified by column chromatography 
on silica gel (30 % ethyl acetate in hexane) to give a white solid (570 mg, 1.63 mmol, 4 %). 
M.p. 168-169 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.80-7.87 (m, 1H), 7.53 (dd, J = 4.0, 8.0 Hz, 1H), 7.47 (dd, 
J = 4.0, 8.0 Hz, 1H), 7.41-7.20 (m, 10H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 151.41, 
142.68, 135.75, 135.51, 132.66, 132.38, 132.20, 130.93, 129.21, 128.00, 126.90, 126.57, 
123.55, 123.50, 122.83, 120.15, 110.46 ppm. IR (KBr): ν~ = 3055 (w), 3013 (w), 1495 (s), 
1457 (s), 1451 (s), 1427 (m), 1383 (s), 1324 (s), 1272 (m), 1262 (m), 1252 (m), 772 (s), 758 
(vs), 742 (vs), 728 (m), 708 (m), 698 (s), 650 (w) cm
-1
. Anal. Calcd. for C19H13BrN2: C 65.35, 
H 3.75, N 8.02; found: C 65.27, H 3.73, N 8.08. 
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2-(2-(Dicyclohexylphosphino)phenyl)-1-phenyl-1H-benzimidazole (5.2-L5) 
2-(2-Bromophenyl)-1-phenyl-1H-benzimidazole (419 mg, 1.2 mmol) was dissolved in freshly 
distilled THF (10 mL) at room temperature under a nitrogen atmosphere. The solution was 
cooled to -78 °C in an ethanol/liquid nitrogen bath. n-BuLi (0.9 mL, 1.6 M, 1.44 mmol) was 
added dropwise by syringe. After the reaction mixture was stirred for 30 min at -78 °C, 
chlorodicyclohexylphosphine (0.3 mL, 1.32 mmol) in THF (5 mL) was added dropwise by 
syringe. The reaction was stirred for 1h at -78 °C and warmed to room temperature overnight. 
The reaction mixture was passed through a pad of celite and silica gel and washed with ethyl 
acetate. After the solvent was removed under reduced pressure, the residue was purified by 
column chromatography on silica gel (20 % ethyl acetate in hexane) to give a white solid 
(301 mg, 0.65 mmol, 54 %). M.p. 167-168 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.80 (d, J = 8.0 Hz, 1H ), 7.54-7.48 (m, 1H), 7.36-7.30 (m, 
4H), 7.28-7.13 (m, 7H), 1.69-1.43 (m, 10H), 1.14-0.90 (m, 10H), 0.50-0.38 (m, 2H) ppm. 
13
C-
NMR (101 MHz, CDCl3): δ = 153.61, 153.58, 142.85, 139.02, 138.70, 136.55, 136.44, 136.33, 
135.37, 132.48, 132.45, 131.53, 131.47, 128.91, 128.64, 128.26, 127.18, 122.96, 122.40, 
119.87, 110.55, 33.75, 33.62, 30.09, 29.92, 28.48, 28.39, 27.23, 27.13, 27.11, 27.06, 26.24 
(unresolved complex C-P splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ 
= -8.06 ppm. ESI-MS (70 eV), m/z (%): 467.2 [M+H]
+
. IR (KBr): ν~ = 3071 (w), 3049 (w), 
2925 (m), 2911 (m), 2837 (m), 1599 (w), 1582 (w), 1525 (w), 1502 (m), 1490 (w), 1447 (m), 
1430 (w), 1373 (m), 1260 (m), 1250 (w), 1194 (w), 778 (m), 757 (s), 748 (m), 737 (vs) cm
-1
. 
Anal. Calcd. for C31H35N2P: C 79.80, H 7.56, N 6.00; found: C 79.31, H 7.24, N 6.03. 
Synthesis of 5.2-L6 
 
 
2-(2-Bromophenyl)-1-(methoxymethyl)-1H-benzimidazole 
EXPERIMENTAL SECTION 
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To a solution of 2-(2-bromophenyl)-1H-benzimidazole (2.7 g, 10 mmol) in acetone (40 mL), 
was added Na2CO3 (7.4 g, 70 mmol) and the suspension was kept stirring for 0.5 h under 
room temperature. Bromomethyl methyl ether (0.9 mL, 10 mmol) was added to the previous 
solution and the reaction mixture was heated to reflux for 2 h. After the reaction was cooled to 
room temperature, the solvent was removed under reduced pressure and the residue was 
diluted with ethyl acetate (50 mL), washed with water (100 mL). The aqueous phase was 
extracted with ethyl acetate (2 x 30 mL), and the conbined organic layers were washed with 
brine dried over MgSO4, and concentrated in vacuum. The residue was purified by column 
chromatography on silica gel (40 % ethyl acetate in hexane) to give a yellow oil (2.86 g, 
9 mmol, 90 %), which was directly used for the next step without further purification. 
 
2-(2-(Dicyclohexylphosphino)phenyl)-1-(methoxymethyl)-1H-benzimidazole (5.2-L6) 
2-(2-Bromophenyl)-1-(methoxymethyl)-1H-benzimidazole (758 mg, 2.4 mmol) was dissolved 
in freshly distilled THF (15 mL) at room temperature under a nitrogen atmosphere. The 
solution was cooled to -78 °C in ethanol/liquid nitrogen bath. n-Butyllithium (1.8 mL, 1.6 M, 
2.9 mmol) was added dropwise by syringe. After the reaction mixture was stirred for 30 min 
at -78 °C, chlorodicyclohexylphosphine (0.6 mL, 2.6 mmol) in THF (5 mL) was added 
dropwise by syringe. The reaction was stirred for 1h at -78 °C and warmed to room 
temperature overnight. The reaction mixture was passed through a pad of celite and silica gel 
and then washed with ethyl acetate. After the solvent was removed under reduced pressure, 
the residue was purified by column chromatography on silica gel (20 % ethyl acetate in 
hexane) to give a light yellow solid, which was further purified by recrystallization from 
acetonitrile giving a white solid (573 mg, 1.3 mmol, 55 %). M.p. 154-155 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.85-7.78 (m, 1H), 7.66-7.61 (m, 1H), 7.60-7.45 (m, 4H), 
7.37-7.28 (m, 2H), 5.33 (s, 2H), 3.06 (s, 3H), 1.88 (br. s, 2H), 1.76-1.60 (m, 10H), 1.27-0.98 
(m, 10H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 154.29, 142.87, 138.28, 137.97, 136.71, 
136.48, 134.23, 132.42, 132.39, 131.54, 131.48, 129.04, 128.68, 122.99, 122.43, 119.76, 
110.72, 75.80, 75.71, 56.03, 33.35, 29.90, 29.74, 29.19, 27.23, 27.17, 27.10, 26.26 
(unresolved complex C-P splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ 
= -8.30 ppm. ESI-MS (70 eV), m/z (%): 435.3 [M+H]
+
. IR (KBr): ν~ = 2920 (m), 2844 (m), 
1736 (w), 1447 (m), 1428 (w), 1377 (w), 1351 (m), 1096 (s), 917 (m), 781 (m), 747 (vs) cm
-
1
.Anal. Calcd. for C27H35N2OP: C 74.63, H 8.12, N 6.45; found: C 74.16, H 7.97, N 6.44. 
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Synthesis of L7 
 
 
2-Bromo-3,4,5-trimethoxybenzaldehyde [CAS No. 35274-53-4] 
N-Bromsuccinimide (9.0 g, 50.0 mmol) and 3,4,5-Trimethoxybenzaldehyde (9.8 g, 
50.0 mmol) were dissolved in chloroform (150 mL). The reaction mixture was heated to 
reflux for 24 h under stirring. After the reaction was cooled to room temperature, saturated 
NaS2O3 solution (50 mL) was added to the reaction solution. The aqueous layer was extracted 
with diethyl ether (2 x 40 mL), and the conbined organic layer was washed with brine dried 
over MgSO4, and concentrated in vacuum. The residue was purified by column 
chromatography on silica gel (40 % ethyl acetate in hexane) to give a white solid (12.0 g, 
43.7 mmol, 88 %). M.p. 76-77 
o
C. 
1
H-NMR (600 MHz, CDCl3): δ = 10.17 (s, 1H), 7.20 (s, 1H), 3.90 (s, 3H), 3.83 (s, 6H) ppm. 
13
C-NMR (151 MHz, CDCl3): δ = 190.58, 152.74, 150.48, 148.40, 128.49, 115.27, 107.16, 
60.96, 60.89, 55.95 ppm. EI-MS (70 eV), m/z (%): 276 (99), 275 (100) [M
+
], 274 (19), 262 
(23), 260 (23), 124 (24). IR (KBr): ν~ = 3003 (w), 2943 (m), 2866 (m), 2836 (w), 1686 (s), 
1578 (m), 1564 (m), 1472 (m), 1449 (s), 1426 (m), 1404 (m), 1383 (vs), 1326 (s), 1285 (m), 
1244 (m), 1198 (vs), 1165 (s), 1105 (vs), 1044 (m), 1002 (s), 981 (vs), 920 (vs), 859 (s), 817 
(m), 774 (m), 726 (m) cm
-1
. Anal. Calcd. for C10H11BrO4: C 43.66, H 4.03; found: C 43.85, H 
4.24. 
 
2-(2-Bromo-3,4,5-trimethoxyphenyl)-1-methyl-1H-benzimidazole 
EXPERIMENTAL SECTION 
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2-Bromo-3,4,5-trimethoxybenzaldehyde (5.2 g, 18.8 mmol) and N-methyl-1,2-
phenylenediamine dihydrochloride (23.7 g, 18.8 mmol) was dissolved in acetonitrile 
(250 mL). 30 % H2O2 solution (1.88 mL, 132 mmol) was added to the previous solution and 
the reaction mixture was kept stirring for 24 h at room temperature. Saturated Na2S2O3 
solution (200 mL) was added into the resulted reaction mixture and the aqueous solution was 
extracted with diethyl ether (3 x 60 mL). The conbined organic layers were washed with brine 
dried over MgSO4, and concentrated in vacuum. The residue was purified by column 
chromatography on silica gel (40 % ethyl acetate in hexane) to give a white solid (3.38 g, 
8.96 mmol, 48 %). M.p. 126-127 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.81 (d, J = 8.0 Hz, 1H), 7.42-7.28 (m, 3H), 6.90 (s, 1H), 
3.96 (s, 3H), 3.94 (s, 3), 3.85 (s, 3H), 3.66 (s, 3H) ppm. 
13
C-NMR (50 MHz, CDCl3): δ = 
152.93, 152.37, 151.08, 144.55, 142.52, 135.37, 127.16, 122.86, 122.27, 119.87, 111.08, 
110.54, 109.51. 61.03, 56.19, 30.74 ppm. ESI-MS (70 eV), m/z (%): 377, 379 [M+H]
+
. IR 
(KBr): ν~ = 3020 (w), 2936 (w), 2849 (w), 1564 (w), 1474 (m), 1466 (m), 1425 (s), 1393 (m), 
1381 (s), 1320 (m), 1248 (m), 1102 (s), 1021 (w), 997 (s), 964 (w), 934 (w), 851 (w), 809 (m), 
741 (vs), 730 (m) cm
-1
. Anal. Calcd. for C17H17BrN2O3: C 54.13, H 4.54, N 7.43; found: C 
54.20, H 4.56, N 7.40. 
 
2-(2-(Dicyclohexylphosphino)-3,4,5-trimethoxyphenyl)-1-methyl-1H-benzimidazole (5.2-
L7) 
2-(2-Bromo-3,4,5-trimethoxyphenyl)-1-methyl-1H-benzoimidazole (377 mg, 1.0 mmol) was 
dissolved in freshly distilled THF (10 mL) at room temperature under a nitrogen atmosphere. 
The solution was cooled to -78 °C in an ethanol/liquid nitrogen bath. n-Butyllithium (0.75 mL, 
1.6 M, 1.2 mmol) was added dropwise by syringe. After the reaction mixture was stirred for 
30 min at -78 °C, chlorodicyclohexylphosphine (0.25 mL, 1.1 mmol) in THF (5 mL) was 
added dropwise by syringe. The reaction was stirred for 1h at -78 °C and warmed to room 
temperature overnight. The reaction mixture was passed through a pad of celite and silica gel 
and washed with ethyl acetate. After the solvent was removed under reduced pressure, the 
residue was purified by column chromatography on silica gel (20 % ethyl acetate in hexane) 
to give a light yellow solid, which was further purified by recrystallization from acetonitrile 
giving a white solid (351 mg, 0.71 mmol, 71 %). M.p. 119-120 
o
C. 
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1
H-NMR (400 MHz, CDCl3): δ = 7.82-7.77 (m, 1H), 7.40-7.36 (m, 1H), 7.34-7.28 (m, 2H), 
6.71 (d, J = 8.0 Hz, 1H), 4.04 (s, 3H), 3.88 (s, 3H), 3.84 (s, 3H), 3.62 (s, 3H), 1.90-0.90 (m, 
22H) ppm; 
13
C-NMR (151 MHz, CDCl3): δ = 156.88, 156.86, 154.95, 154.91, 154.59, 142.50, 
135.17, 134.92, 122.24, 122.06, 121.88, 121.81, 119.53, 109.51, 109.41, 109.36, 60.60, 60.45, 
55.89, 36.48, 36.40, 34.36, 34.29, 32.57, 32.42, 32.06, 31.92, 31.25, 31.07, 31.03, 30.35, 
27.23, 37.01, 26.91, 26.44, 26.10 (unresolved complex C-P splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ = 4.32 ppm. ESI-MS (70 eV), m/z (%): 495.3 [M+H]
+
. IR 
(KBr): ν~ = 2922 (m), 2846 (w), 1582 (w), 1556 (w), 1463 (m), 1445 (m), 1424 (m), 1365 (m), 
1327 (w), 1310 (m), 1241 (m), 1193 (w), 1103 (vs), 1017 (m), 941 (m), 849 (w), 820 (w), 768 
(w), 736 (m) cm
-1
. EI-HRMS m/z calcd. for C29H39N2O3P: 494.2698, m/z found: 494.2709. 
Synthesis of L8 
 
 
2-(2-Bromophenyl)-5,6-dichloro-1H-benzimidazole 
2-Bromobenzoic acid (3.11 g, 15.0 mmol) and 4,5-dichloro-o-phenylenediamine (2.92 g, 
16.5 mmol) were taken in polyphosphoric acid (21 g) and heated to 150 °C for 6 h. The 
reaction mixture was poured over crushed ice and kept in a refrigerator overnight. The 
resulting violet solid precipitate was filtered and added to 0.5 M Na2CO3 solution (300 mL), 
stirred for 30 min and filtered. The yellow solid was dissolved in warm methanol (100 mL), 
and water (100 mL) was added dropwise to the previous solution within 1 h. A white solid 
(4.5 g, 13.2 mmol, 88 %) was obtained after filtration and drying under vacuum overnight. 
M.p. 234-235 °C. 
1
H-NMR (400 MHz, DMSO-d6): δ = 13.11 (br. s, 1H), 7.99 (s, 1H), 7.85-7.75 (m, 3H), 7.60-
7.45 (m, 2H) ppm. 
13
C-NMR (101 MHz, DMSO-d6): δ = 152.98, 142.82, 133.99, 133.50, 
132.30, 131.87, 131.49, 127.90, 125.09, 124.31, 121.46, 120.31, 113.06 ppm. EI-MS (70 eV), 
m/z (%):344 (49), 343 (16), 342 (100) [M
+
], 341 (11), 340 (61), 262 (9), 226 (29), 207 (23). 
IR (KBr): ν~ = 2920 (w), 2850 (w), 1445 (m), 1428 (s), 1387 (vs), 1296 (m), 762 (vs) cm
-1
. 
Anal. Calcd. for C13H7BrCl2N2: C 45.65, H 2.06, N 8.19; found: C 45.40, H 2.26, N 8.19. 
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2-(2-Bromophenyl)-5,6-dichloro-1-methyl-1H-benzimidazole 
To a solution of 2-(2-bromophenyl)-5,6-dichloro-1H-benzimidazole (2.4 g, 7.0 mmol) in THF 
(30 mL), KHMDS (0.5 M in toluene, 14.7 mL, 7.4 mmol) was added under nitrogen at 0 °C. 
After 5 min, the ice bath was removed, and the formed brown solution was stirred for 1.5 h at 
room temperature. The reaction mixture was cooled to 0 °C, and iodomethane (0.46 mL, 7.4 
mmol) was added dropwise to the solution. The resulting suspension was stirred for 2 h at 
room temperature. Saturated ammonium chloride solution (50 mL) was added to the resulting 
reaction mixture, and the aqueous solution was extracted with ethyl acetate (3 x 30 mL). The 
conbined organic layers were washed with brine, dried over MgSO4, and filtered through a 
thin pad of silica gel. After removing the solvent under reduced pressure, a light yellow solid 
(2.4 g, 6.74 mmol, 96 %) was obtained, which was pure enough for the next step. 
M.p. >300 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.91 (s, 1H), 7.73 (d, J = 8.0 Hz, 1H), 7.56-7.39 (m, 4H), 
3.83 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 154.43, 1412.00, 134.72, 132.93, 132.16, 
131.83, 131.25, 127.65, 127.03, 126.50, 123.60, 121.28, 111.13, 31.11 ppm. EI-MS (70 eV), 
m/z (%):358 (43), 357 (40), 356 (100) [M
+
], 355 (51), 354 (62), 353 (26), 277 (180), 276 (16), 
275 (31), 207 (38). IR (KBr): ν~ = 2918 (m), 2850 (w), 1465 (s), 1451 (m), 1426 (s), 1382 (vs), 
1311 (m), 1023 (m), 839 (m), 755 (s), 727 (m) cm
-1
. Anal. Calcd. for C13H9BrCl2N2: C 47.23, 
H 2.55, N 7.87; found: C 47.35, H 2.72, N 7.75. 
 
5,6-Dichloro-2-(2-(dicyclohexylphosphino)phenyl)-1-methyl-1H-benzimidazole (5.2-L8) 
2-(2-Bromophenyl)-1-methyl-1H-benzoimidazole (2.63 g, 7.3 mmol) was dissolved in freshly 
distilled THF (30 mL) at room temperature under a nitrogen atmosphere. The solution was 
cooled to -78 °C in ethanol/liquid nitrogen bath. n-BuLi (4.8 mL, 1.6 M, 7.7 mmol) was 
added dropwise by syringe. After the reaction mixture was stirred for 30 min at -78 °C, 
chlorodicyclohexylphosphine (1.74 mL, 7.7 mmol) in THF (10 mL) was added dropwise by 
syringe. The reaction was stirred for 40 minutes at -78 °C and warmed to room temperature 
within 2 h, and then kept stirring for another 0.5 h. The reaction mixture was passed through a 
pad of celite and silica gel and washed with ethyl acetate. After the solvent was removed 
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under reduced pressure, the obtained yellow solid was purified by recrystallization from 
acetonitile to give a white solid (2.67 g, 5.64 mmol, 77 %). M.p. 160-161 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.88 (s, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.60-7.44 (m, 4H), 
3.53 (s, 3H), 1.90-1.56 (m, 12H), 1.30-0.90 (m, 10H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 
156.68, 156.65, 141.91, 137.75, 137.54, 136.59, 136.45, 134.44, 132.60, 132.58, 130.78, 
130.73, 129.26, 128.89, 126.17, 125.73, 120.71, 111.01, 33.21, 31.14, 31.08, 29.93, 29.82, 
29.06, 27.14, 27.06, 27.00, 26.18 (unresolved complex C-P splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ = -7.35 ppm. ESI-MS (70 eV), m/z (%): 473.2 [M+H]
+
. IR 
(KBr): ν~ = 2925 (vs), 2845 (s), 1464 (m), 1446 (vs), 1421 (vs), 1375 (vs), 1304 (m), 1088 (m), 
867 (m), 834 (m), 835 (m), 791 (m), 775 (m), 742 (m) cm
-1
. Anal. Calcd. for C26H31Cl2N2P: C 
65.96, H 6.60, N 5.92; found: C 65.99, H 6.71, N 5.85. 
Synthesis of L9 
 
 
Ethyl 2-bromobenzimidate tetrafluoroborate [CAS No. 77250-67-0]: 
The solution of triethyloxonium tetrafluoroborate (1.0 M in dichloromethane, 24 mL, 
24 mmol) was added dropwise to ortho-bromobenzamide (41.2 g, 20 mmol) within 20 min 
under N2 at room temperature. The yellowish slurry solution was stirred for 24 h at room 
temperature. After the resulting suspension had been filtered, the filtrate was removed under 
reduced pressure and dried under vacuum overnight to yield a light yellow solid (6.32 g, 
20 mmol, 100 %) quantatively, which was used directly for the next step without further 
purification. 
 
2-(2-bromophenyl)-5,6-dimethoxy-1H-benzimidazole 
A solution of the freshly prepared imidate (4.74 g, 15.0 mmol) and 4,5-dimethoxybenzene-
1,2-diamine (2.68 g, 15.8 mmol) in anhydrous EtOH (40 mL) was stirred for 1 h at room 
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temperature and warmed to reflux overnight. After the evaporation of the solvent under 
reduced pressure, the residue was neutralized by 1M NaOH solution. The resulting mixture 
was extracted with dichloromethane (3 x 20 mL), and the combined organic phases were 
washed with brine (20 mL), dried over Na2SO4 and concentrated. This crude product was 
purified by column chromatography on silica gel (ethyl acetate) giving a light yellow solid 
(4.47 g, 13.4 mmol, 90 %), which was pure enough for the next step. 
 
2-(2-Bromophenyl)-5,6-dimethoxy-1-methyl-1H-benzimidazole 
To a solution of 2-(2-bromophenyl)-5,6-dimethoxy-1H-benzimidazole (1.2 g, 3.6 mmol) in 
THF (10 mL), KHMDS (0.5 M in toluene, 7.6 mL, 3.8 mmol) was added under nitrogen at 
0 °C. After 5 min, the ice bath was removed, and the formed brown solution was stirred for 
1.5 h at room temperature. The reaction mixture was cooled to 0 °C, and iodomethane 
( 0.24 mL, 3.8 mmol) was added dropwise to the solution. The resulting suspension was 
stirred for 2 h at room temperature. Saturated ammonium chloride solution (50 mL) was 
added to the resulted reaction mixture. The aqueous solution was extracted with ethyl acetate 
(3 x 30 mL). The combined organic layers were washed with brine, dried over MgSO4, 
filtered through a thin pad of silica gel and washed with ethyl acetate. After removing the 
solvent under reduced pressure, a light yellow solid was obtained (1.1 g, 3.17 mmol, 88%), 
which was pure enough for the next step. M.p. 181-182 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.64 (dd, J = 1.0, 8.0 Hz, 1H), 7.47 (dd, J = 1.0, 8.0 Hz, 1H), 
7.42-7.35 (m, 1H), 7.34-7.28 (m, 1H), 6.83 (s, 1H), 3.93 (s, 3H), 3.91 (s, 3H), 3.57 (s, 3H) 
ppm; 
13
C-NMR (101 MHz, CDCl3): δ = 150.69, 147.27, 146.62, 135.95, 132.49, 132.23, 
132.07, 130.98, 128.97, 127.22, 123.78, 101.76, 92.31, 56.17, 56.07, 30.74 ppm; EI-MS 
(70 eV), m/z (%): 348 (100) [M
+
], 346 (94) [M
+
], 349 (17), 347 (16), 333 (43), 331 (41), 207 
(30); IR (KBr): ν~ = 2937 (w), 2840 (w), 1485 (s), 1448 (m), 1428 (vs), 1390 (s), 1211 (s), 
1200 (vs), 1154 (vs), 1090 (vs), 1002 (s), 855 (m), 809 (m), 761 (m), 729 (m) cm
-1
; Anal. 
Calcd. for C16H15Br N2O2: C 55.35, H 4.35, N 8.07; found: C 55.70, H 4.68, N 7.96. 
 
2-(2-(Dicyclohexylphosphino)phenyl)-5,6-dimethoxy-1-methyl-1H-benzimidazole (5.2-L9) 
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2-(2-Bromophenyl)-5,6-dimethoxy-1-methyl-1H-benzimidazole (552 mg, 1.59 mmol) was 
dissolved in freshly distilled THF (30 mL) at room temperature under a nitrogen atmosphere. 
The solution was cooled to -78 °C in an ethanol/liquid nitrogen bath. n-BuLi (1.1 mL, 1.6 M, 
1.75 mmol) was added dropwise by syringe. After the reaction mixture was stirred for 30 min 
at -78 °C, chlorodicyclohexylphosphine (0.4 mL, 1.75 mmol) in THF (8 mL) was added 
dropwise by syringe. The reaction was stirred for 40 min at -78 °C and warmed to room 
temperature overnight. The volatiles were removed under reduced pressure. The residue was 
diluted with ethyl acetate (20 mL), passed through a pad of celite and silica gel and washed 
with ethyl acetate. After the solvent was removed under reduced pressure, the obtained yellow 
solid was purified by recrystallization from hexane and diethyl ether to give a white solid 
(600 mg, 1.29 mmol, 81 %). M.p. 81-82 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.62 (d, J = 8.0 Hz, 1H), 7.55-7.42 (m, 3H), 7.32 (s, 1H), 
6.84 (s, 1H), 3.98 (s, 3H), 3.96 (s, 3H), 3.53 (s, 3H), 1.90-1.56 (m, 12H), 1.30-0.90 (m, 10H) 
ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 152.87, 147.12, 146.83, 136.79, 136.57, 132.46, 
132.44, 131.33, 131.26, 128.81, 128.76, 128.68, 101.80, 92.73, 56.43, 56.33, 33.36, 31.11, 
31.02, 30.01, 29.85, 29.06, 27.27, 27.18, 27.15, 27.11, 26.28 (unresolved complex C-P 
splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ = -8.00 ppm. ESI-MS (70 eV), 
m/z (%): 465.3 [M+H]
+
. IR (KBr): ν~ = 3019 (w), 2940 (w), 1506 (m), 1361 (vs), 1329 (s), 
1208 (s), 1175 (s), 1135 (m), 1112 (m), 820 (m), 809 (m), 751 (s) cm
-1
. EI-HRMS m/z calcd. 
for C28H37N2O2P: 464.2593, m/z found: 464.2568. 
 
Synthesis of 5.2-L11 and L16. 
 
 
2-(2-Bromophenyl)-3a,4,5,6,7,7a-hexahydro-1H-benzimidazole 
A solution of the freshly prepared imidate (11.1 g, 35.0 mmol) and (±)-trans-1,2-
Diaminocyclohexane (4.24 g, 36.8 mmol) in anhydrous EtOH (40 mL) was stirred for 1h at 
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room temperature and warmed to reflux overnight. After the evaporation of the solvent under 
reduced pressure, the residue was neutralized by 1 M NaOH solution. The resulting mixture 
was extracted with dichloromethane (3 x 40 mL), and the combined organic phases were 
washed with brine (30 mL), dried over Na2SO4 and concentrated yielding a light yellow solid 
(7.9 g). This crude product was purified by recrystalization from ethyl acetate to give a white 
solid ( 5.34 g, 19.1 mmol, 55 %). M.p. 166-167 °C. 
1
H-NMR (600 MHz, Methanol-d4): δ = 7.67-7.64 (m, 1H), 7.47-7.38 (m, 2H), 7.37-7.32 (m, 
1H), 3.21-3.13 (m, 2H), 2.27-2.22 (m, 2H), 1.89-1.82 (m, 2H), 1.59-1.52 (m, 2H), 1.45-1.35 
(m, 2H) ppm. 
13
C-NMR (151 MHz, Methanol-d4): δ = 168.64, 135.47,134.34, 132.53, 131.52, 
128.68, 122.37, 71.15, 31.85, 26.18 ppm. EI-MS (70 eV), m/z (%): 280 (38) [M
+
], 278 (45) 
[M
+
], 237 (100), 235 (98), 102 (28). IR (KBr): ν~ = 3024 (w), 2942 (w), 2822 (w), 1686 (s), 
1583 (m), 1360 (m), 1300 (m), 1160 (vs), 923 (m), 902 (m), 817 (s), 762 (m) cm
-1
. Anal. 
Calcd. for C13H15BrN2: C 55.93, H 5.42, N 10.03; found: C 55.72, H 5.54, N 9.99. 
 
2-(2-Bromophenyl)-4,5,6,7-tetrahydro-1H-benzimidazole 
A stirred solution of oxalyl chloride (0.53 mL, 5.5 mmol, 1.1 equiv.) in dichloromethane 
(10 mL) under Nitrogen at -78 °C was treated with DMSO (0.79 mL, 11 mmol, 2.2 equiv.) in 
dichloromethane (5 mL), dropwise over 5 min. After 10 min, 2-(2-Bromophenyl)-
3a,4,5,6,7,7a-hexahydro-1H-benzoimidazole (1.4 g, 5.0 mmol) in dichloromethane (10 mL) 
was added within 10 min, followed by triethylamine (3.66 mL, 25 mmol, 5.0 equiv.) dropwise 
over 10 min. The mixture was stirred with gradual warming overnight, and then the reaction 
was quenched with water. The organic phase was washed with brine, dried over MgSO4, 
filtered, and concentrated to give a white solid which was washed by diethyl ether to give a 
white powder (926 mg, 3.34 mmol, 67 % ). M.p. 205-206 °C. 
1
H-NMR (400 MHz, Methanol-d4): δ = 7.68 (d, J = 8.0 Hz, 1H), 5.57 (d, J = 8.0 Hz, 1H), 
7.43-7.38 (m, 1H), 7.28 (t, J = 8.0 Hz, 1H), 2.62 (br. s, 4H), 1.86 (br. s, 4H) ppm. 
13
C-NMR 
(101 MHz, Methanol-d4): δ = 144.43, 134.67, 134.08, 132.91, 131.33, 128.75, 122.83, 24.59, 
23.66 ppm. EI-MS (70 eV), m/z (%):278 (79) [M
+
], 276 (83), 250 (100), 248 (98), 207 (22), 
181 (13), 102 (14). IR (KBr): ν~ = 2943 (m), 2905 (w), 2848 (w), 1608 (m), 1590 (w), 1437(s), 
1390 (s), 1044 (m), 1025 (m), 866 (m), 759 (s), 722 (vs) cm
-1
. Anal. Calcd. for C13H13BrN2: C 
56.34, H 4.73, N 10.11; found: C 56.07, H 4.64, N 10.02. 
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2-(2-Bromophenyl)-1-methyl-4,5,6,7-tetrahydro-1H-benzimidazole 
To a solution of 2-(2-bromophenyl)-5,6-dimethyl-1H-benzimidazole (1.03 g, 3.7 mmol) in 
THF (30 mL), KHMDS (0.5 M in toluene, 7.8 mL, 3.9 mmol) was added under nitrogen at 
0 °C. After 5 minutes, the ice bath was removed, and the formed brown solution was stirred 
for 1.5 h at room temperature. The reaction mixture was cooled to 0 °C, and iodomethane 
(0.24 mL, 3.9 mmol) was added dropwise to the solution. The resulting suspension was stirred 
for 2 h at room temperature. Saturated ammonium chloride solution (30 mL) was added into 
the resulted reaction mixture and the aqueous solution was extracted with ethyl acetate (3 x 
30 mL). The conbined organic layers were washed with brine, dried over MgSO4, and filtered 
through a thin pad of silica gel. After removing the solvent under reduced pressure, the 
residue was diluted with diethyl ether, and a orange solid precipitated. The rest was 
recrystallized from hexane and dichloromethane to give another crop of orange solid (Total 
amount: 911 mg, 3.13 mmol, 85 %). M.p. 122-123 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.65 (dd, J = 1.1, 8.0 Hz, 1H), 7.49-7.44 (m, 1H), 7.38 (dt, J 
= 1.1, 8.0 Hz, 1H), 7.32-7.26 (m, 1H), 3.35 (s, 3H), 2.69-2.64 (m, 2H), 2.59-2.54 (m, 2H), 
1.95-1.81 (m, 4H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 144.64, 135.97, 133.19, 132.89, 
132.57, 130.42, 127.26, 126.51, 124.40, 30.72, 24.23, 23.40, 22.97, 20.89 ppm. EI-MS 
(70 eV), m/z (%): 292 (100) [M
+
], 290 (100), 264 (72), 262 (72), 207 (23), 183 (30). IR (KBr): 
ν~ = 2934 (m), 2845 (w), 1469 (m), 1446 (m), 1433 (m), 1422 (m), 1389 (m), 1022 (s), 760 (vs) 
cm
-1
. Anal. Calcd. for C14H15BrN2: C 57.75, H 5.19, N 9.62; found: C 57.72, H 5.63, N 9.50. 
 
2-(2-Bromophenyl)-1-octyl-4,5,6,7-tetrahydro-1H-benzimidazole 
Sodium hydride (60 %, suspension in mineral oil, 104 mg, 2.6 mmol) was added to the 
magnetically stirred 2-(2-bromophenyl)-5,6-dimethyl-1H-benzimidazole (360 mg, 1.3 mmol) 
in anhydrous THF (30 mL). 1-Bromooctane (507 mg, 2.6 mmol) was added dropwise to the 
mixture at room temperature. The reaction mixture was heated to 60 °C for 24 h, which was 
monitored by TLC (aluminium oxide neutral, 20 % ethyl acetate in hexane). After the reaction 
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was complete, the reaction mixture was partitioned between saturated aqueous NH4Cl (30 mL) 
and ethyl acetate (30 mL). The organic layer was separated and the aqueous layer was 
extracted with ethyl acetate (3 x 30 mL). The combined organic layers were washed with 
water, dried over Na2SO4, and concentrated under reduced pressure. The residue was purified 
by flash column chromatography on aluminium oxide neutral (20 % ethyl acetate in hexane) 
to give a yellow oil (329 mg, 0.85 mmol, 65 %). 
1
H-NMR (400 MHz, CDCl3): δ = 7.63 (dd, J = 1.1, 8.0 Hz, 1H), 7.43-7.32 (m, 2H), 7.30-7.24 
(m, 1H), 3.65 (t, J = 8.0 Hz, 2H), 2.69-2.54 (m, 4H), 1.92-1.80 (m, 4H), 1.52-1.42 (m, 2H), 
1.30-1.02 (m, 10H), 0.84 (t, J = 8.0 Hz, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 144.15, 
135.96, 133.57, 132.78, 132.56, 130.31, 127.07, 125.70, 124.61, 44.10, 31.61, 30.33, 28.89, 
28.80, 26.38, 24.24, 23.36, 23.07, 22.50, 21.27, 14.00 ppm. EI-MS (70 eV), m/z (%): 390 (90) 
[M
+
], 388 (100), 207 (82), 109 (35). IR (KBr): ν~ = 2928 (vs), 2854 (vs), 1467 (m), 1440 (m), 
1402 (m), 1372 (m), 1024 (m), 761 (m), 729 (w) cm
-1
. EI-HRMS m/z calcd. for C21H29BrN2 
(M
+
, 
81
Br): 390.1494, m/z found: 390.1502; EI-HRMS m/z calcd. for C21H29BrN2 (M
+
, 
79
Br): 
388.1514, m/z found: 388.1525. 
 
2-(2-(Dicyclohexylphosphino)phenyl)-1-methyl-4,5,6,7-tetrahydro-1H-benzimidazole 
(5.2-L11) 
2-(2-Bromophenyl)-1-methyl-4,5,6,7-tetrahydro-1H-benzo[d]imidazole (612 mg, 2.1 mmol) 
was dissolved in freshly distilled THF (15 mL) at room temperature under a nitrogen 
atmosphere. The solution was cooled to -78 °C in an ethanol/liquid nitrogen bath. n-
Butyllithium (1.57 mL, 1.6 M, 2.52 mmol) was added dropwise by syringe. After the reaction 
mixture was stirred for 30 min at -78 °C, chlorodicyclohexylphosphine (586 g, 2.52 mmol) in 
THF (5 mL) was added dropwise by syringe. The reaction was stirred for 1 h at -78 °C and 
warmed to room temperature overnight. The reaction mixture was filter through a pad of 
celite and silica gel and washed with ethyl acetate. The reaction mixture was passed through a 
pad of celite and silica gel and washed with ethyl acetate. After the solvent was removed 
under reduced pressure, the residue was purified by column chromatography on aluminium 
oxide neutral (30 % ethyl acetate in hexane), giving a white solid (582 mg, 1.42 mmol, 68 %). 
M.p. 133-134 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.56-7.50 (m, 1H), 7.45-7.33 (m, 3H), 3.23 (s, 3H), 2.66-
2.51 (m, 4H), 1.90-1.58 (m, 16), 1.30-0.98 (m, 10H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 
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146.22, 146.19, 139.82, 139.62, 136.57, 136.43, 135.11, 132.13, 132.10, 131.78, 131.73, 
128.47, 127.91, 125.08, 33.34, 33.27, 30.72, 30.65, 29.92, 29.81, 29.14, 29.08, 27.30, 27.22, 
27.19, 27.14, 26.31, 24.22, 23.42, 23.01, 20.84 (unresolved complex C-P splittings were 
observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ = -7.60 ppm. ESI-MS (70 eV), m/z (%): 
409.3 [M+H]
+
. IR (KBr): ν~ = 2918 (vs), 2847 (s), 1441 (s), 1388 (m), 754 (m) cm
-1
. Anal. 
Calcd. for C26H37N2P: C 76.43, H 9.13, N 6.86; found: C 76.43, H 9.11, N 6.71. 
 
2-(2-(Dicyclohexylphosphino)phenyl)-1-octyl-4,5,6,7-tetrahydro-1H-benzimidazole (5.2-
L12) 
2-(2-Bromophenyl)-1-octyl-4,5,6,7-tetrahydro-1H-benzoimidazole (779 mg, 2.0 mmol) was 
dissolved in freshly distilled THF (15 mL) at room temperature under a nitrogen atmosphere. 
The solution was cooled to -78 °C in an ethanol/liquid nitrogen bath. n-Butyllithium (1.38 mL, 
1.6 M, 2.2 mmol) was added dropwise by syringe. After the reaction mixture was stirred for 
30 min at -78 °C, chlorodicyclohexylphosphine (512 g, 2.2 mmol) in THF (5 mL) was added 
dropwise by syringe. The reaction was stirred for 1h at -78 °C and warmed to room 
temperature overnight. The reaction mixture was passed through a pad of celite and silica gel 
and washed with ethyl acetate. The reaction mixture was passed through a pad of celite and 
silica gel and washed with ethyl acetate. After the solvent was removed under reduced 
pressure, the residue was purified by column chromatography on aluminium oxide neutral 
(10 % ethyl acetate in hexane), giving a light yellow oil (760 mg, 1.5 mmol, 75 %). 
1
H-NMR (400 MHz, CDCl3): δ = 7.56-7.50 (m, 1H), 7.45-7.33 (m, 3H), 3.60 (t, J = 8.0 Hz, 
2H), 2.66-2.51 (m, 4H), 1.90-1.58 (m, 14), 1.45-0.98 (m, 22H), 0.84 (t, J = 8.0 Hz, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 145.53, 136.47, 136.26, 135.01, 131.99, 131.98, 131.94, 
128.29, 127.86, 124.53, 44.15, 44.08, 31.64, 30.09, 29.86, 29.71, 29.24, 28.87, 28.75, 27.30, 
27.24, 27.20, 27.17, 26.50, 26.31, 24.21, 23.37, 23.13, 22.49, 21.23, 13.99 (unresolved 
complex C-P splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ = -8.07 ppm; 
ESI-MS (70 eV), m/z (%): 507.4 [M+H]
+
. IR (KBr): ν~ = 3053 (w), 2920 (vs), 2849 (s), 1652 
(w), 1599 (w), 1445 (s), 1416 (m), 1273 (w), 1177 (m), 770 (m), 729 (m) cm
-1
. EI-HRMS m/z 
calcd. for C33H51N2P: 506.3790, m/z found: 506.3780. 
Synthesis of 5.2-L0 and L13-16 
EXPERIMENTAL SECTION 
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2-(2-Bromophenyl)-5,6-dimethyl-1H-benzimidazole: 
2-bromobenzoic acid (10.1 g, 50 mmol) and 4,5-dimethylbenzene-1,2-diamine (7.6 g, 
55 mmol) were dissolved in polyphosphoric acid (70 g) and heated to 150 °C for 6 h. The 
reaction mixture was poured on crushed ice and kept in a refrigerator overnight. The resulting 
violet solid precipitate was filtered and added to 0.5 M Na2CO3 solution (650 mL), stirred for 
30 min and filtered. The yellow solid was dissolved in warm methanol (100 mL) and water 
(100 mL) was added dropwise to the previous solution in 1 h. A green-yellow solid (14.6 g, 
48.5 mmol, 97 %) was obtained after filteration and drying under vacuum overnight. M.p. 
191-192 °C. 
1
H-NMR (400 MHz, DMSO-d6): δ = 12.5 (br. s, 1H), 7.80 (d, J = 8.0 Hz, 1H), 7.75 (dd, J = 
4.0, 8.0 Hz, 1H), 7.53 (t, J = 8.0 Hz, 1H), 7.43 (t, J = 8.0 Hz, 1H), 7.38 (s, 2H), 2.33 (s, 6H) 
ppm. 
13
C-NMR (101 MHz, DMSO-d6): δ = 149.45, 137.16, 133.58, 133.31, 132.43, 132.26, 
132.17, 131.26, 130.93, 127.89, 127.72, 121.59, 115.32, 20.20, 19.91 ppm. EI-MS (70 eV), 
m/z (%): 302 (96) [M
+
], 300 (100) [M
+
], 287 (36), 285 (31), 207 (80). IR (KBr): ν~ = 3502 (m), 
2641 (m), 1447 (vs), 1435 (vs), 1405 (s), 1355 (w), 1312 (m), 1040 (m), 1028 (s), 1000 (m), 
968 (m), 874 (w), 856 (m), 756 (vs), 730 (m) cm
-1
. EI-HRMS m/z calcd. for C15H13BrN2: 
300.0262, m/z found: 300.0274. 
 
2-(2-Bromophenyl)-1,5,6-trimethyl-1H-benzimidazole 
To a solution of 2-(2-bromophenyl)-5,6-dimethyl-1H-benzoimidazole (2.4 g, 8.0 mmol) in 
THF (30 mL), KHMDS (0.5 M in toluene, 16.8 mL, 8.4 mmol) was added under nitrogen at 
0 °C. After 5 min, the ice bath was removed, and the formed brown solution was stirred for 
1.5 h at room temperature. The reaction mixture was cooled to 0 °C, and iodomethane 
(0.52 mL, 8.4 mmol) was added dropwise to the solution. The resulting suspension was stirred 
for 2 h at room temperature. Saturated ammonium chloride solution (50 mL) was added into 
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the resulting reaction mixture. The aqueous solution was extracted with ethyl acetate (3 x 
30 mL). The combined organic layers were washed with brine, dried over MgSO4, and filtered 
through a thin pad of silica gel. After removing the solvent under reduced pressure, a light 
yellow solid (2.4 g, 7.6 mmol, 95 %) was obtained, which was pure enough for the next step. 
M.p. 158-159 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.71 (d, J = 8.0 Hz, 1H), 7.61 (s, 1H), 7.56-7.51 (m, 1H), 
7.45 (dt, J = 1.0, 8.0 Hz, 1H), 7.41-7.35 (m, 1H), 7.20 (s, 1H), 3.62 (s, 3H), 2.45 (s, 3H), 2.42 
(s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 151.73, 141.36, 134.03, 132.69, 132.40, 
132.38, 132.09, 131.20, 131.38, 127.38, 123.96, 120.07, 109.81, 30.74, 20.59, 20.25 ppm. EI-
MS (70 eV), m/z (%): 316 (47) [M
+
], 314 (41) [M
+
], 281 (32), 235 (16), 207 (100). IR (KBr): 
ν~ = 2959 (m), 2929 (m), 2919 (m), 1641 (vs), 1617 (s), 1523 (vs), 1481 (s), 1409 (s), 1383 
(vs), 1371 (s), 1332 (vs), 1292 (s), 1266 (m), 1208 (m), 1146 (m), 1126 (w), 1098 (s), 1062 
(m), 1040 (m), 1026 (m), 1004 (m), 948 (w), 874 (w), 838 (m), 784 (w), 762 (s), 746 (s), 694 
(m) cm
-1
. Anal. Calcd. for C16H15BrN2: C 60.97, H 4.80, N 8.89; found: C 60.79, H 4.78, N 
8.60. 
 
2-(2-Bromophenyl)-1-isopropyl-5,6-dimethyl-1H-benzimidazole 
K2CO3 (2.8 g, 20.0 mmol) was added to magnetically stirred 2-(2-Bromophenyl)-5,6-
dimethyl-1H-benzimidazole (3.0 g, 10.0 mmol) in acetonitrile (40 mL). The reaction mixture 
was heated to 80 °C for 0.5 h, then cooled to room temperature and isopropyl iodide (3.4 g, 
20.0 mmol) was added dropwise in 10 min. The resulting reaction mixture was kept stirring 
overnight at 50 °C. The solvent was removed under reduced pressure and the residue was 
diluted by water (20 mL), extracted with dichloromethane (3 x 20 mL). The combined organic 
layers were washed with brine (30 mL), dried over MgSO4, and concentrated under reduced 
pressure. The residue was purified by flash chromatography (dichloromethane / ethyl acetate 
= 9:1) to give a mixture of unreacted starting material and product. After recrystallitation from 
dichloromethane and hexane, most of the unreacted starting material was removed. A light 
yellow foam (1.1 g, 3.2 mmol, 32 %) was obtained as a mixture of unreacted starting material 
and product (ratio was around: 1:2.4), which was used directly for the next step without 
further purification. 
EXPERIMENTAL SECTION 
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2-(2-Bromophenyl)-1-butyl-5,6-dimethyl-1H-benzimidazole 
Sodium hydride (60 %, suspension in mineral oil, 240 mg, 6.0 mmol) was added to the 
magnetically stirred 2-(2-bromophenyl)-5,6-dimethyl-1H-benzimidazole (904 mg, 3.0 mmol) 
in anhydrous THF (15 mL). 1-Iodobutane (0.67 mL, 6.0 mmol) was added dropwise to the 
mixture, which was maintained below 5 °C for 0.5 h, and then stirred at room temperature. 
The reaction was monitored by TLC (30 % ethyl acetate in hexane). After the reaction was 
complete, the reaction mixture was partitioned between saturated aqueous NH4Cl (30 mL) and 
ethyl acetate (30 mL). The organic layer was separated and the aqueous layer was extracted 
with ethyl acetate (3 x 30 mL). The combined organic layers were washed with water, dried 
over Na2SO4, and concentrated under reduced pressure. The residue was purified by flash 
column chromatography (20 % ethyl acetate in hexane) to give a yellow oil (920 mg, 
2.6 mmol, 86 %). 
1
H-NMR (400 MHz, CDCl3): δ = 7.71 (dd, J = 4.0, 8.0 Hz, 1H), 7.61 (s, 1H), 7.54-7.50 (m, 
1H), 7.45 (t, J = 8.0 Hz, 1H), 7.37 (dt, J = 4.0, 8.0 Hz, 1H), 7.21 (s, 1H), 4.00 (t, J = 8.0 Hz, 
2H), 2.44 (s, 3H), 2.41 (s, 3H), 1.68 (quint, J = 8.0 Hz, 2H), 1.17 (sext, J = 8.0 Hz, 2H), 0.78 
(t, J = 8.0 Hz, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 151.35, 141.59, 133.08, 132.74, 
132.69, 132.31, 131.89, 131.08, 131.02, 127.26, 123.99, 120.18, 110.27, 44.18, 31.47, 20.63, 
20.22, 19.78, 13.42 ppm. EI-MS (70 eV), m/z (%): 358 (92) [M
+
], 356 (100) [M
+
], 315 (30), 
313 (28), 281 (27), 234 (53), 207 (77). IR (NaCl): ν~ = 3060(m), 3025 (m), 2932 (s), 2873 (s), 
1629 (m), 1524 (m), 1454 (s), 1394 (s), 1177 (s), 1026 (s), 998 (m), 868 (m), 843 (m), 765 
(m), 733 (m) cm
-1
. EI-HRMS m/z calcd. for C19H21BrN2: 356.0888, m/z found: 356.0886. 
 
2-(2-Bromophenyl)-5,6-dimethyl-1-octyl-1H-benzimidazole 
Sodium hydride (60 %, suspension in mineral oil, 336 mg, 14.0 mmol) was added to the 
magnetically stirred 2-(2-Bromophenyl)-5,6-dimethyl-1H-benzimidazole (2.1 g, 7.0 mmol) in 
anhydrous THF (30 mL). 1-Bromooctane (2.7 g, 14.0 mmol) was added dropwise to the 
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mixture, which was maintained below 5 °C for 0.5 h, and then stirred at room temperature. 
The reaction was monitored by TLC (30 % ethyl acetate in hexane). After the reaction was 
complete, the reaction mixture was partitioned between saturated aqueous NH4Cl (30 mL) and 
ethyl acetate (30 mL). The organic layer was separated, and the aqueous layer was extracted 
with ethyl acetate (3 x 30 mL). The combined organic layers were washed with water, dried 
over Na2SO4, and concentrated under reduced pressure. The residue was purified by flash 
column chromatography (30% ethyl acetate in hexane) to give a yellow oil (2.7 g, 6.5 mmol, 
93 %). 
1
H-NMR (400 MHz, CDCl3): δ = 7.71 (dd, J = 1.0, 8.0 Hz, 1H), 7.61 (s, 1H), 7.54-7.49 (m, 
1H), 7.45 (t, J = 8.0 Hz, 1H), 7.38 (t, J = 8.0 Hz, 1H), 7.21 (s, 1H), 3.99 (t, J = 8.0 Hz, 1H), 
2.44 (s, 3H), 2.42 (s, 3H), 1.69 (t, J = 8.0 Hz, 1H), 1.28-1.10 (m, 10H), 0.85 (t, J = 8.0 Hz, 1H) 
ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 151.35, 141.61, 133.08, 132.78, 132.73, 132.34, 
131.91, 131.08, 131.05, 127.26, 124.01, 120.02, 110.28, 44.42, 31.64, 29.34, 28.94, 28.85, 
26.55, 22.53, 20.64, 20.24, 14.02 ppm. EI-MS (70 eV), m/z (%): 414 (95) [M
+
], 412 (100) 
[M
+
], 315 (22), 313 (25), 234 (43), 207 (29). IR (NaCl): ν~ = 3058 (w), 3024 (w), 2926 (vs), 
2855 (s), 1629 (w), 1523 (m), 1446 (vs), 1394 (m), 1322 (m), 1026 (s), 868 (m), 841 (m), 764 
(s), 732 (m) cm
-1
. EI-HRMS m/z calcd. for C23H29BrN2: 412.1514, m/z found: 412.1519. 
 
2-(2-Bromophenyl)-5,6-dimethyl-1-octadecyl-1H-benzimidazole 
Sodium hydride (60 %, suspension in mineral oil, 336 mg, 14.0 mmol) was added to the 
magnetically stirred 2-(2-Bromophenyl)-5,6-dimethyl-1H-benzimidazole (2.1 g, 7.0 mmol) in 
anhydrous THF (30 mL). 1-Bromooctadecane (4.7 g, 14.0 mmol) was added dropwise to the 
mixture, which was maintained below 5 °C for 0.5 h, and then stirred at room temperature. 
The reaction was monitored by TLC (30 % ethyl acetate in hexane). After the reaction was 
complete, the reaction mixture was partitioned between saturated aqueous NH4Cl (30 mL) and 
ethyl acetate (30 mL). The organic layer was separated, and the aqueous layer was extracted 
with ethyl acetate (3 x 30 mL). The combined organic layers were washed with water, dried 
over Na2SO4, and concentrated under reduced pressure. The residue was purified by flash 
column chromatography (30 % ethyl acetate in hexane) to give a yellow solid (3.8 g, 
6.9 mmol, 98 %). M. p. 47-48 °C. 
EXPERIMENTAL SECTION 
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1
H-NMR (400 MHz, CDCl3): δ = 7.71 (dd, J = 1.1, 8.0 Hz, 1H), 7.61 (s, 1H), 7.54-7.49 (m, 
1H), 7.48-7.42 (m, 1H), 7.41-7.35 (m, 1H), 7.21 (s, 1H), 3.99 (t, J = 8.0 Hz, 1H), 2.45 (s, 3H), 
2.42 (s, 3H), 1.69 (t, J = 8.0 Hz, 1H), 1.35-1.10 (m, 30H), 0.89 (t, J = 8.0 Hz, 1H) ppm. 
13
C-
NMR (101 MHz, CDCl3): δ = 151.33, 141.58, 133.06, 132.76, 132.71, 132.33, 131.89, 131.07, 
131.03, 127.25, 124.01, 120.19, 110.27, 44.40, 31.88, 29.65, 29.62, 29.59, 29.53, 29.44, 29.32, 
29.28, 28.88, 26.53, 22.65, 20.63, 20.23, 14.08 ppm. EI-MS (70 eV), m/z (%): 553.3, 555.3 
[M+H]
+
. IR (KBr): ν~ = 2915 (vs), 2849 (vs), 1471 (s), 1444 (m), 1430 (m), 1400 (w), 1024 
(m), 883 (w), 842 (m), 759 (m), 753 (m), 718 (m) cm
-1
. Anal. Calcd. for C33H49BrN2: C 71.59, 
H 5.06, N 8.92; found: C 71.48, H 8.87, N 5.04. 
 
2-(2-(Dicyclohexylphosphino)phenyl)-1,5,6-trimethyl-1H-benzimidazole (5.2-L10) 
2-(2-Bromophenyl)-1,5,6-trimethyl-1H-benzoimidazole (2.14 g, 6.8 mmol) was dissolved in 
freshly distilled THF (30 mL) at room temperature under a nitrogen atmosphere. The solution 
was cooled to -78 °C in ethanol/liquid nitrogen bath. n-Butyllithium (4.7 mL, 1.6 M, 
7.5 mmol) was added dropwise by syringe. After the reaction mixture was stirred for 30 min 
at -78 °C, chlorodicyclohexylphosphine (1.65 mL, 7.5 mmol) in THF (10 mL) was added 
dropwise by syringe. The reaction was stirred for 1 h at -78 °C and warmed to room 
temperature overnight. The reaction mixture was passed through a pad of celite and silica gel 
and washed with ethyl acetate. After the solvent was removed under reduced pressure, the 
residue was purified by column column chromatography on silica gel (20 % ethyl acetate in 
hexane) to give a light yellow solid. After the solvent was removed, hexane (10 mL) was 
added to the residue and evaporated again under reduced pressure precipitating a white solid, 
which was collected by filtration. The filtrate was concentrated, and recrystallized from 
acetonitrile giving another white solid. (Total amount: 2.6 g, 6.0 mmol, 88 %). M.p. 166-
167 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.65-7.60 (m, 1H), 7.57 (s, 1H), 7.55-7.40 (m, 3H), 7.15 (s, 
1H), 3.52 (s, 3H), 2.43 (s, 3H), 2.40 (s, 3H), 1.90-1.60 (m, 12H), 1.29-1.00 (m, 10H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 153.80, 153.75, 141.29, 139.06, 138.75, 136.79, 136.56, 
133.73, 132.33, 132.30, 131.23, 131.12, 131.06, 130.39, 128.64, 128.60, 119.65, 109.75, 
33.23, 30.80, 30.72, 29.96, 29.80, 29.03, 27.21, 27.14, 27.10, 27.06, 26.25, 20.47, 20.18 
(unresolved complex C-P splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ 
= -7.89 ppm. ESI-MS (70 eV), m/z (%): 433.3 [M+H]
+
. IR (KBr): ν~ = 3049 (w), 2914 (vs), 
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2847 (s), 1486 (m), 1445 (vs), 1423 (s), 1389 (s), 1324 (m), 1262 (w), 996 (m), 860 (s), 773 
(vs), 742 (m), 724 (m), 717 (m) cm
-1
. Anal. Calcd. for C28H37N2P: C 77.74, H 8.62, N 6.48; 
found: C 77.56, H 8.65, N 6.41. 
 
2-(2-(Dicyclohexylphosphino)phenyl)-1-isopropyl-5,6-dimethyl-1H-benzimidazole (5.2-
L13) 
2-(2-Bromophenyl)-1-isopropyl-5,6-dimethyl-1H-benzimidazole (1.0 g, 2.0 mmol) was 
dissolved in freshly distilled THF (20 mL) at room temperature under a nitrogen atmosphere. 
The solution was cooled to -78 °C in an ethanol/liquid nitrogen bath. n-Butyllithium (3.4 mL, 
1.6 M, 5.4 mmol) was added dropwise by syringe. After the reaction mixture was stirred for 
30 min at -78 °C, chlorodicyclohexylphosphine (1.3 g, 5.4 mmol) in THF (10 mL) was added 
dropwise by syringe. The reaction was stirred for 1h at -78 °C and warmed to room 
temperature overnight. The reaction mixture was passed through a pad of celite and silica gel, 
then washed with ethyl acetate. After the solvent was removed under reduced pressure, the 
residue was purified by column chromatography on silica gel (15 % ethyl acetate in hexane) 
giving a light yellow solid (360 mg, 0.78 mmol, 38 %). M.p. 91-92 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.62 (d, J = 8.0 Hz, 1H), 7.55 (s, 1H), 7.53-7.45 (m, 1H), 
7.42 (t, J = 8.0 Hz, 1H), 7.39-7.33 (m, 2H), 4.20 (quint, J = 8.0 Hz, 1H), 2.42 (s, 3H), 2.39 (s, 
3H), 2.16 (br. s, 1H), 1.85-0.97 (m, 27 H) ppm. 
13
C-NMR (151 MHz, CDCl3): δ = 153.01, 
142.39, 139.92, 139.70, 137.27, 137.13, 132.44, 132.41, 131.06, 130.71, 130.67, 130.10, 
128.58, 128.39, 120.13, 112.19, 48.45, 35.55, 35.45, 32.17, 32.09, 30.31, 30.23, 29.94, 29.91, 
29.82, 28.60, 27.64, 27.55, 27.05, 26.98, 26.92, 26.84, 26.47, 26.22, 21.59, 21.48, 20.70, 
20.15 (unresolved complex C-P splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): 
δ = -9.78 ppm. ESI-MS (70 eV), m/z (%): 461.3 [M+H]+. IR (KBr): ν~ = 2921 (vs), 2848 (vs), 
1446 (vs), 1428 (m), 1369 (s), 1310 (s), 1180 (m), 997 (m), 849 (m), 770 (s), 741 (m) cm
-1
. 
EI-HRMS m/z calcd. for C30H41N2P: 460.3007, m/z found: 460.2984. 
 
 
1-Butyl-2-(2-(dicyclohexylphosphino)phenyl)-5,6-dimethyl-1H-benzimidazole (5.2-L14) 
EXPERIMENTAL SECTION 
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2-(2-Bromophenyl)-1-butyl-5,6-dimethyl-1H-benzimidazole (704 mg, 2.0 mmol) was 
dissolved in freshly distilled THF (20 mL) at room temperature under a nitrogen atmosphere. 
The solution was cooled to -78 °C in ethanol/liquid nitrogen bath. n-Butyllithium (1.35 mL, 
1.6 M, 2.2 mmol) was added dropwise by syringe. After the reaction mixture was stirred for 
30 min at -78 °C, chlorodicyclohexylphosphine (0.48 mL, 2.2 mmol) in THF (10 mL) was 
added dropwise by syringe. The reaction was stirred for 1 h at -78 °C and warmed to room 
temperature overnight. The reaction mixture was filtered through a pad of celite and silica gel, 
then washed with ethyl acetate. After the solvent was removed under reduced pressure, the 
residue was purified by column chromatography on silica gel (15 % ethyl acetate in hexane) 
giving a light yellow solid (720 mg, 1.52 mmol, 77 %). M.p. 52-53 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.65-7.59 (m, 1H), 7.57 (s, 1H), 7.53-7.40 (m, 3H), 7.18 (s, 
1H), 3.94 (t, J = 8.0 Hz, 1H), 2.43 (s, 3H), 2.40 (s, 3H), 1.98-0.88 (m, 26H), 0.74 (t, J = 
8.0 Hz, 1H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 153.25, 153.21, 141.45, 139.17, 138.86, 
136.49, 136.26, 132.85, 132.19, 132.16, 131.32, 131.25, 131.03, 130.20, 128.50, 128.43, 
119.72, 110.19, 44.13, 44.06, 31.26, 29.86, 29.71, 29.14, 27.16, 27.09, 26.24, 20.52, 20.16, 
19.80, 13.34 (unresolved complex C-P splittings were observed) ppm. 
31
P-NMR (162 MHz, 
CDCl3): δ = -8.29 ppm. ESI-MS (70 eV), m/z (%): 475.3 [M+H]
+
. IR (KBr): ν~ = 2921 (vs), 
2851 (m), 1447 (s), 1431 (m), 1396 (m), 775 (m), 728 (vs) cm
-1
. EI-HRMS m/z calcd. for 
C31H43N2P: 474.3164, m/z found: 474.3117. 
 
2-(2-(Dicyclohexylphosphino)phenyl)-5,6-dimethyl-1-octyl-1H-benzimidazole (5.2-L15) 
2-(2-Bromophenyl)-5,6-dimethyl-1-octyl-1H-benzimidazole (2.5 g, 6.1 mmol) was dissolved 
in freshly distilled THF (30 mL) at room temperature under a nitrogen atmosphere. The 
solution was cooled to -78 °C in an ethanol/liquid nitrogen bath. n-Butyllithium (4.2 mL, 
1.6 M, 6.7 mmol) was added dropwise by syringe. After the reaction mixture was stirred for 
30 min at -78 °C, chlorodicyclohexylphosphine (1.48 mL, 6.7 mmol) in THF (10 mL) was 
added dropwise by syringe. The reaction was stirred for 1 h at -78 °C and warmed to room 
temperature overnight. The reaction mixture was passed through a pad of celite and silica gel, 
then washed with ethyl acetate. After the solvent was removed under reduced pressure, the 
residue was purified by column chromatography on silica gel (15% ethyl acetate in hexane) 
giving a light yellow oil (2.8 g, 5.3 mmol, 87%). 
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1
H-NMR (400 MHz, CDCl3): δ = 7.61 (d, J = 8.0 Hz, 1H), 7.56 (s, 1H), 7.53-7.40 (m, 3H), 
7.17 (s, 1H), 3.92, 2.43 (s, 3H), 2.40 (s, 3H), 1.80-1.60 (m, 12H), 1.30-0.94 (m, 20H), 0.85 (t, 
J = 8.0 Hz, 1H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 153.31, 153.27, 141.53, 139.30, 
138.98, 136.49, 136.27, 132.91, 132.26, 132.22, 131.40, 131.33, 131.09, 130.25, 128.55, 
128.48, 119.77, 110.24, 44.39, 44.32, 31.66, 29.91, 29.78, 29.14, 28.90, 28.79, 27.21, 27.15, 
26.61, 26.29, 22.51, 20.57, 20.22, 14.01 (unresolved complex C-P splittings were observed) 
ppm. 
31
P-NMR (162 MHz, CDCl3): δ = -8.33 ppm. ESI-MS (70 eV), m/z (%): 531.4 [M+H]
+
. 
IR (KBr): ν~ = 2922 (vs), 2851 (s), 1519 (w), 1447 (s). 1390 (m), 1321 (w), 1157 (s), 997 (w), 
774 (m) cm
-1
. EI-HRMS m/z calcd. for C35H51N2P: 530.3790, m/z found: 530.3791. 
 
2-(2-(Dicyclohexylphosphino)phenyl)-5,6-dimethyl-1-octadecyl-1H-benzimidazole (5.2-
L16) 
2-(2-Bromophenyl)-5,6-dimethyl-1-octyl-1H-benzimidazole (2.93 g, 5.3 mmol) was dissolved 
in freshly distilled THF (30 mL) at room temperature under a nitrogen atmosphere. The 
solution was cooled to -78 °C in an ethanol/liquid nitrogen bath. n-Butyllithium (4.0 mL, 
1.6 M, 6.36 mmol) was added dropwise by syringe. After the reaction mixture was stirred for 
30 min at -78 °C, chlorodicyclohexylphosphine (1.53 g, 6.36 mmol) in THF (10 mL) was 
added dropwise by syringe. The reaction was stirred for 1h at -78 °C and warmed to room 
temperature overnight. The reaction mixture was filtered through a pad of celite and Silica gel, 
then washed with ethyl acetate. After the solvent was removed under reduced pressure, the 
residue was purified by column chromatography on silica gel (15 % ethyl acetate in hexane), 
giving a light yellow oil (3.3 g, 4.92 mmol, 93 %). 
1
H-NMR (400 MHz, CDCl3): δ = 7.62 (d, J = 8.0 Hz, 1H), 7.57 (s, 1H), 7.53-7.40 (m, 3H), 
7.17 (s, 1H), 3.92 (br. s, 2H), 1.80-1.50 (m, 12H), 1.40-0.94 (m, 40H), 0.89 (t, J = 8.0 Hz, 1H) 
ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 153.23, 141.48, 139.21, 138.99, 136.44, 136.29, 
132.86, 132.23, 132.21, 131.38, 131.34, 131.10, 130.26, 128.55, 128.49, 119.74, 110.23, 
44.37, 44.31, 31.87, 29.87, 29.77, 29.64, 29.62, 29.59, 29.58, 29.51, 29.46, 29.30, 29.24, 
29.21, 29.11, 28.82, 27.19, 26.58, 26.29, 22.63, 20.57, 20.20, 14.06 (unresolved complex C-P 
splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ = -8.33 ppm. ESI-MS (70 eV), 
m/z (%): 671.5 [M+H]
+
. IR (NaCl): ν~ = 2920 (vs), 2850 (vs), 1464 (m), 1450 (s), 1427 (m), 
1173 (vs), 784 (m), 723 (m) cm
-1
. EI-HRMS m/z calcd. for C45H71N2P: 670.5355, m/z found: 
670.5322. 
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Synthesis of 5.2-L17 
 
 
1-(Di-1-adamantylphosphino)-2-(2-(dicyclohexylphosphino)phenyl)-5,6-dimethyl-1H-
benzimidazole (5.2-L17) 
Pd(OAc)2 (6.41 mg, 0.028 mmol, 4 mol%) was placed in a vial and dissolved in freshly 
distilled toluene (2.0 mL). This solution was then transferred to a vial containing DiPPF (1,1’-
bis(diisopropylphosphino)ferrocene, 14.6 mg, 0.035 mmol, 5 mol %) and the mixture was 
stirred for 10 min. A separate glass vial was first charged with NaOtBu (103 mg, 1.05 mmol, 
1.5 equiv.), and then a solution of (1-adamantyl)2PH (212 mg, 0.7 mmol) in toluene (2.0 mL) 
was added. 2-(2-Bromophenyl)-1,5,6-trimethyl-1H-benzimidazole (232 g, 0.74 mmol, 
1.05 equiv.) and the above Pd(OAc)2/DiPPF solution were then added and the vial was sealed 
with a cap containing a PTFE septum. The mixture was stirred for 20 h at 110 °C, at which 
point the reaction was deemed complete on the basis of 
31
P NMR data obtained from a 
withdrawn aliquot. The reaction mixture was then allowed to cool and passed through a plug 
of silica, and the plug was then washed with CH2Cl2 (40 mL) and ethyl acetate (50 mL). The 
combined eluent was collected and the solvent was removed in vacuo. The resulting pale-
orange solid was purified by column chromatography on aluminium oxide neutral yielded the 
product as a white powder (120 mg, 0.224 mmol, 32 %). M.p. 286-287 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.93 (d, J = 8.0 Hz, 1H), 7.55 (s, 1H), 7.53-7.40 (m, 3H), 
7.16 (s, 1H), 3.57 (s, 3H), 2.45 (s, 3H), 2.42 (s, 3H), 2.04-1.57 (m, 30H) ppm. 
13
C-NMR 
(101 MHz, CDCl3): δ = 154.37, 141.44, 140.31, 139.88, 136.48, 136.38, 136.35, 136.19, 
133.73, 131.52, 131.44, 131.09, 130.32, 128.49, 127.75, 119.72, 109.74, 42.52, 41.00, 36.83, 
31.44, 31.39, 28.79, 20.54, 20.25 (unresolved complex C-P splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ = 25.92 ppm. ESI-MS (70 eV), m/z (%): 537.3 [M+H]+; 
IR (KBr): = 2897 (vs), 2849 (s), 1480 (m), 1443 (vs), 1428 (s), 1387 (m), 1321 (m), 845 (m), 
781 (s) cm
-1
. EI-HRMS m/z calcd. for C36H45N2P: 536.3320, m/z found: 536.3313. 
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8.8.2 General Procedure for the Synthesis of Potassium Carboxylate salts 
A 250 mL, two-necked, round-bottomed flask was charged with the carboxylic acid 
(20.0 mmol) and ethanol (20.0 mL). To this, a solution of potassium tert-butoxide (2.24 g, 
20.0 mmol) in ethanol (20.0 mL) was added dropwise over 2 h. After complete addition, the 
reaction mixture was stirred for another 1 h at room temperature. A gradual formation of a 
white precipitate was observed. The resulting solid was collected by filtration washed 
sequentially with ethanol (2 x 10.0 mL) and cold (0 °C) diethyl ether (10.0 mL), and dried in 
vacuum to provide the corresponding potassium salts of the carboxylic acids. 
 
Potassium 2-nitrobenzoate (5.2-1a) [CAS No. 15163-59-4] 
Compound 5.2-1a was prepared following the general procedure starting from 2-nitrobenzoic 
acid (16.7 g, 100 mmol) and potassium tert-butoxide (11.2 g, 100 mmol). After filtration, the 
carboxylate salt was isolated as a white powder (18 g, 88 %). M.p. 241-242 °C. 
1
H NMR (400 MHz, D2O): δ = 8.00 (d, J = 8.0 Hz, 1H), 7.69 (t, J = 8.0 Hz, 1H), 7.52-7.45 (m, 
2H) ppm. 
13
C NMR (101 MHz, D2O): δ = 174.69, 144.62, 135.86, 134.79, 129.14, 127.53, 
124.09 ppm. IR (KBr): ν~  = 1611 (vs), 1597 (vs), 1521 (vs), 1379 (m), 1350 (vs), 862 (m), 829 
(m), 795 (m), 747 (s), 700 (vs) cm
-1
. Anal. Calcd. for C7H4KNO4: C, 40.97; H, 1.96; N, 6.83. 
Found: C, 41.07; H, 2.17; N, 6.85. 
 
Potassium 5-methyl-2-nitrobenzoate (5.2-1b) [CAS No. 59639-92-8] 
Compound 5.2-1b was prepared following the general procedure starting from 5-methyl-2-
nitrobenzoic acid (3.62 g, 20 mmol) and potassium tert-butoxide (2.24 g, 20 mmol). After 
filtration, the carboxylate salt was isolated as a white powder (4.27 g, 97 %). M.p. 232-233 °C 
(decomposed). 
1
H NMR (600 MHz, D2O): δ = 7.92 (d, J = 8.2 Hz, 1H), 7.29 (d, J = 8.5 Hz, 1H), 7.25 (s, 1H), 
2.37 (s, 3H) ppm. 
13
C NMR (151 MHz, D2O): δ = 175.26, 147.11, 142.01, 136.20, 129.50, 
127.75, 124.30, 20.81 ppm. IR (KBr): ν~  = 1600 (s), 1573 (vs), 1516 (vs), 1345 (vs), 850 (m) 
cm
-1
. Anal. Calcd. for C8H6KNO4: C, 43.83; H, 2.76; N, 6.39. Found: C, 43.82; H, 2.85; N, 
6.40. 
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Potassium 5-methoxy-2-nitrobenzoate (5.2-1c) [CAS No.: 1071850-00-4] 
Compound 5.2-1c was prepared following the general procedure starting from 5-methoxy-2-
nitrobenzoic acid (1.38 g, 7 mmol) and potassium tert-butoxide (0.78 g, 7 mmol). After 
filtration, the carboxylate salt was isolated as a light yellow powder (1.5 g, 91 %). M.p. 215-
216 °C. 
1
H NMR (600 MHz, D2O): δ = 8.17 (d, J = 9.2 Hz, 1H), 7.07 (d, J = 9.2 Hz, 1H), 7.00 (s, 1H), 
3.96 (s, 3H) ppm. 
13
C NMR (151 MHz, D2O): δ = 174.7, 164.4, 139.0, 137.0, 127.1, 114.0, 
112.0, 56.3 ppm. IR (KBr): ν~  = 1595 (vs), 1583 (vs), 1508 (vs), 1381 (m), 1333 (vs), 1243 
(vs), 1063 (s), 1021 (m), 856 (m) cm
-1
. Anal. Calcd. for C8H6KNO5: C 40.85, H 2.57, N 5.95. 
Found: C 40.69, H 2,87, N 5.79. 
 
Potassium 3-methyl-2-nitrobenzoate (5.2-1d) [CAS No. 80841-44-7] 
Compound 5.2-1b was prepared following the general procedure starting from 3-methyl-2-
nitrobenzoic acid (3.7 g, 20 mmol) and potassium tert-butoxide (2.24 g, 20 mmol). After 
filtration, the carboxylate salt was isolated as a white powder (4.0 g, 91 %). M.p. 266-267 °C 
(decomposed). 
1
H NMR (600 MHz, D2O): δ = 7.49-7.39 (m, 2H), 7.35 (dd, J = 7.5, 0.7 Hz, 1H), 2.26 (s, 3H) 
ppm. 
13
C NMR (151 MHz, D2O): δ = 172.85, 148.76, 132.87, 132.77, 131.18, 130.69, 126.47, 
16.81 ppm. IR (KBr): ν~  = 2930 (w), 1612 (vs), 1599 (vs), 1572 (vs), 1520 (vs), 1370 (vs), 922 
(m), 858 (m), 791 (s), 768 (s), 699 (m) cm
-1
. Anal. Calcd. for C8H6KNO4: C, 43.83; H, 2.76; 
N, 6.39. Found: C, 43.90; H, 2.83; N, 6.52. 
 
Potassium 5-fluoro-2-nitrobenzoate (5.2-1e) [CAS No. 92449-40-6] 
Compound 5.2-1e was prepared following the general procedure starting from 5-fluoro-2-
nitrobenzoic acid (3.74 g, 20 mmol) and potassium tert-butoxide (2.24 g, 20 mmol). After 
filtration, the carboxylate salt was isolated as a white powder (3.98 g, 89 %). M.p. 229 °C 
(Decomposed). 
1
H NMR (600 MHz, D2O): δ = 8.15 (dd, J = 9.1, 4.7 Hz, 1H), 7.3-7.1 (m, 2H) ppm. 
13
C NMR 
(151 MHz, D2O): δ = 173.35, 165.70 (d, JC-F = 256.7 Hz), 140.52, 139.13 (d, JC-F = 7.6 Hz), 
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127.59 (d, JC-F = 12.1 Hz), 116.05 (d, JC-F = 24.2 Hz), 114.50 (d, JC-F = 25.7 Hz) ppm. IR 
(KBr): ν~  = 1643 (m), 1610 (m), 1579 (m), 1514 (vs), 1367 (vs), 1222 (m), 826 (s), 789 (s), 
747(m) cm
-1
. Anal. Calcd. for C7H3FKNO4: C, 37.67; H, 1.35; N, 6.28. Found: C, 37.73; H, 
1.57; N, 6.35. 
 
Potassium 6-methyl-2-nitrobenzoate (5.2-1g) [CAS No. 1227469-81-9] 
Compound 5.2-1g was prepared following the general procedure starting from 6-methyl-2-
nitrobenzoic acid (1.15 g, 6.2 mmol) and potassium tert-butoxide (0.7 g, 6.2 mmol). After 
filtration, the carboxylate salt was isolated as a white powder (0.86 g, 63 %). M.p. 223-224 °C 
(decomposed). 
1
H NMR (600 MHz, D2O): δ = 7.96 (d, J = 8.5 Hz, 1H), 7.59 (d, J = 7.6 Hz, 1H), 7.38 (t, J = 
7.9 Hz, 1H), 2.33 (s, 3H) ppm. 
13
C NMR (151 MHz, D2O): δ = 174.88, 143.65, 136.92, 
135.83, 135.48, 128.0, 121.7, 18.5 ppm. IR (KBr): ν~  = 2918 (w), 2850 (w), 1592 (vs), 1526 
(vs), 1611 (vs), 1458 (m), 1433 (m), 1373 (s), 1346 (vs), 1295 (m), 862 (m), 829 (m), 740 (s) 
cm
-1
. Anal. Calcd. for C8H6KNO4: C, 43.83; H, 2.76; N, 6.39. Found: C, 43.76; H, 2.84; N, 
6.48. 
 
Potassium 2-methoxybenzoate (5.2-1h) [CAS No. 16463-34-6] 
Compound 5.2-1h was prepared following the general procedure starting from 2-
methoxybenzoic acid (3.1 g, 20 mmol) and potassium tert-butoxide (2.24 g, 20 mmol). After 
filtration, the carboxylate salt was isolated as a white powder (2.1 g, 55 %). M.p. 272-273 °C 
(decomposed). 
1
H NMR (400 MHz, D2O): δ = 7.37 (dd, J = 7.5, 1.3 Hz, 1H), 7.34-7.23 (m, 1H), 7.03-6.84 
(m, 2H), 3.73 (s, 3H) ppm. 
13
C NMR (101 MHz, D2O): δ = 176.17, 155.78, 130.55, 128.50, 
128.38, 120.59, 112.03, 55.57 ppm. IR (KBr): ν~  = 2918 (w), 2850 (w), 1602 (m), 1586 (m), 
1566 (vs), 1389 (m), 1237 (m), 841 (m), 753 (m), 742 (m) cm
-1
. Anal. Calcd. for C8H7KO3: C, 
50.51; H, 3.71. Found: C, 49.80; H, 4.02. 
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Potassium 3-methylthiophene-2-carboxylate (5.2-1i) [CAS No. 1227469-82-0] 
Compound 5.2-1i was prepared following the general procedure starting from 3-
methylthiophene-2-carboxylic acid (2.93 g, 20 mmol) and potassium tert-butoxide (2.24 g, 
20 mmol). After filtration, the carboxylate salt was isolated as a white powder (2.8 g, 78 %). 
M.p. > 300 °C (decomposed). 
1
H NMR (400 MHz, CD3OD): δ = 7.22 (d, J = 5.1 Hz, 1 H), 6.82 (d, J = 5.1 Hz, 1 H), 2.49 (s, 
3 H) ppm. 
13
C NMR (101 MHz, CD3OD): δ = 171.57, 141.50, 137.91, 132.36, 127.16, 
15.88 ppm. IR (KBr): ν~  = 2918 (m), 2850 (w), 1563 (vs), 1539 (vs), 1418 (s), 1367 (m), 1349 
(vs), 803 (m), 792 (s), 705 (m) cm
-1
. Anal. Calcd. for C6H5KO2S: C, 39.98; H, 2.80; S, 17.79. 
Found: C, 39.72; H, 2.92; S, 17.61. 
 
Potassium 3-methylbenzothiophene-2-carboxylate (5.2-1j) [CAS No. 1312551-98-6] 
Compound 5.2-1j was prepared following the general procedure starting from 3-
methylbenzothiophene-2-carboxylic acid (1.35 g, 7 mmol) and potassium tert-butoxide 
(0.79 g, 7 mmol). After filtration, the carboxylate salt was isolated as a white powder (1.3 g, 
81 %). M.p. > 300 °C. 
1
H NMR (400 MHz, CD3OD): δ = 7.78-7.72 (m, 2 H), 7.25-7.40 (m, 2 H), 2.71 (s, 3 H) ppm. 
13
C NMR (101 MHz, CD3OD): δ = 171.63, 142.71, 140.91, 138.50, 135.17, 126.59, 124.92, 
123.96, 123.35, 13.06 ppm. IR (KBr): ν~  = 2918 (m), 2850 (w), 1575 (vs), 1560 (vs), 1375 
(vs), 753 (m), 728 (m) cm
-1
. Anal. Calcd. for C10H7KNO4: C 52.15, H 3.06, S 13.92. Found: C 
50.06, H 3.42, S 13.40. 
 
Potassium 3-methylbenzofuran-2-carboxylate (5.2-1k) [CAS No. 835912-81-7] 
Compound 5.2-1k was prepared following the general procedure starting from 3-
methylbenzofuran-2-carboxylic acid (1.06 g, 6 mmol) and potassium tert-butoxide (0.67 g, 
6 mmol). After filtration, the carboxylate salt was isolated as a white powder (1.15 g, 90 %). 
M.p. > 300 °C (decomposed). 
1
H NMR (400 MHz, CD3OD): δ = 7.55-7.62 (m, 1 H), 7.47 (d, J = 8.3 Hz, 1 H), 7.34 (td, J = 
7.7, 1.2 Hz, 1 H), 7.18-7.26 (m, 1 H), 2.56 (s, 3 H) ppm. 
13
C NMR (101 MHz, CD3OD): δ = 
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168.50, 154.94, 148.57, 131.55, 127.04, 123.62, 121.58, 120.52, 112.49, 9.66 ppm. IR (KBr): 
ν~  = 2919 (w), 1613 (s), 1571 (vs), 1390 (vs), 1374 (vs), 1321 (vs), 845 (m), 747 (m), 735 (m) 
cm
-1
. Anal. Calcd. for C10H7KO3: C 56.06, H 3.29; Found: C 55.46, H 3.69. 
 
Potassium 1-methyl-1H-indole-2-carboxylate (5.2-1l) [CAS No. 1354455-59-6] 
Compound 5.2-1l was prepared following the general procedure starting from 1-methyl-1H-
indole-2-carboxylic acid (0.88 g, 5 mmol) and potassium tert-butoxide (0.56 g, 5 mmol). 
After filtration, the carboxylate salt was isolated as a white powder (1.01 g, 95 %). M.p. > 
300 °C (decomposed). 
1
H NMR (400 MHz, CD3OD): δ = 7.55 (d, J = 7.8 Hz, 1H), 7.36 (d, J = 8.3 Hz, 1H), 7.20 (td, 
J = 7.6, 1.1 Hz, 1H), 6.95-7.08 (m, 2 H) 4.05 (s, 3 H) ppm. 
13
C NMR (101 MHz, CD3OD): δ 
= 170.75, 140.27, 137.94, 128.08, 124.00, 122.51, 120.64, 111.00, 107.15, 31.97 ppm. IR 
(KBr): ν~  = 2934 (w), 1556 (vs), 1521 (vs), 1458 (s), 1391 (vs), 1325 (s), 1308 (m), 842 (m), 
788 (s), 753 (s), 733 (vs) cm
-1
. Anal. Calcd. for C10H8KNO2: C 56.32, H 3.78, N 6.57; Found: 
C 55.57, H 4.21, N 6.36. 
 
Potassium 4,5-dimethoxy-2-nitrobenzoate (5.2-1m) 
Compound 5.2-1m was prepared following the general procedure starting from 4,5-
dimethoxy-2-nitrobenzoic acid (4.64 g, 20.0 mmol) and potassium tert-butoxide (2.24 g, 
20.0 mmol). After filtration, the carboxylate salt was isolated as a yellow powder quantatively. 
M.p. 285-286 °C (decomposed). 
1
H NMR (600 MHz, D2O): δ = 7.63 (s, 1H), 6.95 (s, 1H), 3.91 (s, 1H), 3.86 (s, 1H) ppm. 
13
C 
NMR (151 MHz, D2O): δ = 174.75, 153.76, 147.57, 136.90, 131.48, 109.08, 107.29, 56.44, 
56.25 ppm. IR (KBr): ν~  = 2934 (w), 1596 (s), 1582 (m), 1514 (s), 1401 (m), 1322 (m), 1256 
(vs), 1219 (s), 1054 (s), 874 (m), 764 (s) cm
-1
. Anal. Calcd. for C9H8KNO6: C 40.75, H 3.04, 
N 5.28; Found: C 40.78, H 3.11, N 5.33. 
8.8.3 General Procedure for the Synthesis of Aryl Mesylates 
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An oven dried round bottom flask equipped with a stirring bar was charged with the 
corresponding phenol and freshly distilled dichloromethane along with pyridine (5.0 equiv.). 
The reaction mixture was cooled to 0 °C in an ice bath under nitrogen. Methanesulfonyl 
chloride (1.5 equiv.) dissolved in dichloromethane was added dropwise with stirring. The 
reaction was allowed to proceed with stirring in the ice water bath for 1 hours, then the 
reaction was allowed to warm slowly to room temperature overnight. The reaction was 
monitored by TLC. The reaction was quenched by addition of water and the organic phase 
was separated. The aqueous phase was further extracted with dichloromethane and the 
combined organic layers were washed successively with 15 % HCl solution and brine, and 
dried over MgSO4. Following filtration, the solvent was removed under reduced pressure and 
purified by recrystallization from dichloromethane and hexane or column chromatography on 
silica gel. 
 
2-Naphthyl methanesulfonate (5.2-2a) [CAS No. 10290-91-2] 
Compound 5.2-2a was synthesized according to the general procedure from 2-naphthol 
(7.21 g, 50 mmol), methansulfonylchloride (5.4 mL, 8.0 mmol) and pyridine (20 mL, 
250 mmol). After recrystallization from dichloromethane and hexane, 5.2-2a (11 g, 
49.5 mmol, 99 %) was obtained as a white solid. M.p. 104-105 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.94-7.84 (m, 3H), 7.78 (d, J = 2.3 Hz, 1H), 7.60-7.50 (m, 
2H), 7.45-7.40 (m, 1H), 3.20 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 146.78, 133.52, 
131.99, 130.24, 127.83, 127.80, 127.11, 126.54, 120.75, 119.37, 37.35 ppm. EI-MS (70 eV), 
m/z (%): 222 (45) [M
+
], 144 (26), 143 (54), 115 (100), 89 (11). IR (KBr): ν~ = 3035 (w), 3020 
(w), 1630 (w), 1592 (m), 1578 (m), 1507 (m), 1362 (vs), 1328 (s), 1174 (vs), 752 (vs) cm
-1
. 
Anal. Calcd. for C11H10O3S: C 59.44, H 4.53, S 14.43; found: C 59.44, H 4.61, S 14.59. 
 
1-Naphthyl methanesulfonate (5.2-2b) [CAS No. 38262-42-9] 
Compound 5.2-2b was synthesized according to the general procedure from 1-naphthol 
(7.21 g, 15 mmol), methansulfonylchloride (2.6 mL, 22.5 mmol) and pyridine (6.1 mL, 
75 mmol). After purification by column chromatography on silica gel, 5.2-2b (2.87 g, 
12.9 mmol, 86 %) was obtained as a yellow oil. 
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1
H-NMR (400 MHz, CDCl3): δ = 8.19-8.14 (m, 1H), 7.92-7.88 (m, 1H), 7.82 (d, J = 8.0 Hz, 
1H), 7.64-7.53 (m, 3H), 7.48 (t, J = 8.0 Hz, 1H), 3.21 (s, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): δ = 145.16, 134.75, 127.91, 127.27, 127.13, 126.88, 125.26, 121.23, 118.27, 
37.77 ppm. EI-MS (70 eV), m/z (%): 222 (48) [M
+
], 144 (18), 143 (94), 115 (100), 89 (14). IR 
(KBr): ν~ = 3060 (s), 3034 (s), 2939 (s), 1633 (m), 1599 (s), 1574 (m), 1506 (m), 1463 (m), 
1388 (m), 1366 (vs), 1180 (s), 969 (s), 889 (s), 809 (s), 772 (s)753 (s), 697 (m) cm
-1
. Anal. 
Calcd. for C11H10O3S: C 59.44, H 4.53, S 14.43; found: C 59.09, H 4.46, S 14.50. 
 
Phenanthren-9-yl methanesulfonate (5.2-2c) [CAS No. 913536-87-5] 
Compound 5.2-2c was synthesized according to the general procedure from 1-naphthol 
(971 mg, 5 mmol), methansulfonylchloride (0.59 mL, 7.5 mmol) and pyridine (2.0 mL, 
25 mmol). After purification by column chromatography on silica gel, 5.2-2c (780 mg, 
2.86 mmol, 57 %) was obtained as a white solid. M.p. 116-117 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 8.75-8.65 (m, 2H), 8.26-8.21 (m, 1H), 7.93-7.89 (m, 1H), 
7.84 (s, 1H), 7.79-7.62 (m, 4H), 3.26 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 143.71, 
131.80, 130.96, 129.20, 128.86, 127.77, 127.41, 127.38, 127.25, 126.21, 123.00, 122.66, 
122.16, 118.07, 37.93 ppm. EI-MS (70 eV), m/z (%): 272 (29) [M
+
], 207 (26), 193 (40), 165 
(100). IR (KBr): ν~ = 3039 (w), 3019 (w), 2914 (w), 1629 (w), 1602 (m), 1498 (w), 1347 (s), 
1332 (s), 1176 (vs), 1168 (s), 1301 (m), 1176 (vs), 1168 (s), 1051 (m), 1026 (m), 972 (m), 821 
(m), 763 (m), 753 (m), 736 (m), 728 (m) cm
-1
. Anal. Calcd. for C15H12O3S: C 66.16, H 4.44, S 
11.77; found: C 66.23, H 4.59, S 11.56. 
 
p-Tolyl methanesulfonate (5.2-2d) [CAS No. 17177-63-8] 
Compound 5.2-2d was synthesized according to the general procedure from 1-naphthol 
(5.46 g, 50 mmol), methansulfonylchloride (4.64 mL, 60 mmol) and pyridine (20.2 mL, 
250 mmol). After purification by column chromatography on silica gel, 5.2-2d (8.5 g, 
45.6 mmol, 91 %) was obtained as a white solid. M.p. 44-45 °C 
1
H-NMR (400 MHz, CDCl3): δ = 7.23-7.16 (m, 4H), 3.12 (s, 3H), 2.37 (s, 3H) ppm. 
13
C-
NMR (101 MHz, CDCl3): δ = 147.07, 137.32, 130.43, 121.65, 37.07, 20.82 ppm. EI-MS 
(70 eV), m/z (%): 187 (18), 186 (82) [M
+
], 108 (51), 107 (100), 79 (40), 78 (11), 77 (45). IR 
(KBr): ν~ = 3030 (w), 2942 (w), 1595 (w), 1503 (m), 1353 (vs), 1332 (m), 1170 (s), 1142 (vs), 
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981 (m), 967 (m), 863 (vs), 839 (s), 821 (s), 801 (m), 767 (m), 678 (m) cm
-1
. Anal. Calcd. for 
C8H10O3S: C 51.60, H 5.41, S 17.22; found: C 51.64, H 5.32, S 17.29. 
 
3-Methoxyphenyl methanesulfonate (5.2-2e) [CAS No. 92017-95-3] 
Compound 5.2-2d was synthesized according to the general procedure from 1-naphthol 
(1.92 g, 15 mmol), methansulfonylchloride (1.78 mL, 22.5 mmol) and pyridine (6.1 mL, 
75 mmol). After purification by column chromatography on silica gel, 5.2-2d (2.57 g, 
12.7 mmol, 85 %) was obtained as a yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.30 (t, J = 8.0 Hz, 1H), 6.89-6.82 (m, 3H), 3.80 (s, 3H), 
3.13 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 160.65, 150.02, 130.23, 113.72, 113.06, 
107.95, 55.45, 37.16 ppm. EI-MS (70 eV), m/z (%): 202 (52) [M
+
], 124 (100), 95 (52). IR 
(KBr): ν~ = 3079 (w), 3025 (s), 2943 (s), 2741 (m), 1608 (vs), 1589 (s), 1487 (m), 1367 (vs), 
1180 (m), 1122 (s), 943 (s), 817 (s), 686 (s) cm
-1
. Anal. Calcd. for C8H10O4S: C 47.51, H 4.98, 
S 15.86; found: C 47.37, H 5.33, S 16.12. 
8.8.4 Synthesis of Vinyl Mesylates 
8.4.2.1 General Procedure for the Synthesis of 5.2-5a-c, 5e-f. 
 
These starting materials were prepared according to literature procedures.
6
 In a round-
bottomed flask under magnetic stirring and nitrogen atmosphere were added the 
corresponding ketones in THF. The reaction mixture was cooled to -20 °C. Sodium tert-
butoxide (1.1 equiv.) was added in one portion. The solution was stirred at -5 °C for 1 h and 
then at room temperature for 30 min. The solution was cooled to -15 °C. Mesyl anhydride 
(1.1-1.3 equiv.) was added in one portion. The resulting solution was stirred at -15 to -5 °C 
for 1.5 h and quenched with aq NaHCO3. The aqueous phase was further extracted with ethyl 
acetate and the combined organic phase was washed with water, brine, dried on Na2SO4, 
concentrated and purified by colomn chromatography on silica gel. 
 
3,4-Dihydronaphthalen-2-yl methanesulfonate (5.2-5a) 
Compound 5.2-5a was synthesized according to the general procedure from beta-tetralone 
(1.43 g, 9.8 mmol), sodium tert-butoxide (1.06 g, 10.8 mmol) and mesyl anhydride (1.88 g, 
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10.8 mmol). After purification by column chromatography on silica gel, 5.2-5a (1.2 g, 
5.35 mmol, 55 %) was obtained as a white solid. M.p. 34-35 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.21-7.12 (m, 3H), 7.09-7.04 (m, 1H), 6.45 (s, 1H), 3.18 (s, 
3H), 3.03 (t, J = 8.0 Hz, 1H), 2.67 (t, J = 8.0 Hz, 1H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 
149.57, 133.00, 132.03, 127.67, 127.38, 126.75, 116.65, 37.75, 28.46, 26.75 ppm. EI-MS 
(70 eV), m/z (%): 224 (30) [M
+
], 145 (35), 117 (100), 115 (53), 91 (15). IR (KBr): ν~ = 3024 
(w), 3004 (w), 2929 (w), 2840 (w), 1657 (m), 1484 (m), 1452 (m), 1436 (m), 1353 (vs), 1332 
(s), 1177 (vs), 1075 (vs), 975 (s), 867 (m), 810 (vs), 761 (m), 739 (m), 710 (m) cm
-1
. Anal. 
Calcd. for C11H12O3S: C 58.91, H 5.39, S 14.30; found: C 58.94, H 5.59, S 14.28. 
 
2,2-Diphenylvinyl methanesulfonate (5.2-5b) 
Compound 5.2-5b was synthesized according to the general procedure from 2,2-
diphenylacetaldehyde (2.35 g, 12 mmol), sodium tert-butoxide (1.29 g, 13.2 mmol) and mesyl 
anhydride (2.72 g, 15.6 mmol). After purification by column chromatography on silica gel, 
5.2-5b (2.5 g, 9.11 mmol, 76 %) was obtained as a white solid. M.p. 89-90 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.43-7.32 (m, 8H), 7.30-7.26 (m, 2H), 7.05 (s, 1H), 2.98 (s, 
3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 137.51, 135.16, 132.49, 131.57, 129.80, 128.54, 
128.34, 128.30, 128.27, 128.21, 37.68 ppm. EI-MS (70 eV), m/z (%): 274 (19) [M
+
], 195 (97), 
167 (100), 165 (54), 115 (19). IR (NaCl): ν~ = 3103 (w), 3013 (w), 1634 (w), 1496 (w), 1445 
(w), 1366 (m), 1350 (s), 1185 (s), 1169 (s), 1063 (vs), 968 (s), 953 (m), 816 (s), 761 (m), 696 
(vs) cm
-1
. Anal. Calcd. for C15H14O3S: C 65.67, H 5.14, S 11.69; found: C 65.95, H 5.18, S 
11.39. 
 
-Styryl methanesulfonate (5.2-5c) 
Compound 5.2-5c was synthesized according to the general procedure from 
phenylacetaldehyde (90 % purity, 2.0 g, 15 mmol), sodium tert-butoxide (1.62 g, 16.5 mmol) 
and mesyl anhydride (2.72 g, 15.6 mmol). After purification by column chromatography on 
silica gel, 5.2-5c (E/Z = 2.3:1, 1.1 g, 5.55 mmol, 37 %) was obtained as a light yellow oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.60-7.56 (m, 2H), 7.42-7.28 (m, 15H), 7.22 (d, J = 12.0 Hz, 
2.5H), 6.74 (d, J = 8.0 Hz, 1H), 6.57 (d, J = 12.0 Hz, 2.3H), 5.92 (d, J = 8.0 Hz, 1H), 3.13 (s, 
6.9 H), 3.09 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 135.92, 133.84, 132.37, 132.24, 
129.12, 128.79, 128.55, 128.27, 128.16, 126.40, 120.48, 116.00, 37.70, 37.31 ppm; 
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EI-MS (70 eV), m/z (%): 198 (28) [M
+
], 119 (31), 91 (100). IR (NaCl): ν~ = 3081 (m), 3029 
(m), 2939 (m), 1653 (s), 1495 (m), 1449 (m), 1368 (vs), 1181 (vs), 1052 (s), 968 (s), 798 (s), 
753 (m), 694 (m) cm
-1
. EI-HRMS m/z calcd. for C9H10O3S: 198.0351, m/z found: 198.0344. 
 
1,1-Diphenylprop-1-en-2-yl methanesulfonate (5.2-5e) 
Compound 5.2-5e was synthesized according to the general procedure from 1,1-
diphenylacetone (3.15 g, 15 mmol), sodium tert-butoxide (1.77 g, 18 mmol) and mesyl 
anhydride (2.87 g, 16.5 mmol). After purification by column chromatography on silica gel, 
5.2-5e (1.6 g, 5.55 mmol, 37 %) was obtained as a colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.39-7.20 (m, 10H), 2.45 (s, 3H), 2.23 (s, 3H) ppm. 
13
C-
NMR (101 MHz, CDCl3): δ = 143.39, 138.93, 138.45, 133.03, 129.89, 129.83, 128.32, 128.22, 
127.74, 127.60, 38.35, 20.07 ppm. EI-MS (70 eV), m/z (%): 288 (4) [M
+
], 207 (39), 167 (100), 
152 (18), 78 (28). IR (NaCl): ν~ = 3056 (m), 3027 (m), 2938 (m), 1651 (m), 1600 (m), 1494 
(m), 1444 (m), 1361 (vs), 1189 (s); 1138 (s), 968 (m), 940 (m), 893 (m), 798 (m), 766 (m), 
701 (m) cm
-1
. Anal. Calcd. for C16H16O3S: C 66.64, H 5.59, S 11.12; found: C 66.27, H 5.97, 
S 11.10. 
 
(E)-1-(4-Methoxyphenyl)prop-1-en-2-yl methanesulfonate (5.2-5f) 
Compound 5.2-5f was synthesized according to the general procedure from 4-
methoxyphenylacetone (985 mg, 6 mmol), sodium tert-butoxide (706 mg, 7.2 mmol) and 
mesyl anhydride (1.15 g, 6.6 mmol). After purification by column chromatography on silica 
gel, 5.2-5f (400 mg, 1.65 mmol, 28 %) was obtained as a colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ = 7.45-7.40 (m, 2H), 6.90-6.86 (m, 2H), 5.99 (s, 1H), 3.81 (s, 
3H), 2.83 (s, 3H), 2.25 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 159.03, 144.18, 130.05, 
125.77, 118.14, 113.98, 55.19, 38.4, 21.35 ppm. EI-MS (70 eV), m/z (%): 242 (6) [M
+
], 200 
(16), 163 (100), 91 (15), 77 (14). IR (NaCl): ν~ = 3033 (m), 2939 (m), 2840 (m), 1678 (m), 
1608 (s), 1511 (s), 1357 (vs), 1253 (s), 1179 (m), 1034 (m), 905 (m), 829 (m), 789 (m), 697 
(m) cm
-1
. EI-HRMS m/z calcd. for C11H14O4S: 242.0613, m/z found: 242.0603. 
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8.8.4.2 Synthesis of 5.2-5d 
 
1-Phenylbut-1-en-1-yl methanesulfonate (5.2-5d) 
This starting material was prepared according to literature procedures.
7
 To a 50 mL vial 
containing alkyne (1.3 g, 10 mmol, 2.0 equiv.), phthalimide (29.4 mg, 0.2 mmol, 4 mol %), 
PPh3AuNO3 (52.1 mg, 0.1 mmol, 2 mol %), and dichlorethane (20 mL) was added 
methanesulfonic acid (0.32 mL, 5 mmol, 1.0 equiv.) under nitrogen. The mixture was then 
sealed and stirred at 100 °C for 4 h. It was quenched with saturated solution of NaHCO3 and 
then extracted with ethyl acetate (3 x 10 mL). The organic layer was washed with brine, dried 
over Na2SO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography giving a light yellow oil (E/Z = 1:3.2, 900 mg, 3.98 mmol, 80 %). 
1
H-NMR (400 MHz, CDCl3): δ = 7.53-7.32 (m, 6.4 H), 5.86-5.77 (m, 1.3 H), 2.97 (s, 1H), 
2.85 (s, 3H), 2.42 (quint, J = 8.0 Hz, 0.64 H), 2.23 (quint, J = 8.0 Hz, 2 H), 1.12 (t, J = 8.0 Hz, 
2 H), 1.08 (t, J = 8.0 Hz, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 145.26, 145.16, 134.68, 
132.86, 129.14, 128.74, 128.60, 128.53, 128.42, 125.58, 125.35, 124.80, 39.32, 38.53, 20.86, 
20.38, 14.07, 13.38 ppm. EI-MS (70 eV), m/z (%): 226 (7) [M
+
], 130 (44), 105 (100), 77 (50). 
IR (NaCl): ν~ = 3032 (w), 2970 (m), 2938 (w), 2876 (w), 1664 (m), 1492 (w), 1364 (vs), 1175 
(vs), 1044 (m), 961 (m), 819 (m), 700 (m) cm
-1
. Anal. Calcd. for C22H14O3S: C 58.38, H 6.24, 
S 14.17; found: C 58.37, H 6.11, S 14.24. 
8.8.4.3 Synthesis of 5.2-5g 
 
Vinyl methanesulfonate (5.2-5g) [CAS No. 63918-53-6] 
This starting material was prepared according to literature procedures.
8
 A solution of n-
butyllithium in hexane (2.5 M in hexane, 15.6 mL, 39 mmol, 1.3 equiv.) was added to a 
mixture of THF (30 mL) and TMEDA (11.9 mL, 78 mmol, 2.6 equiv.) and the resulting 
yellow solution was stirred for 3 h at 35 °C in a 250 mL Schlenk flask. Then the reaction 
mixture was cooled to -78 °C. A solution of mesyl anhydride (5.23 g, 30 mmol) in THF 
(10 mL) was added dropwise with a syringe over a period of 30 min. Then the reaction 
mixture was stirred for 30 min at -78 °C and slowly warmed to room temperature overnight. 
The reaction solution was poured into 80 mL of diethyl ether and 80 mL of ice, saturated 
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NaHCO3 solution was added under vigorous stirring. The aqueous phase was extracted with 
diethyl ether (3 x 50 mL) and the combined organic phase was washed with 2 N HCl solution 
(2 x 50 mL) and brine (2 x 30 mL) and dried over sodium sulfate. After concentration in 
vacuo the crude product was purified by column chromatography on silica gel (30 % diethyl 
ether in pentane), which was monitored by TLC with the indicator of KMnO4 solution. This 
afforded the product as colorless oil (1.9 g, 15.6 mmol, 52 %). 
1
H-NMR (400 MHz, CDCl3): δ = 6.71 (dd, J = 6.0, 13.6 Hz, 1 H), 5.09 (dd, J = 2.5, 13.7 Hz, 
1 H), 4.84 (dd, J = 2.7, 5.9 Hz, 2 H), 3.08 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 
141.44, 102.64, 37.40 ppm. IR (NaCl): ν~ = 3093 (w), 3034 (m), 2943 (m), 1642 (s), 1366 (vs), 
1184 (vs), 1106 (s), 958 (vs), 807 (s), 741 (m), 689 (m) cm
-1
. EI-HRMS m/z calcd. for 
C3H6O3S: 122.0038, m/z found: 122.0039. 
8.8.4.4 Synthesis of 5.2-5h 
 
Methyl 2-((methylsulfonyl)oxy)cyclopent-1-enecarboxylate (5.2-5h) [CAS No. 132079-95-
9 ] 
This starting material was prepared according to the literature.
9
 To a mixture of 2-
acetylcyclohexanone (1.28 mL, 10 mmol) in DME (100 mL) at 0 °C were added triethylamine 
(7.2 mL, 49 mmol, 4.9 equiv.) and then mesyl chloride (2.05 mL, 26 mmol, 2.6 equiv.). The 
reaction mixture was then allowed to warm to room temperature within 12 h, diluted with 
Et2O (100 mL), and washed with water (120 mL). The aqueous layer was back-extracted with 
Et2O (3 x 50 mL), and the organic layers were combined, washed with water (2 x 50 mL) and 
brine (2 x 50 mL), dried over Na2SO4, and filtered through a pad of silica gel. Concentration 
under reduced pressure afforded a brown oil, which was distilled under reduced pressure to 
give a colorless oil (1.51 g, 6.7 mmol, 67 %).  
Caution: β-Mesyloxy enones decompose on standing neat at room temperature for several 
hours, but can be stored in dichloromethane or chloroform in fridge for several days. The 
mesylates were generally used in coupling reactions without further purification immediately 
after formation. 
1
H-NMR (400 MHz, CDCl3): δ = 3.73 (s, 3H), 3.23 (s, 3H), 2.82-2.75 (m, 2H), 2.66-2.59 (m, 
2H), 1.96 (quint, J = 8.0 Hz, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 163.34, 156.53, 
119.67, 51.43, 39.14, 33.65, 29.00, 19.04 ppm. IR (NaCl): ν~ = 3023 (w), 2954 (w), 2860 (w), 
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1713 (vs), 1656 (m), 1438 (m), 1355 (vs), 1160 (vs), 1130 (s), 811 (vs) cm
-1
. Anal. Calcd. for 
C8H12O5S: C 43.63, H 5.49, S 14.56; found: C 43.06, H 5.37, S 14.73. 
8.8.4.5 Synthesis of 5.2-5i 
 
3,3,3-trifluoroprop-1-en-2-yl methanesulfonate (5.2-5i) [CAS No. 25230-01-7] 
This starting material was prepared according literature procedures.
10
 To a solution of 1,1,1-
trifluoroacetone (2.77 mL, 30 mmol) and mesyl chloride (2.37 ml, 30 mmol) in diethyl ether, 
was added dry triethylamine (4.39 mL, 30 mmol) at -10 °C under nitrogen. The reaction 
mixture was stirred under -10 °C for 2 h and then quenched by addition of saturated NaHCO3 
solution (30 mL). The aqueous phase was extracted with diethyl ether and the combined 
organic layers were washed with 1 N HCl solution and brine, and dried over MgSO4. The 
solvent was removed under reduced pressure and the light yellow crude product (93 % purity 
determined by GC) was further purified by Kugelrohr distillation (105 °C under 84 mbar) to 
give a colorless oil (4.2 g, 22.1 mmol, 74 %). 
19
F-NMR (376 MHz, CDCl3): δ = - 72.04 (s, -CF3) ppm. 
1
H-NMR (200 MHz, CDCl3): δ = 
5.77-5.69 (m, 2H), 3.20 (s, 3H) ppm. 
13
C-NMR (51 MHz, CDCl3): δ = 140.83 (q, JC-F = 
38.2 Hz), 118.71 (q, JC-F = 272.7 Hz), 109.26 (q, JC-F = 3.5 Hz), 38.40 ppm. IR (NaCl): ν~ = 
3149 (w), 3034 (m), 2948 (m), 1673 (s), 1378 (vs), 1342 (s), 1191 (vs), 1148 (s), 1125 (s), 
957 (s), 810 (s), 674 (m), 522 (s) cm
-1
. Anal. Calcd. for C4H5F3O3S: C 25.27.63, H 2.65, S 
16.86; found: C 25.40, H 2.84, S 17.25. 
8.8.5 General Procedures for the Decarboxylative Coupling of Mesylates 
Method A: The decarboxylative coupling of carboxylate salts with aryl mesylates under 
microwave conditions 
An oven-dried, nitrogen-flushed 10 mL microwave vessel was charged with the potassium 
carboxylate (0.50 mmol), bis(dibenzylideneacetone)palladium(0) (14.4 mg, 0.025 mmol, 
5.0 mol %), copper(I) oxide (1.81 mg, 0.0125 mmol, 2.5 mol %), 3,4,7,8-tetramethyl-1,10-
phenanthroline (5.91 mg, 0.025 mmol, 5.0 mol %), and aryl mesylate (0.75 mmol, 1.5 equiv.). 
A degassed solution of L15 in NMP (0.06 M, 1 mL, 0.06 mol, 12 mol %) and mesitylene 
(3 mL) was added via syringe. The resulting solution was then stirred for 5 min at 50 ºC 
followed by microwave irradiation at 180 ºC for 30 min at a maximum power of 100 W and 
cooled afterwards with air jet cooling. The maximal pressure noted was 2 bar. The isolated 
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yield was determined by combining two identical 0.5 mmol-scale reactions. The mixture was 
then diluted with aqueous HCl (1 N, 20 mL) and extracted with ethyl acetate (3 x 20 mL). The 
combined organic layers were washed with water and brine, dried over MgSO4, filtered, and 
concentrated in vacuo. The residue was purified by column chromatography (SiO2, ethyl 
acetate/hexane gradient) yielding the corresponding biaryl. 
Method B: The decarboxylative coupling of carboxylate salts with alkenyl mesylates 
under thermal conditions 
An oven-dried, nitrogen-flushed 10 mL microwave vessel was charged with the potassium 
carboxylate (0.50 mmol), palladium acetate (5.73 mg, 0.025 mmol, 5.0 mol %), L8 (28.4 mg, 
0.06 mmol, 5.0 mol %), copper(I) oxide (1.81 mg, 0.0125 mmol, 2.5 mol %), 2,2’-bipyridine 
(3.94 mg, 0.025 mmol, 5.0 mol %), and alkenyl mesylate (0.75 mmol, 1.5 equiv.). A degassed 
mixture of NMP (1 mL) and mesitylene (3 mL) was added via syringe. The resulting solution 
was then stirred at 170 ºC for 1 h. The isolated yield was determined by combining two 
identical 0.5 mmol-scale reactions. After the reaction was complete, the mixture was cooled 
to room temperature, diluted with aqueous HCl (1 N, 20 mL) and extracted with ethyl acetate 
(3 x 20 mL). The combined organic layers were washed with water and brine, dried over 
MgSO4, filtered, and concentrated in vacuo. The residue was purified by column 
chromatography (SiO2, ethyl acetate/hexane gradient) yielding the corresponding aryl olefin. 
8.8.5 Synthesis of Biaryls from Aryl Mesylates 
 
2-(2-Nitrophenyl)naphthalene (5.2-3aa) [CAS-No. 94064-83-2] 
Compound 5.2-3aa was prepared following method A from potassium 2-nitrobenzoate 
(103 mg, 0.5 mmol) and 2-naphthyl mesylate (167 mg, 0.75 mmol) in a mixture of NMP 
(1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-scale reactions, 
compound 5.2-3aa was obtained as a yellow solid (214 mg, 86 %). M.p. 104-105 
o
C.
 
1
H-NMR (400 MHz, CDCl3): δ = 8.00-7.86 (m, 4H), 7.84 (s, 1H), 7.66 (t, J = 8.0 Hz, 1H), 
7.60-7.50 (m, 4H), 7.43 (d, J = 8.0 Hz, 1H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 149.29, 
136.39, 134.93, 133.23, 132.80, 132.37, 132.26, 128.30, 128.21, 128.15, 127.74, 126.94, 
126.53, 125.73, 124.19 ppm. EI-MS (70 eV), m/z (%): 249 (80) [M
+
], 248 (86), 232 (100), 
204 (83), 193 (38), 165 (35). IR (KBr): ν~ = 3047 (w), 1608 (w), 1596 (w), 1518 (vs), 1351 
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(vs), 862 (m), 818 (m), 758 (m), 707 (m) cm
-1
. Anal. Calcd. for C16H11NO2: C 77.10, H 4.45, 
N 5.62; found: C 77.16, H 4.53, N 5.63. 
 
2-(5-Methyl-2-nitrophenyl)naphthalene (5.2-3ba) [CAS-No. 1218992-99-4] 
Compound 5.2-3ba was prepared following method A from potassium 5-methyl-2-
nitrobenzoate (110 mg, 0.5 mmol) and 2-naphthyl mesylate (167 mg, 0.75 mmol) in a mixture 
of NMP (1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-scale 
reactions, compound 5.2-3ba was obtained as a white solid (232 mg, 88 %). M.p. 111-112 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.92-7.84 (m, 4H), 7.82 (s, 1H), 7.58-7.50 (m, 2H), 7.41 (d, 
J = 8.0 Hz, 1H), 7.34 (s, 1H), 7.31 (d, J = 8.0 Hz, 1H), 2.49 (s, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): δ = 146.90, 143.53, 136.61, 135.41, 133.24, 132.90, 132.73, 128.71, 128.13, 128.10, 
127.73, 126.77, 126.43, 126.42, 125.86, 124.50, 21.38 ppm. EI-MS (70 eV), m/z (%):264 (16), 
263 (89) [M
+
], 262 (65), 246 (100), 234 (40), 218 (68), 203 (33), 133 (37). IR (KBr): ν~ = 3057 
(w), 2921 (w), 2850 (w), 1607 (w), 1599 (w), 1582 (w), 1512 (vs), 1347 (vs), 831 (m), 817 
(m), 758 (m), 751 (m) cm
-1
. Anal. Calcd. for C17H13NO2: C 77.55, H 4.98, N 5.32; found: C 
77.47, H 5.09, N 5.22. 
 
2-(5-Methoxy-2-nitrophenyl)naphthalene (5.2-3ca) [CAS-No.1218993-02-2] 
Compound 5.2-3ca was prepared following method A from potassium 5-methoxy-2-
nitrobenzoate (118 mg, 0.5 mmol) and 2-naphthyl mesylate (167 mg, 0.75 mmol) in a mixture 
of NMP (1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-scale 
reactions, compound 5.2-3ca was obtained as a yellow solid (236 mg, 85 %). M. p. 63-64 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 8.08-8.04 (m, 1H), 7.93-7.85 (m, 3H), 7.81 (s, 1H), 7.57-
7.51 (m, 2H), 7.40 (dd, J = 4.0, 12.0 Hz, 1H), 7.00-6.95 (m, 2H), 3.92 (s, 1H) ppm; 
13
C-NMR 
(101 MHz, CDCl3): δ = 162.51, 141.97, 139.53, 135.82, 133.19, 132.76, 128.10, 128.04, 
127.76, 127.13, 126.59, 126.47, 125.83, 117.28, 113.14, 55.93 ppm; EI-MS (70 eV), m/z (%): 
280 (14), 279 (76) [M
+
], 278 (33), 262 (100), 234 (32), 219 (33), 208 (41), 202 (13), 190 (31), 
152 (14), 106 (15); IR (KBr): ν~ = 3056 (w), 3016 (w), 2920 (w), 2850 (w), 1609 (m), 1599 
(m), 1571 (m), 1509 (vs), 1337 (s), 1293 (s), 1232 (m), 1097 (m), 1020 (m), 862 (m), 749 (s) 
cm
-1
; EI-HRMS m/z calcd. for C17H13NO3: 279,0895, m/z found: 279.0901. 
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2-(3-Methyl-2-nitrophenyl)naphthalene (5.2-3da) [CAS-No. 1218993-01-1] 
Compound 5.2-3da was prepared following method A from potassium 3-methyl-2-
nitrobenzoate (110 mg, 0.5 mmol) and 2-naphthyl mesylate (167 mg, 0.75 mmol) in a mixture 
of NMP (1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-scale 
reactions, compound 5.2-3da was obtained as a white solid (222 mg, 84 %). M. p. 89-90 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.92-7.84 (m, 4H), 7.56-7.52 (m, 2H), 7.47 (t, J = 8.0 Hz, 
2H), 7.39 (s, 1H), 7.35 (t, J = 8.0 Hz, 1H), 2.43 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ 
= 150.99, 134.31, 134.10, 133.14, 132.90, 130.28, 130.02, 129.80, 128.92, 128.51, 128.26, 
127.69, 127. 32, 126. 59, 126.54, 125.66, 17.50 ppm. EI-MS (70 eV), m/z (%): 264 (14), 263 
(78) [M
+
], 247 (100), 234 (36), 219 (47), 203 (28). IR (KBr): ν~ = 3058 (w), 2929 (w), 1578 
(w), 1596 (w), 1520 (vs), 1479 (m), 1458 (m), 1370 (s), 784 (s), 751 (s), 708 (m) cm
-1
. Anal. 
Calcd. for C17H13NO2: C 77.55, H 4.98, N 5.32; found: C 77.57, H 5.00, N 5.30. 
 
2-(5-Fluoro-2-nitrophenyl)naphthalene (5.2-3ea) 
Compound 5.2-3fa was prepared following method A from potassium 5-fluoro-2-
nitrobenzoate (230 mg, 1.0 mmol) and 2-naphthyl mesylate (115 mg, 0.5 mmol) in a mixture 
of NMP (1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-scale 
reactions, compound 5.2-3ea was obtained as a bright yellow solid (214 mg, 80 %). M. p. 85-
86 
o
C. 
19
F-NMR (376 MHz, CDCl3): δ = -104.50 (m, 1F) ppm. 
1
H-NMR (400 MHz, CDCl3): δ = 
7.87 (dd, J = 4.0, 8.0 Hz, 1H), 7.79-7.75 (m, 3H), 7.69 (s, 1H), 7.44-7.40 (m, 2H), 7.26 (d, J = 
8.0 Hz, 1H), 7.13-7.02 (m, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 163.92 (d, JC-F = 
256.6 Hz), 145.23 (d, JC-F = 3.0 Hz), 139,66 (d, JC-F = 9.1 Hz), 134.04, 133.03 (d, JC-F = 
19.1 Hz), 128.44, 128.17, 127.75, 127.08, 126.98, 126.88, 126.80, 126.68, 125.28, 119.11 (d, 
JC-F = 24.1 Hz), 115.11 (d, JC-F = 23.1 Hz) ppm. EI-MS (70 eV), m/z (%): 268 (15), 267 (100) 
[M
+
], 266 (55), 238 (46), 223 (73), 221 (48), 211 (22), 210 (20). IR (KBr): ν~ = 3055 (w), 1619 
(m), 1598 (m), 1580 (m), 1521 (s), 1340 (s), 1284 (m), 748 (m) cm
-1
. Anal. Calcd. for 
C16H10FNO2: C 71.91, H 3.77, N 5.24; found: C 71.98, H 3.96, N 5.19. 
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2-(Perfluorophenyl)naphthalene (5.2-3fa) [CAS-No. 52331-48-3] 
Compound 5.2-3fa was prepared following method A from potassium pentafluorobenzoate 
(250 mg, 1.0 mmol) and 2-naphthyl mesylate (115 mg, 0.5 mmol) in a mixture of NMP (1 mL) 
and mesitylene (3 mL). GC yield: 4%. EI-MS (70 eV), m/z (%): 295 (17), 294 (100) [M
+
], 
275 (23), 255 (3), 244 (5), 147 (5), 127 (1). 
 
2-(2,3,5,6-Tetrafluorophenoxy)naphthalene (5.2-3fa′) 
Compound 5.2-3fa was prepared following method A from potassium 5-fluoro-2-
nitrobenzoate (250 mg, 1.0 mmol) and 2-naphthyl mesylate (115 mg, 0.5 mmol) in a mixture 
of NMP (1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-scale 
reactions, compound 5.2-3ea was obtained as a white solid (126 mg, 43 %). M. p. 93-94 °C. 
19
F-NMR (376 MHz, CDCl3): δ = -138.49 (m, 2F), -153.85 (m, 2F) ppm. 
1
H-NMR (400 MHz, 
CDCl3): δ = 7.87 (t, J = 8.0 Hz, 2H), 7.73 (t, J = 8.0 Hz, 1H), 7.53-7.42 (m, 2H), 7.35 (d, J = 
8.0 Hz, 1H), 7.21 (s, 1H), 7.08-6.98 (m, 1H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 154.99, 
146.51 (ddt, JC-F = 4.0, 12.1, 249.5 Hz), 141.61 (dm, JC-F = 251.5 Hz), 134.24 (tt, JC-F = 4.0, 
13.1 Hz), 133.91, 130.32, 130.18, 127.79, 127.11, 126.91, 125.02, 117.16, 110.18, 102.05 (t, 
JC-F = 22.2 Hz) ppm. EI-MS (70 eV), m/z (%): 293 (17), 292 (100) [M
+
], 272 (11), 265 (24), 
149 (2), 127 (25), 115 (14). IR (KBr): ν~ = 3093 (w), 1644 (w), 1628 (m), 1599 (m), 1512 (vs), 
1499 (m), 1485 (vs), 1460 (m), 1245 (m), 1208 (m), 1179 (m), 1162 (s), 1063 (m), 1053 (m), 
940 (vs), 844 (s), 817 (m) cm
-1
. Anal. Calcd. for C16H8OF4: C 65.76, H 2.76; found: C 65.87, 
H 3.06. 
EXPERIMENTAL SECTION 
278 
 
2-(2-Methyl-6-nitrophenyl)naphthalene (5.2-3ga) 
Compound 5.2-3ga was prepared following method A from potassium 6-methyl-2-
nitrobenzoate (220 mg, 1.0 mmol) and 2-naphthyl mesylate (115 mg, 0.5 mmol) in a mixture 
of NMP (1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-scale 
reactions, compound 5.2-3ga was obtained as light yellow oil (132 mg, 50 %). 
1
H-NMR (400 MHz, CDCl3): δ = 7.96 (d, J = 8.0 Hz, 1H), 7.94-7.92 (m, 1H), 7.87-7.84 (m, 
1H), 7.75 (d, J = 8.0 Hz, 1H), 7.68 (s, 1H), 7.60-7.52 (m, 3H), 7.46-7.38 (m, 2H), 2.19 (s, 3H) 
ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 150.44, 139.35, 135.22, 133.76, 133.57, 133.15, 
132.64, 128.15, 127.97, 127.85, 127.74, 127.04, 126.60, 126.33, 126.31, 121.04, 20.62 ppm. 
EI-MS (70 eV), m/z (%): 264 (16), 263 (100) [M
+
], 262 (66), 246 (43), 234 (29), 218 (54), 
203 (22). IR (NaCl): ν~ = 3055 (s), 2977 (w), 2927 (w), 2868 (w), 1599 (m), 1519 (vs), 1455 
(m), 1359 (vs), 1285 (m), 821 (m), 801 (m), 748 (m), 712 (m) cm
-1
. Anal. Calcd. for 
C17H13NO2: C 77.55, H 4.98, N 5.32; found: C 77.21, H 5.03, N 5.31. 
 
2-(2-Methoxyphenyl)naphthalene (5.2-3ha) [CAS-No. 93321-12-1 
Compound 5.2-3ha was prepared following method A from potassium potassium 2-
methoxybenzoate (95 mg, 0.5 mmol) and 2-naphthyl mesylate (167 mg, 0.75 mmol) in a 
mixture of NMP (1 mL) and mesitylene (3 mL). GC yield: 17 %. EI-MS (70 eV), m/z (%): 
235 (19), 234 (100) [M
+
], 220 (48), 219 (17), 203 (3), 192 (25), 128 (6). 
 
3-Methyl-2-(2-naphthyl)thiophene (5.2-3ia) 
Compound 5.2-3ia was prepared following method A from potassium potassium 3-
methylthiophene-2-carboxylate (91 mg, 0.5 mmol) and 2-naphthyl mesylate (167 mg, 
0.75 mmol) in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining two 
identical 0.5 mmol-scale reactions, compound 5.2-3ia was obtained as a colorless oil (100 mg, 
45 %). 
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1
H-NMR (400 MHz, CDCl3): δ = 8.03 (s, 1H), 8.00-7.90 (m, 3H), 7.72 (d, J = 8.0 Hz, 1H), 
7.62-7.54 (m, 2H), 7.34 d, J = 8.0 Hz, 1H (d, J = 8.0 Hz, 1H), 7.05 (d, J = 8.0 Hz, 1H), 2.50 (s, 
3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 137.81, 133.44, 133.30, 132.29, 132.19, 131.15, 
128.01, 127.96, 127.63, 127.20, 126.33, 126.00, 123.64, 15.00 ppm. EI-MS (70 eV), m/z (%): 
225 (20), 224 (100) [M
+
], 223 (61), 191 (11), 127 (4). IR (NaCl): ν~ = 3056 (m), 2922 (m), 
2863 (w), 1599 (s), 1500 (s), 1451 (m), 891 (w), 856 (s), 815 (vs), 746 (s), 710 (s) cm-
1
. Anal. 
Calcd. for C15H12S: C 80.31, H 5.39, S 14.29; found: C 80.34, H 5.63, S 13.65. EI-HRMS m/z 
calcd. for C15H12S: 224.0660, m/z found: 224.0666. 
 
3-Methyl-2-(2-naphthyl)benzothiophene (5.2-3ja) 
Compound 5.2-3ja was prepared following method A from potassium potassium 3-
methylbenzothiophene-2-carboxylate (115 mg, 0.5 mmol) and 2-naphthyl mesylate (167 mg, 
0.75 mmol) in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining two 
identical 0.5 mmol-scale reactions, compound 5.2-3ja was obtained as a white solid (200 mg, 
73 %) M.p. 96-97 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 8.05 (s, 1H), 7.97-7.88 (m, 4H), 7.80 (d, J = 8.0 Hz, 1H), 
7.73 (dd, J = 4.0, 8.0 Hz, 1H), 7.60-7.53 (m, 2H), 7.47 (t, J = 8.0 Hz, 1H), 7.41 (t, J = 8.0 Hz, 
1H), 2.57 (s, 1H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 141.27, 139.04, 138.04, 133.24, 
132.64, 132.17, 128.76, 128.13, 128.11, 127.76, 127.71, 127.52, 126.49, 126.38, 124.32, 
124.17, 122.13, 12.75 ppm. EI-MS (70 eV), m/z (%): 275 (22), 274 (100) [M
+
], 259 (6) 240 
(6), 147 (7), 127 (3). IR (KBr): ν~ = 3049 (w), 2922 (w), 2852 (w), 1598 (m), 1501 (m), 1459 
(w), 1434 (m), 1218 (m), 823 (vs), 744(vs), 725 (vs) cm
-1
. Anal. Calcd. for C19H14S: C 83.17, 
H 5.14, S 11.69; found: C 82.87, H 5.24, S 11.39. 
 
3-Methyl-2-(2-naphthyl)benzofuran (5.2-3ka) 
Compound 5.2-3ka was prepared following method A from potassium 3-methylbenzofuran-2-
carboxylate (107 mg, 0.5 mmol) and 2-naphthyl mesylate (167 mg, 0.75 mmol) in a mixture 
of NMP (1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-scale 
reactions, compound 5.2-3ka was obtained as a white solid (130 mg, 50 %). M.p. 92-93 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 8.30 (s, 1H), 8.02-7.86 (m, 4H), 7.63-7.51 (m, 4H), 7.39-
7.28 (m, 2H), 2.60 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 153.89, 150.71, 133.32, 
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132.72, 131.23, 128.82, 128.32, 128.24, 127.71, 126.47, 126.36, 125.84, 124.41, 124.32, 
122.39, 119.30, 111.74, 110.93, 9.64 ppm. EI-MS (70 eV), m/z (%): 259 (22),258 (100) [M
+
], 
229 (6), 131 (5), 127 (3). IR (KBr): ν~ = 3053 (w), 2919 (w), 2856 (w), 1594 (m), 1500 (m), 
1340 (m), 1101 (s), 860 (s), 822 (s), 748 (m), 736 (vs) cm
-1
. Anal. Calcd. for C19H14O: C 
88.34, H 5.46; found: C 88.26, H 5.69. 
 
1-Methyl-2-(2-naphthyl)-1H-indole (5.2-3la) [CAS-No. 244141-64-8] 
Compound 5.2-3la was prepared following method A from potassium 1-methyl-1H-indole-2-
carboxylate (107 mg, 0.5 mmol) and 2-naphthyl mesylate (167 mg, 0.75 mmol) in a mixture 
of NMP (1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-scale 
reactions, compound 5.2-3la was obtained as a white solid (160 mg, 62 %). M.p. 152-153 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 8.02 (s, 1H), 7.99-7.92 (m, 3H), 7.74-7.66 (m, 2H), 7.61-
7.54 (m, 2H), 7.44 (d, J = 8.0 Hz, 1H), 7.33 (t, J = 8.0 Hz, 1H), 7.22 (t, J = 8.0 Hz, 1H), 6.72 
(s, 1H), 3.85 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 141.52, 138.49, 133.21, 132.69, 
130.20, 128.26, 128.10, 128.07, 128.01, 127.74, 127.17, 126.51, 126.36, 121.75, 120.49, 
119.90, 109.62, 102.10, 31.32 ppm. EI-MS (70 eV), m/z (%): 258 (44), 257 (100) [M
+
], 255 
(21), 242 (12), 128 (16), 127 (10). IR (KBr): ν~ = 3551 (w), 2940 (w), 1600 (m), 1503 (w), 
1463 (m), 1341 (m), 865 (m), 823(m), 791 (s), 751 (s), 733 (s) cm
-1
. Anal. Calcd. for C19H15N: 
C 88.68, H 5.88, N 5.44; found: C 88.28, H 6.19, N 5.33. 
 
1-(2-Nitrophenyl)naphthalene (5.2-3ab) [CAS-No. 5415-59-8] 
Compound 5.2-3ab was prepared following method A from potassium 2-nitrobenzoate 
(144 mg, 0.7 mmol) and 1-naphthyl mesylate (233 mg, 1.05 mmol) in a mixture of NMP 
(1 mL) and mesitylene (3 mL). After combining two identical 0.7 mmol-scale reactions, 
compound 5.2-3ab was obtained as a yellow solid (90 mg, 27 %). M.p. 92-93 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 8.11 (dd, J = 4.0, 12.0 Hz, 1H), 7.95 (d, J = 20.0 Hz, 2H), 
7.75-7.36 (m, 8H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 149.71, 135.45, 135.15, 133.38, 
133.0, 132.47, 131.40, 128.58, 128.49, 128.39, 126.50, 125.99, 125.98, 125.15, 124.77, 
124.13 ppm. EI-MS (70 eV), m/z (%): 250 (25), 249 (100) [M
+
], 232 (89), 219 (14), 204 (76), 
203 (53). IR (KBr): ν~ = 3053 (w), 2916 (w), 2846 (w), 1611 (w), 1591 (w), 1575 (m), 1520 
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(vs), 1337 (vs), 778 (s), 750 (m) cm
-1
. Anal. Calcd. for C16H11NO2: C 77.10, H 4.45, N 5.62; 
found: C 76.93, H 4.65, N 5.51. 
 
9-(2-Nitrophenyl)phenanthrene (5.2-3ac) [CAS-No. 911217-05-5] 
Compound 5.2-3ac was prepared following method A from potassium 2-nitrobenzoate 
(103 mg, 0.5 mmol) and 9-phenanthyl mesylate (211 mg, 0.75 mmol) in a mixture of NMP 
(1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-scale reactions, 
compound 5.2-3ac was obtained as a yellow solid (78 mg, 26 %). M.p. 138-139 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 8.79 (d, J = 8.0 Hz, 1H), 8.75 (d, J = 8.0 Hz, 1H), 8.15 (d, J 
= 8.0 Hz, 1H), 7.89 (d, J = 8.0 Hz, 1H), 7.75-7.60 (m, 6H), 7.57-7.49 (m, 3H) ppm. 
13
C-NMR 
(101 MHz, CDCl3): δ = 149.87, 135.35, 134.49, 133.11, 132.76, 131.15, 130.67, 130.32, 
130.27, 128.74, 128.72, 127.06, 126.92, 126.87, 126.74, 125.71, 124.29, 123.06, 122.61 ppm; 
EI-MS (70 eV), m/z (%): 299 (14) [M
+
], 282 (19), 267 (100), 240 (14), 207 (75), 133 (20). IR 
(KBr): ν~ = 3063 (w), 2916 (w), 2851 (w), 1607 (w), 1515 (vs), 1347 (vs), 745 (m), 726 (m), 
714 (m) cm
-1
. EI-HRMS m/z calcd. for C20H13NO2: 299.0946, m/z found: 299.0955. 
 
4'-Methyl-2-nitro-1,1'-biphenyl (5.2-3ad) [CAS-No. 70680-21-6] 
Compound 5.2-3ad was prepared following method A from potassium 2-nitrobenzoate 
(103 mg, 0.5 mmol) and p-tolyl mesylate (186 mg, 1.0 mmol) in a mixture of NMP (1 mL) 
and mesitylene (3 mL). After combining two identical 0.5 mmol-scale reactions, compound 
5.2-3ad was obtained as a yellow oil (60 mg, 28 %). 
1
H-NMR (400 MHz, CDCl3): δ = 7.86 (d, J = 8.0 Hz, 1H), 7.63 (t, J = 8.0 Hz, 1H), 7.52-7.45 
(m, 2H), 7.31-7.24 (m, 4H), 2.44 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 149.34, 
138.09, 136.18, 134.33, 132.12, 131.86, 129.38, 127.84, 127.69, 123.92, 21.16 ppm. EI-MS 
(70 eV), m/z (%): 212 (21), 198 (14), 196 (100), 185 (86), 184 (44), 170 (46), 168 (97), 156 
(60), 129 (47), 115 (54), 77 (21). IR (NaCl): ν~ = 3062 (w), 3028 (m), 2923 (m), 2886 (m), 
1614 (m), 1525 (vs), 1476 (m), 1356 (s), 853 (m), 819 (m), 782 (m), 750 (m) cm
-1
. Anal. 
Calcd. for C13H11NO2: C 72.23, H 5.20, N 6.57; found: C 73.06, H 5.39, N 6.54. 
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3'-Methoxy-2-nitro-1,1'-biphenyl (5.2-3ae) [CAS-No. 92017-95-3] 
Compound 5.2-3ae was prepared following method A from potassium 2-nitrobenzoate 
(103 mg, 0.5 mmol) and 3-methoxyphenyl mesylate (202 mg, 1.0 mmol) in a mixture of NMP 
(1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-scale reactions, 
compound 5.2-3ae was obtained as a yellow solid (80 mg, 35 %). M.p. 69-70 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.86 (dd, J = 4.0, 8.0 Hz, 1H), 7.62 (dt, dd, J = 4.0, 8.0 Hz, 
1H), 7.52-7.44 (m, 2H), 7.35 (t, J = 4.0, 8.0 Hz, 1H), 6.98-6.87 (m, 3H), 3.83 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 159.62, 149.26, 138.61, 136.02, 132.15, 131.75, 129.66, 
128.16, 123.88, 120.19, 113.64, 113.57, 55.19 ppm. EI-MS (70 eV), m/z (%): 229 (55) [M
+
], 
212 (12), 201 (100), 198 (15), 186 (29), 170 (49), 168 (27), 158 (58), 152 (19). IR (KBr): ν~ = 
3008 (w), 2961 (w), 2937 (w), 2833 (w), 1597 (s), 1571 (m), 1522 (vs), 1426 (s), 1351 (s), 
1321 (s), 1322 (s), 1221 (vs), 788 (s), 749 (s), 694 (m) cm
-1
. Anal. Calcd. for C13H11NO3: C 
68.11, H 4.84, N 6.11; found: C 68.04, H 4.94, N 5.93. 
8.8.6 Synthesis of Aryl Olefins from Alkenyl Mesylates 
 
3-(2-Nitrophenyl)-1,2-dihydronaphthalene (5.2-6aa) 
Compound 5.2-6aa was prepared following method B from potassium 2-nitrobenzoate 
(103 mg, 0.5 mmol) and 3,4-dihydronaphthalen-2-yl methanesulfonate (174 mg, 0.75 mmol) 
in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-
scale reactions, compound 5.2-6aa was obtained as a yellow solid (108 mg, 86 %). M.p. 92-
93 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.98-7.93 (m, 1H), 7.61 (t, J = 8.0 Hz, 1H), 7.45 (t, J = 
8.0 Hz, 2H), 7.25-7.16 (m, 3H), 7.15-7.09 (m, 1H), 3.01 (t, J = 8.0 Hz, 2H), 2.56 (dt, J = 4.0, 
8.0 Hz, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 148.24, 138.08, 137.59, 134.86, 133.84, 
132.93, 130.79, 128.04, 127.56, 127.38, 126.78, 126.61, 126.57, 124.43, 28.22, 27.91 ppm. 
EI-MS (70 eV), m/z (%): 251 (1) [M
+
], 250 (4), 235 (19), 234 (100), 217 (43), 216 (85), 204 
(32), 203 (29), 179 (11), 178 (11), 132 (16), 128 (14), 91 (26). IR (KBr): ν~ = 3012 (w), 2931 
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(w), 2829 (w), 1609 (w), 1568 (w), 1515 (vs), 1484 (m), 1337 (vs), 864 (m), 763 (s), 744 (m) 
cm
-1
. Anal. Calcd. for C16H13NO2: C 76.48, H 5.21, N 5.57; found: C 76.39, H 5.39, N 5.51. 
 
3-(5-Methyl-2-nitrophenyl)-1,2-dihydronaphthalene (5.2-6ba) 
Compound 5.2-6ba was prepared following method B from potassium 5-methyl-2-
nitrobenzoate (132 mg, 0.6 mmol) and 3,4-dihydronaphthalen-2-yl methanesulfonate (208 mg, 
0.9 mmol) in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining two identical 
0.6 mmol-scale reactions, compound 5.2-6ba was obtained as a yellow solid (260 mg, 82 %). 
M. p. 151-152 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.91 (d, J = 8.0 Hz, 1H), 7.26-7.09 (m, 6H), 6.50 (s, 1H), 
3.01 (t, J = 8.0 Hz, 2H), 2.53 (t, J = 8.0 Hz, 2H), 2.46 (s, 3H) ppm. 
13
C-NMR (101 MHz, 
CDCl3): δ = 145.91, 144.24, 138.32, 138.28, 134.90, 133.95, 131.41, 128.62, 127.44, 127.38, 
126.53, 126.27, 124.74, 119.93, 28.28, 28.06, 21.38 ppm. EI-MS (70 eV), m/z (%): 265 (14) 
[M
+
], 248 (99), 230 (100), 202 (52), 146 (23). IR (KBr): ν~ = 3066 (w), 3025 (w), 2945 (w), 
2839 (w), 1604 (m), 1579 (m), 1509 (vs), 1482 (m), 1340 (vs), 885 (m), 837 (s), 751 (s) cm
-1
. 
Anal. Calcd. for C17H15NO2: C 76.96, H 5.70, N 5.28; found: C 76.73, H 5.71, N 5.25. 
 
3-(5-Methoxy-2-nitrophenyl)-1,2-dihydronaphthalene (5.2-6ca) 
Compound 5.2-6ca was prepared following method B from potassium 5-methoxy-2-
nitrobenzoate (141 mg, 0.6 mmol) and 3,4-dihydronaphthalen-2-yl methanesulfonate (208 mg, 
0.9 mmol) in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining two identical 
0.6 mmol-scale reactions, compound 5.2-6ca was obtained as a yellow oil (284 mg, 84 %). 
1
H-NMR (400 MHz, CDCl3): δ = 8.08 (d, J = 8.0 Hz, 1H), 7.23 (m, 3H), 7.15-7.10 (m, 1H), 
6.91 (dd, J = 4.0, 8.0 Hz, 1H), 6.87 (d, J = 4.0 Hz, 1H), 6.50 (s, 1H), 3.92 (s, 3H), 3.04 (t, J = 
8.0 Hz, 2H), 2.54 (t, J = 8.0 Hz, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 163.10, 141.12, 
140.94, 138.87, 134.87, 133.82, 127.42, 127.35, 127.32, 126.48, 126.45, 125.88, 115.74, 
112.88, 55.86, 28.23, 28.09 ppm. EI-MS (70 eV), m/z (%): 281 (15) [M
+
], 264 (37), 249 (100), 
232 (42), 204 (50). IR (NaCl): ν~ = 3015 (w), 2918 (s), 2849 (w), 1607 (m), 1573 (s), 1508 (vs), 
1480 (m), 1330 (s), 1295 (s), 1226 (s), 1086 (s), 1027 (m), 749 (vs) cm
-1
. Anal. Calcd. for 
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C17H15NO3: C 72.58, H 5.37, N 4.98; found: C 72.01, H 5.41, N 4.98. EI-HRMS m/z calcd. 
for C17H15NO3: 281.1052, m/z found: 281.1054. 
 
3-(4,5-Dimethoxy-2-nitrophenyl)-1,2-dihydronaphthalene (5.2-6ma) 
Compound 5.2-6ma was prepared following method B from potassium 4,5-dimethoxy-2-
nitrobenzoate (159 mg, 0.6 mmol) and 3,4-dihydronaphthalen-2-yl methanesulfonate (208 mg, 
0.9 mmol) in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining two identical 
0.6 mmol-scale reactions, compound 5.2-6ma was obtained as a yellow solid (310 mg, 83 %). 
M.p. 123-124 
o
C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.65 (s, 1H), 7.21-7.09 (m, 4H), 6.79 (s, 1H), 6.47 (s, 1H), 
3.99 (s, 3H), 3.98 (s, 3H), 3.03, 2.52 (t, J = 8.0 Hz, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ 
= 152.92, 147.96, 140.09, 139.16, 134.89, 133.94, 133.34, 127.41, 127.38, 126.50, 126.38, 
125.77, 112.47, 107.90, 56.44, 56.36, 28.41, 28.37 ppm. EI-MS (70 eV), m/z (%): 311 (5) 
[M
+
], 294 (17), 279 (100), 262 (33), 234 (31), 219 (20), 190 (16). IR (KBr): ν~ = 2927 (w), 
2827 (w), 1614 (w), 1572 (m), 1515 (s), 1498 (s), 1316 (s), 1283 (s), 1263 (s), 1219 (vs), 1081 
(s), 1019 (m), 855 (m), 788 (m), 750 (m) cm
-1
. Anal. Calcd. for C18H17NO4: C 69.44, H 5.50, 
N 4.50; found: C 69.64, H 5.79, N 4.51. 
 
3-(3-Methyl-2-nitrophenyl)-1,2-dihydronaphthalene (5.2-6da) 
Compound 5.2-6da was prepared following method B from potassium 3-methyl-2-
nitrobenzoate (136 mg, 0.6 mmol) and 3,4-dihydronaphthalen-2-yl methanesulfonate (208 mg, 
0.9 mmol) in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining two identical 
0.6 mmol-scale reactions, compound 5.2-6da was obtained as a yellow solid (272 mg, 85 %). 
M. p. 100-101 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.29 (t, J = 8.0 Hz, 1H), 7.19-7.04 (m, 5H), 7.03-6.97 (m, 
1H), 6.46 (s, 1H), 2.84 (t, J = 8.0 Hz, 2H), 2.50 (t, J = 8.0 Hz, 2H), 2.29 (s, 3H) ppm. 
13
C-
NMR (101 MHz, CDCl3): δ = 149.98, 135.65, 135.43, 134.72, 133.66, 130.05, 129.97, 129.85, 
127.74, 127.64, 127.30, 126.85, 126.80, 126.60, 28.02, 27.56, 17.60 ppm. EI-MS (70 eV), m/z 
(%): 265 (35) [M
+
], 248 (69), 230 (100), 220 (58), 202 (67), 146 (53). IR (KBr): ν~ = 2918 (m), 
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2850 (m), 1606 (w), 1520 (vs), 1476 (m), 1372 (s), 781 (s), 757 (vs) cm
-1
. Anal. Calcd. for 
C17H15NO2: C 76.96, H 5.70, N 5.28; found: C 76.44, H 6.01, N 4.98. 
 
3-(5-Fluoro-2-nitrophenyl)-1,2-dihydronaphthalene (5.2-6ea) 
Compound 5.2-6ea was prepared following method B from potassium 5-fluoro-2-
nitrobenzoate (159 mg, 0.6 mmol) and 3,4-dihydronaphthalen-2-yl methanesulfonate (208 mg, 
0.9 mmol) in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining two identical 
0.6 mmol-scale reactions, compound 5.2-6ea was obtained as a yellow solid (258 mg, 80 %). 
M. p. 78-79 
o
C. 
19
F-NMR (376 MHz, CDCl3): δ = - 104.01 (m, 1F) ppm. 
1
H-NMR (400 MHz, CDCl3): δ = 
8.06-8.00 (m, 1H), 7.25-7.09 (m, 6H), 6.54 (s, 1H), 3.01 (t, J = 8.0 Hz, 2H), 2.54 (t, J = 8.0 
Hz, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 164.44 (d, JC-F = 256.6 Hz), 144.29, 141.37 
(d, JC-F = 9.1 Hz), 136.77, 134.87, 133.47, 127.86, 127.44, 127.33 (d, JC-F = 10.1 Hz), 127.30, 
126.79, 126.64, 117.67 (d, JC-F = 24.1 Hz), 114.92 (d, JC-F = 22.1 Hz), 28.11, 27.73 ppm. EI-
MS (70 eV), m/z (%): 269 (14) [M
+
], 252 (71), 235 (97), 234 (100), 220 (47), 91 (18). IR 
(KBr): ν~ = 3073 (w), 3018 (w), 2966 (w), 2887 (w), 2834 (w), 1615 (w), 1577 (m), 1519 (vs), 
1473 (m), 1350 (s), 881 (m), 763 (m), 751 (s) cm
-1
. Anal. Calcd. for C16H12FNO2: C 71.37, H 
4.49, N 5.20; found: C 71.30, H 4.66, N 5.16. 
 
3-(Perfluorophenyl)-1,2-dihydronaphthalene (5.2-6fa) 
Compound 5.2-6fa was prepared following method B from potassium 2,3,4,5,6-
pentafluorobenzoate (175 mg, 0.7 mmol) and 3,4-dihydronaphthalen-2-yl methanesulfonate 
(243 mg, 1.05 mmol) in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining 
two identical 0.7 mmol-scale reactions, compound 5.2-6fa was obtained as a white solid (92 
mg, 22 %). M. p. 119-120 
o
C. 
19
F-NMR (376 MHz, CDCl3): δ = -141.18 (dd, JF = 7.5, 15.1 Hz, 2F), -156.85 (t, JF = 15.1 Hz, 
1F), -162.57 (dt, JF = 7.5, 15.1 Hz, 2F) ppm. 
1
H-NMR (200 MHz, CDCl3): δ = 7.27-7.10 (m, 
4H), 6.72 (s, 1H), 2.99 (t, J = 8.0 Hz, 2H), 2.64 (t, J = 8.0 Hz, 2H) ppm. 
13
C-NMR (50 MHz, 
CDCl3): δ = 144.24 (dm, JC-F = 251.6 Hz), 139.98 (dm, JC-F = 253.1 Hz), 137.77 (dm, JC-F = 
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252.6 Hz), 135.01, 133.11, 132.24 (dt, JC-F = 1.0, 2.5 Hz), 128.28, 127.50, 127.03, 126.75, 
125.29 (m), 116.83 (dt, JC-F = 4.0, 17.6 Hz), 27.88, 27.53 (t, JC-F = 2.5 Hz) ppm. EI-MS (70 
eV), m/z (%): 296 (100) [M
+
], 274 (18), 115 (82). IR (KBr): ν~ = 3021 (w), 2954 (w), 2835 (w), 
1650 (w), 1516 (m), 1483 (vs), 1456 (m), 981 (vs), 751 (m) cm
-1
. Anal. Calcd. for C16H8F5: C 
64.87, H 3.06; found: C 65.09, H 3.27. 
 
3-(2-Methyl-6-nitrophenyl)-1,2-dihydronaphthalene (5.2-6ga) 
Compound 5.2-6ga was prepared following method B from potassium 6-methyl-2-
nitrobenzoate (110 mg, 0.5 mmol) and 3,4-dihydronaphthalen-2-yl methanesulfonate (168 mg, 
0.75 mmol) in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining two 
identical 0.5 mmol-scale reactions, compound 5.2-6ga was obtained as a yellow oil (111 mg, 
42 %). 
1
H-NMR (400 MHz, CDCl3): δ = 7.73 (d, J = 8.0 Hz, 1H), 7.49 (d, J = 8.0 Hz, 1H), 7.35 (t, J 
= 8.0 Hz, 1H), 7.21-7.17 (m, 3H), 7.07-7.02 (m, 1H), 6.27 (s, 1H), 3.23-2.95 (m, 2H), 2.75-
2.56 (m, 2H), 2.41 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 149.68, 138.43, 136.74, 
136.09, 134.72, 134.08, 133.58, 127.38, 126.49, 126.36, 126.12, 121.27, 28.00, 27.76, 
19.92 ppm. EI-MS (70 eV), m/z (%): 265 (8) [M
+
], 248 (68), 230 (100), 202 (37), 115 (17). IR 
(NaCl): ν~ = 3064 (w), 3019 (w), 2937 (m), 2892 (w), 2833 (w), 1606 (w), 1530 (vs), 1355 (s), 
802 (s), 757 (s) cm
-1
. Anal. Calcd. for C17H15NO2: C 76.96, H 5.70, N 5.28; found: C 76.73, H 
5.83, N 5.19. 
 
2-(3,4-Dihydronaphthalen-2-yl)-3-methylbenzothiophene (5.2-6ja) 
Compound 5.2-6ja was prepared following method B from potassium 3-
methylbenzothiophene-2-carboxylate (161 mg, 0.7 mmol) and 3,4-dihydronaphthalen-2-yl 
methanesulfonate (243 mg, 1.05 mmol) in a mixture of NMP (1 mL) and mesitylene (3 mL). 
After combining two identical 0.7 mmol-scale reactions, compound 5.2-6ja was obtained as a 
light yellow solid (210 mg, 54 %). M. p. 77-78 °C. 
1
H-NMR (200 MHz, CDCl3): δ = 7.85 (dd, J = 2.0, 8.0 Hz, 1H), 7.74 (dd, J = 2.0, 8.0 Hz, 1H), 
7.50-7.32 (m, 2H), 7.29-7.17 (m, 4H), 6.82 (s, 1H), 3.04 (t, J = 8.0 Hz, 2H), 2.84 (t, J = 
8.0 Hz, 2H), 2.57 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 141.31, 139.64, 138.17, 
134.60, 134.05, 133.49, 128.61, 127.39, 127.34, 126.67, 126.64, 124.24, 124.05, 122.05, 
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121.81, 28.96, 28.17, 13.44 ppm. EI-MS (70 eV), m/z (%): 276 (100) [M
+
], 261 (20), 161 (11). 
IR (KBr): ν~ = 3053 (w), 3015 (w), 2935 (w), 2888 (w), 2832 (w), 1599 (w), 1484 (m), 1450 
(m), 1433 (m), 749 (vs), 726 (s) cm
-1
. EI-HRMS m/z calcd. for C19H16S: 276.0973, m/z found: 
276.1006. 
 
(2-(2-Nitrophenyl)ethene-1,1-diyl)dibenzene (5.2-6ab) 
Compound 5.2-6ab was prepared following method B from potassium 2-nitrobenzoate 
(103 mg, 0.5 mmol) and 2,2-diphenylvinyl methanesulfonate (206 mg, 0.75 mmol) in a 
mixture of NMP (1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-
scale reactions, compound 5.2-6ab was obtained as a yellow solid (250 mg, 83 %). M.p. 133-
134 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 8.00-7.95 (m, 1H), 7.40-7.34 (m, 5H), 7.30-7.21 (m, 6H), 
7.15-7.11 (m, 2H), 7.06-7.01 (m, 1H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 148.90, 145.47, 
142.21, 139.21, 133.74, 132.66, 132.31, 130.70, 128.26, 128.23, 128.16, 128.14, 127.65, 
127.35, 124.26, 123.73 ppm. EI-MS (70 eV), m/z (%): 301 (1) [M
+
], 285 (10), 284 (37), 256 
(37), 119 (100), 105 (39), 92 (85). IR (KBr): ν~ = 3058 (w), 3021 (w), 1620 (w), 1602 (m), 
1568 (w), 1512 (vs), 1443 (m), 1341 (s), 696 (s) cm
-1
. Anal. Calcd. for C20H15NO2: C, 79.72, 
H 5.02, N 4.65; found: C 79.46, H 4.93, N 4.66. 
 
1-Nitro-2-styrylbenzene (5.2-6ac) [CAS-No. 4714-25-4] 
Compound 5.2-6ac was prepared following method B from potassium 2-nitrobenzoate 
(103 mg, 0.5 mmol) and styryl methanesulfonate (E/Z = 2.3/1) (149 mg, 0.75 mmol) in a 
mixture of NMP (1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-
scale reactions, compound 5.2-6ac was obtained as a mixture of E- and Z-isomers. (194 mg, 
86 %, E/Z = 2.8/1, the ratio was determined according to the GC yields). After 
recrystallization from hexane, the pure E-isomer product was obtained as a yellow solid. 
M.p.66-67 °C. 
(E)-1-Nitro-2-styrylbenzene [CAS-No. 4264-29-3]: 
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1
H-NMR (400 MHz, CDCl3): δ = 7.96 (d, J = 8.0 Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.65-7.54 
(m, 4H), 7.43-7.31 (m, 4H), 7.10 (d, J = 16.0 Hz, 1H), 6.79 (d, J = 12.0 Hz, 1H), 6.66 (d, J = 
12.0 Hz, 1H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 147.84, 136.35, 133.70, 132.96, 132.82, 
128.68, 128.47, 128.00, 127.81, 126.96, 124.80, 123.32 ppm. EI-MS (70 eV), m/z (%): 225 (1) 
[M
+
], 208 (39), 180 (30), 152 (24), 119 (95), 92 (100), 77 (35) ppm. IR (KBr): ν~ = 3053 (w), 
3027 (w), 1631 (w), 1603 (m), 1568 (m), 1510 (s), 1495 (m), 1342 (vs), 957 (s), 753 (vs), 739 
(s), 698 (s), 690 (s) cm
-1
.Anal. Calcd. for C14H11NO2: C, 74.65, H 4.92, N 6.22; found: C 
74.83, H 5.05, N 6.07. 
 
1-Nitro-2-(1-phenylbut-1-en-1-yl)benzene (5.2-6ad) 
Compound 5.2-6ad was prepared following method B from potassium 2-nitrobenzoate 
(206 mg, 1.0 mmol) and 1-phenylbut-1-en-1-yl methanesulfonate (E/Z = 1/3.2) (113 mg, 
0.5 mmol) in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining two identical 
0.5 mmol-scale reactions, compound 5.2-6ad was obtained as a light yellow oil. (100 mg, 
40 %, E/Z = 1/2, the ratio was determined according to the 
1
H NMR). 
1
H-NMR (400 MHz, CDCl3) (a mixture of E- and Z-isomers, ratio = 1/2): δ = 8.25 (d, J = 
8.0 Hz, 1H), 8.03 (dd, J = 4.0, 8.0 Hz, 1H), 7.78-7.69 (m, 1H), 7.68-7.62 (m, 1H), 7.59-7.48 
(m, 2.5H), 7.43-7.37 (m, 1H), 7.36-7.30 (m, 1.5H), 7.31-7.18 (m, 8H), 6.18 (vinyl H of Z-
isomer) (t, J = 8.0 Hz, 1H), 5.77 (vinyl H of E-isomer) (t, J = 8.0 Hz, 0.5H), 2.29 (quintet, J = 
8.0 Hz, 1H), 1.95 (quintet, J = 8.0 Hz, 2H), 1.06 (t, J = 8.0 Hz, 1.5H), 1.00 (t, J = 8.0 Hz, 3H) 
ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 140.29, 138.63, 136.96, 135.18, 134.86, 134.56, 
132.83, 132.76, 132.25, 132.02, 129.62, 129.29, 128.28, 128.25, 127.93, 127.75, 127.31, 
127.19, 126.44, 124.47, 123.93, 123.49, 23.34, 22.88, 14.08, 13.88 ppm. EI-MS (70 eV), m/z 
(%): 253 (11) [M
+
], 236 (38), 221 (80), 207 (47), 206 (100), 195 (63), 178 (43), 167 (70), 105 
(79). IR (NaCl): ν~ = 3060 (w), 3025 (w), 2968 (m), 2933 (w), 2874 (w), 1607 (m), 1526 (vs), 
1495 (m), 1352 (vs), 763 (s), 701 (s) cm
-1
. Anal. Calcd. for C16H15NO2: C, 75.87, H 5.97, N 
5.53; found: C 76.09, H 5.67, N 5.76. 
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(2-(2-Nitrophenyl)prop-1-ene-1,1-diyl)dibenzene (5.2-6ae) 
Compound 5.2-6ae was prepared following method B from potassium 2-nitrobenzoate 
(103 mg, 0.5 mmol) and 1,1-diphenylprop-1-en-2-yl methanesulfonate (223 mg, 0.75 mmol) 
in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-
scale reactions, compound 5.2-6ae was obtained as a light yellow solid (200 mg, 63 %). M. p. 
91-92 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.84-7.76 (m, 1H), 7.50-7.22 (m, 10H), 7.05-6.85 (m, 5H), 
2.14 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 148.86, 141.86, 141.74, 139.88, 139.78, 
132.65, 132.16, 132.08, 129.57, 128.14, 127.59, 127.35, 126.92, 126.37, 124.36, 22.61 ppm. 
EI-MS (70 eV), m/z (%): 315 (2) [M
+
], 283 (100), 165 (77), 133 (86), 104 (35). IR (KBr): ν~ = 
3064 (w), 3023 (w), 2923 (w), 2853 (w), 1604 (w), 1568 (w), 1521 (vs), 1491 (m), 1441 (m), 
1346 (s), 761 (s), 748 (s), 698 (vs) cm
-1
. EI-HRMS m/z calcd. for C21H17NO2: 315.1259, m/z 
found: 315.1298. 
 
(E)-1-(1-(4-Methoxyphenyl)prop-1-en-2-yl)-2-nitrobenzene (5.2-6af) 
Compound 5.2-6af was prepared following method B from potassium 2-nitrobenzoate 
(103 mg, 0.5 mmol) and (E)-1-(4-methoxyphenyl)prop-1-en-2-yl methanesulfonate (187 mg, 
0.75 mmol) in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining two 
identical 0.5 mmol-scale reactions, compound 5.2-6af was obtained as a light yellow solid 
(197 mg, 73 %). M. p. 66-67 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 8.00 (d, J = 8.0 Hz, 1H), 7.55 (t, J = 8.0 Hz, 1H), 7.43 (t, J 
= 8.0 Hz, 1H), 7.25 (dd, J = 4.0, 8.0 Hz, 1H), 6.75 (d, J = 8.0 Hz, 2H), 6.63 (d, J = 8.0 Hz, 
2H), 6.49 (s, 1H),3.71 (s, 3H), 2.19 (s, 3H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ = 156.16, 
148.43, 138.30, 133.63, 133.14, 131.43, 129.49, 129.22, 127.90, 127.39, 124.66, 113.49, 
55.05, 25.92 ppm. EI-MS (70 eV), m/z (%): 269 (22) [M
+
], 237 (59), 178 (33), 165 (26), 133 
(100), 104 (73), 78 (21). IR (KBr): ν~ = 3010 (w), 2962 (w), 2905 (w), 2836 (w), 1605 (s), 
1572 (m), 1523 (s), 1509 (vs), 1342 (vs), 1295 (m), 1248 (vs), 1178 (s), 1030 (s), 856 (m), 
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826 (m), 759 (m), 737 (m), 702 (m) cm
-1
. Anal. Calcd. for C16H15NO3: C, 71.36, H 5.61, N 
5.20; found: C 71.15, H 5.81, N 5.08. 
 
1-Nitro-2-vinylbenzene (5.2-6ag) [CAS No. 579-71-5] 
Compound 5.2-6ag was prepared following method B from potassium 2-nitrobenzoate 
(103 mg, 0.5 mmol) and vinyl methanesulfonate (183 mg, 1.5 mmol) in a mixture of NMP 
(1 mL) and mesitylene (3 mL). After combining two identical 0.5 mmol-scale reactions, 
compound 5.2-6ag was obtained as a light yellow oil (81 mg, 54 %). 
1
H-NMR (200 MHz, CDCl3): δ = 7.94 (d, J = 8.0 Hz, 1H), 7.68-7.54 (m, 2H), 7.47-7.37 (m, 
1H), 7.26-7.11 (m, 2H), 5.76 (dd, J = 0.9, 16 Hz, 1H), 5.50 (dd, J = 0.9, 12 Hz, 1H) ppm. 
13
C-
NMR (50 MHz, CDCl3): δ = 147.90, 133.35, 133.07, 132.47, 128.48, 128.32, 124.39, 
118.93 ppm. EI-MS (70 eV), m/z (%): 150 (2) [M
+
 +1], 120 (79), 104 (29), 91 (84), 65 (100), 
51 (60). IR (NaCl): ν~ = 3085 (w), 3028 (s), 2921 (m), 2871 (w), 1943, 1857, 1802, 1736, 1604 
(m), 1497 (s), 1466 (s), 1378 (m), 1080 (m), 1030 (m), 728 (s), 694 (m) cm
-1
. 
 
Methyl 2-(2-nitrophenyl)cyclopent-1-enecarboxylate (5.2-6ah) 
Compound 5.2-6ah was prepared following method B from potassium 2-nitrobenzoate 
(220 mg, 1.05 mmol) and methyl 2-((methylsulfonyl)oxy)cyclopent-1-enecarboxylate 
(159 mg, 0.7 mmol) in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining 
two identical 0.7 mmol-scale reactions, compound 5.2-6ah was obtained as a light yellow oil. 
(90 mg, 26 %). 
1
H-NMR (200 MHz, CDCl3): δ = 8.08 (dd, J = 2.0, 8.0 Hz, 1H), 7.60 (dt, J = 2.0, 8.0 Hz, 1H), 
7.45 (dt, J = 2.0, 8.0 Hz, 1H), 7.22 (dd, J = 2.0, 8.0 Hz, 1H), 3.50 (s, 3H), 2.92-2.74 (m, 4H), 
2.10 (quintet, J = 8.0 Hz, 2H) ppm. 
13
C-NMR (50 MHz, CDCl3): δ = 165.04, 152.22, 147.47, 
134.36, 132.90, 130.11, 129.17, 128.09, 124.16, 51.14, 40.63, 33.58, 22.42 ppm. EI-MS 
(70 eV), m/z (%): 247 (3) [M
+
], 216 (11), 201 (41), 188 (39), 146 (89), 145 (100), 132 (63), 
115 (77), 104 (18), 91 (21), 77 (26). IR (NaCl): ν~ = 3067 (w), 2952 (s), 2858 (m), 1714 (vs), 
1651 (m), 1525 (vs), 1435 (s), 1352 (vs), 1258 (s), 1193 (m), 1126 (m), 1049 (m), 853 (m), 
787 (m), 769 (m), 747 (m), 700 (m) cm
-1
. EI-HRMS m/z calcd. for C13H13NO4: 247.0845, m/z 
found: 247.0844. 
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3,3,3-Trifluoroprop-1-en-2-yl 2-nitrobenzoate (5.2-6aiꞌ) 
Compound 5.2-6aiꞌ was prepared following method B from potassium 2-nitrobenzoate 
(144 mg, 0.7 mmol) and 3,3,3-trifluoroprop-1-en-2-yl methanesulfonate (399 mg, 2.1 mmol) 
in a mixture of NMP (1 mL) and mesitylene (3 mL). After combining two identical 0.7 mmol-
scale reactions, compound 5.2-6aiꞌ was obtained as a light yellow oil. (76 mg, 21 %). 
19
F-NMR (376 MHz, CDCl3): δ = - 71.97 (s, -CF3) ppm. 
1
H-NMR (200 MHz, CDCl3): δ = 
8.09-8.00 (m, 1H), 7.81-6.67 (m, 3H), 5.90-5.76 (m, 2H) ppm. 
13
C-NMR (101 MHz, CDCl3): 
δ = 162.34, 147.65, 144.51 (q, JC-F = 38.2 Hz), 133.47, 132.61, 129.85, 126.15, 124.34, 
119.00 (q, JC-F = 272.7 Hz), 109.42 (q, JC-F = 3.0 Hz) ppm. EI-MS (70 eV), m/z (%): 167 (2), 
150 (100), 104 (9), 76 (29). IR (NaCl): ν~ = 3142 (w), 3083 (w), 3034 (w), 1774 (vs), 1677 (m), 
1541 (vs), 1352 (s) ,1281 (m), 1247 (m), 1197 (s), 1141 (vs), 1057 (m), 931 (m), 853 (m), 788 
(m), 725 (m), 602 (m) cm
-1
. EI-HRMS m/z calcd. for C10H6F3NO4: 261.0249, m/z found: 
261.0234. 
8.8.7 Synthesis of PdCl2-L15 Complex 
 
To a solution of L15 (372 mg, 0.7 mmol) in 8 mL of dichloromethane, the solution of 
Pd(PhCN)2Cl2 (268 mg, 0.7 mmol) in 10 mL of dichloromethane was added dropwise under 
nitrogen. This mixture was kept stirring for 1h under nitrogen. After the complition of the 
reaction checked by TLC, the solution was filtered. The filtrate was concentrated under 
reduced pressure. Diethylether (10 mL) was added to the residue and dried again. The 
precipitated solid was filtered and washed with diethyl ether and hexane to give a yellow 
powder (445 mg, 0.63 mmol, 90 %). M.p. 233.2 °C (decomposed). 
1
H-NMR (400 MHz, CDCl3): δ = 8.65 (s, 1H), 7.77-7.59 (m, 4H), 7.13 (s, 1H), 4.13 (t, J = 8.0 
Hz, 2H), 2.42 (s, 3H), 2.37 (s, 3H), 1.88-0.83 (m, 30H) ppm. 
13
C-NMR (101 MHz, CDCl3): δ 
= 145.76, 145.68, 138.46, 135.35, 134.30, 134.18, 132.09, 131.99, 131.66, 130.90, 130.88, 
130.70, 130.63, 130.32, 130.25, 129.07, 126.72, 126.35, 122.63, 110.20, 46.14, 31.57, 30.87, 
29.72, 28.89, 28.76, 27.04, 26.92, 26.82, 26.55, 25.47, 22.50, 20.62, 20.33, 13.98 (unresolved 
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complex C-P splittings were observed) ppm. 
31
P-NMR (162 MHz, CDCl3): δ = 34.4 ppm. 
ESI-MS (70 eV), m/z (%): 743.2 [M+Cl]
-
. IR (KBr): ν~ = 2926 (vs), 2853 (s), 1480 (m), 1464 
(m), 1448 (s), 1424 (m), 1373 (m), 1204 (m), 1000 (m), 851 (m), 777 (m) cm
-1
. Anal. Calcd. 
for C35H51Cl2N2PPd: C, 59.37, H 7.26, N 3.96; found: C 59.40, H 7.34, N 4.05. 
8.8.8 Crystal Structure of PdCl2-L15 Complex 
 
Hydrogen atoms haven been omitted for clarity. Selected bond distance [Å] and angles [°]: 
Pd(1)-N(1) 2.0415 (16), Pd(1)-P(1) 2.2393 (5), Pd(1)-Cl(1) 2.3796 (5), Pd(1)-Cl(2) 2.2897 (5), 
C(13)-P(1) 1.839(2), N(1)-Pd(1)-P(1) 82.97(5), N(1)-Pd(1)-Cl(1) 90.49(5), N(1)-Pd(1)-Cl(2) 
173.07(5), P(1)-Pd(1)-Cl(1) 170.060(18), P(1)-Pd(1)-Cl(2) 96.225(18), Cl(2)-Pd(1)-Cl(1) 
91.158(18), C(13)-P(1)-Pd(1) 102.46(6), C(8)-C(13)-P(1) 119.02(15), C(7)-N(1)-Pd(1) 
127.75(13), N(1)-C(7)-C(8) 124.24(17), C(13)-C(8)-C(7), 119.21(17). 
Crystal data and structure refinement 
Identification code     12029ocu 
Empirical formula     C36H52Cl5N2PPd 
Formula weight     827.42 
Temperature      150(2) K 
Wavelength      1.54184 Å 
Crystal system     Triclinic 
Space group      P -1 
Unit cell dimensions    a = 10.3547(3) Å = 79.796(3)°. 
      b = 13.1988(5) Å = 70.872(3)°. 
      c = 15.3560(5) Å  = 74.047(3)°. 
Volume     1897.68(11) Å
3
 
Z      2 
Density (calculated)    1.448 Mg/m
3
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Absorption coefficient   7.788 mm
-1
 
F(000)      856 
Crystal size     0.41 x 0.20 x 0.18 mm
3
 
Theta range for data collection  3.06 to 62.65°. 
Index ranges     -11<=h<=8, -15<=k<=15, -17<=l<=16 
Reflections collected    12824 
Independent reflections   6039 [R(int) = 0.0182] 
Completeness to theta = 62.65°  99.3 %  
Absorption correction    Analytical 
Max. and min. transmission   0.3346 and 0.1425 
Refinement method    Full-matrix least-squares on F2 
Data / restraints / parameters   6039 / 6 / 505 
Goodness-of-fit on F
2
    1.053 
Final R indices [I>2sigma(I)]   R1 = 0.0238, wR2 = 0.0620 
R indices (all data)    R1 = 0.0245, wR2 = 0.0624 
Extinction coefficient    0.00295(11) 
Largest diff. peak and hole   0.539 and -0.799 e.Å
-3
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